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ABSTRACT 
 
Lacunar strokes account for approximately a quarter of all ischaemic strokes and 
traditionally are thought to result from occlusion of a small deep perforating arteriole in the 
brain. Lacunar infarcts can be up to 2cm in diameter and are found in deep brain structures 
such as the thalamus and internal capsule. Despite their prevalence and specific 
accompanying clinical syndromes, the cause of lacunar stroke and its associated vascular 
pathology remain unclear.  
Many hypotheses as to the cause exist, which fall broadly into two categories; firstly, a direct 
occlusion via emboli or thrombus usually from a cardiac or large artery source, 
microatheroma (intrinsic lenticulostriate occlusion) or macroatheroma (parent artery 
occlusion) all operating primarily via ischaemia. Secondly, there could be an indirect 
occlusion resulting from vasospasm, endothelial dysfunction or other forms of endovascular 
damage (e.g. inflammation). Therefore the question of whether the resulting lesions are truly 
“ischaemic” or actually arise secondary to an alternative process is still under debate. 
To clarify the chain of pathological events ultimately resulting i  lacunar stroke, in this 
thesis I firstly undertook a systematic assessment of human lacunar stroke pathology 
literature to determine the information currently available and the quality of these studies 
(including terminology). The majority of these studies were performed in patients who had 
died long after their stroke making it difficult to determine th  early changes, and there were 
few patients with a clinically verified lacunar syndrome. 
Therefore I adopted alternative approaches. In this thesis, I systematically looked for all 
potential experimental models of lacunar stroke and identified what appears at present to be 
the most pertinent - the spontaneous pathology of the stroke-prone spontaneously 
hypertensive rat (SHRSP). However, the cerebral pathology described in this model to date 
is biased towards end stage pathology, with little information concerning the 
microvasculature (as opposed to the brain parenchyma) and confounding by use of salt to 
exacerbate pathology.   
Therefore, the aim of the experimental work in this thesis wa  to assess pathological changes 
within the cerebral vasculature and brain parenchyma of the SHRSP across a variety of ages 
(particularly young pre-hypertensive animals) and to look at the effects of salt loading on 
both the SHRSP and its parent strain (the Wistar Kyoto rat - WKY).  
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Three related studies (qualitative and quantitative histology, immunohistochemistry and a 
microarray study of gene expression confirmed by quantitative PCR), revealed that the 
presence of inflammation (via significant changes in gene expression in the acute phase 
response pathway and increased immunostaining of activated microglia and astrocytes) plus 
alterations in vascular tone regulation, (via genetic alteration of the nitric oxide signaling 
pathway probably secondary to abnormal oxidative state), impaired structural integrity of the 
blood brain barrier (histological evidence of endothelial dysfunctio  and significantly 
decreased Claudin-5 staining) and reduced plasma oncotic potential (reduced albumin gene 
expression) are all present in the native SHRSP at 5 weeks of age, i.e. well before the onset 
of hypertension and without exposure to high levels of salt. We also confirmed previous 
findings of vessel remodelling at older ages likely as a secondary response to hypertension 
(thickened arteriolar smooth muscle, increased smooth muscle actin immunostaining). 
Furthermore, we found not only that salt exacerbated the changes see in the SHRSP at 21 
weeks, but also that the control animals (WKY) exposed to a high salt intake developed 
features of cerebral microvascular pathology independently of hypertension (e.g. white 
matter vacuolation and significant changes in myelin basic protein expression).  
In conclusion, via the assessment of the most pertinent experimental odel of lacunar stroke 
currently available, this thesis has provided two very important pieces of evidence: firstly 
that  cerebral small vessel disease is primarily caused by a non-ischaemic mechanism and 
that any thrombotic vessel lesions occur as secondary end stage pathology; secondly that 
these features are not simply the consequence of exposure to raised blood pressure but occur 
secondary to abnormal endothelial integrity, inflammation, abnormal oxidative pathways 
influencing regulation of vascular tone and low plasma oncotic pressur . Patients with an 
innate susceptibility to increased blood brain barrier permeability and/or chronic 
inflammation could therefore have a higher risk of developing small vessel disease 
pathology and ultimately lacunar stroke and other features of small vessel disease. Research, 
addressing whether lacunar stroke patients should be treated diff rently to those with 
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LIST OF ABBREVIATIONS 
(Abbreviations within figures are spelt out in the accompanying figure legend, all gene 
names are fully spelt out in chapter 8 before being subsequently abbreviated) 
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SECTION 1) GENERAL INTRODUCTION AND SYSTEMATIC REVIEWS 
 
CHAPTER 1 :GENERAL INTRODUCTION 
1.1 Stroke – why is it important? 
Stroke is defined as “a clinical syndrome characterized by an acute loss of focal cerebral 
function with symptoms lasting over 24 hours”(Warlow et al. 2008e). Depending on the 
region of the brain affected, a stroke may cause paralysis, speech impairment, loss of 
memory and reasoning ability, coma, or even death (www.who.int).  
Stroke is extremely common – according to the UK Stroke Association every 5 minutes 
someone in the UK has a stroke (www.stroke.org.uk), which equates to approximately 
150,000 strokes a year. The overall incidence of stroke has declined s ghtly in developed 
countries with estimates of incidence of 3-38% over the past 40 years(Feigin et al. 2003), 
however the majority of the decline tends to be in younger patients (aged 35-
64)(Thorvaldsen et al. 1997) and does not include all subtypes – the incidence of 
subarachnoid haemorrhagic has not altered in the past 30 years(Rothwell e  al. 2004). The 
crude annual incidence rate of all strokes (including first-ever-in-a-lifetime and recurrent 
strokes of all subtypes) in a Scottish population from the most recent estimation is 
approximately 2.8 per 1000 per year(Syme et al. 2005). 
 
1.1.1 Disability and recurrence 
Worldwide, stroke is the third leading cause of death and the leading cause of severe 
disability (www.who.int). Over 250,000 people in the UK live with disabilities caused by 
stroke (www.stroke.org.uk). A statistical model in 2003 predicted that for every patient who 
experiences a stroke, the cost to the NHS in the UK is £15,000 over 5 y ars and when 
informal care costs are included, the amount increases to £29,000(Youman et al. 2003). 
 
1.1.2 What constitutes a stroke? 
There are two principle types of stroke – ischaemic and haemorrhagic. 
Ischaemic stroke accounts for over 80% of all strokes, whilst haemorrhagic stroke, although 
accounting for less than 20% of all strokes causes up to 30% of deaths ue to its more severe 
nature(Lawlor et al. 2002;Rothwell et al. 2004). Haemorrhagic stroke results from the 
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rupture of a blood vessel, whereas ischaemic stroke is attributed to a blockage in the blood 
supply to the brain, usually via an artery becoming occluded, although veins can also be 
blocked. Numerous causes of these blockages are thought to exist, e.g. thrombosis, embol m 
and intrinsic disease of the small vessel of the brain(Warlow et al. 2008e). 
 
1.2 Anatomy of stroke 
1.2.1 The cerebral blood supply  
The brain receives blood from two main sources: the internal carotid arteries and the 
vertebral arteries(Warlow et al. 2008d). The internal carotid ar eries (ICA) branch inside the 
skull to form the anterior and middle cerebral arteries (ACA and MCA respectively), which 
supply the forebrain, whilst the right and left vertebral arteries join at the pons to form the 
basilar artery (BA)(Purves et al. 2007). The BA divides into the posterior cerebral arteries 
(PCA), which supply the occipital lobes and the thalamus. Communicating rteries join the 
internal carotids, the PCA’s and the ACA to form the circle of Willis - an arterial ring at the 
base of the brain (figure 1.1). 
The arteries of the anterior circulation (the ACA and MCA and PCA) are the origin for 
numerous branches that supply the cortical tissue and others, which penetrate the basal 
surface of the brain, supplying subcortical brain structures lik  the thalamus, internal capsule 
and basal ganglia(Purves et al. 2007).  
The lenticulostriate arteries (LSA’s), which can branch from the ICA, PCA, BA and MCA in 
particular, are prominent penetrating arterioles(Warlow et al. 2008d). The perforating 
arteries and arterioles within deep brain structures control the exposure of the brain to 
changes in vascular reactivity and blood flow. They are essentially, ‘end arteries’ and do not 
have a collateral blood supply like their cortical equivalents. Cortical pial vessels anastomose 
with each other enabling any interruptions in blood flow to be managed more 
effectively(Warlow et al. 2008d). 
 






Figure 1.1  The blood supply to the brain as seen from the infe rior side.  
Figure adapted from ‘Neuroscience’ chapter 1. Purves et al. 4th Edition 2007.  
 
1.2.2 Autoregulation 
Cerebral blood flow (CBF) needs to be tightly controlled in order to meet the metabolic 
needs of the brain. Maintenance of CBF depends on maintaining a balance between 
intracranial pressure (ICP) and mean arterial pressure (MAP), known as 
autoregulation(Warlow et al. 2008a). The cerebral blood vessels (in particular arterioles) are 
able to regulate the flow of blood through them by altering their diameters and subsequently 
maintain intracranial pressure within an optimal range to counteract both an increase in ICP, 
which can lead to edema and brain enlargement(Eames et al. 2002) (Dawson et al. 2003), as 
well as a decrease in pressure, which can result in ischaemic damage(Walters FJM 1998). 
Autoregulation is still a relatively poorly understood mechanism; however metabolic, 
Basilar artery 
Circle of Willis 
 
Anterior cerebral artery 
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myogenic and neurogenic factors are all said to be involved. Neural (neurogenic) activity is 
by far the largest determinant of CBF in the brain. In addition to this however, the diameters 
of the proximal vessels are thought to be mostly under myogenic control(Ursino and 
Gianessi 2010) responding to intraluminal pressure fluctuations. If the intraluminal pressure 
increases, smooth muscle fibres within the vessel walls stretch to a point where reflex 
contraction of reflex fibres results in the constriction of the vessel diameter(Eames et al. 
2002;Dawson et al. 2003). Myogenic mechanisms also include endothelial d pendent 
dilatation and constriction controlled by the L-arginine – nitric oxide – cGMP 
pathway(Schlaich et al. 2004). Vasomotion of the small arteries and arterioles is influenced 
more by metabolic stimulation. Fluctuations in extracellular pH, levels of carbon dioxide, 
adenosine and glycolytic intermediates can trigger very rapid changes in flow (~1 second 
after neuronal excitation) in the microvasculature(Wagerle et al. 1983;Eames et al. 2002).  
 
1.3 The effect of ischaemia on different vascular territories determines the 
clinical classification of stroke subtypes. 
If a major cerebral artery such as the MCA or ACA is occluded, the area of resulting 
ischaemic damage is widespread and these infarcts are often referred to as ‘hemispheric’, 
‘territorial’(Lee et al. 2004) or in some classifications, such as the Oxford Community Stroke 
Project (OSCP)(Bamford et al. 1991), which classifies clinical stroke subtypes based on their 
vascular territory and site of occlusion, as total anterior circulation infarcts (TACI) (see 
figure 1.2). Patients suffering this type of proximal MCA occlusion (~20% of the ischaemic 
stroke population); incur the most severe levels of disability, as ischaemia has occurred in 
both the deep and superficial territories of the artery. Multiple motor, cognitive and 
behavioural deficits result(Bamford et al. 1991). The underlying cause is mostly 
atherothrombolic, embolic or closely associated with carotid stenosis(Warlow et al. 2008d). 
Therapeutic interventions are generally geared towards this subtype e.g. the use of 
antiplatelet agents and thrombolysis(Feigin et al. 2003).   
Occlusion of a second order branch of the MCA or other parent c rebral artery can also 
result in a large area of ischaemic brain damage and severe disability, although collateral 
flow from anastomoses within the cortical vasculature can go some way to abating the local 
loss of blood flow (see figure 1.2)(Bamford et al. 1991;Ng et al. 2007). This type of stroke is 
classified as a partial anterior circulation infarct (PACI) by the OSCP(Bamford et al. 1991). 
Patients with PACI present with characteristic cortical deficits, such as, aphasia, neglect or 
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hemianopia. PACI occur in approximately 40% of all strokes and affect only the superficial 
territory of the parent artery or the basal ganglia, but not both. Atrial fibrillation and 
atherothromboembolism are considered more as risk factors for cortical stroke (both TACI 
and PACI) over the other subtypes(Dulli et al. 1998;Jackson and Sudlow 2005a). Cortical 
PACI have an approximate survival rate at 4 weeks of 77%(Milan et al. 1991).  
Striatocapsular infarcts (another type of PACI) result from either a transient occlusion of the 
MCA or a longer occlusion of the same artery, but in a patient with a good cortical collateral 
blood supply. The resulting infarction can encompass several structures of the basal ganglia 
(see figure 1.2)(Nishida et al. 2000). The OSCP classes this type of infarct as either a TACI 
or a PACI depending on the associated clinical symptoms(Bamford et al. 1991).  
Lacunar infarcts (known as LACI by the OSCP) by contrast, are restricted areas of 
parenchymal damage due to the occlusion of a single perforating vessel (see figure 1.2). It is 
this subtype of stroke, which forms the focus of this thesis. Lacunar lesions rarely reach over 
2cm in diameter in any direction(Lammie 2002a). 25% of ischaemic strokes are thought to 
be lacunar and infarcts are thought to be caused by intrinsic diease of a single basal 
perforating artery, rather than atherosclerosis of a parent art ry(Bamford et al. 1987;Bamford 
et al. 1991). It is thought that a restriction in blood flow to second / third order branches of 
perforating arterioles can cause small lacunar lesions usually nder 1cm in diameter and 
clinically silent (see figure 1.2) or leukoaraiosis, both of which can ultimately contribute to 
cognitive decline(Feekes et al. 2005). The causative factors of lacunar stroke are discussed 
later in this introduction. 
The final stroke subtype defined in the OSCP concerns posterior circulation infarcts (POCI). 
These infarcts are clearly associated with the vertebrobasilar rterial territory (cerebellum, 
brainstem and occipital lobes) (see figure.1.1). POCI account for app oximately 15% of 
ischaemic strokes and result from embolism (either cardiac or artery-artery in situ 
thrombosis) or hemodynamic disruption(Bamford et al. 1991;Piechowski-Józwiak and 
Bogousslavsky 2008). They present with a wide variety of symptoms and episodes are often 
staggered and more protracted than anterior circulation strokes. Mortality rates vary from 20-
60%, but patients presenting with bilateral vertebral artery occlusion fare worse, with a 
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1.4 Lacunar Stroke  
1.4.1 Clinical Syndromes 
Lacunar stroke is thought to cause one of 4 so called classic lacunar syndromes;  
1.4.1.1 Pure Motor Stroke  
The most common amongst symptomatic lacunar stroke patients accounting for up to 2/3rds 
of admissions(Warlow et al. 2008d). It is marked by hemiparesis or hemiplegia that typically 
affects the face, arm, or leg of one side. 
1.4.1.2 Pure Sensory Stroke  
The opposite of pure motor stroke. Patients with pure sensory stroke present with transien  or 
persistent numbness and mild sensory loss on one side of the body. Only 6% patients usually 
present with pure sensory stroke and often have thalamic lesions(Warlow et al. 2008d). 
1.4.1.3 Sensorimotor Stroke  
A combined sensory and motor deficit. Estimates of prevalence for sensorimotor stroke 
range from 20-38% of symptomatic patients. On magnetic resonance imaging (MRI), lesions 
that cause a sensorimotor syndrome are larger than lesions that cause other lacunar 
syndromes and are often located in the internal capsule(Papamitsakis 2007;Warlow et al. 
2008d). 
1.4.1.4 Ataxic Hemiparesis & Dysarthria Clumsy Hand Syndrome 
Approximately 20% of symptomatic lacunar stroke patients present with weakness of the 
lower limb (especially the ankle and toes), or dysmetria of the arm and leg on the same 
side(Bejot et al. 2008;Warlow et al. 2008d).  
 
Aside from these recognised syndromes however, there are up 10% of lacunar stroke patients 
who present with atypical symptoms. Dysarthria, facial paresis and hemiballismus(Arboix et 
al. 2006) are just three of several atypical presentations cau ed by a verified lacunar 
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1.4.2 Prognosis 
The acute prognosis (e.g. 30 days post stroke) of lacunar stroke is th  best of all the stroke 
subtypes, with some studies reporting a mortality rate of as little as 1%(Bamford et al. 1987). 
The long term prognosis for lacunar stroke however, is not so favourable and is similar to 
that of larger anterior circulation strokes(Jackson and Sudlow 2005b). There is also the risk 
of recurrent stroke. For all stroke subtypes, there is approximately a 10% chance of a 
recurrent stroke and the recurrent stroke tends to be the same type as the initial stroke, so 
patients who have had a lacunar stroke are more likely to have a recurrent lacunar stroke 
than a large artery stroke and vice versa(Jackson and Sudlow 2005b). 
 
1.4.3 Risk Factors  
Smoking, obesity, high salt intake and hypercholesterolemia are all risk factors for stroke in 
general. High blood pressure is also a significant risk factor for stroke in general and for the 
prevalence of WMLs on MRI(de Leeuw et al. 2002). Large artery stroke has a more defined 
set of risk factors including atrial fibrillation, atherothromboembolism and carotid stenosis – 
all shown to be more commonly associated with large artery stroke(Jackson and Sudlow 
2005a). There is no evidence however, that these risk factors are more associated with 
lacunar stroke than cortical stroke(Jackson et al. 2010) and specific risk factors for lacunar 
stroke are less well defined, but are likely to be different(Jackson et al. 2010) due to the 
differing clinical symptoms and specific vascular territories involved. There is evidence that 
lacunar arteriopathy may differ from atherosclerotic arterial disease(Wardlaw et al. 2009), 
ischaemic heart disease and carotid stenosis – both atherosclerotic disorders have a lower 
prevalence in lacunar stroke when compared to non-lacunar stroke(Jackson et al. 2010).  
 
1.4.4 Brain and vascular territory 
Recognition of a small vessel (or lacunar) subtype of stroke was first documented in 1901 by 
Marie and Ferrand(Marie P 1901;Ferrand J 1902). Via pathological examination of human 
autopsy specimens, they described the appearance of a typical lacunar cavity as a “healed 
infarct resulting from rupture or obliteration of a perforating artery and/or its branches due to 
local atherosclerosis.” Topographical distribution of lacunar lesions encompassed the 
lenticular nucleus, thalamus, internal capsule, caudate nucleus, pons, centrum semiovale and 
finally the corpus callosum(Ferrand J 1902). These brain areas r  upplied by the LSA’s 
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(i.e. perforating arteries), which branch off at approximately a 90° angle from the MCA, 
ACA, ICA or PCA. See figure 1.3 for a diagrammatical representation of a lacunar stroke 
relative to the vascular territory within the brain. The majority of lacunar strokes occur 
within the anterior cerebral circulation(Warlow et al. 2008f) and are associated with the 
perforating arteries and/or arterioles of the MCA and ACA arteries. The precise nature of the 
vascular territory in which lacunar lesions are found, limits their size and explains why 
lacunar strokes are rarely fatal and more often than not silen on imaging(Chen et al. 2009). 
However, even though lacunar strokes are small, if situated in a region of high connectivity 
within the brain, they can cause severe disability.  
The exact vascular territory of lacunar infarcts is still under debate with 2/3rds said to be 
anatomically related to the 1st/2nd order branches of penetrating arterioles in the basal 
ganglia(Challa et al. 1990). A more general picture however, places over 90% of lacunar 
infarcts as resulting from occlusion or stenosis of the 2nd/3rd order branches from the major 
penetrators(Moody et al. 2004). Others, describe infarcts of a pertinent size and territory as a 
consequence of occluding 3rd order arterioles(Feekes et al. 2005). In general the volume of 
an individual lacunar infarct is dependent on the site of occlusion - the more proximal to the 
parent artery the larger the infarct(Warlow et al. 2008d). These differences however, may 
reflect sampling bias in small studies, as pathology studies in lacunar stroke generally are on 
few patients. This will be discussed further in chapter 2 of this thesis.  
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Figure 1.2. The effect of occluding different arter ial territories within the anterior circulation of 
the brain.   
A = occlusion of the main branch of the MCA. This results in a ‘hemispheric’ infarct and results in 
widespread ischaemic damage. B = occlusion of a secondary branch (M2) of the MCA. This results in a 
more contained area of ischaemic damage but still affects roughly 1/3 of the hemisphere. C = occlusion 
of the MCA not affecting cortical tissue due to good collateral flow and/or a transient episode. These 
are known as striatocapsular infarcts. D = occlusion of one LSA or similar sized vessel. These are 
lacunar infarcts. E = occlusion of the second / third order branches of LSA’s. This type of occlusion can 
result in small often asymptomatic lesions on imaging. All images captured by diffusion weighted MRI. 
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Figure 1.3. Images of lacunar lesions and the assoc iated vascular territories.  
A) Lacunar lesions within the territory of the basal ganglia (arrow). B) Radiographs / fluorescent dye 
overlap of injected medial and lateral LSA’s (arrowheads) and recurrent artery of Heubner (arrow) in 
the human basal ganglia, Cd = caudate nucleus; ic = internal capsule; Pu = putamen. Line bar _ 1cm. 
Figures adapted from Feekes et al 2005. Annals of Neurology 58: 18-30.  
 
1.5 The appearance of acute lacunar lesions on imaging (see figure 1.4). 
Detection of lacunar lesions on imaging is based on the development of intracellular or 
extracellular edema within the damaged region, which appears hyperintense on some MRI 
sequences or low attenuation on CT(Warlow et al. 2008c). Diffusion MRI(DWI) is 
particularly sensitive to acute ischaemic change and so is god for detecting small lesions 
like lacunar ischaemic stroke that may be hard to see on CT. MRI generally shows more 
small lesions than CT. Overall approximately only 50% of lacunar i farcts at most are 
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small deep infarcts compared to MRI(Longstreth, Jr. et al. 1998). CT is good however, for 
displaying old lesions(Warlow et al. 2008c).  
Lacunar lesions can be missed on imaging due to having wide interslice gaps on both, CT 
and MRI, partial volume averaging on CT and limitations in contrast and spatial resolution. 
Furthermore, up to a fifth of lacunar infarcts are misdiagnosed clinically, as cortical 
infarcts(Potter et al. 2010a). Variation in imaging sequences used by different groups and 
variation within the terminology used to describe lacunar lesions and overlapping small 
vessel disease entities, have also contributed to this potential u derestimation of lacunar 
lesion prevalence.  
In addition, clinically imaging the small perforating arteries r ponsible for lacunar lesions 
can be extremely difficult, as scanners do not possess the resolution to display them 
reliably(Wardlaw 2005). They can be seen on high resolution intra arterial angiography and 
some are visible on high field MRI (7T), but the resolution is limited. Hyperintensities on T2 
weighted images are often required to distinguish small deep infarcts from dilated 
perivascular spaces or other manifestations of SVD(Bokura et al. 1998). Trying to image the 
small vessels is therefore difficult, but trying to pinpoint exactly which vessel has caused the 
symptomatic lesion is even more so. One study found only 9/80 symptomatic lacunar stroke 
patients had evidence of an abnormal or occluded perforating artery in a pertinent brain 
region(Wardlaw et al. 2001). 
 
1.5.1 Cavitation of lacunar lesions 
Aside from imaging parameters, another reason for underestimating the burden of lacunar 
lesions is the incidence of cavitation. Lacunar lesions are often defined as ‘cerebrospinal 
fluid filled cavities’ on imaging, however evidence is emerging that the majority of lacunar 
lesions do not actually cavitate to form a true ‘lacune’ and some only partially go through 
this process (see figure 1.4). Potter et al(Potter et al. 2010b) discovered that only 
approximately 20% of symptomatic lacunar lesions definitely go on to cavitate on MRI, 
whereas the majority persisted as lesions that looked similar to WMLs (median 227 days 
after stroke onset). Age, stroke severity, hypertension and other imaging features (WMLs, 
EPVS etc) were not associated with cavitation(Potter et al. 2010b).  
Due to this observation many lacunar lesions in patients presenting with a lacunar syndrome 
may be missed due to delays in obtaining suitable imaging therefor  studies which count 
only cavitated lacunes, may be seriously underestimating the incidence of la unar lesions.  
 




Figure 1.4. The appearance of cavitated and non cavitated lacunar lesions on imaging.  
A) A definite cavitated lacunar lesion on fluid attenuation inversion recovery (FLAIR) MRI, in the 
centrum semiovale. B) A partially cavitated lacunar lesion in the centrum semiovale again on FLAIR 
MRI. C) A lacunar lesion in the thalamus on CT. Image taken from Potter et al. Stroke 2010:41:267-
272.  
 
1.6 The wider implications and features of disease in the small deep perforating 
arterioles 
It is now more widely recognised that lacunar lesions may in fact be a single manifestation 
of a whole spectrum of pathology, clinical and imaging markers of a diffuse abnormality in 
the small deep vessels. These markers include WML, enlarged perivascular spaces (EPVS) 
and brain microbleeds.  
For example, this cerebral small vessel disease (SVD) is thought to be a major cause of 
vascular dementia as well as lacunar stroke, with an incidence over 6 times that of any 
symptomatic stroke(Leary and Saver JL 2003). SVD generally refers to the pathological and 
radiological changes, along with clinical syndromes, associated with disease of the small 
perforating arteries supplying the subcortical areas of the brain. SVD is found mainly in the 
white matter and deep grey structures of the brain(Mohr 1982). It manifests as WMLs seen 
on MRI or computerised tomography (CT) plus lacunar stroke, enlarged perivascular spaces 
(EPVS) and microbleeds(Morris et al. 2009). Age alone is said to bea risk factor for SVD 
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with evidence of WML on MRI scans found in over 40% of people aged over 80(Bryan et al. 
1997). There are currently several types of vascular pathology described in SVD, including 
intracranial atherosclerosis, in some cases small vessel atherosclerosis, and lipohyalinosis 
(concentric rings of thickening in the vessel wall caused by the build up of fatty hyaline 
material and often also referred to as hyaline arteriolosclerosis)(Lammie 2002a). Small 
vessel atherosclerosis appears to be related to hypertension with, in simple terms, the 
hypertension extending the distribution of atherosclerotic changes to small vessels. Most 
autopsy derived specimens will show old, or healed lipohyalinosis, however, occasionally a 
case will be examined which shows the acute phase of this process, with fibrinoid necrosis of 
the vessel wall(Lammie 2002a). The term fibrinoid necrosis is used to describe eosinophilic 
fibrin-like deposits, usually of degenerated collagen in arterial walls(L mmie 2002a).  
 
1.7 General Pathophysiology 
1.7.1 Parenchymal lesions 
Imaging and pathological descriptions of lacunar lesions share similar features. According to 
the available literature, lacunar lesions pathologically, are usually 2 to 20 mm in diameter 
and are presumed to result from the occlusion of single, small, perforating arteries supplying 
the deep subcortical reas of the brain(Hughes et al. 1954;Fisher 1965). See figure 1.5 for the
macroscopic pathological appearance of lacunar lesions. A pathological classification system 
for lacunes was proposed by Poirier & Derouesne(Poirier et al. 1985), which divided lacunar 
lesions into three types – type I, II and III. Lammie et al added a subclassification (type 1b 
lacunes)(Lammie et al. 1998) and more recently there have been calls to add a further type 
IV lacune. Further descriptions of the pathology of lacunar lesions are provided in chapter 2 
of this thesis. Briefly however; 
Type I(a) is an old small cavity containing brain fragments and small patent rterioles and/or 
capillaries(Poirier et al. 1985).  
Type I(b) – ‘incomplete’ or ‘partially’ cavitated lacunar lesions(Lammie et al. 1998). 
Type II - old small haemorrhages(Poirier et al. 1985).  
Type III – dilated perivascular spaces (Virchow Robin spaces)(Derouesne and Poirier 1999) 
Type IV – expanding lacunes. A more extreme dilatation of the perivascular space sometimes 
accompanied by an inflammatory reaction of the blood vessel, which results in fibrinoid 
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necrosis of the vessel wall. This type is rare and thought to be due to an impairment in the 





Figure 1.5.The macroscopic pathological appearance of type I lacunar infarcts (arrows) taken 
from a coronal brain slice.   
This particular specimen has bilateral thalamic lacunes. Image courtesy of www.neuropathologyweb.org.  
 
1.7.2 Vascular pathology 
SVD has, for many years, been thought to be closely related to ather sclerosis, a disorder of 
large vessels which underlies cortical infarcts, and which has well defined risk factors 
including hypertension(Lammie 2002b). The assumption has been that atherosclerosis and 
SVD share common risk factors and are similar pathological processes. This association has 
its origins in the detailed studies of Fisher in the 1960s(Fisher 1965;Fisher 1968), in which 
lipohyalinosis, or “segmental arterial disorganisation” as he described it, was considered to 
be responsible for 46 of 68 lacunes examined(Fisher 1968) (see figur 1.6). In those vessels 
where no occlusive lesion was seen, embolus was assumed.  
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The relationship between lipohyalinosis and hypertension is uncertain and in this era of 
aggressive pharmacological intervention in the management of hypertension, lipohyalinotic 
lesions are still seen at autopsy, albeit less commonly(Lammie 2002b). The relationship 
between healed lipohyalinosis and intracerebral haemorrhage also remains uncertain and 
while aneurysmal dilatations are well described in healed lipohyalinosis, there is no evidence 
of subsequent increased incidence of rupture and haemorrhage.  
Since Miller Fisher’s research into lacunar stroke pathology in the 1960’s, the treatment of 
hypertension has improved and Lammie(Lammie 2000) amongst others(Ogata 1999), 
proposes that lacunar strokes are nowadays more likely to resultfrom decreases in local 
cerebral blood flow (see above section on autoregulation), plus small vessel stenosis, rather 
than occlusive lipohyalinosis caused by hypertension, because poorly c ntrolled 
hypertension occurs less frequently, although hypertension is extremely common amongst 




Figure 1.6. The progression of small vessel disease .  
A) shows mild hyaline thickening of a small thalamic artery. B) is a similar sized vessel from the 
putamen with moderate concentric hyaline thickening. C) is a severely affected vessel again from the 
putamen this time with noticeable encroachment upon the lumen. D) represents the final stages of 
complex small vessel disease displaying an arterial lesion from the putamen. Scale bar = 40µm. Figure 
adapted from Lammie et al 1997. Stroke 28:2222-2229. 
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The above sections, briefly assessing the parenchymal and vascular lesions encountered in 
lacunar stroke, provide a background to this area of stroke research that is conventional, but 
still open to interpretation and therefore is not necessarily complete or correct. A more 
thorough review of human lacunar stroke pathology, the potential causative mechanisms and 
the evidence for them, will be given in chapter 2 of this thesis.  
 
1.8 What causes lacunar stroke? Evidence for a distinct arteriopathy. 
Although abnormalities in the small deep perforating, or lenticulostriate, arteries are often 
cited as the cause of lacunar stroke, how often other abnormalities ffecting the small vessels 
might also lead to lacunar stroke, is unknown(Davis and Donnan 2004). Many hypotheses 
exist, including embolic or thrombotic occlusion usually from a cardiac or large artery 
source, microatheroma - consisting of intrinsic lenticulostriate occlusion, as well as parent 
artery occlusion also known as macroatheroma(Wardlaw 2005). Additionally vasospasm, 
endothelial dysfunction(Knottnerus ILH et al. 2009;Stevenson et al. 2010) or other forms of 
endovascular damage (e.g. inflammation) have also been implicated(Arboix and Marti-
Vilalta 2004). See figure 1.7 for a diagrammatical representatio  of the range of possible 
causative mechanisms. Furthermore, it is not known if the resulting lesions are truly 
“ischaemic” or actually arise secondary to an alternative process, such as perivascular edema 
following blood-brain barrier (BBB) derangement and therefore endovascul r 
leakage(Lammie et al. 1997;Lammie et al. 1998;Wardlaw et al. 2003). 
Evidence in support of an embolic source is often conflicting(Futrell 2004;Norrving 
2004;Jackson and Sudlow 2005a). While most will agree that emboli can cause lacunar 
lesions, the discovery of a clear embolic source in a lacunar stroke patient is rare. In a study 
of 10 patients, Chowdury et al could only attribute a potential embolic cause to a single 
patient suggesting that emboli are not a common cause of lacunar lesions(Chowdhury et al. 
2004). Atrial fibrillation and carotid stenosis are also considered uncommon etiologies in 
lacunar stroke patients(Jackson et al. 2010). Macroatheroma in the large parent arteries is 
also unlikely to account for the majority of lacunar lesions, as Fisher found little evidence to 
suggest that the obstruction of the mouths of the parent artery by atherosclerosis was to 
blame(Fisher 1965) and there has been no evidence since to contradict his finding. 
Thrombosis of the penetrating vessels is often cited as a cause of lacunar lesions, however 
the thrombus directly responsible for the vessel occlusion has rarely been found(Fisher 
1968). This may be because the vessels recanalized before death and so verifying this 
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mechanism at autopsy will always be difficult. Others have suggested that thrombus is a late 
stage event and that the primary cause of pathology is related to the integrity of the blood 
brain barrier (BBB)(Wardlaw 2005). 
Evidence of endothelial dysfunction in human lacunar stroke has been pr sent for many 
years, but has been overlooked until recently(Samuelsson et al. 1994;Wardlaw et al. 2008). 
Increased levels of markers representing endothelial dysfunction (e.g. Inter-cellular adhesion 
molecule 1 (ICAM1), Tissue Factor (TF) and homocysteine) have been found in lacunar 
stroke and leukoaraiosis patients independent of hypertension, diabetes nd age(Hassan et al. 
2004;Zylberstein et al. 2008). Most studies of endothelial function however, used normal age 
matched controls with no neurological disease present, or age and risk factor matched 
controls, but failed to compare them to other stroke subtypes. When compared with cortical 
stroke patients for example, there is little good evidence that endothelial dysfunction in 
lacunar stroke is more than just exposure to risk factors, but there are few relevant 
studies(Stevenson et al. 2010). More recently, a paper assessing generalized cerebral blood 
brain barrier (BBB) leak between mild cortical and lacunar stroke patients with MRI and 
intravenous gadolinium has been published(Wardlaw et al. 2008). Post stroke measurement 
demonstrated higher background BBB leakage in the cerebrospinal fluid and white matter in 
lacunar patients than cortical stroke controls(Wardlaw et al. 2008). Others have found 
increased BBB leak in patients with lacunar stroke and leukoaraiosis (but not versus cortical 
stroke controls) and in vascular dementia(Farrall and Wardlaw 2009;Topakian et al. 2010).  
 
1.9 The problems of studying lacunar stroke pathology. 
Pathological studies of human tissues have informed our understanding of SVD, even though 
they are limited by being a static, often late analysis of a dynamic process. Unfortunately, 
recognised risk factors and pathological descriptions from scarce and often old material do 
little to describe the underlying mechanisms of the vessel damage. In addition to the limiting 
factors described above, the added obstacles of trying to assess lacunar stroke pathology 
include the difficulty of dissecting subcortical small vessels, the unavailability of human 
tissue from autopsy - autopsy rates have declined over the past 40 years(Burton and 
Underwood 2007)- and post mortem material is often obtained late after the initial event. 
Lacunar stroke is rarely a fatal condition meaning that any brain tissue recove d will display 
old vessel abnormalities, which will have partially or extensively healed and the likelihood 
of scanning a patient immediately pre and post infarct formation is as mentioned previously, 
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minute. Imaging techniques are becoming more sophisticated, but the available levels of 
resolution on MRI scans are still not enough to capture perforating vessels at the level of 
detail required. Consequently, animal models could be very valuable in this area.  
 
 
Figure 1.7.  The possible causes of lacunar stroke lesions displ ayed with regards to the 
spectrum of the underlying process .  
BP = blood pressure. BBB = blood brain barrier.  
 
1.9.1 Why would an animal model be useful? 
Animal models are useful in research of cerebral ischaemia, as they can replicate human 
ischaemic damage in some ways, in particular the middle cerbral artery occlusion 
model(Belayev et al. 1999). In lacunar stroke the difference in opinion on and lack of 
defined terminology regarding the pathophysiological events, makes it impossible (as with 
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most animal models) to faithfully recreate the entire human disease state. Ideally an animal 
model of lacunar stroke should display both the vascular and parenchymal pathology 
associated with the disease and the disease should be introduced by a pathologically relevant 
mechanism e.g. occluding a large artery with an intraluminal thread is not appropriate for 
producing lacunar lesions. At present there are still several proposed causative mechanisms 
that could be modelled including reduced cerebral blood flow, vasospasm and endothelial 
(BBB) dysfunction. A model that can mimic at least some featur s of one or more of the 
proposed mechanisms of human lacunar stroke, or can imitate some of th pathological 
features would undoubtedly be valuable to improve understanding of the disease and to test 
potential treatments. Lacunar stroke is now a recognised distinct troke subtype, however 
acute treatment and secondary prevention are not tailored towards it and this can only be 
done once the underlying mechanisms are understood.  
 
1.10 Systematic Reviews – the value of and design  
In order to find and clarify the potential causative mechanisms of lacunar stroke, it was 
necessary to review both the available human and animal data in n u biased and systematic 
way. Systematic reviews consequently, play an important role in this thesis.   
A systematic review is a literature review focused on a single question that tries to identify, 
appraise, select and synthesize all relevant high quality research evidence. Systematic 
reviews are often needed whenever there are several primary studies with disparate findings 
related to the same substantive question, thereby causing uncertainty.  
A systematic review uses an objective and transparent approach f r research synthesis, with 
the aim of minimizing bias. It often uses statistical techniques (meta-analysis) to combine the 
data from valid studies. This approach can also be applied to a wholerang  of different 
studies and guidance is available from the Equator Network (see below). Systematic reviews 
are generally based on a peer-reviewed protocol, so that they can be easily replicated.  
Systematic reviews offer a way to interpret the findings of studies in an unbiased manner and 
present a balanced and impartial summary of the findings, taking into account any flaws in 
the evidence.  
Conducting systematic reviews has been aided in recent years by the publication of 
recommended reporting guidelines for observational studies, clinical trials and experimental 
studies. The Equator Network website (www.equator-network.org) lists most of these tools, 
enabling the author to generate a study quality checklist, relevant to the type of studies their 
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review will be mostly comprised of. There are now specific datab ses for systematic reviews 
in particular subject areas (e.g. the Cochrane collaboration covers treatments and diagnostic 
tests).  
 
1.11 Aims of the thesis 
In light of questions and gaps in our knowledge demonstrated by the above intr duction the 
aims of this thesis were as follows; 
i) Systematically review the cerebral pathology of human lacun r stroke in order to 
make unbiased comparisons between animal and man and identify the exact gaps in our 
knowledge of lacunar stroke pathology. 
ii) Conduct a systematic review of potential animal models of lacunar stroke currently 
in the published literature.  
iii) Consequently, systematically assess the cerebral pathology of the most suitable 
animal model. 
iv) Conduct histopathological assessment of vascular pathology in the most suitable 
animal model in brain regions, encompassing the territory of lacunar stroke. 
v) Conduct RNA microarray analysis of pertinent markers of vascular pathology in this 
model. 
 
In this thesis we have assigned each of the systematic reviews to an individual chapter. In 
addition we have conducted our own original laboratory work therefore this thesis will be 
split into three sections –  
Section 1) General introduction and systematic reviews – incorporating this chapter, an 
introduction to systematic reviews and chapters 2-4, each of which is a systematic review.  
Section 2) Original laboratory work - incorporating general materials and methods and three 
results chapters (chapters 5-8).  
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As stated in the general introduction to this thesis, about 20% of all strokes (about 25% of all 
ischaemic stroke) are lacunar in type(Sudlow and Warlow 1997). These small lesions (<2cm 
in diameter, <1.5cm in some definitions) affect the white matter nd deep grey matter of the 
cerebral hemispheres and brainstem and are associated with several discrete neurological 
syndromes(Fisher 1982b;Arboix et al. 2006;Ghandehari and Izadi 2009). They are associated 
with an abnormal deep perforating arteriole but the small size of the brain and vascular 
lesions make pathological examination of lacunar lesions technically difficult. In addition 
lacunar stroke is rarely fatal and the autopsy rate is declining.   
A previous review of lacunar stroke pathology found only 10 studies (11 including their 
own), most from before 1980(Arboix et al. 1996). Various descriptive re iews of lacunar 
stroke pathology have been published since then(Lammie 2000;Arboix and M rti-Vilalta 
2004;Pantoni et al. 2006), but descriptive reviews rarely provide an in depth appreciation of 
the quality, breadth and reliability of the published knowledge. Other reviews focused more 
generally on ageing rather than lacunar stroke(Grinberg and Thal 2010) or compared 
multiple features of small vessel disease seen on imaging with pathology(Gouw et al. 2010). 
Hence we performed a systematic examination of all human lacu ar stroke pathology to help 
summarise all of the available published studies of the pathology of lacunar stroke.   
 
2.2 Materials and methods 
2.2.1 Search strategy  
We searched for all available studies describing lacunar stroke pathology using, at the very 
least, a macroscopic assessment of brain slices. We developed a comprehensive electronic 
search strategy using terms such as lacun$, lipohyalinosis, patholo$, stroke and autopsy in 
Embase and Medline from inception to February 2011 (see appendix A for full search 
strategy), hand searched reference lists in review papers and text books and two relevant 
journals (Stroke and Acta Neuropathologica). We excluded editorials, conference abstracts 
and review papers that did not contain any new primary data.  
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2.2.2 Inclusion/Exclusion criteria 
We included studies published in full, in any language, that described the pathology of 
human lacunar lesions, whether symptomatic (the patient had a documented lacunar 
syndrome) or asymptomatic (including truly asymptomatic or initial stroke of uncertain 
subtype, or with atypical symptoms). We included lacunar lesions of any age (from acute to 
old) and appearance (cavitated or not), studies of brain banked tissue f they specifically 
described lacunar lesions, and all lesions explicitly described as lacunar in nature by the 
study authors, as well as lesions we considered to be lacunar from the descriptions given, 
even if the term ‘lacunar’ was not specifically used by the authors. We  defined lacunar 
lesions based on Poirier et al and Lammie et al(Lammie et al. 1998;Derouesne and Poirier 
1999) where a type 1a lacune is a cavitated lesion with a ring of gliosis and a type 1b lacune 
is a partially cavitated lesion, but also included non-cavitated lacunar ischaemic stroke 
lesions to avoid undue focus on cavitated lesions. Types II (old haemorrhage), III and IV 
lacunes (dilated and very dilated perivascular spaces respectively) were not relevant. 
We excluded studies of: leukoaraiosis, Binswanger’s disease or vascular dementia (but 
checked for descriptions of lacunar lesions within these studies and included pathological 
details if given); patients with primary intracerebral haemorrhage (as our focus was on 
ischaemic lesions); experimental models (because the absence of agreement on what causes 
human lacunar stroke limits the relevance of animal studies); c rebral autosomal dominant 
arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL) and other 
monogenic disorders;  and striatocapsular infarcts (which are larg r than lacunar infarcts and 
due to middle cerebral artery (MCA) atherothromboembolic occlusion(F sher 1979;Donnan 
et al. 1991)). 
 
2.2.3 Data extraction 
One reviewer (E.L.B) extracted information on: study population, number of patients, 
symptoms, vascular risk factors, previous stroke, age of patients at time of stroke and death 
or time lapse from stroke to death, cause of death, use of imaging, pathological methods, 
brain regions and vessels examined and brain/vascular lesion findi gs (see appendix B for 
full data extraction form) including lesion location and size and specific evidence of 
ischaemia, inflammation or blood brain barrier disruption. We noted any other terms used by 
authors to describe what we considered to be lacunar lesions. A second reviewer (J.M.W) 
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checked the extracted information. Differences were resolved by consensus with a third 
reviewer (C.L.M.S).  
 
2.2.4 Study quality  
We assessed study quality using a checklist based on the STROBE statement(von Elm et al. 
2007) and the MOOSE criteria(Stroup et al. 2000) which factors such as; study population 
(e.g. an aging cohort, stroke population, brain bank study etc), number of patients, reporting 
of risk factors (e.g. hypertension, smoking, diabetes etc), the number and expertise of 
observers (e.g. neuropathologist, neurologist, radiologist etc), whether the observers were 
blinded to clinical data and whether lesion size (in any dimension) and / or lesion location 
was reported. Factors such as whether the pathology interpretation w s appropriately blinded 
to clinical data are important as they highlight the potential problem that knowledge of risk 
factors may influence the examination of the specimen and bias the results.  
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We devised the checklist using influences from the STROBE statement (von Elm et al. 2007) and the 
MOOSE criteria (Stroup et al. 2000). 
 
 
2.2.5 Data analysis 
We entered data into a spreadsheet and performed summary statistical analysis. We planned 
to perform a formal meta-analysis of the association of lesion location and size with 
symptoms, and of the frequency of features indicating ischaemia, infl mmation or blood 




Study population reported– stroke, aging cohort, etc  
How patients were sampled – inclusion criteria  
Number of patients  
Risk factors reported (including age)  
Number of & expertise of observers  
Observers blinded to clinical data?  
Use of validated histopathological methods  
Size of Infarcts recorded  
Location of infarcts recorded  
Total /9  
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2.3 Results 
2.3.1 Search results 
Our initial search produced 1796 studies (figure 2.1): excluding animal studies, non cerebral 
lacunes, duplicates and review papers left 1240 studies. Of these, 672 were full journal 
articles. We excluded 362/673 studies which only reported on vascular dementia and/or 
Alzheimer’s pathology, 165 studies of imaging or retinopathy only and 106 studies of 
leukoaraiosis, none of which included data on lacunar lesions, of CADASIL, two studies that 
looked relevant but provided no data on lacunar pathology(van Swieten et al. 1991;Yamada 
et al. 1995) and the early reports of Dechambre(Dechambre 1838) and Durant-
Fardel(Durand-Fardel 1843) whose patient populations are not specific and do not provide 
enough detailed pathological information. This left 39 relevant studies (se  table 2.2). 
 
2.3.2 Study characteristics 
38/39 studies included a total of 2340 subjects (1 study did not report the number of 
subjects), with a median of 14 subjects per study (interquartile range [IQR] 2-45, range 1 to 
>1000)(Dozono et al. 1991a). The number of lesions studied was reported in 22 studies (total 
lesions 4110) but not in the other 17 studies. Nine studies reported the median number of 
lesions studied per patient (2, range 1-5). 
Fifteen studies (38%) described symptomatic brain lesions and six studies (15%) reported 
asymptomatic lacunar lesions on pre-mortem imaging followed by autopsy in aging studies. 
The remaining 18/39 studies (46%) described lacunar lesions in patients with a history of 
stroke (subtype unspecified and not clearly linked to a lesion on pathology, 10 studies) or 
who had stroke risk factors but had died of non-neurological causes (8 studies). The time 
interval between symptoms and death ranged from one month to approximately ten years. 
29/39 studies (74%) reported on hypertension (which affected >50% of subjects in those 
studies), 14/39 studies reported on diabetes (less frequent than hypertension) and a few 
studies reported other risk factors e.g. atrial fibrillation or serum cholesterol (table 2.2). 
 The 15 studies of symptomatic lesions included 554 patients but the actual number of 
individual lesions assessed was unclear (some gave the total and some the mean per patient) 
and six studies did not state the number at all. From those studi that gave the total or mean 
number of lesions per patient, we calculated that at least 1200 lesions were assessed in 
patients with a lacunar syndrome, although it was unclear how manyof these were truly 
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symptomatic. In patients with multiple lacunar lesions, it was noted that at least half the 
patients had lesions which did not fit their symptoms(Pullicino et al. 1980).  
24 studies of subjects with asymptomatic (including not definitely symptomatic) lacunar 
lesions included six aging cohorts with asymptomatic lacunar lesions on pre-mortem 
imaging (71 subjects) and 18 studies of autopsy brains from patients without neurological 
symptoms in life or who had a previous history of stroke but of undefined subtype. 9/24 
studies reported the number of lesions (total approximately 2700), 2567 of which came from 
one study with 1086 subjects(Dozono et al. 1991a). Nine studies did not repor the total 
number of lesions. Sixteen studies used brain imaging (nine CT, four MRI and two used CT 
and MRI), nine before death, one after death and four both before and after ea h, to match 
lesions in life to those at autopsy – none of these lesions were symptomatic (table 2.2).  
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Figure 2.1 The results of the search strategy along  with exclusion criteria applied to the studies 
in order to retrieve pertinent literature.  
Initial search across 3 online databases 
1240 studies  
672 studies  
305 studies  
Duplicates, animal data and 
studies which were not original 
journal articles e.g. reviews. 
Studies unavailable in full 
text format e.g. 
conference abstracts.  
Studies focused on Alzheimer’s 
or vascular dementia pathology. 
140 studies  
Studies focused on pre 
mortem imaging or 
retinopathy. 
33 studies of la cunar stroke pathology  
Studies focused on CADASIL, 
monogenic disorders, 
leukoaraiosis, whiter matter 
lesions or Binswanger's 
disease. 
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Table 2.2  A full list of studies which met our inclusion crit eria, arranged in chronological order. 
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Loeb(Loeb et al. 1990) 1990 34 
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Number of patients refers to the number of patients with lacunar lesions (therefore not necessarily the total number in the study). HT = hypertension. DM = diabetes 
mellitus. AF = atrial fibrillation. CVD = cerebrovascular disease. AD = Alzheimer’s disease. IC = internal carotids.  H&E = hematoxylin and eosin. EVG = elastic van 
gieson. PAS = periodic acid-Schiff. PTAH = phosphotungstic acid hematoxylin. LFB = luxol fast blue. GFAP = glial fibrillary acidic protein. AP = alkaline phosphatase. 
IgG = immunoglobulin G. CV = cresyl violet. MSB =martius scarlet blue. 
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2.3.3 Pathological assessments  
Ten studies provided only a macroscopic assessment of brain slices. Amongst the 29/39 
studies reporting microscopic data, 25 different histological st in  were used, the most 
common being hematoxylin & eosin (22 studies) then luxol fast blue (seven studies). Sixteen 
different antibodies for immunohistochemistry were used of which Glial Fibrillary Acidic 
Protein (GFAP) was the most common (nine studies). Sixteen studies (41%) reported 
findings of typical type I cavitated lacunar lesions without refe ence to the lesion age, 9 
studies (23%) reported cavitated lacunar lesions with some reference to lesion age (i.e. 
subacute or old) and the remaining 14 studies (36%) reported on lesions in varying stages of 
development describing softenings, partially cavitated lesions, gliosis and associated 
perivascular space dilatations.  
 
2.3.4 Terminology and definitions 
Descriptions of lacunar lesions varied widely, making it difficult to distinguish whether 
authors were referring to lacunar lesions, related pathology and/or imaging features (table 
2.3). Terms used for clinical or imaging features included lacunr infarct(ion), lacune, small 
deep infarcts and lacunar cavities. Pathological descriptions favoured the term ‘lacune’, 
followed by various descriptions of cavities (small, lacunar, trabeculated etc) (table 2.3). 
‘Softening’ was most often used to describe more acute lesions(Hughes et al. 1954;Fisher 
1965). Although 23/39 (59%) of studies defined what they meant by a lacunar lesion, 
descriptions ranged from only the lesion size and location to more detailed pathological 
descriptions of lacunar lesion types; six studies used terms such a  ‘small deep infarcts’ or 
‘small subcortical infarcts’; and ten studies did not define what they meant by lacunar lesions 
at all. Terms used to describe vessel lesions included lipohyalinosis, hyalinization, hyaline 
arteriosclerosis and segmental arteriolar disorganization, all of which described apparently 
similar lesions.  
  
2.3.5 Study quality score 
The average study quality score was 6/9 (range 4-9). The most common ite s omitted were 
blinding between clinical and pathological data, the number and expertise of observers and 
lesion size. Where reported, neuropathologists were the most common observers (7/15 
studies), but others were reported as simply ‘pathologists’ and 24 studie  (62%) did not 
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report the specialty of the person performing the pathology. Only five studies blinded the 
observer to potentially confounding clinical data (13%). 
 
2.3.6 Pathological  findings 
29 studies (74%) examined both parenchymal and associated vascular pathology, nine 
studies (23%) reported only parenchymal pathology and one study only reported vascular 
pathology(Ogata et al. 2008). 
 
2.3.6.1 Parenchymal Lesions  
Location: Most studies sampled many areas of the brain, if not the entire brain, with little 
evidence of sampling bias, but data were not provided on the exact number of lesions found 
in each brain structure. Studies of symptomatic lesions more often reported precise locations 
(e.g. caudate or lentiform nucleus) than those of asymptomatic lesions (e.g. “basal ganglia”). 
Most lesions were in the thalamus (18/39), putamen (12/39), caudate and internal capsule 
(11/39). Studies of symptomatic subjects reported almost double the number of lesions in the 
internal capsule (seven versus four studies) and almost 3 times as many studies reported 
lesions in the caudate nucleus (eight versus three studies), compared to studies in 
asymptomatic subjects (see table 2.4).   
Size: Twenty-five studies (64%) reported lacunar lesion size, by: diameter (<5 to 30mm, 17 
studies); volume (0.1 to 525m3, 8 studies); area (0.1- to 28mm2, 6 studies) and some used 
more than one unit of measurement. Many studies used 1cm as the maximu  diameter for a 
lacunar lesion. There was no difference in size between symptomatic and asymptomatic 
lesions with a range of 1-30mm diameter encompassing both types of lion. Determining 
the mean size of symptomatic versus asymptomatic lesions was impossible due to the 
different types of measurements reported. 
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Clinical/General descriptions N Imaging N Pathology N 
Lacunar infarct(ion)(s) 7 Lacune (ae)(s) 6 Lacune(as)(s) 14 
Lacune (ae)(s) 7 Lacunar infarct(ion)(s) 4 Cavities (small/cystic/cribriform/slit like/trabeculated/lacunar) 12 
Small deep (cerebral) infarct(s) 6 Small lesions 3 Lacunar infarct(ion)(s) 10 
Lacunar cavities 2 Small deep lesions 3 small (subcortical) infarcts 8 
Lacunar stroke 2 Small infarcts 2 Microinfarcts 6 
Little/mild/small strokes 2 Lacunar lesion 2 Subcortical/brain stem/WM/thalamic infarctions 6 
Patches / patchy lesions 2 Etat crible 1 Cystic infarcts/lesions/encephalomalacia 6 
Subcortical lesions 2 Slit like/ ovoid infarct(s) 1 Small deep infarcts 5 
Caps 1 Slit like irregular cavity 1 Etat crible 4 
Cystic infarct 1 Patchy lesions 1 Softenings (small&/ischaemic) 4 
Etat lacunaire 1 Microinfarcts 1 Ischaemic necrotic foci 2 
Expanding lacunes 1 Small deep infarct 1 WM infarcts 2 
Lacunar disease 1 Lacunar sized infarct/lesion 1 Lacunar stroke 2 
Lacunar lesions 1 Lacunar cavities 1 Lacunar scars 1 
Lacunar sized infarct/lesion 1 Lacunar state 1 Parenchymal rarefaction 1 
Piriform lacunes 1 Multiple ischaemic infarctions 1 Etat lacunaire 1 
Punctate lesions 1    Etat vermoulu 1 
Rims 1     Status cribrosus 1 
Slient infarct/lesion/stroke 1     Space-occupying/expanding infarcts 1 
Small cerebrovascular lesions 1     Infarcted lesion 1 
Small deep lesions 1     Silent infarct 1 
Small ischaemic brain lesions 1     Proliferative/inflammatory/atheromatus lesions 1 
Status lacunaris 1         
Total  23 Total 16 Total 22 
KEY 
 Stand alone terms 
  Term used in both clinical and imaging settings 
  Term used in both imaging and pathology settings 
  Term used in both clinical and pathology settings 
  Term used in all three settings 
WM = white matter. N= number of studies using the term.  
 
Table 2.3 .The varying terminology used to describe lacunar le sions in both clinical and pathology settings . 
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Macroscopic appearance – Lesions were of varying sizes, generally bilateral, in the territory of the 
lenticulostriate arterioles (>75%) and a mixture of old and more acute(Marie P 1901;Ferrand J 1902). 
Those in the deep grey matter were often more irregular shaped and collapsed than those in the white 
matter(Fisher 1965). Occasional haemorrhage and Charcot-Bouchard / saccular aneurysms (or 
microaneursyms) were also found close to lacunar lesions(Cole and Yates 1967;Fisher 
1978;Benhaiem-Sigaux et al. 1986;Tuszynski et al. 1989;Revesz et al. 1989).  
 






Thalamus 8 Basal Ganglia 9 
Caudate 8 Thalamus 8 
Putamen 7 Putamen 5 
Internal Capsule 6 Pons 4 
Pons 4 Frontal/deep WM 4 
Globus pallidus 4 Cerebellum 3 
Frontal/deep WM 4 Caudate 3 
Cerebellum 3 Internal Capsule 3 
Corpus Callosum 2 Brain Stem 2 
Basis Pontis 2 Centrum Semiovale 2 
Basal Ganglia 2 Globus pallidus 1 
Mid Brain 1 Mid Brain 1 
Medulla Oblongata 1 Medulla Oblongata 1 
Unknown 1 Dentate Nuclei 1 
Lenticular nucleus 1 
Optic tract 1 
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Microscopic appearance - Old lesions were described as small pale cavities with irregular borders, 
often trabeculated with connective tissue and accompanied by a ring of gliosis(Benhaiem-Sigaux et al. 
1987;Bokura et al. 1998;Kawamoto et al. 2006). Macrophages and fibrous astrocyte  were observed at 
the lesion border(Mancardi GL et al. 1988;Chimowitz et al. 1992;Mayer et al. 1993). Acute lesions 
more often had plump macrophages, liquefaction necrosis and little g osis(Fisher 1968) and were 
often described as “softenings”(Cole and Yates 1967). Hemosiderin laden macrophages were 
occasionally encountered. The surrounding parenchyma showed varying degrees of edema and 
spongiosis as well as reactive astrocytes(Mancardi GL et al. 1988;Lammie et al. 1998), but little direct 
specific evidence of infarction. Small capillaries/arterioles often lay within or crossed the lesion(Fisher 
1968;Benhaiem-Sigaux et al. 1987). Some lacunar lesions had perivascular raref ction and selective 
neuronal loss without full cavitation(Ma and Olsson 1997;Lammie et al. 1998) and were labelled as 
‘oedema associated lesions’ reflecting the impression that edema was a key factor in their 
formation(Ma and Olsson 1997;Lammie et al. 1998). Dilated perivascular spaces with a round regular 
border surrounded by rarefied and gliotic nervous tissue were often found close to lacunar 
lesions(Benhaiem-Sigaux et al. 1987;Mancardi GL et al. 1988;Loeb et al. 1990;Bokura et al. 1998) 
e.g. in the putamen at the point of entry of the lenticulostriate arteries(Loeb et al. 1990) and were 
rarely associated with lacunar clinical syndromes. This appearance was common in normal aging 
brains(Braffman et al. 1987) or in those with vascular dementia(Revesz et al. 1989;Vinters et al. 
2000). Neuronal loss around the lesions was rare(Hughes et al. 1954), but increased levels of 
inflammatory markers were common(Tomimoto et al. 2002). 
 
2.3.7 Vascular  lesions 
Fourteen studies (44%) attempted to trace the arteriole thought to be responsible for the symptomatic 
lesion. Nine studies that measured the affected arteriole reported diameters ranging from 14-400µm. 
No arteriole >400µm diameter was cited as having directly caused a lacunar lesion. Changes in 
arteries, arterioles and capillaries were reported; veins and/or venules were rarely mentioned(Alex et 
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2.3.7.1 Large vessels – circle of Willis and major branches 
We found similar descriptions of large vessel pathology in both symptomatic and asymptomatic 
patients, including atherosclerosis and dolichoectasia. Ferrand(Ferrand J 1902) described the basilar 
artery (BA) of patients with lacunes at autopsy as being ‘atheromatous’, with alterations of the internal 
membrane, proliferation of elastic tissue and infiltration of macrophages. Atherosclerosis of the circle 
of Willis, ICA, BA, posterior cerebral (PCA), MCA and anterior cerebral (ACA) arteries in 
symptomatic lacunar stroke patients was reported in several studie  as either ‘moderate’ or ‘severe’ in 
at least 50% of patients (‘moderate’ and ‘severe’ were not defined), more commonly in patients with 
hypertension in life than in normotensive patients(Fisher 1965;Tuszynski et al. 1989). 
Mancardi(Mancardi GL et al. 1988) described atherosclerotic changes consisting of collagen or fibrin 
deposits, cholesterol crystals, duplication and splitting of the elastic lamina and thickening of the 
adventitia in patients with lacunar syndromes and other neurologica  symptoms (but did not provide 
information on hypertension). Patients with incomplete lacunar lesions (not clearly associated with 
symptoms) showed mild (60% of patients) to moderate (30% of patients) atheroma in the ipsilateral 
ICAs(Lammie et al. 1998) but these patients had various previous stroke episodes not just lacunar. 
Asymptomatic patients showed similar changes, with more atheroscl sis typically associated with 
more lacunes(Bokura et al. 1998), particularly in patients with vascul r dementia(Revesz et al. 
1989;Vinters et al. 2000). Widening of the internal and external diameters of the vertebral, ICA and 
MCAs (dolichoectasia) was also described, for example the median diameter of the BA was almost 
doubled in patients with asymptomatic lacunar lesions and those with a ‘history of stroke’(Pico et al. 
2007). 
 
2.3.7.2 Small penetrating arteries, arterioles and capillaries 
We found no quantitative differences in the small vessel lesions in symptomatic versus asymptomatic 
patients. Ferrand described small penetrating arterioles in symptomatic lacunar stroke patients as 
having thick walls and dilated perivascular spaces in areas with lacunes as well as in areas in the 
ipsilateral hemisphere devoid of lacunes(Ferrand J 1902). Hughes(Hughes et al. 1954) described 
perforating arterioles as being sclerotic and without occlusion but it was unclear whether these 
arterioles were directly related to lacunar lesions.  
The first detailed description of small arteriolar changes directly related to lacunar lesions came from 
Fisher who found abnormal penetrating arterioles or their branches in six patients, some of which were 
occluded, and which he stated was not due to atheroma(Fisher 1965). In a separate study, he identified 
‘segmental arteriolar disorganisation’ in 45/50 lacunar lesions in four patients(Fisher 1968). The 
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‘segmental arteriolar disorganization’ was distributed along the length of arterioles, 40-200µm in 
diameter and included a disintegrating arteriolar wall consisti g of a loose mesh of collagenous 
strands, infiltration of fatty macrophages and/or foam cells and deposition of fibrinoid material(Fisher 
1982b). ‘Lipohyalinosis’ was not mentioned until 1978 when he described thalamic infarcts in two 
hypertensive patients(Fisher 1978) in whom the external diameters of the small arterioles were 
enlarged to twice the diameter of any adjacent normal artery, the wall architecture was lost and the 
lumenae were occluded by a fine trabecular meshwork of hyaline material(Fisher 1978).  
Intimal thickening and hyalinization, fibrosis of the wall and occasional microaneurysms were seen in 
the putamen(Masuda et al. 1983;Benhaiem-Sigaux et al. 1987), thalamoperforating and lenticulostriate 
arterioles(Mancardi GL et al. 1988) and other small intraparenchymal vessels(Benhaiem-Sigaux et al. 
1986;Tuszynski et al. 1989). Intraluminal thrombi were rare and the arterioles were assumed to have 
recanalised(Mancardi GL et al. 1988). Ferrand described leukocytes infiltrating the walls of small 
arterioles and macrophages and active microglia in perivascular parenchymal lesions(Ferrand J 1902). 
One exception to the above is a single case report describing a patient with multiple cholesterol emboli 
in the perforating arteries with no evidence of vascular hyalinosis(Laloux and Brucher 1991). 
There were additional comments pertaining to arterioles in asymptomatic patients. Most lacunes 
occurred on the 1st or 2nd order branches of the penetrating arterioles of hypertensive patients(Challa et 
al. 1990). Arteriosclerosis with medial hyalinization(Challa et al. 1990;Reed et al. 1994;Schneider et 
al. 2005), dense adventitial fibrosis and foamy macrophages in the vessel wall were common in 
patients with lacunar lesions dying of non-stroke neurologic or non-neurologic causes(Vinters et al. 
2000). The degree of small arteriolar pathology increased with the number of lacunes visible 
pathologically in an ageing hypertensive population(Dozono et al. 1991a) or with the number of 
lacunar lesions and leukoaraiosis visible on imaging(Gupta et al. 1988;Rossi et al. 2004). One study 
suggested that fibrinoid necrosis was commoner in patients with diastolic hypertension than in those 
with systolic and borderline hypertension(Masuda et al. 1983). 
Intimal hyalinization and thickening were more frequent in patients with lacunar ischaemic stroke than 
in those with haemorrhage(Reed et al. 1994). In non-cavitated (type Ib) lacunar lesions, hyaline 
arteriolar wall thickening was present but fibrinoid necrosis, luminal thrombi and foam cells were 
not(Lammie et al. 1998;Vinters et al. 2000). There was no cerebral amyloid angiopathy on staining 
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2.4 Discussion  
Lacunar stroke is part of the spectrum of cerebral small vessel disease and represents an expanding 
global public health problem(Hachinski 2002). With out better understanding of the cause, it will be 
difficult to deliver better treatments. Amongst 39 studies including approximately 4000 lacunar lesions 
in 2300 subjects, we found consistent descriptions of a segmental non-atheromatous thickening of 
small artery/arteriole walls, along with breakdown of muscular and elastic fibres. Information on 
venular pathology was rare. There were signs of inflammation in the arteriolar wall and perivascular 
tissue, of perivascular edema-related damage, but little evidence of infarction or arteriolar occlusion 
except as an occasional late stage phenomenon secondary to extreme vessel wall damage(Ogata 1999). 
The inflammation had been noted as long ago as 1900(Ferrand J 1902). The absence of much direct 
evidence of true infarction could be because most studies were perform d late in the disease course by 
which time the initiating features could have been obliterated. However, there were many studies that 
reported on the various evolutionary stages of lacunar lesions, including areas of initial softening and 
edema and/or partially cavitated lesions. Symptomatic lesions may occur in the internal capsule or 
caudate nucleus more often than asymptomatic ones, but otherwise there was little difference in the 
size or location of parenchymal or vascular lesions between symptomatic and asymptomatic 
patients/lesions. The notion that symptomatic lesions were larg r than asymptomatic ones may have 
originated from studies of striatocapsular infarcts(Fisher 1979) – striatocapsular lesions occur due to 
transient MCA main stem occlusion or longer duration MCA occlusion in patients with good collateral 
pathways to protect the peripheral MCA territory, are due to large artery atherothromboembolic 
disease(Nishida et al. 2000). Other points of note were that the microvascular changes were spread 
throughout the deep grey and white matter (i.e. not just around one symptomatic lesion), moderate 
large artery atheroma and dolichoectasia were common and, where stat d, many of the patients were 
hypertensive. However, the absence of comparisons between patits with other stroke subtypes, e.g. 
cortical ischemic stroke, makes it difficult to say whether the large artery atheroma is relevant, or 
whether it simply indicates exposure to vascular risk factors such as hypertension which was present 
in more than 50% of patients where stated. Further than that, considerable variation in pathological 
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2.4.1 Strengths & weaknesses of the review and primary studies: 
This is the first review of this topic to take a systematic pproach. Hence, we hope that it provides 
additional insights into this topic. There was no evidence to suggest that the l ck of difference between 
symptomatic and asymptomatic patients was due to sampling bias. However it was difficult to be 
certain we had found all the relevant papers. Publication bias is almost certain to affect this topic, but 
in the absence of much quantitative data, we did not test formally for it. We excluded studies of 
leukoaraiosis, Binswanger’s encephalopathy, Alzheimer’s disease and vascular dementia (unless they 
specifically described lacunar lesions) and genetic disorders (e.g. CADASIL). However, the reliance 
on the author’s description and interpretation of lacunar lesions, even with our inclusive approach, 
may have inadvertently excluded papers or introduced bias.   
 We noted the very early and frequently quoted studies by Durand-Fardel(Durand-Fardel 1843) and 
Dechambre(Dechambre 1838) but did not formally include them because we found that, when 
translated, they contained only a small number of patients and these were of very mixed often non 
stroke-related backgrounds. For example, epileptic patients featured in both studies, some patients had 
previous episodes of encephalitis and others had severe cognitive impairments loosely described as 
‘idiotisme’. Therefore it is difficult to attribute any of the pathological descriptions to solely to a 
diagnosis of stroke.  
There were other limitations of the included studies. Studies using brain bank material often stated 
there had been a stroke in life but not the stroke subtype. Studies of symptomatic patients need to 
pinpoint the relevant lacunar lesion. However efforts to do this, and/or to match a lacunar lesion to the 
responsible vessel lesion/s were often futile, due to normal i aging appearances(Gouw et al. 2010), 
difficulties singling out one lesion often among many, difficulties racing vascular trees and the delay 
between clinical diagnosis and autopsy(Nelson et al. 1980). Changes resulting from fixation (e.g. 
shrinkage and changes in tissue proton relaxation characteristics) must also be considered when trying 
to correlate post mortem pathology or imaging with in vivo MRI findings(Gouw et al. 2010). Lacunar 
lesions rarely occurred in isolation (white matter lesions, dilated perivasular spaces etc were frequently 
encountered within the same subject) and as much patient information as possible is needed here in 
order to distinguish clinically relevant lesions from asymptomatic findings. Reporting of risk factors 
varied precluding attempts to differentiate causative from co-ass ciated findings such as large artery 
atheroma and lacunar stroke. The exact brain regions examined were often poorly described. Most, 
after cutting 2cm coronal sections, only took regions which were macroscopically interesting, 
potentially missing many smaller lacunar lesions and other primary pathology. Studies differed in their 
diameter definition of lacunar lesions, some classifying lesions <1cm diameter as lacunar and other 
studies including lesions of up to 2cm diameter. However 36% of studies did not me tion lesion size.  
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2.4.2 Interpretation 
The notion that most lacunar stroke is due to “occlusion of small perforating arterioles” is not 
supported by this in depth, structured, examination of the literatur . Perhaps, by association with large 
artery ischaemic stroke which is due largely to atherothromboemlic occlusion of large intracranial 
arteries, investigators assumed that lacunar stroke was also largely ischaemic and also due to arterial 
occlusion. Investigators may have assumed that, when not occluded, that arterioles must have 
recanalised as do thromboembolic occlusions of large arteries, rather than that the arterioles might 
never have been occluded in the first place.  
There are many parallels between these findings in lacunar stroke and findings in other forms of small 
vessel disease, particularly in leukoaraiosis and features that are generally associated with 
ageing(Fazekas et al. 1993;Baloh and Vinters 1995;Vinters et al. 2000;Udaka et al. 2002;Wang et al. 
2009;Grinberg and Thal 2010). In leukoariaosis and indeed normal aging, atherosclerosis of large 
intracranial arteries has been reported accompanied by vessel wall and / or perivascular macrophage 
infiltration and activated microglia(Vinters et al. 2000;Grinberg and Thal 2010). Enlarged perivascular 
spaces are a feature of cerebral small vessel disease(Zhu t al. 2010;Doubal et al. 2010) are also 
associated with active inflammation(Wuerfel et al. 2008) and impaired drainage of cerebral interstitial 
spaces. All, of the above are also associated with hypertension. Hence the association between 
increased brain features of small vessel disease and large artery atheroma could be because both are 
the result of hypertensive damage rather than because large artery atheroma causes cerebral small 
vessel disease. The blood brain barrier becomes increasingly permeable with advancing age, even 
more so in dementias (especially vascular dementia) and leukoaraiosis(Farrall and Wardlaw 2009). 
Patients with lacunar stroke have more permeable blood brain barrier than do those with cortical 
stroke: larger numbers of enlarged perivascular spaces are associated with further increases in blood 
brain barrier permeability(Wardlaw et al. 2009). Hence, inflammtory damage to the small vessel 
endothelium, perhaps triggered by or as part of hypertension, could aggrav te the arteriolar wall 
segmental disintegration and perivascular tissue damage that manifests as lacunar stroke clinically or 







Doctor of Philosophy University of Edinburgh 42 
2.5 Conclusion 
Terminology and definitions used for lacunar disease in pathology have been highlighted as a 
continuing problem in this field since the 1960’s(Fisher 1982a;Pantoni et al. 2006) but also affect 
descriptions of lacunar lesions clinically and on imaging(Wardlaw 2008;Potter et al. 2010a). When 
compared to the numerous imaging studies of lacunar stroke patients, the lack of pathology reports is 
explained by lacunar stroke rarely resulting in death soon after onset(Mihara 1980;Jackson and 
Sudlow 2005b), meaning that any acute abnormalities will have evolved. The difficulty of preserving 
and dissecting subcortical small vessels means that better use should be made of high field strength 
scanners, that are now much more widely available (e.g. 7T for experimental or human imaging), to 
match pre-mortem clinical and imaging features to post morte  imaging to help localise the relevant 
lacunar lesion and quantify associated features of small vessel di ease(Wardlaw et al. 2011). Studies 
of lacunar lesions in general lack histology targeting specific pathological processes, e.g. using newer 
methods such as immunohistochemistry or mRNA expression analysis. Given the continually 
dwindling autopsy rate and difficulties in retaining material for research, perhaps some material from 
previous studies could even be re-examined with these methods? Brain tissue banks are becoming 
essential to overcome these problems, but are of limited use without detailed clinical and other in vivo 
information. More detailed information on the patient in life especially stroke symptoms, subtype and 
vascular risk factors, should be recorded in primary research on lacunar disease or kept with brain 
tissue in brain banks(Gouw et al. 2010). We should aim, through these approaches, to make the best 
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Our systematic review of human lacunar stroke pathology (see pr vious chapter) and available 
epidemiological evidence suggests that the prognosis of lacunar stroke differs from large artery stroke 
with carotid stenosis and atrial fibrillation less common and the risk of early recurrence lower in 
lacunar stroke patients(Jackson and Sudlow 2005a;Jackson and Sudlow 2005b). This evidence thereby 
indicates that the underlying causes of lacunar stroke probably differ from other ischaemic stroke 
subtypes. 
The small subcortical ‘Lacunes’  which characterize the conditi  are generally considered to be 
“ischaemic”, however some data from patients suggests that they could arise secondary to an 
alternative initial process such as perivascular edema following BBB derangement(Lammie et al. 
1998).   
Animal models are useful in cerebral ischaemia research to replicate ischaemic damage encountered in 
humans. In contrast to large artery occlusive ischaemic stroke, the lack of clarity regarding the 
pathophysiological events in lacunar stroke makes it particularly difficult to model. However a model 
that can mimic at least some features of human lacunar stroke w uld undoubtedly be valuable to 
improve understanding of the disease in humans and to test treatments. We therefore undertook a 
systematic review to assess the suitability of all avail ble animal models pertinent to lacunar stroke. 
Subsequently, we assessed their likely pathological mechanisms in order to determine their relevance 
to the human condition.  
 
3.2 Materials and Methods 
3.2.1 Study Identification 
We used Cochrane Collaboration methodology for systematic reviews modified for observational 
studies (www.equator-network.org)(von Elm et al. 2007). We also applied the CAMARADES 
(Collaborative Approach to Meta Analysis and Review of Animal D ta from Experimental Stroke) 
checklist for systematic reviews of animal models in stroke(Macleod et al. 2004). We sought to 
include a broad range of studies that claimed to (or could be taken to) mimic the vascular pathology 
and/or the brain damage associated with lacunar stroke (i.e. that produced small lesions secondary to a 
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disorder of a perforating artery of a size and distribution csistent with human lacunar lesions).  We 
also sought models of conditions associated with similar pathology (e. . generalised white matter 
disease or vascular dementia) as unlike our systematic review of human pathology we wanted to 
capture any potential animal model of related pathology that could be pertinent to lacunar stroke not 
just those which explicitly claimed to be so. 
 
3.2.2 Search Strategy 
We identified studies with a search strategy developed with advice from the Cochrane Collaboration 
Stroke Group, across three English language databases (Medline, Embase and Biosis Previews) 
adjusted to accommodate different medical subject heading (MeSH) terms or subcategories available 
on each database (see appendix C). We searched from 1st January 1950 to 30th June 2007, and included 
English and non-English language publications. We also hand searched two journals which had 
published a large proportion of relevant material (Stroke and Journal of Cerebral Blood Flow and 
Metabolism) and cross-checked reference lists of primary papers, review articles and books on 
subcortical stroke.  
 
3.2.3 Inclusion and Exclusion Criteria 
We sought animal models which could produce small subcortical lesions, in white or de p grey matter, 
by ischaemic or other mechanisms. We excluded studies published only in abstract (due to insufficient 
information). We were careful to include each study only once (although in the case of multiple 
publications, all available relevant data from each study were included). We specifically excluded 
(Figure 3.1): non-stroke literature; human studies; primary cerebral haemorrhage, global ischaemia 
and distal middle cerebral artery occlusions (MCAO, as only cortical infarcts are produced); models 
which only produced lesions over 100mm3 in volume, (too large); and the collagen type IV alpha 1 
subunit (COL4A1) genetic mouse(Gould et al. 2006) (develops primary intracerebral haemorrhage at 
birth). We included the CADASIL transgenic mouse(Ruchoux et al. 2003) as it displays small vessel 
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3.2.4 Data Extraction 
From each study we extracted data pertaining to; purpose of the model and the aspect of pathology 
being modelled, characteristics of animals used (species, strain, weight, sex, age, any comorbidity), 
number of animals, method of stroke induction, use of randomization (if appropriate), outcomes 
assessed (histology, imaging, neurobehavioural tests, etc), blinding of outcome assessment to key 
variables, lesion size and brain territory affected. For the full data extraction form see appendix (D). 
 
3.2.5 Study Quality Assessment 
We assessed study quality using the CAMARADES database(Macleod et al. 2004). We focused on 
seven of the 10 CAMARADES items relevant to observational studies (see table 3.1). We categorised 
studies by induction method and analysed the type and distribution of tissue and vessel lesions 
produced in each model and their relevance to human lacunar stroke. 
 









Checklist based on the CAMARADES checklist devised by MacLeod et al(Macleod et al. 2004). 
 
 
Blood characteristics – was blood pressure taken and /or blood gases monitored?  
Published in a peer review journal?  
Was body temperature controlled?  
Anaesthesia - does the anaesthetic used have intrinsic neuroprotective properties?  
Sample size calculation performed?  
Statement of compliance with regulatory requirements – e.g. UK Home Office regulations.  
Conflict of interest statement?  
Total /7  
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3.3 Results 
Our systematic search produced 17821 articles in the first instance (figure 3.1). We reviewed (and 
where necessary translated) the abstracts of 5670 publications wth relevant titles. After meeting 
abstracts and review articles were excluded, 340 primary papers were examined in full. Following 
discussion amongst co-authors, 46 papers were deemed appropriate describing 41 studies (table 3.1).  
 
3.3.1 Methodological characteristics of included studies 
Eight publications openly stated (either within the aim, conclusion or title) that their model 
represented lacunar stroke. Three models were cited as representing lacunar stroke in subsequent 
literature by others but were not claimed as a model of lacunar stroke by the original authors. 
Seventeen appeared to us to be pertinent (although were not directly attributed by the authors to) 
lacunar stroke because they produced small deep lesions in relevant are s of brain. The remaining 12 
models attempted to recreate an aspect of small vessel stroke pathology (e.g. vasoconstriction via 
endothelin-1 injection) which might be relevant and so where included.   
Most models used rodents, but dogs, primates and rabbits were also used (table 3.1). The mean 
number of animals per study was 42 (range 6-242), with considerable variation in number between 
induction techniques. The sex and age of animals were particularly difficult to extract: 42% of studies 
used male animals only, 5% female only, 30% both and 23% did not specify the sex. At least 18% 
used adults (age not given), 10% used adolescents, 25% used a range of ges; 47% did not specify the 
















Duplicates - 7,954 
Exclusion on basis of 
title - 12,151 
5,670 
400 
Exclusion after reading 
abstract -  5,270 
355 
Irrelevant documents (e.g. 
meeting abstracts, posters, 
reviews) - 45 
Foreign Abstracts 
translated and not 
deemed relevant - 15 
340 
46 publications (41 separate studies)  
Exclusion after reading full 
text - 295 
Exclusion criteria 
- all human data 
- all non stroke data 
- all non cerebral data 
- all haemorrhagic data 
- all global ischaemia data 
- all distal MCAO models  
- all lesion sizes over 100mm3   
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Infarct size was poorly described and standardised. 39% did not give infarct measurements at all. Of 
those that did, there were ten different measurement methods (figure 3.2). Standardised comparisons 
of infarct size between or within models were therefore limited to descriptive analyses. From 
descriptions and figures provided, infarcts from many studies were diversely spread around the brain 
in cortical grey and white matter. Many subcortical lesions better resembled a human striatocapsular 
than a lacunar infarct. Figure 3.3 demonstrates the size of a lacunar lesion relative to each species’ 
brain assuming a similar lesion:brain size ratio to humans. These small deep lesions are not only 
extremely difficult to create but also difficult to measure accurately with current techniques. The 
figure also demonstrates the added complication of the substantial differences in white:grey matter 
ratios between primates and rodents. 
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Physiological variables during surgery were poorly reported: 28/41 studies stated that body 
temperature was controlled, but blood pressure and respiration were only stated to be controlled in 
eight (20%) and five (12%) respectively. Most models sacrificed animals within a week of surgery: 
9/41 (22%) within 24 hours, 23/41 (56%) between one and seven days. Long term survival 
experiments were conducted mainly in transgenic animals or spontane usly hypertensive stroke-prone 
rats (SHRSP). There were few neurological assessments: 10/41 (24%) publications used a validated 
neurological test; 12/41 others (29%) used a self-devised scale usually described as ‘mild’, ‘moderate’ 
and ‘severe’. The median score on the CAMARADES study quality checklist(Macleod et al. 2004) 
was 3/7 (range of 2-6/7), reflecting rather poor reporting of key methodologica  cr teria. 
 
3.3.2 Lesion induction methods  
There were six categories of primary stroke induction technique: embolism, MCAO, individual 
perforating vessel occlusion, parenchymal endothelin-1 (ET-1) injection, spontaneous lesions and 
miscellaneous (table 3.1).  
 
3.3.2.1 Embolism: 
(8 studies(Molinari 1970a;Molinari 1970b;Futrell et al. 1991;Macdonald et al. 1995;Roos et al. 
1996;Roos and Sperber 1998;Chen et al. 2001;Atochin et al. 2004;Lozano et al. 2007),433 animals, 
mostly rodents): Injection of different amounts and sizes of emboli (microspheres, black beads, 
silicone rubber cylinders, preformed clots) into the internal carotid artery produced unpredictable 
infarcts(Molinari 1970a;Molinari 1970b;Roos et al. 1996;Roos and Sperber 1998;Chen et al. 
2001;Atochin et al. 2004). Whilst small emboli in sparse numbers could produce subcortical infarcts, 
most emboli produced cortical infarcts(Macdonald et al. 1995). Some models irradiated the 
internal/common carotid arteries in the presence of a photosensitiv dye to produced an embolic 
source said to mimic thrombus generation on an atherosclerotic carotid artery plaque(Lozano et al. 
2007). This produced multiple infarcts, mostly cortical with a fewin the basal ganglia and the caudate 
nucleus, but the subcortical lesions were poorly documented making their rel vance to lacunar 
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3.3.2.2 MCA occlusion:  
(7 studies(Crowell et al. 1970;DeGirolami et al. 1984;Memezawa et al. 1992;Belayev et al. 1999;He et 
al. 1999;He et al. 2000;Lindner et al. 2003;Gharbawie et al. 2006) ,385 animals; primates, pigs and 
rodents): Two approaches were described: a) the intraluminal MCA thread occlusion; and b) selective 
anterior choroidal or hypothalamic artery occlusion. The intraluminal thread occlusion model is a 
widely used large artery ischaemic stroke model, which first damages subcortical and later cortical 
structures(Crowell et al. 1970). 30 minutes of MCA occlusion produced purely subcortical lesions 
<1cm diameter in primates(DeGirolami et al. 1984). Occlusion for up to 4 hours created infarcts in 
subcortical structures in primates(DeGirolami et al. 1984) that mimicked human striatocapsular 
infarcts(Warlow et al. 2008f) in terms of size and structures aff cted. Striatocapsular infarcts affect the 
majority of the basal ganglia or adjacent white matter and are accounted for by either transient MCA 
mainstream occlusion with early reperfusion, or if the occlusion persists, then with very good 
collateral flow from the anterior or posterior arteries to the cortical MCA territory. Selective occlusion 
of the anterior choroidal and hypothalamic artery origins by precise placing of the intraluminal thread 
in the artery mouth(He et al. 1999;He et al. 2000) produced subcortical infarcts. The anterior choroidal 
lesions were generally of striatocapsular dimensions; the hypothalamic lesions seemed particularly 
pertinent to lacunar stroke but were poorly described. 
 
3.3.2.3 Perforating artery occlusion:  
(8 studies(Yonas et al. 1981;Vajda et al. 1985;del Zoppo et al. 1986;Kuwabara et al. 1988;Brenowitz 
and Yonas 1990;Pevsner et al. 2001;Wang and Walz 2003;Hua and Walz 2006), 119 animals; rat, 
monkey, dog): Small cortical infarcts, produced in rats by occluding a cortical pial artery on the brain 
surface using forceps or photochemical irradiation(Pevsner et al. 2001;Wang and Walz 2003) were 
described as mimicking lacunar infarction because the showed “cavitation caused specifically by 
ischaemia of smaller vessels” (however the lesions were cortical)(Hua and Walz 2006).  In primates, a 
balloon cuff placed around the proximal MCA and inflated for 3 hours produced thrombus formation 
within the lenticulostriate arteries(del Zoppo et al. 1986)and resulted in tissue softening, necrosis and 
cyst formation with an average volume of 3.9cm3. Others coagulated or crushed many arterioles 
(thalamoperforators, lenticulostriates, etc). These lenticulostriate occlusion models produced lesions 
equivalent in size to a striatocapsular infarct in a variety of brain regions, rather than lacunar lesions in 
more characteristically defined areas.  
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3.3.2.4 ET-1 injection: 
(4 studies(Fuxe et al. 1992;Hughes et al. 2003;Whitehead et al. 2005;Frost et al. 2006), 114 animals; 
rats): ET-1, a powerful vasoconstrictor,  when injected into the subcortical tissues in a dose-dependent 
manner produces ischaemic lesions(Sharkey et al. 1993). The powerful vasoconstrictive action may 
affect several microvessels. ET-1 injected into deep grey matter caused a small lesion with neuronal 
and astrocyte loss and delayed macrophage/microglia response;(Fuxe et al. 1992) into white matter 
caused axonal and oligodendrocyte disruption followed by myelin damage and increased astrocyte 
reactivity(Whitehead et al. 2005). The histological changes in the vasoconstricted vessels were not 
reported. 
 
3.3.2.5 Spontaneous lesions:  
(9 studies(Knox et al. 1980;Ogata et al. 1981;Ogata et al. 1982;Fredriksson et al. 1985;Tagami et al. 
1987;Fredriksson et al. 1988;Su et al. 1998;Lin et al. 2001;Sironi et al. 2004;Garosi et al. 
2006;Rossmeisl, Jr. et al. 2007), 466 animals; rats, dogs): The SHRSP(Okamoto et al. 1974) develops 
hypertension followed by stroke-like neurological symptoms withincreasing age. Studies in rats from 
4-52 weeks of age showed that a combination of malignant hypertension, a ge etic predisposition to 
stroke and high salt diet were all risk factors for spontaneous stroke(Knox et al. 1980;Ogata et al. 
1981;Ogata et al. 1982;Fredriksson et al. 1985;Fredriksson et al. 1988;Lin et al. 2001;Sironi et al. 
2004). Pathology, all in the perforating arteriolar territories, included microinfarcts, small 
haemorrhages and multiple white matter cysts. The primary event was endothelial disruption, with 
BBB breakdown (shown using multiple techniques) being the likely cause of the “ischaemic” 
lesions(Sironi et al. 2004) with arteriolar wall thickening, luminal narrowing or dilatation and 
thrombotic occlusion being late secondary features, long after extnsive subcortical damage was 
already apparent. Elderly dogs also suffer spontaneous strokes with neurological deficits (hemiparesis, 
facial hypalgesia and hemianopia), but are less researched(Su et al. 1998;Garosi et al. 2006;Rossmeisl, 
Jr. et al. 2007). 
 
3.3.2.6 Miscellaneous: 
(5 studies(Yoshimoto et al. 1978;Matsumoto et al. 1990;Toshima et al. 2000;Ruchoux et al. 
2003;Shibata et al. 2004), 194 animals; various species): Simultaneous occlusion of four main cerebral 
arteries for 60-120mins in dogs produced thalamic infarction alone, and w s considered to be a low 
perfusion model(Yoshimoto et al. 1978). Sodium Laurate injected into a cortical cerebral artery in rats 
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induced endothelial necrosis, intravascular thrombus formation and occlusive stroke but caused 
damage that was predominantly cortical and too extensive for lacunar stroke(Toshima et al. 2000). 
Unilateral carotid occlusion from 5 to 30 minutes in the gerbil produced a large artery territorial 
infarct(Matsumoto et al. 1990). A transgenic notch3 mouse modelling CADASIL pathology produced 
smooth muscle proliferation in the small arteriolar walls similar to human CADASIL (mostly in the 
tail not the brain) and few stroke lesions(Ruchoux et al. 2003). Bilateral carotid artery stenosis, created 
by placing microcoils around the carotid arteries in mice, produced hypoperfusion accompanied 14 
days later by white matter lesions(Shibata et al. 2004) judged to be a cumulative consequence of 
hypoperfusion. However these white matter lesions share common features with those seen in 
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 Author/Reference Year  Induction method Species n 
Age & Co-




Molinari(Molinari 1970a) 1970 Silicone Rubber Emboli Dog 25 unknown  unknown  3 
Futrell(Futrell 1991) 1991 Photo-coagulation of ICA Rat 33 unknown 200-1200uM diam 3 
Miyake(Miyake et al. 1993) 1993 Microsphere emboli Rat 242 unknown  77% of ipsil hemis 6 
MacDonald(Macdonald et al. 1995) 1995 Microsphere emboli Monkey 9 unknown  unknown  5 
Roos(Roos et al. 1996) 1996 Black bead emboli Rabbit 18 unknown  0.5-3mm diam 4 
Chen(Chen et al. 2001) 2001 Preformed fibrin clot into right ICA Rat 27 unknown  unknown  4 








  Lozano(Lozano et al. 2007) 2007 Photo-coagulation of ICA Mice 35 Range 7-15% brain volume 4 
Crowell(Crowell et al. 1970) 1970 Scoville clip on MCA origin Monkey 65 unknown  3mm diameter average 3 
DeGirolami(DeGirolami et al. 1984) 1984 Transorbital snare ligation of MCA Monkey 87 unknown  < 2cm diameter 2 
Memezawa(Memezawa et al. 1992) 1992 Intraluminal thread MCA occlusion Rat 42 unknown 40% of Caudoputamen 4 
Belayev(Belayev et al. 1999) 1999 Intraluminal thread MCA occlusion Mice 49 unknown  4.5 - 9mm2 5 
He(He et al. 1999) 1999 Intraluminal occlusion of AChA & HTA Rat 80 Adolescent 6-48mm3 6 







  Gharbawie(Gharbawie et al. 2006) 2006 Intraluminal thread MCA occlusion Rat 12 Adolescent 
% of 3 structures 
damaged 
4 
Yonas(Yonas et al. 1981) 1981 Retro-orbital occlusion of lateral lenticulostriates Monkey 9 unknown  Unknown 3 
Vajda(Vajda et al. 1985) 1985 Posterior thalamic arteries occluded Monkey 10 unknown  unknown  2 
Del Zoppo(del Zoppo et al. 1986) 1986 Balloon cuff around MCA Monkey 22 Adolescent 3.9cm3 4 
Kuwabara(Kuwabara et al. 1988) 1988 Occlusion of Posterior Cerebral perforators Dog 24 unknown  Unknown 3 
Brenowitz(Brenowitz and Yonas 
1990) 1990 Occlusion of Anterior cerebral artery branches Dog 42 unknown  0.73cm3 
3 
Pevsner(Pevsner et al. 2001) 2001 Cortical Photo-coagulation Rat 12 Adult 1.7-4.2mm depth 3 
Wang(Wang and Walz 2003) 2003 Cortical pial vessel crush Rat UK  Adult 










Hua(Hua and Walz 2006) 2006 Cortical pial vessel crush Rat UK  Adult 1.09mm3 3 
Table 3.2 . Summary of included studies by induction method.  
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 Author Year  Induction method Species n Age & Co-morbidity? Infa rct Size 
Study 
Quality 
Fuxe(Fuxe et al. 1992) 1992 ET-1 injection (Intra-striatal) Rat 11 unknown  1-6mm3 3 
Hughes(Hughes et al. 2003) 2003 ET-1 injection (striatum and subcortical WM) Rat 38 Adult 17.5ul / 20um2 5 






Whitehead(Whitehead et al. 2005) 2006 ET-1 injection (Internal Capsule) Rat 25 unknown  
~500uM 
diameter 5 
Knox(Knox et al. 1980) 1980 Naturally occurring strokes in SHRSP Rat 43 Range + Hypertension Unknown 4 
Ogata(Ogata et al. 1981) 1981 Naturally occurring strokes in SHRSP Rat 88 Range + Hypertension 
150um - 1.5mm 
diameter 3 
Fredriksson(Fredriksson et al. 1985) 1985 Naturally occurring strokes in SHRSP Rat 55 Range + Hypertension Unknown 3 
Tagami(Tagami et al. 1987) 1987 Naturally occurring strokes in SHRSP Rat 84 Range + Hypertension Unknown 2 
Su(Su et al. 1998) 1998 Naturally occurring strokes  Dogs 18 Range Unknown 3 
Lin(Lin et al. 2001) 2001 Naturally occurring strokes in SHRSP Rat 38 Range + Hypertension Unknown 2 
Sironi(Sironi et al. 2004) 2004 Naturally occurring strokes in SHRSP Rat 96 unknown + Hypertension Unknown 2 










Rossmeisl(Rossmeisl, Jr. et al. 
2007) 
2007 Naturally Occurring strokes Dog 6 Range 9-21mm 
diameter 
3 
Yoshimoto(Yoshimoto et al. 1978) 1978 
Simultaneous occlusion of ICA, ACA, MCA 




Matsumoto(Matsumoto et al. 1990) 1990  Unilateral carotid occlusion Gerbil 20 unknown </> 0.2mm 3 
Toshima(Toshima et al. 2000) 2000 2 injections of sodium laurate into ICA Rat 56 Adult 
8% of slice 
area? 3 





Shibata(Shibata et al. 2004) 2004 Bilateral Carotid Artery Occlusion Mice 60 Adolescent Unknown 3 
N = number of animals; SHRSP = Spontaneously Hypertensive Stroke-Prone Rat = MCA, Middle Cerebral Artery; ICA = Internal Carotid Artery; ACA = Anterior 
Cerebral Artery; PCA = Posterior Cerebral Artery; HTA = Hypothalamic Artery; AChA = Anterior Choroidal Artery; WM = White matter; ET-1 = Endothelin-1; CADASIL 
= Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy. 
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3.4 Discussion 
Our systematic search discovered animal models (using over 10 different induction 
techniques) which were able to reproduce  brain lesions, microvessel pathology, or both, 
which could be representative of lacunar stroke. However, mostdels produced infarcts 
which were too large or affected the wrong brain territory to be fully pertinent. Some models 
could be useful for evaluating novel treatments for lacunar-sized schaemic subcortical 
lesions, but few attempted to explain the small vessel changes associated with most lacunar 
stroke in humans. Only one established model, the SHRSP, produced lesions that mimicked 
the small vessel and brain parenchymal pathology. In this particul  model, the primary 
event is BBB disruption, with vessel occlusion and brain ischaemia occurring well after 
tissue damage caused by edema fluid is visible. The widespread and primarily cortical infarct 
distribution encountered in models using emboli indicated that emboli or microthrombi were 
an unlikely cause of most human lacunar stroke. This finding is consiste t with human 
epidemiological data(Jackson and Sudlow 2005a). 
This review has limitations. The methodology for systematic reviews of observational 
studies in animals is still evolving. Trying to capture the exact literature is difficult as 
currently, key word usage is too generalised and potentially subjective. We used multiple 
overlapping study ascertainment methods but may still have missed ome key models. Any 
full assessment of the relevance of experimental models of subcortical stroke is hampered by 
the incomplete knowledge and confusing terminology of lacunar stroke pathology in 
humans. The location and small lesion size makes modelling of lacunar stroke difficult in 
small mammals. Reproducing a 1cm3 human infarct relative in size to a mouse or rat’s brain 
requires skill and advanced measuring techniques (figure 3.3)(Yang et al. 1998;Zhang and 
Sejnowski 2000;Bush and Allman 2003). A further limitation is the substantially lower 
white:grey matter ratio in rodents (approximately 14:86%) compared with primates 
(40:60%)(Bush and Allman 2003). 
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Figure 3.3 Approximate brain volume (cm 3) and grey: white matter ratio in healthy (young) a nimals shown relative to the human brain 
Red dots indicate a human sized lacunar lesion superimposed onto animal species’ brains. The red dots also illustrate the difficulty in targeting a small lacunar-like 
lesion to white matter, particularly in smaller rodents, due to the paucity of white matter. 
MOUSE = 2cm3 
GM:WM = 90:10 
RAT = 6cm3 
GM:WM = 86:14 
RABBIT = 28cm3 
GM:WM =80:20 
DOG = 72 cm3  
GM:WM = 65:35 
HUMAN = 1400cm3 




CHIMPANZEE = 420cm3 
GM:WM = 61:39 
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Study reporting was suboptimal, with the average score for key methodological factors 
(based on the CAMARADES score) of only 3/7. Few studies used older animals or animals 
with pre-existing vascular problems, even though most lacunar stroke patients are considered 
old and present with vascular risk factors (Dozono et al. 1991b). Few neurological / 
behavioural assessments occurred in animal models, whilst clinical examination for ‘lacunar 
syndromes’(Warlow et al. 2008e) is the first assessment of a potential lacunar stroke patient. 
Therefore behavioural tests which are sensitive enough to detect the effects of lacunar-like 
syndromes in animals are important in order to establish the symptomatic relevance of any 
inflicted lesions. Additionally, some models cause damage that restricts neurological 
assessment (e.g. blindness)(Shibata et al. 2004). The short time fro  induction to sacrifice 
did not allow the affected areas to mature, further limiting determination of lesion size and 
relevance. 
All of the models had limitations, when trying to extrapolate results to human lacunar 
disease. The embolic technique produced small infarcts, but most were cortical not 
subcortical. Poor documentation of subcortical lesions in several models precluded reliable 
assessment of whether the lesions were large subcortical (i.e. striatocapsular equivalent) or 
true lacunar. Human lacunar stroke may be caused by MCA atheroma occluding the 
lenticulostriate artery origin. The most promising model equivalent was selective occlusion 
of the anterior choroidal or hypothalamic arteries which produced some small infarcts (He et 
al. 1999). The hypothalamic infarcts in particular appeared comparable with lacunar infarcts 
(author’s comment), but were overlooked in favour of the anterior chooidal artery 
lesions(He et al. 2000). Other models that occluded lenticulostriate unks or multiple ostia 
produced striatocapsular-like not lacunar lesions(Brenowitz and Yonas 1990). ET-1 injection 
produced small subcortical lesions but caused several microvessels to be constricted 
simultaneously so was inconsistent with the “single vessel” th ory of lacunar stroke. The 
CADASIL transgenic mouse mimics some aspects of human CADASIL(Ruchoux et al. 
2003), but the vessel changes are mainly encountered in the tail with minimal effects on the 
cerebral vessels and few if any cerebral lesions. A lacunar stroke model in the miniature pig 
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3.5 Conclusion 
The only model that mimics both microvessel and parenchymal changes is the spontaneous 
stroke in SHRSP(Blezer et al. 1998;Sironi et al. 2004). However the initiating step is BBB 
disruption leading to parenchymal and arteriolar damage, so the mechanism is not primarily 
ischaemic, in that although arteriolar wall thickening could lea to luminal narrowing and 
thrombosis, these only occur late, secondary to earlier events, after much brain damage due 
to perivascular edema fluid has already occurred. Several other features commonly 
associated with human lacunar stroke have also been observed in SHRSP (e.g. dilated 
perivascular spaces). This species is highly inbred and may therefore b  f limited relevance, 
but the microvascular and brain morphological features are so similar to those described in 
humans that it is hard to ignore. However, if the SHRSP truly does mimic human lacunar 
disease, then a major move away from traditional occlusive/ichaemic mechanisms towards 
endothelial/BBB disruption mechanisms will be required in order to advance understanding 
of the development of lacunar stroke and associated features of small vessel disease in 
humans(Yamori et al. 1976a). Further studies to characterise the mall vessel morphological 
changes in SHRSP in more detail would be worthwhile.  
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CHAPTER 4 : THE SPONTANEOUSLY HYPERTENSIVE STROKE PRONE 




The Spontaneously Hypertensive Rat family was developed by selectiv  cross breeding of 
out bred Wistar Kyoto Rats (WKY) and consists of two main members: the Spontaneously 
Hypertensive Rat (SHR) (1963) which has elevated blood pressure (~180mmHg systolic) but 
rarely shows signs of stroke (sometimes known as the stroke-resistant SHR – 
SHRSR)(Okamoto and Aoki 1963) and the Spontaneously Hypertensive Stroke Prone Rat 
(SHRSP) (1974)(Okamoto et al. 1974) selectively bred from a substrain of the SHR that 
showed signs of stroke and had malignant hypertension (~220mmHg systolic); The precise 
mechanisms underlying the stroke-proneness and stroke-resistance are unclear. The SHR 
family has been used to model a wide range of conditions from attention deficit hyperactivity 
disorder to osteoporosis. In stroke research, the SHRSP has mainly been used in middle 
cerebral artery (MCA) occlusion models to produce large MCA territory infarcts. In contrast, 
the spontaneous strokes suffered by SHRSP have received less attention but are generally 
assumed to be consequent upon elevated blood pressure and manifest as cortic l and 
subcortical infarcts and haemorrhages(Takiguchi 1983). 
In systematic reviews of potential animal models of lacunar stroke, we(Bailey et al. 2009) 
and others(Hainsworth and Markus 2008) noted that SHRSP seemed to d monstrate similar 
pathological features to the small vessel disease underlying human lacunar stroke 
pathology(Fisher 1968). Given human small cerebral vessels are difficult to study and tissue 
for histopathology is difficult to obtain, the cause of human lacun r stroke remains 
unclear(Wardlaw 2005). Numerous studies describe the cerebral pathology encountered in 
SHRSP, but no systematic summary of this literature is available. Clarification of the 
pathology underlying the spontaneous vascular and tissue lesions in SHRSP would aid 
understanding of human lacunar stroke and related small vessel disease.  
Therefore, we gathered all published studies documenting spontaneous cerebral pathological 
changes in both vessels and tissue of SHRSP for a detailed assssment of the type and 
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4.2 Materials and Methods 
4.2.1 Search strategy 
We searched using the terms ‘SHRSP’ and/or ‘Spontaneously-Hypertensive Stroke Prone 
Rat’ and all possible variants of these text strings in three online databases, Medline, Embase 
and Biosis Previews. We limited the search to full textprimary research articles, describing 
cerebral vascular or tissue pathology, published between 1974 (the SHRSP was developed in 
1974) and May 2010. We removed duplicate publications, conference abstracts, reviews, 
publications on artificially induced ischemia, non-cerebral changes, drug interventions and 
genetics. Where multiple publications arose from the same animal cohort, we attributed all 
results to one study to avoid artificially inflating total sample siz .  
 
4.2.2 Data extraction 
We extracted data on: the pathology studied (e.g. vessels, tissue or both); methodologies; the 
number of SHRSP and control animals, their age; the area of the vasculature and/or brain 
studied; blood pressure and its relationship to pathological ch nges; and whether the rats 
were raised on a “Japanese diet” (high sodium (4%):low potassium (0.75%)), had sodium 
chloride (1%) supplemented into their drinking water (“salt loaded”)(DiNicolantonio and 
Silvapulle 1988) or were fed standard rat chow. 
We subcategorized studies into those which focused on blood vessels alone, brain tissue 
alone, both vessels and tissue, and those which examined other hematological and 
biochemical changes (using serum, urine or CSF biomarkers, e.g. nitric oxide concentration 
or platelet aggregation). We defined small cerebral vessels a  arterioles that penetrated into 
the brain tissue and were less than 150µm diameter and larger arteries as arteries over 150µm 
in diameter including the basal intracranial large arteries, carotid/vertebral arteries and other 
systemic large arteries.  
 
4.2.3 Study quality 
We assessed study methodology with the CAMARADES criteria(Sena et al. 2007), the 
STARD (Standards for the Reporting of Diagnostic Accuracy studies) statement(Bossuyt et 
al. 2003) and MOOSE (The Meta-analysis Of Observational Studies in Epidemiology) 
criteria(Stroup et al. 2000) (www.equatornetwork.org). We did not seek data on body 
temperature, anaesthesia or compliance with animal welfare regulations as surgical 
procedures were rare.  
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4.3 Results 
4.3.1 The available literature. 
The initial search produced 4000 potentially relevant articles (Figure 4.1). Excluding 
conference abstracts, reviews, duplicates and artificially-induced ischemia left 496 papers. 
Of these, 132 papers described cerebral pathology, of which 30 were multiple publications 
arising from the same animals, leaving 102 independent studies. 
Of the 102 studies, 10 primarily described brain tissue histopathology, 27 described vessel 
pathology, 14 addressed both tissue and vessel changes and 51 described serum, urine or 
CSF biomarkers. All studies used WKY, SHR (SHRSR) or occasionlly Sprague Dawley 
rats as controls, although Sprague Dawley’s were always used in conjunction with WKY 
(summary data of all the studies included are listed in appendix E of this thes ). 
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Figure.4.1 Search strategy for the retrieval of pat hological papers to be included in the review. 
 
 
Initial search across 3 online d atabases = 4000 publications  
Limiting to fu lltext articles only = 1677  
After removing duplicates = 972  
After exclusion of all publications focussing on MC A occlusion 
induced artificial ischaemia = 496  
Cerebral Pathology 
= 132 (102) 
Drug interventions 
= 185 
Genetics = 53  
Non-cerebral 
data = 126 
Brain Tissue 
Alone = 10 
Vessels 
Alone = 27 
Both Brain 
Tissue & 
Vessels = 14 
Plasma 
biomarkers = 51 
Secondary 
publications i.e. 
data from same 
animals = 30 
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4.3.2 Study methodology 
No study mentioned whether authors were blinded to SHRSP or control rat status.  Blood 
pressure readings were rarely documented. The total number of experimental animals per 
study ranged from 5(Ogata et al. 1981) (an in depth characterization of tissue and vessel 
pathology) to 1278(Yamori et al. 1976a), median 43 (inter quartile range 24 to 77). Nineteen 
studies (18%) did not state the number of rats used. Age at sacrifice (given in 97 studies) 
ranged from animals that were developing hypertension (i.e. >9 weeks old), had established 
hypertension (>12 weeks old) or had reached the high risk age for stroke (>16 weeks). Only 
9 studies documented changes in pre-hypertensive animals (i.e. <9 weeks old) (figure 4.2). 
Five studies did not state age of sacrifice. In 24 studies (23%), rats were fed a Japanese diet 
(JPD) or had salt added to their drinking water (figure 4.3). Use of alt was rare prior to the 
1980’s but increased from 1990 onwards. We indicate whether animals were salt-loaded in 
relevant sections of the results. All studies that assessed inflammatory biomarkers (e.g. 
thiostatin) used animals raised on high salt (via diet or water supplements, n=5) or did not 
state the diet used (n=2).  
Examination of tissue/vessel changes was mostly by histology (e. . haematoxylin and eosin), 
immunohistochemistry or electron microscopy. Other methods included in vivo MRI, 
proteomics or combinations of these. Cerebral blood flow was measured with laser Doppler 
or hydrogen clearance methods.   
Vascular pathology was described in 41 studies (27 vessels only; 14 both tissue and vessel 
changes): 23 described large artery changes (MCA, posterior cerebral artery (PCA), basilar 
artery (BA) and the internal carotid artery (ICA)); eight described arterioles of 150µm 
diameter or less. The remaining 10 studies analysed vessels of an unspecific size and / or 
brain region. We found no studies of venular pathology or pre-hypertensive changes in 
arterioles (only large arteries) as all studies describing small vessel pathology sacrificed 
animals after 13 weeks of age. Tissue damage was described in 23 studies, but most (n=19) 
described data from the cortex (predominantly frontal cortex) with only occasional 
references to deep grey matter and little information (n=2) on white matter. Data on numbers 

































Figure.4.2. Ages of animals used in pathological st udies .  
Prehypertensive = majority of animals sacrificed at 9 weeks of age or less. Hypertensive = majority of 
animals sacrificed between 10-16 weeks of age. Stroke Prone = animals sacrificed at any time over 16 
weeks of age. Longitudinal study = animals sacrificed at various ages over 9 weeks of age. Unknown = 
























Figure 4.3. Number of studies using salt- in pathol ogical studies by decade . 
Studies that stated whether salt was administered salt- n= 24. Studies that did not add salt to the rat’s 
diet n = 78. Some groups administered salt from as young as 4 weeks old others did not introduce salt 
until 9 weeks old and beyond. Salt included the JPD on its own, JPD plus 1% NaCl in drinking water or 
just varying levels of NaCl within drinking water (~1-4% solution).  
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4.3.3 Structural Pathological Findings - Brain parenchyma (Figure. 4.4): 
Most (12/14) studies examined animals during or after the onset of hypertension. Tissue 
damage in SHRSP seemed mostly to occur in the frontal cortex and basal ganglia(Yamori et 
al. 1976a;Rodda et al. 1983;Tabuchi et al. 2002), usually within the territory of the 
MCA/ACA, MCA/PCA borderzones(Coyle and Feng 1993) and the lenticulostriate 
arteries(Yamori et al. 1976a). Cerebral pathology included cortical inf rcts, enlarged 
perivascular spaces(Tagami et al. 1987;Fredriksson et al. 1988), white matter damage, 
microinfarcts and microaneurysms(Yamori et al. 1976a;Takiguchi 1983;Minami et al. 
1985;Chue et al. 1993) although the overall incidence of each type of these lesions is 
unclear. Studies that examined lesion distribution found most lesions occurred in the basal 
ganglia(Yamori et al. 1976a). The earliest brain tissue abnormalities in SHRSP were 
documented with MRI(Sironi et al. 2004),(Guerrini et al. 2002). Here, animals raised on a 
Japanese diet from 6 weeks of age, by 10-12 weeks had blood brain bar ier (BBB) failure on 
intravenous gadolinium-enhanced MRI(Sironi et al. 2004) and tissue lesions consisting of 
small foci of perivascular extracellular edema as shown by abnormal  apparent diffusion 
coefficient (ADC) of water(Guerrini et al. 2002). Lesions started in the caudate and 
putamen(Rieke et al. 1981) and spread through the subcortical region. At sacrifice, lesions 
were associated with fibrinoid necrosis in the media, althoug the type/size of vessel 
displaying this pathology was unclear(Sironi et al. 2004). 
White matter lesions (WML) were more often seen in SHRSP than in SHR and increased 
with advancing age(Lin et al. 2001). At 20 weeks, WML were more frequent (p<0.05) in 
four separate brain regions (corpus callosum, anterior commisure, internal capsule and 
caudate) in SHRSP compared to WKY and SHR. SHR had lesions in the caudate only(Lin et 
al. 2001). In SHRSP aged >24 weeks, white matter was rarefied and cystic, particularly in 
deeper layers where myelinated fibres are abundant(Ogata et al. 1982). At 24 weeks, in areas 
with BBB leakage demonstrated with Evans Blue(Fredriksson et al. 1985), the deep 
arterioles showed fibrinoid necrosis and subcortical gray/white matter showed 
haemorrhages, vacuoles and ‘necrotic cysts’. By one year of age 75% of SHRSP with WML 
on MRI had bilateral lesions(Henning et al. 2010). 
In SHRSP aged >24 weeks, perivascular spaces were dilated around perforating 
arterioles(Tagami et al. 1987) and within BBB leakage sites(Fr driksson et al. 1988). In 
SHRSP, the number of affected segments of vessels increased towards the arterial 
borderzones. In SHRSP aged >40 weeks, microinfarcts less than 150µm in diameter were 
frequently encountered in the neocortex around arterioles showing fibrinoid necrosis, infarcts 
of varying ages were present in the cortex and subcortex(Ogata et al. 1982). 
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Figure 4.4. Summary of the timescale of cerebral pa thological changes and their relation to age in SHR SP.  
rCBF = regional cerebral blood flow. BBB = Blood brain barrier 
AGE 
BLOOD PRESSURE 








> 20  
Rapid increase in blood pressure continuing 
until 12 weeks of age. 
Established systolic blood pressure of 
approximately 210mmHg. 
Blood pressure starts to rise. Reduction in 
rCBF to 50% in frontal cortex and possible 
increase in intraluminal pressure.  
Cerebral oedema detected. Areas of softening 
observed (petechiae). 
Rarefaction of white matter, cytolytic destruction 
of neurons and small foci related to BBB leak 
found. 
White matter cysts form resulting from 
accumulation of oedema fluid and a decrease in 
CBF. 
Small “infarcts”, <150µm usually in neocortex, 
fuse into larger infarcts as a result of spreading 
fibrinoid necrosis. Aneursyms & haemorrhage 
also common. 
Proteinuria & inflammatory markers detected 
in serum & urine. 
6 
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4.3.4 Structural findings: Vessels (Figure 4.5.) 
4.3.4.1 Large vessels (>150µm) 
A) Prior to, or unattributed to hypertension.  
Publications between 1974 and 1990 reported few structural changes in the large arteries. 
Ogata found no evidence of atherosclerosis or thrombosis in the major arteries(Ogata et al. 
1982), however, a later study reported the external diameter of the carotid artery was less in 
SHRSP aged 4-8 weeks compared to WKY(Zanchi et al. 1997). Another s udy found 
vascular smooth muscle cell disorganisation (deviation from the normal 90° orientation) in 
all three layers of the media in the basilar artery of eight week old SHRSP compared to age-
matched WKY(Arribas et al. 1996). This was not corrected by antihypertensive agents. 
 
B) Following development of/directly attributable to hypertension  
Numerous studies (17/40) described large vessel changes attributed to hypertension. 
Hypertrophic remodelling was common in the large arteries of SHRSP over 12 weeks of age 
versus WKY(Kanbe et al. 1983;Tamaki et al. 1984b;Shimizu et al. 1988;Contard et al. 1993) 
and media: lumen ratios were increased in SHRSP versus SHR from 8 weeks of age. In the 
basilar artery, PCA and MCA, this was attributed to increased smooth muscle cell layers in 
the media(Mangiarua and Lee 1992). Increasing media thickness also caused a progressive 
increase in the external diameter of the MCA. Others reported a thicker media and/or smaller 
internal diameter in the basilar artery, MCA and PCA versus age-matched WKY(Nordborg 
et al. 1985). A scanning and transmission electron microscopy study revealed as many as 
10% of all smooth muscle cells in the MCA of SHRSP were necrotic by 24 weeks with no 
necrotic vessels in age-matched WKY(Fujiwara et al. 1990). Increased amounts of 
fibronectin in large vessel arterial walls in 13 week old SHR P versus WKY was attributed 
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4.3.4.2 Small vessels (<150µm)  
A) Prior to, or unattributed to hypertension.  
Only one study examined the small vessels prior to development of hypertension(Tagami et 
al. 1987). In this study, SHRSP were sacrificed from 4 weeks of age, then every 4 
subsequent weeks. The authors reported no small vessel changes visibl  with lead citrate and 
uranyl acetate staining before 12 weeks of age; a full description of changes was not given 
until 16 weeks.  
 
B) Following development of / directly attributable to hypertension 
After the onset of hypertension, most pathological changes describd were in the arterioles 
and smaller arteries ~30µm in diameter(Mies et al. 1999), particularly the lateral group f 
lenticulostriate arteries in the basal ganglia(Yamori et al. 1976a), at bifurcations and 
anastomoses between subcortical and cortical vessels.  
In 10 week old SHRSP, the mean internal diameter of ACA, MCA branches and the ACA-
MCA anastomotic collateral arterioles were significantly smaller than in WKY rats(Coyle 
1987). While this may be an early response to rising blood pressure, it may also suggest the 
arterioles in SHRSP are constitutionally smaller than WKY (in addition to the large 
arteries(Zanchi et al. 1997)) as hypertension is not fully establi hed at 10 weeks. At 16 
weeks, focal deposition of collagen and cytoplasmic necrosis were noted in the outer layers 
of the media of penetrating vessels in SHRSP(Tagami et al. 1987). This spread along the 
media with advancing age resulting in widespread medial necrosis and atrophy with eventual 
replacement of the medial muscle with collagen and cell debris(Yamori et al. 1975;Tagami 
et al. 1987).  
In 24 week old SHRSP, the internal (84µm) and external diameters (104µm) of the 3rd order 
branches of the PCA were smaller than WKY (127µm and 140µm respectively) at all levels 
of intravascular pressure(Hajdu and Baumbach 1994). There was no accompanying 
hypertrophy, suggesting the arterioles were constitutionally small, although this may have 
been secondary to hypertension which is well established at 24 weeks. At 28 weeks, 
small/medium arterioles close to cerebral lesions showed hyaline degeneration, fibrinoid 
necrosis and thrombosis(Tagami et al. 1981). The presence of thrombi within the deep 
arterioles of nine month old SHRSP was considered a secondary event following luminal 
narrowing and accumulation of fibrin-rich material found at BBB leakage sites(Fredriksson 
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et al. 1985;Tagami et al. 1987). Interestingly, in SHRSP without evidence of BBB leakage, 
no necrotic lesions were seen in the gray matter and white matter ppeared 
normal(Fredriksson et al. 1985). At 28 weeks, Tagami et al(Tagami et al. 1987) noted 
monocyte adhesion to endothelial cells with migration through the arteriolar wall into the 
media; the monocytes carried plasma components and then degranulated in the media, 
leading to further monocyte and fibrin adhesion, with eventual luminal narrowing, occlusion 
and enlarged perivascular spaces. No studies described venular changes. 
 
4.3.5 Functional Changes – Vessels 
4.3.5.1 Large vessels (>150µm) 
A) Prior to, or independent of hypertension 
One study found loss of cerebral blood flow autoregulation in SHRSP at six weeks(Tamaki 
et al. 1984a), suggesting an impaired vasoactive response may precede the onset of 
hypertension, although the precise location and timing of this loss wasn’t clear. We found no 
reports of vasoactive changes in large vessels prior to hypertension. At 12 and 52 weeks, 
endothelial-dependent relaxation was markedly reduced in the basilar rteries in response to 
acetyl choline or substance P in SHRSP versus SHR and SHRSP/SHR hybrids(Volpe et al. 
1996;Sekiguchi et al. 2001). This reduction was described as not entirely due to blood 
pressure as comparisons were made between animals with similar blood pressures(Takeshita 
et al. 1982). 
 
B) Following development of, or directly attributable to hypertension  
Functional changes were attributed directly to hypertension(Smeda and King 1999;Taka et 
al. 2002;Izzard et al. 2003;Izzard et al. 2006). In early hypertension (e ght weeks), regional 
cerebral blood flow (CBF) in SHRSP was reduced to 50% of normal (versus WKY) in the 
frontal cortex, and fell further as blood pressure increased(Yamori and Horie 1977). At nine 
weeks, SHRSP also showed decreased baroreceptor sensitivity and increased sympathetic 
nerve outflow versus age-matched WKY, possibly indicating greater sensitivity to blood 
pressure changes or failure of the feedback loop(Luft et al. 1986;Yang et al. 1995). However, 
another study found 10 week old SHRSP showed normal autoregulation versus WKY 
despite falling CBF(Smeda et al. 1999;Smeda and King 2000;Jesmin et al. 2004). 
Autoregulatory ability in SHRSP was eventually lost by 13 weeks in the MCA and PCA in 
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areas of prominent tissue damage(Smeda et al. 1999). At one year, large artery resistance in 
SHRSP was at least double that of WKY indicating increased art rial stiffness or impaired 
vascular reactivity(Werber and Heistad 1984). 
 
4.3.5.2 Small vessels (<150µm)  
We found no data prior to the development of hypertension. We found the available data on 
small vessel reactivity difficult to interpret as reports were conflicting and much could be 
secondary to hypertension(Sunano et al. 1999). For example, at 5-10 weeks, the distensibility 
of small PCA branches was reported to increase in SHRSP, but larger PCA branches had 
decreased distensibility versus WKY(Zanchi et al. 1997). 32 week old SHRSP also had 
increased passive distensibility in cerebral arterioles in vitro(Zanchi et al. 1997). At one year, 
the resistance and pressure in pial arterioles was greater in SHRSP(Werber and Heistad 
1984), they also showed a “sausage string” appearance(Werber and Heistad 1984). No 













Structural Changes Functional Changes Structural Changes Functional Changes 
External diameter of carotid 
artery in SHRSP less than 
WKY. Internal diameter 
unaffected. 
 
Localized vascular smooth 
muscle cell geometric 
disorganisation in SHRSP 
basilar artery.  
In Aorta & Basilar arteries – 
endothelial dependent 
relaxation reduced in SHRSP 
compared to SHR & WKY. 
Hypertrophic remodelling in 
SHRSP PCA & MCA– media: 
lumen ratio increased due to 
thicker media &/ smaller 
internal radius. 
Total fibronectin produced by 
smooth muscle cells in MCA 
higher = increased cell matrix 
interactions.  
 Pressure dependent 
constriction attenuated in 
SHRSP, plus large artery 
resistance double that of WKY. 
SHRSP display decrease in 
baroceptor activity implying 
impairment of ability of 
autoregulate responses to 
changes in blood pressure. 
Resistance of fully relaxed 
collateral vessels = higher in 
SHRSP. 
Focal cytoplasmic necrosis in 
outer media of lenticulostriate 
arteries spreads through the 
media along the vessel in 
SHRSP. 
Arteries close to cerebral 
lesions in SHRSP display 
hyaline degeneration, fibrinoid 
necrosis and thrombosis.  Resistance and maximal dilation 
of pial vessels increased 
compared to WKY. 
SHRSP show altered vascular 
permeability to HRP indicating 
BBB leakage. 
12 
Pial arteries connected to large 
arteries with low resistance 
show a sausage string 
appearance in SHRSP 
External diameter of MCA 
increased as a function of 
increasing pressure in SHRSP.  
Ability to autoregulate CBF lost 
in MCA & PCA domains in 
SHRSP & up to 10% of smooth 
muscle cells in MCA are 
necrotic. 
Mean internal diameter of 
ACA/MCA anastomoses 
smaller in SHRSP. 
Endothelial cell growth rate 
greater in SHRSP versus WKY 
as a measure of doubling time. 
HYPERTENSION  
Figure 4.5 . Summary of the timescale of structural and functional changes affecting both large & small vessels with increasing age.  
Levels of blood pressure begin to rise at approximately 8 weeks with hypertension fully established at 12 weeks. WKY = Wistar Kyoto. SHRSP = Spontaneously 
Hypertensive Stroke Prone Rat. BBB = Blood Brain Barrier. PCA = Posterior Cerebral Artery. MCA = Middle Cerebral Artery. ACA = Anterior Cerebral Artery. HRP = 
Horse Radish Peroxidase.  
AGE LARGE VESSELS (>100µm diameter)  SMALL VESSELS (<100µm diameter)  
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4.3.6 Endothelial and systemic abnormalities 
4.3.6.1  Prior to, or unattributed to hypertension 
Cerebral endothelial function was impaired in SHRSP, manifesting as BBB impairment 
documented histopathologically(Yamori et al. 1976a;Hazama et al. 1979;Sadoshima and 
Heistad 1982;Fredriksson et al. 1985;Tagami et al. 1987;Lee et al. 2007) or on 
imaging(Guerrini et al. 2002;Sironi et al. 2004). However, all studies of inflammatory 
markers in SHRSP used animals with a high salt intake. At 10 weeks of age, 
proteinuria(Sironi et al. 2003), raised inflammatory blood markers (see table 1) and BBB 
impairment were detected in SHRSP on MRI(Sironi et al. 2004). Thiostatin, an acute-phase 
reactant, increased sharply in the urine and serum of SHRSP on a Japanese diet plus 1% salt-
loading from six weeks of age, peaking at least four weeks before stroke (~15 
weeks)(Ballerio et al. 2007). Additionally, two groups found early cerebral vasogenic edema 
secondary to BBB leak using both proteomics and MRI(Blezer et al. 1998;Sironi et al. 
2001;Guerrini et al. 2002). Salt-loading from six weeks resulted in an ‘atypical inflammatory 
condition’ in SHRSP versus both SHR and WKY, manifesting as an acute-phase protein 
accumulation in the serum and urine (table 1)(Shimamura et al. 1999;Sironi et al. 2001). 
Excretion of inflammatory serum proteins in the urine preceded cerebral edema by three to 
15 days(Blezer et al. 1998).  
 
4.3.6.2  Following development of/directly attributable to hypertension. 
Several studies showed that endothelial function deteriorated with increasing 
hypertension(Knox et al. 1980;Kitazono et al. 1995;Lee et al. 2007). Ogata et al found 
edema fluid around abnormal perforating arterioles(Ogata et al. 1980), whilst 
Tagami(Tagami et al. 1987) described monocyte adhesion and infiltration of plasma 
components through endothelial cells in 16 week old SHRSP on an undisclosed diet. In 12 
week old SHRSP injected in vivo with Horse Radish Peroxidase (HRP) via a tail vein, a 
greater proportion of HRP reaction product appeared around arterioles of the hippocampus 
and hypothalamus (particularly in proximal segments), versus age-mtched WKY, indicating 
leakage(Ueno et al. 2004a;Ueno et al. 2004b). Spontaneous BBB leakage detected using 
intravenous Evans Blue was found in 33% of SHRSP aged 5-9 months versus 
WKY(Fredriksson et al. 1987). Injections of albumin and trypan blue have lso 
demonstrated spontaneous leakage in hypertensive 32 week old SHRSP versus both WKY 
and SHR(Yamori et al. 1975). In addition, arteriolar endothelial cells in SHRSP had 
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disturbed electrophysiological function of the tight junctions, which could lead to subtle 
changes in BBB polarity(Lippoldt et al. 2000). SHRSP capillaries showed increased 
endothelial cell contraction which resulted in leakage between endothelial cells(Tagami et al. 
1981). Cultured cerebral endothelial cells from large vessels of 8-9 week old SHRSP grew 
faster(Ito et al. 1995b) but produced less than half the amount of tissue plasminogen 
activator (tPA) as age-matched WKY rats(Matsuo et al. 1992).  
Oxidative stress is increased by hypertension and increased reactive oxygen species were 
found in the rostral ventrolateral medulla of 14 week old SHRSP rats (diet unknown)(Kishi 
et al. 2004). Nitric oxide expression was increased in areas of BBB leak and was implicated 
in the development of tissue lesions in SHRSP at 16 weeks(Gotoh et al. 1996). 
 
 
4.4 Discussion   
4.4.1 Primary Findings 
We identified 102 studies of cerebral pathology in the SHRSP. This review, a comprehensive 
and systematic analysis of the SHRSP, highlights gaps in knowledge which could be 
fundamental to understanding the causes of subcortical stroke in patie ts, a point that was 
recognised almost immediately after the strain was developed(Yamori et al. 1976a;Ogata et 
al. 1982). Although SHRSP suffer both cortical infarcts and cerebral haemorrhages, the 
predominant lesions are small subcortical lesions. Of note, five separate research 
groups(Yamori et al. 1975;Fredriksson et al. 1987;Blezer et al. 1998;Mies et al. 1999;Sironi 
et al. 2004) have found evidence of, or actively demonstrated, BBB leakage in SHRSP 
starting prior to overt vessel or tissue damage, with and without added dietary salt. We found 
no evidence of atheroma in the SHRSP.  
Early publications describe extensive histopathological investigations of tissue and vascular 
changes after stroke, whilst more recent studies focus on plasma biomarkers, changes in CBF 
and genetics. We found only one potential sequential histopathological investigation of 
arteriolar and tissue changes throughout the SHRSPs life(Tagami et al. 1987) This study 
sacrificed SHRSP every 4 weeks, reported on electron microscopic hanges in perforatoring 
arterioles and documented serial vessel wall damage. They found monocyte adhesion and 
invasion of the arteriolar wall, fibrin deposition, disruption of the v ssel wall with 
enlargement of the perivascular space and secondary luminal thrombosis in latter 
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stages(Tagami et al. 1987). The relationship of these small vessel changes to stroke lesions 
has not been specifically studied, despite much agreement that the small vessels suffer the 
major impact of the vascular changes(Mies et al. 1999).  
 
4.4.2 Discussion of the pathological data 
In SHRSP, small vessel lipohyalinosis and fibrinoid necrosis are ssociated with 
microinfarcts, white matter lesions and hemorrhage(Yamori et al. 1976a). However, the root 
cause of the small vessel pathology is unclear. The general absence of i farcts in the territory 
of arterioles occluded by thrombus, the late appearance of thrombus and sparse evidence of 
large artery atheroma, mitigate against a mainly thrombotic cause(Chander et al. 2003). 
However, the difficulty of identifying which small arteriole was associated with a particular 
vascular territory could be partly to blame. We found vascular damage and functional 
changes were more often encountered in the smaller arterioles (<150µm). However, the lack 
of information regarding arteriolar integrity before hypertensio  makes it difficult to 
ascertain whether hypertension was the main or initial cause of at least some of the arteriolar 
features. In contrast, most of the large vessel changes (especially functional) occurred after 
12 weeks of age suggesting they are a response to hypertension, alth ugh evidence was 
conflicting, especially regarding dilatory and resistance mechanisms. There was no 
information on venules, yet venules are increasingly recognised to be important markers of 
small vessel pathology in human lacunar stroke(Lindley et al. 2009;Doubal et al. 2009) and 
of inflammation in the brain(Hamilton et al. 2001;Black and Garbutt 2002;Wuerfel et al. 
2008). 
Multiple experimental approaches pointed to a primary causative role for BBB leakage and 
inflammation with evidence of increased BBB permeability in SHRSP preceding the 
development of full hypertension (12 weeks)(Yamori et al. 1975;Fredriksson et al. 1985;Ito 
et al. 1995a;Blezer et al. 1998;Mies et al. 1999;Sironi et al. 2001;Michihara et al. 
2001;Guerrini et al. 2002;Sironi et al. 2004). Several studies demonstrated spontaneous BBB 
leakage(Yamori et al. 1975;Hazama et al. 1979;Sadoshima and Heistad 1983;Fredriksson et 
al. 1987) although frequency varied, possibly due to differences in salt int ke, genetic 
factors(Hazama et al. 1979;Ito et al. 2001), or whether BBB leakage was actually sought. 
The inflammatory acute-phase reaction seen in SHRSP on a high salt intake was not 
observed in SHR under identical environment conditions(Sironi et al. 2001). This reaction 
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may exacerbate vascular dysfunction by increasing BBB permeability through alterations at 
the endothelial tight junctions. 
 The above findings suggest the initiating cerebral pathological event in SHRSP could be 
BBB disruption rather than vasospasm, thrombosis or ischemia. Indeed no vessel alterations 
were seen in regions with preserved BBB function(Fredriksson et al. 1988). This suggests 
that endothelial damage could lead to the lipohyalinosis/fibrinoid necrosis observed in older 
animals alongside white matter rarefaction and cysts(Ogata et al. 1981). However, further 
studies are needed to determine whether this change can be attri uted to high salt 
intake(Henning et al. 2010). 
There are alternative causative hypotheses. Some vasoactive responses and structural 
changes such as vessel wall thickening(Mizuno et al. 1999) may all be the result of adaptive 
responses to limit the effects of rising blood pressure. Other c anges, such as the loss of 
autoregulation at 10 weeks, may expose the brain to elevated systemic blood pressure and 
increase the damage(Werber and Heistad 1984;Smeda et al. 1999;Smeda and King 2000). 
Falling CBF could also lead to ischaemia, which in turn causes BBB disruption and 
edema(Henning et al. 2010). However the falling CBF could repres nt a loss of brain tissue 
to supply following brain damage from an alternative cause. 
 
4.4.3  Methodological considerations 
Our review has some weaknesses. We have not described renal vessels, mesenteric arteries 
and other systemic vessels. SHRSP, like humans, do not just suffer from a cerebral 
disease(Thompson and Hakim 2009). Even though our literature search was robust we 
cannot exclude having overlooked some literature.  
There are methodological issues within the SHRSP literature. In particular, no studies 
mentioned blinding of analysis to rat strain, meaning the pathologica results reported are 
potentially susceptible to opinion bias. Not all authors stated the age of animals at sacrifice. 
Most animals (where age was given) were at least 12 weeks old, by which time hypertension 
is fully established. Many vessels included in histopathological investigations were cortical 
rather than subcortical, probably because it is technologically less demanding to analyse 
cortical vessels. Therefore, further study of the exact sequence of path logical differences in 
the small subcortical arterioles is required. Some studies did not give the number of animals 
studied and none provided an estimate of sample size. This may be because many were 
undertaken as exploratory pilot studies. If this is true it would mean larger definitive studies 
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are required. Recent studies use a high salt intake(Enea et al. 2000) to hasten pathological 
changes, potentially masking the natural development of disease. The Japanese diet contains 
on average, 4% sodium chloride rather than the usual 0.4% in standard rat chow(Matsuo and 
Nagaoka 1981) and accelerates the development of hypertension in SHRSP(Stier et al. 
1988;Schmidlin et al. 2005); most SHRSP on a high salt intake die before 28 weeks. Salt-
loading via drinking water usually includes 1% NaCl. Compared to WKY, SHRSP are said 
to prefer salty water(Stier et al. 1988;Hilgers et al. 1993;Bourjeili et al. 1995). Dietary salt 
modulates the blood pressure of SHR and SHRSP but is said to have little effect on 
WKY(DiNicolantonio and Silvapulle 1988). A higher salt intake in SHRSP may increase 
BBB permeability, increase production of reactive oxygen species and lead to early 
death(Kim-Mitsuyama et al. 2005;Ishizuka et al. 2007). However, as no tudies provided 
direct comparisons between animals randomly allocated to high salt intake or not, it is 
difficult to say what components of brain or vessel pathology are influenced by salt rather 
than other factors. Furthermore high salt is no more a risk factor for lacunar stroke than any 
other stroke subtype(Jackson et al. 2010) and therefore we would discourage the use of salt 
when assessing pathology in relation to human small vessel disease. These studies were 
performed on several different colonies of SHRSP, all with differing genetic phenotypes, 
breeding programs, levels of systolic hypertension etc. However, it is encouraging to see 
concordant results from several different groups. Testing hypotheses on rats from several 
colonies would help overcome problems of colony-specific rats. Finally, the use of both in 
vitro and in vivo methods to study small vessels may have contributed to contrasting results 
as the environment around the vessel influences its function, so studies of isolated cell or 
other in vitro preparations should be interpreted cautiously(Hajdu and Baumbach 1994).  
 
4.5 Conclusions 
This review has added weight to the case made in two recent reviews of potential animal 
models of subcortical stroke(Hainsworth and Markus 2008;Bailey et al. 2009) that the 
spontaneous cerebral pathology of the SHRSP (and without dietary or surgical interventions) 
mimics human subcortical stroke. However, there is missing data which needs to be 
addressed in order to fully utilise this model of the human disease. Future studies should 
include profiling inflammatory markers in SHRSP that have not been exposed to excess salt, 
more quantitative assessments of biomarkers at pre-hypertensive ages (<9 weeks), detailed 
analysis of the differences in all levels of vessels betwe n SHRSP and controls and how 
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changes in the arterioles and venules relate to the sequence of spontaneous tissue 
pathological changes.  
 
The above conclusions provided the rationale for the original laboratory work presented in 



































Doctor of Philosophy University of Edinburgh 79 
SECTION 2) EXPERIMENTAL WORK 
CHAPTER 5 :GENERAL MATERIALS AND METHODS 
 
The conclusions from the three systematic reviews conducted at the beginning of the thesis 
highlighted the Spontaneously Hypertensive Stroke-Prone Rat (SHRSP) to be the best 
potential animal model of lacunar stroke. Consequently all of the original laboratory work 
contained within this thesis has been conducted on this rat strain.  
 
5.1 The SHRSP rat (Rattus Norvegicus) – genetic background, breeding history, 
Glasgow colony. 
The Spontaneously Hypertensive Rat family was developed by selectiv  cross breeding of 
Wistar Kyoto Rats (WKY) and consists of three members; the Spontaneously Hypertensive 
Rat (SHR) developed in 1963,(Okamoto and Aoki 1963) the Spontaneously Hypertensive 
Stroke Prone Rat (SHRSP) in 1974(Okamoto et al. 1974).  
We obtained SHRSP and Wistar Kyoto rats (WKY) from the Glasgow colony(Graham et al. 
2007). The Glasgow colony (SHRSP/Gcrc) has been running since 1991 and is the result of 
strain specific brother-sister mating of 13 SHRSP (6 males nd 7 females) from Dr D.F. 
Bohr (Department of Physiology, University of Michigan, Ann Arbor). The colony is 
maintained by selecting rats with particular levels of systolic blood pressure for mating. 
Males with blood pressure of 170-190mmHg are bred with females with blood pressure 
readings of 130-150mmHg at approximately 10 weeks of age. This process produces 
offspring with an approximate mean systolic blood pressure of 187mmHg compared to 
WKY rats at 134mmHg at 9 weeks of age (figure 5.1). Normal blood pressure for a WKY rat 
is considered to be approximately 130/90mmHg(Higashino et al. 1995).  
 
5.1.1 Animal maintenance 
We administered a normal diet (standard rat chow) to one group of animals that we 
sacrificed at 5 & 16 weeks of age. We assessed 21 week old rats reared on both a normal diet 
and animals which were salt-loaded from 18 weeks of age by adding 1% NaCl to their 
drinking water. All animals were male and maintained on a 12 hour light/dark cycle with 
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food and water freely available in compliance with UK home office regulations. All brain 
extractions and exsanguinations were performed by Dr. Delyth Graham (University of 
Glasgow) and were conducted under a project and personal license issued by the UK home 
office under the animals (scientific procedures) act 1986.  
 
Systolic Blood Pressure Measured by 
Tail Cuff Plethysmography



























Figure 5.1. Systolic blood pressure readings measur ed by tail cuff plethysmography taken from 
male SHRSP and WKY rats aged 5 to 16 weeks in the G lasgow colony.   
Error bars represent standard error of the mean. Data points represent the mean of 6-8 measurements 
from each animal in one sitting. 
 
 
5.2 Tissue collection, fixation and storage.  
We sacrificed animals by overdose of isofluorane at 5, 16 and 21 weeks of age, to enable 
assessment of the SHRSP at a normotensive, hypertensive and malignant hypertensive stage 
and age matched controls. After extraction we divided all brains in half along the saggital 
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plane with a scalpel. We fixed one hemisphere in formalin for subsequent paraffin 
embedding and histology, the other we froze in liquid nitrogen for cryostat sectioning and 
ribonucleic acid (RNA) extraction. We stored the formalin fixed brains at room temperature 
for paraffin processing and the frozen hemispheres in a -80°C freezer until required for 
cutting on a cryostat.  
 
5.3 Histology – formalin fixed tissue.  
5.3.1 Development of a standard sampling protocol for quantitative assessmnt of 
histology - part 1.  
No standardised sampling method for extracting a specified area brain tissue from animals of 
varying ages (and therefore varying brain sizes) currently xists in the literature therefore we 
tried to rectify this by devising a protocol. Each sample of tissue we received from the 
Glasgow colony was assigned an ID number (e.g. C6157) which gave no indication of the 
age, strain and /or diet of each animal to ensure that our analysis was as blinded as possible. 
Full blinding is difficult to achieve as 5 week old brains are smaller to the naked eye than 16 
and 21 week brains. We cut each hemisphere into 2mm thick coronal slices using a matrix 
(Zivic™) to produce consistent and replicable results. This resulted in approximately 6 
sections per brain (7 in 21 week old animals). We processed and embedded the slices in 
paraffin blocks, which we then cut into thinner sections (7µm for H&E staining and 4µm for 
immunohistochemistry) on a microtome. From the coronal slices we selected one from 
approximately +1.8mm Bregma to capture a frontal section and one frm approximately -
1.72mm Bregma to capture areas of the basal ganglia and internal capsule (mid coronal 
section)(Paxinos and Watson 2007)(figure.5.2). These areas are said to display the majority 
of brain abnormalities in SHRSP(Fredriksson et al. 1985). To account f r differences in 
brain size across the different ages and ensure standard sampling from consistent brain 
regions regardless of age, we used a stereotactic atlas to iden ify prominent structures within 
our two desired sections (e.g. the anterior commissure and lateral ventricle for the frontal 
section and the internal capsule and anterior hippocampus for the mid coronal 
section)(Paxinos and Watson 2007). We based our final decision on a series of haematoxylin 
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5.3.2 Hematoxylin and Eosin staining. 
We used Hematoxylin and Eosin (H&E) staining as a standard method which has been used 
in previous studies and against which we could interpret any changes seen using other 
pathology techniques. H&E staining delineates anatomical regions and cell morphology as 
well as defining ischaemic neuronal damage(Bancroft and Gamble 2002). Haematoxylin 
stains nuclei blue/black and Eosin stains cytoplasm red. White matter stains a deeper pink 
than grey matter and stains the following structures accordingly; 
Muscle fibres – deep pinky red 
Collagen – pale pinky red 
Red blood cells – orange/red 
Fibrin – deep pink 
 
5.3.2.1 Protocol:  
For the full H&E staining protocol see appendix E. Briefly, we dewaxed slides in xylene and 
hydrated them via absolute alcohol and 99% Industrial Methylated Spirit to 70% alcohol, 
before incubating the slides in picric acid for 30 minutes. We rinsed the slides in water and 
placed them in Harris haematoxylin solution for 10 minutes. After a second wash with water 
and differentiation in acid alcohol we placed the slides in lithium carbonate solution until 
blue (usually 3-5 dips). Emersion in Putts Eosin solution for 10-12 minutes, followed by 
dehydration in alcohols completed the process. We left the slid s in xylene to clear then 
mounted them with cover slips. 
 
5.4 Qualitative assessment of morphological changes 
Three observers (EB, Dr Colin Smith & Prof. Joanna Wardlaw) assessed slides for any gross 
pathology under a light microscope (Olympus BX51). Precise featur s were discussed to 
clarify features relevant to prior studies and to map to other data. We recorded incidences of 
vessel thickening and the size of the vessel affected, white matt r rarefaction, inflammation 
and any other evidence of microinfarction, haemorrhage or white matter lesions. We also 
looked at the ependyma of the ventricle for ependymal thickening or periventricular 
rarefaction as evidence of structural damage which could suggest leakage of CSF. 
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5.4.1 Development of a standard sampling protocol for quantitative assessmnt of 
histology - part 2.  
We developed a standard sampling protocol to assess the same 3 regions of interest across all 
animals; cortical grey matter, white matter and deep grey matter (see figure 5.3 for 
anatomical representation of these regions). We defined a crosssectional area using 
prominent features which were clearly visible across all age groups and strains of rat. For 
frontal sections, the most lateral edge of the lateral ventricle provided one boundary whilst 
the entorhinal cortex provided the other. In mid coronal sections the most lateral part of the 
emerging hippocampus provided one boundary whilst the rhinal fissure provided the other 
(see figure 5.3).  Using these boundaries we could then define each region using the free 
hand tool on ImagePro™.  
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Figure 5.2. Sections of the rat brain taken for his tology experiments (both staining and immunohistoch emistry).   
Images based on sections in the Rat Brain Atlas (Paxinos & Watson 6th Edition). In the frontal section the anterior lateral ventricle is visible along with the anterior 
commisure and entorhinal cortex. Within the mid coronal section the anterior hippocampus is visible and we aimed to obtain the largest area of the internal capsule 
possible to maximise the amount of white matter sampled. 
Frontal section 
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5.4.2 Quantitative assessments  
5.4.2.1 Vessel density and Cell Counts –  
Using image analysis consisting of a CoolSNAPTM camera (Roper Scientific Photometrics) 
attached to a light microscope (Olympus BX40 with x10 eye pieces) complete with platform 
(Prior Scientific), we counted various features on our anonymously coded slides using a 
random sampling protocol of three regions on Image-ProTM plus 6.3 software. These 
included; vessel density (capillaries and large vessels separately), neurons and 
oligodendrocytes. All structures which could be confidently identifi d by the observer (see 
chapter 6 for further details).  
Using the software, we designed a stereology experiment. Each slide was tiled (using 
snapshots tiled side by side) to create a full on screen image at x4 magnification. We set 





Figure 5.3. The cross sectional areas used in A) th e frontal section and B) the mid coronal 
section to sample cortical grey, white matter and d eep grey regions from all SHRSP and WKY 
animals regardless of age.   
The red boundary lines were defined using A) the most lateral edge of the lateral ventricle and the 
entorhinal cortex and B) the rhinal fissure and the most lateral point of the hippocampus. CG = Cortical 
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Regions – Cortical Grey, White Matter and Deep Grey 
Count frame – 300µm2 
Random points per region – 3 
Thickness – 7µm 
Experimental objective – x20 
Counts – capillaries, large vessels, neurons, oligodendrocytes.  
 
We then drew the first region of interest (i.e. cortical grey) using the free hand tool on 
ImagePro™. Once this region was defined we generated three random sampling points 
within the area using the software (figure.5.4). Within each point (300µm2) we then 
performed the above counts. Once the experiment was running, each count frame (random 
point per region) was brought up independently and we performed the counts for all objects 
one after the other. The software colour coded the separate structures accordingly (figure 
5.5). Once we had counted all the large vessels, capillaries, neurons and oligodendrocyt s for 
that count frame, the software transferred to the next count frame and the process continued 
until all three random points had been counted for that region. We then drew the next region 
of interest (i.e. white matter) and repeated the process until the last sampling point within the 
deep grey matter had been counted. We loaded the next slide, drew the cortical grey region 
and so on.  
Both frontal and mid coronal sections were analysed using the described protocol. We 
exported data to an excel spreadsheet for analysis.  
 
5.4.2.2 Measurement of sclerotic index:  
Using the same defined regions (cortical grey, white matter and deep grey) we also measured 
evidence of atherosclerosis in both cortical and perforating arterioles using Lammie’s 
sclerotic index(Lammie et al. 1997) where the following formula is applied; 
 
Ratio = 1-(internal diameter/external diameter). 
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From this formula normal vessels are considered to lie within the range of ratios of 0.2-0.3, 
0.3-0.5 constitutes moderate sclerosis, and severe sclerosis is anything over a value of 
0.5.We sampled 5 vessels from the cortical and deep grey matter and three from the white 
matter for each animal (the likelihood of finding vessels preserved well enough to measure 
in the white matter was lower due to the area of white matter being smaller).  
Using the measurement tool on Image ProTM we measured the diameter of both the lumen 
(internal) and the entire vessel. We took measurements at the same point along the vessel so 
that the lines superimposed one another. This minimised human error (figure.5.6). 
We exported the data to an excel spreadsheet for calculation of the ratio and further 
statistical analyses. 
 
5.4.3 Data analysis 
We performed statistical analysis using R software. We adjusted counts for age by 
calculating ratios - 5:16 weeks & 16:21 weeks for all cross section areas and applying the 
ratio to the counts. 
For example;  
                       21wk cortical grey area/16wk cortical grey area = 1.34 
                       16wk count stays the same 
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Figure 5.4. A screenshot from ImagePro™ showing the generation of random sampling points 




With these adjusted values we performed a general linear model (GLM). For each region we 
firstly took the median count from the three randomly generated sampling points in each 
animal. Then we took the median value from all 5 animals to use in the final analysis and 
based the GLM on a quasi poisson distribution because the data were over-disperse .  
For all of the statistical analysis, we analysed frontal and mid-coronal sections separately as 
there were significant differences in the distribution of grey and white matter within the 
sections. We also analysed each region (cortical grey, white mattr and deep grey) separately 
as there are substantial anatomical differences as well as differences in the area between 
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Figure 5.5. A screenshot from ImagePro™ showing the stereology experiment designed to 
perform counts of different cell types.  
This particular shot is taken from a sampling point within the cortical grey matter of a mid coronal 
section at x20 objective. The red and green lines represent the boundary of the sampling point. 
Capillaries (red squares), neurons (red triangles) and oligodendrocytes (yellow circles with crosses) are 
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Figure 5.6 . Measurement of sclerotic ratio(Lammie et al. 1997) using the measurement tool on 
Image Pro™.   




5.5.1 General principles of immunohistochemistry 
Immunohistochemistry is used to localize antigens in cells of a tissue section using 
antibodies which bind specifically to the selected antigen. It is used to understand the 
distribution of a variety of cell types, proteins and enzymes in different parts of a tissue 
section(Bancroft and Cook 1994).  
There are two methods of immunohistochemical staining; the direct m thod and the indirect 
method(Bancroft and Gamble 2002). The direct method is a one-step staining method, and 
involves an antibody labelled with a fluorescent tag or enzyme which reacts directly with the 
antigen. This method is fast and simple but does not amplify signal very well so is less 
commonly used(Ross and Pawlina 2005). In this study we used the indir ct method of 
 
Doctor of Philosophy University of Edinburgh 91 
immunohistochemistry. This uses an unlabelled primary antibody against the antigen being 
probed for and a second, labelled, antibody against the first(Bancroft and Cook 1994). The 
secondary antibody is raised against Immunoglobulin G (IgG) of the animal species in which 
the primary antibody has been developed. E.g. A mouse primary antibody must be coupled 
with an anti-mouse secondary antibody in order to prevent any immunoreactivity of the host 
species taking place. The indirect method is more sensitive becaus  signal amplification 
occurs through several secondary antibody reactions with different antigenic sites on the 
primary antibody(Ross and Pawlina 2005). The secondary antibody is then labelled with a 
fluorescent dye or an enzyme. The indirect method is also advantgeous because a labelled 
secondary antibody raised against mouse IgG, works well with any primary antibody raised 
in mouse. With the direct method, it would be necessary to make custom labeled antibodies 
against every antigen of interest. 
For this study we used a biotinylated secondary antibody coupled with streptavidin-
horseradish peroxidase, which we reacted with 3,3'-Diaminobenzidine (DAB) to produce a 
brown staining wherever primary and secondary antibodies are attached. We lightly 
counterstained with hematoxylin to highlight basic structures and neurons.  
We applied the Avidin Biotin Complex (ABC) immunoperoxidase method (Vector 
Laboratories)(http://www.ihcworld.com/_protocols/general_IHC/standard_abc_method.htm) 
of indirect immunohistochemistry to all slides. All antibody dilutions and incubation times 
are available in table 5.2. We performed all incubations at room te perature unless 
specified. For the full ABC protocol see appendix G 
For a list of all the antibodies used in this thesis see table 5.1.  
 
5.5.2 Blocking and reducing background staining 
We blocked all sections in 10% hydrogen peroxide for 10 minutes to prevent any 
endogenous peroxidase activity contributing to non-specific background staining. We also 
blocked endogenous biotin where necessary using the provided reagents within the ABC kit. 
Where necessary, blocking of cross reactive antigens within the tissue was also applied by 
choosing the correct secondary antibody.  For example the monoclonal myelin basic protein 
(MBP) antibody we used was raised in rat and using this antibody in rat tissue meant any 
endogenous immunoglobulins would be detected by the antibody as well as those aimed at 
the exogenous antibody. To prevent this, a rabbit anti rat secondary antibody was applied to 
sections to remove any cross reactivity.  
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5.5.3 Heat mediated antigen retrieval 
Fixation of tissue in formalin can create protein cross links which can cause antig nic sites to 
be masked and unable to bind to antibodies. By breaking these cross links, more antibody – 
antigen interactions can occur thereby increasing the overall signal obtained(Bancroft and 
Gamble 2002). Heat, in the form of a microwave, water bath or inur case, pressure cooker 
enables these cross links to be broken. We used a Menarini (A.Menarini Diagnostics) digital 
pressure cooker which heated the slides for 20 minutes before co ling gradually for a further 
20 minutes. In most cases we immersed the slides in citric acid buffer (pH 6.0) which acted 
as the retrieval solution. For MBP staining we found TRIS-EDTA (pH 9.0) to be more 
effective.  
 
5.5.4 Antibody optimization 
We used human glioma tissue (for matrix metallopeptidase 9 (MMP9)) and rats donated 
from Prof. J. McCulloch’s lab (all remaining antibodies) for the optimization of antibodies. 
Two rats (approximately 11 weeks old) underwent permanent bilatera  carotid ligation and 2 
were subjected to a sham procedure as part of the animal experiments for which they were 
being used. Bilateral carotid ligation is considered to be a model of low cerebral blood flow 
and rats develop white matter damage(Shibata et al. 2004). After a week of recovery we 
sacrificed the rats via cardiac perfusion with saline followed by paraformaldehyde for 
fixation. We transferred one hemisphere to PBS (Physiological Buffered Saline) for paraffin 
sectioning (see above) and froze the other hemisphere using isopentane to eventually be used 
for cryostat and laser microdissection training. We titrated all antibodies to values 
recommended by specification sheets from the supplier if the information was available. If 
no information was available trial and error was used to determin  the optimal dilution, pre-
treatment and incubation period used. Optimal dilution was reached wn staining was clear, 
uniform and isolated to the appropriate structures across the section.  
 
5.5.5 Image Analysis and reproducibility study  
We measured percentage staining using ImageProTM s ftware (version 6.3), blinded to 
species and age, in cortical, deep grey and white matter in the frontal and mid coronal 
sections as described earlier. We assessed intra-observer r liability using a randomly 
selected slide counted on 5 separate occasions (see chapter 6 for results). We used the same 
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standard sampling protocol developed for quantitative assessment of H&E slides described 
previously (see figure.5.3). We repeated the full image analysis protocol on both frontal and 
mid coronal sections in each animal blind to strain, age and diet. We hen applied colour 
matched pixel counts to the entire hemisphere, counting each region of interest separately as 
described for the H&E stained slides. We converted counts into percentage areas of staining 
as a measure of immunoreactivity using ImagePro™, once each region had been defined by 
hand (figure 5.7).  
 










Collagen I Abcam Monoclonal Rabbit anti Mouse 
(Dako) 
Found in smooth muscle as a 
sign of scarring or repair. 
Collagen IV Abcam Polyclonal Swine anti Rabbit 
(Dako) 
Indicates structural integrity of 
the basal lamina. 
MMP9 Abcam Monoclonal Rabbit anti Mouse 
(Dako) 
Expression indicates breakdown 




Abcam Monoclonal Rabbit anti Mouse 
(Dako) 
Cytoskeletal protein – indicator 
of basement membrane 
integrity. 
Claudin 5 Lifespan 
Biosciences 
Monoclonal Rabbit anti Mouse 
(Dako) 
Transmembrane protein present 
in the tight junctions of 
endothelial cells. 
Iba-1 Abcam Polyclonal Rabbit anti Goat 
(Dako) 
Activated microglial cells - 
inflammation 
MBP Abcam Monoclonal Rabbit anti Rat 
(Dako) 
Myelin Basic protein – integrity 
of WM tracts 
GFAP Dako Polyclonal Swine anti Rabbit 
(Dako) 
Indicator of astrocyte function. 
Occludin Lifespan 
Biosciences 
Polyclonal Swine anti Rabbit 
(Dako) 
Tight junction protein within 
endothelial cells 
Caspase 3 Abcam Polyclonal Swine anti Rabbit 
(Dako) 
Indicator of cell death 
 
Antibodies highlighted in red were intended for use but did not optimise well in brain tissue and were 
subsequently excluded from the panel. MMP9 = Matrix metallopeptidase 9. Iba-1 = ionized calcium 
binding adaptor molecule 1). MBP = Myelin Basic Protein. GFAP = Glial Fibrillary Acidic Protein. 
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5.5.6 Data Analysis 
We performed statistical analysis in Minitab using a general linear model two-way ANOVA 
followed by Tukeys test for pairwise comparisons as the data consisted of mean percentages. 
For intra-observer reliability we used coefficient of variance analysis and measured the 
effect of day on staining count. For the assessment of antibodies we calculated the effects of 
strain and age. We assessed the effect of salt-loading and strai  for the salt-loaded animals. 
For all of the statistical analysis, we analysed frontal and mid-coronal sections separately. 
We also analysed each region (cortical grey, white matter nd deep grey) separately. P 
values of <0.05 were considered statistically significant.  
 
Table 5.2. Dilutions and incubation periods used fo r primary antibodies.
Antibody Dilution  Pretreatment Incubation 
period (hrs) 
Temperature 
Collagen I 1:400 Heat mediated antigen 
retrieval in citric acid buffer. 
24 4°C. 
Collagen IV 1:200 Heat mediated antigen retrieval in citric acid buffer. 24 4°C. 




Muscle Actin 1:400 
Heat mediated antigen 
retrieval in citric acid buffer. 1 
Room 
temperature. 
Claudin 5 1:200 Heat mediated antigen retrieval in citric acid buffer. 24 4°C. 
GFAP 1:800 Heat mediated antigen retrieval in citric acid buffer. 0.5 
Room 
temperature. 
MBP 1:150 Heat mediated antigen retrieval in EDTA buffer. 0.5 
Room 
temperature 
Iba-1 1:75 Heat mediated antigen retrieval in citric acid buffer. 0.5 
Room 
temperature 
Hrs = Hours. EDTA = ethylenediaminetetraacetic acid 
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Figure 5.7. A screen shot taken from ImagePro (vers ion 6.2) showing areas of immunoreactivity as highl ighted pixels (red crosses) .  
This image is taken from a mid coronal section of a 5 week old WKY. The blue lines represent the boundaries of our standardised cross section (see figure 5.3).
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5.6 RNA Microarray 
The purpose of a microarray is to measure for each gene, the amount of message that was 
broadcast through the RNA. They are useful for measuring how much RNA was produced 
by each gene and the transcription levels of different genes in different cells / conditions. For 
a diagrammatical representation of the steps necessary to produce a RNA microarray see 




Figure 5.8. Schematic representation of the steps r equired to perform a microarray experiment.   
Source: http://www.scq.ubc.ca/wp-content/eukaryoticexpressionsarra.gif. mRNA = messenger RNA. cRNA = 
complementary RNA. 
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5.7 Materials and methods  
We used 4 hemispheres from each group of animals (5, 16, 21 week and 21 week salt-loaded 
from each strain) for total RNA extraction. Total animals n=32. 
 
5.7.1 Laser capture microdissection- pilot study 
We aimed to capture precise areas of the neurovascular unit so that changes in gene 
expression could be directly related to vascular pathology. To do this we employed laser 
capture microdissection. We removed each frozen hemisphere from -80°C freezer and placed 
it into a pestle and mortar containing liquid nitrogen. We treated ll equipment mentioned in 
this section with RNAzap before use. We used the pestle to knock off a chunk of tissue that 
would have an edge suitable for mounting onto a cryostat. We mounted the tissue onto a 
chuck with Tissue-Tek® Optimal Cutting Temperature (OCT) comp und and sectioned it 
coronally at a thickness of 6µm. We placed some sections straight into PCR tubes and kept 
them on dry ice for RNA quality assessment. We mounted the rest of the sections on slides 
which were kept on dry ice until all the required tissue was cut. We then incubated all of the 
sections in 70% ethanol for 1 minute, washed them in nuclease free water and incubated the 
sections in RNA later for 4 minutes before staining with cresyl violet. Simply, slides were 
hydrated in graded alcohols, stained with cresyl violet (by direct application of 300µl of 
cresyl violet to the slide) washed and dehydrated down the samgrade of alcohols before 
being cleared in xylene.  
Cresyl violet highlights nuclear structures blue. It has been shown t  have no adverse effects 
in terms of RNA degeneration and is recommended along with Acridine Orange for laser 
capture microdissection(Roozen et al. 2010).  
We used slides of both unstained and stained tissue for laser microdissection (LCM). On an 
ArcturusXT ™ LCM instrument and using Capsure® LCM caps (Applied Biosystem ) we 
took approximately 100 pulses per slide using the following settings; laser settings diameter 
7µm, power ~ 60mW. We removed the film from the cap with tweezers and placed into 
0.5ml Eppendorf containing 100µl lysis buffer (Qiazol) and kept the sample on ice for RNA 
extraction. 
After numerous attempts at the above protocol it became clear that we could not obtain 
consistent samples of a high enough RNA quality to proceed to microarray nalysis. We 
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therefore decided to use homogenized tissue slices (similar to those used in H&E and 
immunohistochemistry).  
 
5.7.2 Homogenized tissue slices (frontal and mid coronal sections) for microarray 
analysis. 
We removed each hemisphere from the -80°C freezer and immersed it in x10 volume of 
RNAlater®-ICE solution (Ambion) in a 20ml falcon. We left the hemisphere for 24 hours in 
a -20°C freezer to enable the RNA-later ice solution to penetrate the issu  completely. 
The next day we mounted the hemisphere in a Zivic rat slicer matrix and cut 2mm coronal 
slices from a frontal and mid coronal region to correspond with the slices taken for 
immunohistochemistry and H&E staining. Therefore we had 64 samples in total (32 animals 
x 2 brain slices per animal). We weighed the slices and placed them in approximately 1.5ml 
(x10 volume) of lysis buffer in 7ml bijoux containers. We homogenized the tissue slices 
using a benchtop POLYTRON® homogenizer (Capitol Scientific Inc.) with an RNA blade 
attached for approximately 30 seconds or until no lumps of tissue remain d. In between each 
sample the blade was washed once in nuclease free water, scraped with a 10µl pipette tip and 
washed twice more in nuclease free water to ensure any RNA from the previous sample was 
removed.  
We then applied a Qiagen RNAeasy lipid tissue minikit (www.qiagen.com) for extraction of 
total RNA from fatty tissues to the homogenates. Briefly, the addition of chloroform 
produced a clear aqueous fraction to form which we transferred onto a microfilter cartridge.  
We added wash solutions and eluted the resulting RNA with nuclease free water (2x50µl). 
We placed half the elute into a second tube and treated it with turbo DNase. We then 
assessed yield and 260:280 ratio of the resulting RNA on a Nanodrop ND 1000 – a 
spectrophotometer (see figure 5.9 for a typical nanodrop RNA profile). Absorbance at 
260nm was used for quantification of nucleic acids. Absorbance ratios (260/280nm) of 
approximately 2.0 for RNA indicated that the RNA preparation was sufficiently free from 
protein contamination. We took averages of duplicate or triplicate readings for samples 
requiring very precise quantification. Finally we extracted a 3µl sample of each RNA stock 
solution diluted to 300ng/µl to send to the Agilent bioanalyser for full assessment of RNA 
quality (see figure 5.10 for a typical RNA profile from the agilent bioanalyser).  
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Figure 5.9. A typical good quality RNA profile from  the nanodrop .  
The 260/280 ratio of a good sample should be approximately 2.0 thereby indicating that genomic DNA 
has successfully been removed. The 260/230 ratio should be above 1.7 which indicates protein 
contamination is unlikely. The pink box in the bottom right hand corner represents the yield in ng/µl.  
 
 
Figure 5.10 A typical total RNA profile obtained fr om the Agilent bioanalyzer.   
FU = Fluorescence units. The peaks represent the 18S (the peak at ~ 42) and 28S (the peak at ~ 49) 
isomers of ribosomal RNA (rRNA) A perfect sample would have a 2:1 ratio (28S:18S). The RNA 
integrity (RIN) value for this particular sample was 9.5. We accepted samples with RIN values of ≥ 7.5.   
 
 
Doctor of Philosophy University of Edinburgh 100 
5.7.3 RNA purification 
We assessed the concentration of the samples of extracted RNA treated with DNase by 
running them on the nanodrop three times to determine a mean concentration. Optimum 
concentration for amplification is 500ng/11µl therefore we prepar d the appropriate dilutions 
with nuclease free water. We prepared a 20µl sample so that the concentration could be 
checked again on the nanodrop. If necessary we made adjustments with either more stock 
sample or nuclease free water and once again the concentration checked. 
 
5.7.4 In vitro transcriptions – amplification and formation of cRNA 
We performed transcriptions from RNA to cRNA using an Ambion Illumina TotalPrep RNA 
amplification kit (www.ambion.com). Samples were done in batches of 12. 1 kit provides 24 
samples worth of reagents. 
We generated first strand complementary DNA (cDNA) by making up a first strand master 
mix containing an oligo (dT) tagged with a phage T7 promotor. We added 9µl of this master 
mix to 11µl of each RNA sample – a total solution of 20µl per 0.5ml Eppendorf.  We 
incubated all the samples on a thermocycler at 42°C (with a heated lid of 50°C to prevent 
condensation forming within the tubes) for 2 hours. We then made a second strand cDNA 
master mix containing DNA polymerase and added 80µl to each sample. We returned the 
samples to the thermocycler for 2 hours this time at 16°C with no heated lid. 
Meanwhile we heated 20µl of nuclease free water per sample to 55°C ready for the elution of 
cDNA. After removing the samples from the thermocycler we added 250µl of cDNA binding 
buffer to each sample and mixed by pipetting. We passed the solution over a column and 
spun it down for 1 minute at 10000g (g = rcf = relative centrifugal force). We discarded the 
flow through and added 500µl of wash buffer to the column and spun the column down at 
10000g for 1 minute or until all the solution had passed through. In orderto r move any 
excess wash solution from the column we discarded the flow through and spu  the column 
down once more to dry the filter. Once dry we placed the filter into a new collection tube. 
We applied 20µl of 55°C water to the centre of the filter and incubated at room temperature 
for 2 minutes. We then spun the column down for 1 minute at 10000g to collect the eluted 
cDNA.  
Meanwhile we prepared an in vitro master mix solution which amplifies and labels the 
cDNA with biotin UTP (deoxyuracil nucleotides) and added 7µl to a new 0.5ml Eppendorf. 
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We then transferred the elute (~20µl) from the collection tube ov r to the Eppendorf 
containing the IVT mix and mixed by pipetting up and down. We briefly spun down the 
samples on a centrifuge before incubating on the thermocycler (37°C with heated lid to 
100°C) for 14 hours. 
The following day we stopped the reaction by adding 75µl of nuclease free water at room 
temperature (to bring the solution to approximately 100µl). We set up a second set of 
columns and microfilters this time for cRNA extraction and heated 200µl of nuclease free 
water per sample to 55°C ready for elution. After removing samples from the thermocycler 
we added 250µl of cRNA binding buffer to each sample followed by 350µl of 100% 200 
proof ethanol. We mixed the solution mixed by pipetting then loaded the total volume 
(~700µl) onto the column and spun it down at 10000g for 1 minute. We discar ed the flow 
through and then added 650µl of wash buffer to each sample and spun down all the s mples 
at 10000g until all the solution had passed through (approximately 1 minute). We again 
discarded the flow through and spun the column dry once more. We placed the filter into a 
new collection tube and applied 200µl of nuclease free water to thecentre of each filter. We 
incubated the samples in a hybridisation oven at 55°C for 10 minutes before spinning the 
column down at 10000g for 1 minute. To increase the RNA concentration in the fi al luted 
sample, we passed the elute over the same column and spun it down for a second time 
leaving a final cRNA elute of just less then 200µl. We checked the cRNA profiles of all 
samples by running them on the agilent bioanalyser (see figure 5.11 for a typical cRNA 
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Figure 5.11. A typical cRNA profile obtained from t he Agilent bioanalyzer.   
FU = Fluorescence units. A good quality sample should be a smooth and equally distributed curve 
around a peak value of 40. Samples with peaks between 35 and 45 were generally accepted 
depending on the shape of the curve obtained. Samples shifted to the left indicate degradation. The 
height of the peak indicates cRNA yield.  
 
5.7.5 Hybridisation to the chip  
We performed the recommended Illumina protocol for hybridisation (www.illumina.com). 
We diluted each cRNA sample to 150ng/µl (as required by the protocol) with nuclease free 
water and nanodropped before hybridisation commenced. ((150/yield) x15 = 5µl total 
volume at 150ng/µl) 
We heated a hybridization oven to 58°C and heated hybridisation buffer and humidity 
control buffer (HCB) to 58°C for 10 minutes prior to use to dissolve any salt crystals that 
may have formed during storage. Once ready we added 5µl of cRNA (~750ng) to 10µl of 
Hyb, mixed the solutions by pipetting and briefly spun them down. We placed 200µl of HCB 
into both top and bottom reservoirs of the hybridisation chamber to prevent the chips drying 
out.  
Meanwhile we heated the cRNA samples for 5 minutes at 65°C and left them to cool to room 
temperature. Once at room temperature, we loaded 15µl of thesample/hyb mix onto the chip 
in the appropriate inlet port. We sealed the lid of the hybridisat on chamber and the 
chambers were incubated at 58°C overnight (16hours). In preparation for washing the next 
day, we prepared 500ml of high-temp wash buffer (50ml of x10 stock to 450ml nuclease free 
water) and heated it in a Hybex water bath to 55°C overnight. 
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5.7.6 Washing and staining the bead chip (all incubations are performed at room 
temperature unless specified). 
We removed the coverseals from the chips by submerging the chip face up in a beaker 
containing E1BC (Expression 1 Bead Chip) buffer (6mls of E1BC buffer in 2L of nuclease 
free water). We then transferred the chips to a slide rack and submerged them in a staining 
dish containing 250mls of wash E1BC solution. Once all chips were de-sealed we transf rred 
the slide rack to the hybex water bath containing the preheated high-temp wash buffer and 
incubated for 10mins.  
After incubation we transferred the slide rack back to the staining chamber containing E1BC 
wash buffer and plunged it in and out of the solution 5-10 times before placing it on an 
orbital shaker for 5 minutes at a medium speed.  
We then moved the slide rack to a clean staining dish containing 250ml fresh 100% 200 
proof ethanol and plunged it in and out 5-10 times before placing it on the orbital shaker for 
10 minutes.  
Once finished the rack we transferred the slide rack to a clean staining d sh containing 250ml 
fresh E1BC wash buffer. Again we plunged it in and out of the solution 5-10 times and 
placed it on the orbital shaker for 2 minutes.  
Meanwhile we prepared wash trays loaded with 4mls of block E1 (Expression 1) buffer in 
each tray. We transferred the chips from the slide rack to the wash trays with tweezers 
making sure that the chips were completely submerged in E1 buffer. We rocked the wash 
trays on the orbital shaker for 10mins at a medium speed.  
We then prepared new wash trays containing 2ml per tray of block E1 buffer plus 1:1000 
dilution of streptavidin-Cy3. We transferred the chips to these new trays with tweezers and 
covered them with a lid (streptavidin is photosensitive and pro uces a green signal when 
scanned). We rocked the trays for 10mins at a medium speed.  
We prepared a third staining chamber containing 250ml of E1BC wash buffer. We 
transferred the chips back into a slide rack with tweezers and plunged the slide rack in and 
out of the wash solution 5-10times. We then shook the slide rack on the orbital shaker for 5 
minutes at a medium to low speed.  
In order to dry the chips we placed the slide rack into a centrifuge and spun them down at 
280g at 25°C for 4 minutes. We stored the chips in the dark until they were ready to be 
scanned on the Illumina BeadArray Reader (www.illumina.com) (~ 1 hour per scan per 
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chip). The reader recorded the intensity of the green fluorescence signal produced by each 
well and if it reached a threshold value of 600 the sample was pas ed as being of good 
enough quality. Target sequences successfully bound to probe sequences generate a signal 
that depends on the strength of the hybridization (dependent on the number of paired bases, 
the hybridization conditions, and washing after hybridization). These intensity values were 
used as the basis for all the following data analysis. 
 
5.7.7 Data analysis 
All data exportation, normalization and statistical analysis performed with the help of Dr 
John McClure, University of Glasgow). The main challenge was to identify those genes 
whose expression is significantly different between the SHRSP and WKY. Fold change is 
the simplest and intuitive approach but this does not provide a significance estimate for any 
observed changes and the necessary cut off value is arbitrary and differs amongst researchers 
(Wit and McClure 2004). After we firstly normalised data from the Bead Array reader in 
Bead Studio (Illumina) and then exported it into third party software we ran a biologically 
motivated test for the detection of differentially expressed g nes in replicated microarray 
experiments (Rank Products analysis)(Breitling et al. 2004).  
 
5.7.7.1 Rank Products (RP) Analysis  
Derived from biological reasoning, a non parametric RP analysis u es the following 
assumptions(Breitling et al. 2004);  
- The relevant expression changes only affect a minority of genes 
- Measurements are independent between replicate arrays 
- Most changes are independent of each other 
- Measurement variance is about equal for all genes 
RP analysis does not depend on an estimate of the gene specific measurement variance and is 
particularly powerful where only a small number of replicates are available(Breitling et al. 
2004). 
RP values can be used to sort the genes according to the likelihood of observing them in a 
high position on lists of differentially expressed genes by chance. Genes with the smallest 
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RP values are the most interesting candidates. For our single channel array the RP values are 
calculated over all pairwise comparisons. To correct for the fact that pairwise comparisons 
between samples are not independent, the significance value has to be adjusted.  
Instead of permuting the ranks of each replicate, we perform permutations of the expression 
values for each array and then calculate the corresponding fold changes for all pairwise 
comparisons. These fold changes are used to produce the RP values. The procedure is always 
performed separately for up and down regulation.  
To determine a threshold for significant differential expression we used a nominal 
significance level of false discovery rate (FDR) q<0.05 to correct for multiple comparisons 
within the RP analysis. We based this on the Benjamini-Hochberg method(Bejamini and 
Hochberg 1995).  
 
5.7.7.2 Approach to analysis using Ingenuity Pathway analysis (IPA) software. 
As well as the above statistical methods, more sophisticated analysis techniques are available 
such as IPA which can be used to look at data from the perspective of int rlinked metabolic 
pathways. IPA is a web based microarray and proteomic data analysis tool that utilises 
published data (Ingenuity® Knowledge Base) in order to identify whether multiple genes are 
involved in a particular pathway(s) or are differentially expressed in comparisons between 
experimental groups. It also uses statistical methods such as Fischers Exact Test to identify 
genes over represented in particular pathways. For more informati n on how IPA analyses 
uploaded data see appendix H. We used IPA to analyse our data using both candidate gene 
and genome wide approaches. For more information see chapter 8.  
 
5.7.8 Quantitative real-time polymerase chain reaction (qRT-PCR) 
In order to quantitatively validate any significant findings of interest from the microarray 
data we performed qRT-PCR. qRT-PCR can amplify any nucleic acid sequence present in a 
sample via a series of heating and cooling cycles(Kubista et al. 2004). Heating the sample to 
a high temperature firstly breaks the strands of the DNA helix (whether DNA or cDNA), 
then subsequent cooling enables the now isolated strands to bind to the DNA template. 
Finally reheating the reaction to approximately 72°C (the optimum temperature for 
polymerases) enables the primers to be extended by incorporating dNTPs (the four 
nucleotide triphosphates). The final amplified sequence can be used to generate a large 
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number of identical copies for quantitative analysis. Real timePCR is a modification of the 
original PCR methodology which allows for the detection and amplification of sequences 
simultaneously enabling the quantity of product formed to be monitored throughout the 
reaction(Higuchi et al. 1992). As the amount of product forms a fluorescent reporter signals 
its presence and subsequent accumulation. With each completed cycle the fluorescent signal 
exponentially increases until the reaction runs out of a critical component (e.g. the primers or 
polymerase) and the level stabilises(Bustin 2002). The number of cycles needed to reach this 
threshold is called the CT value. The CT value in gene expression analysis reflects the 
transcriptional activity within that particular sample(Kubista e  al. 2004).  
 
5.7.9 Materials 
We used Applied Biosystems gene expression assays (Taqman®) for all qRT-PCRs in this 
thesis. If a pre-designed assay was not available, a custom asay was designed using Applied 
Biosystems software. Each Taqman® assay contained a x20 reaction mix containing 
template-specific forward and reverse primers and a probe that annealed between the two 
primers. Taqman® probes are hydrolysis probes and have two types of fluorescent dye. The 
probe DNA is fluorescently tagged at its 3' end, but fluorescence from intact probes is 
prevented by a quencher molecule that is bound to its 5' end(Holland et al. 1991). 
During PCR amplification, the 5'-3' nucleolytic activity of the DNA polymerase cleaves the 
quencher from the probe, resulting in fluorescence levels proportional o the amount of PCR 
product present. All of the probes were designed to anneal across tw  exons in cDNA, 
guaranteeing that non-specific amplification did not occur from esidual genomic DNA. 
Every effort was made to ensure that the amount of template cDNA was the same in each 
reaction of an experiment, however given the sensitivity of qRT-PCR, to allow for 
differences in the amount of cDNA obtained we normalized gene expression to a 
housekeeping gene. Ideally the housekeeping gene should be one whose expresion is not 
expected to change over experimental groups or conditions and often beta actin is used. 
However as this gene is central to vascular structural integr ty we used Glyceraldehyde-3-
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5.7.10 Protocol – Two step qRT-PCR (figure 5.12) 
 In order for levels of gene expression to be measured by qRT-PCR, extracted RNA samples 
need to be reverse transcribed to cDNA. All of the qRT-PCR reactions in this thesis were 
performed using the same DNase treated RNA extracted for assessment using the microarray 






Figure 5.12. The three stages of PCR.   
T = Temperature in degrees Celsius. Figure adapted from Kubista et al 2006. Denaturation – the 
sample is heated to approximately 95°C to break the  strands of either RNA or DNA. Annealing – the 
temperature is lowered to approximately 50°C to ena ble the primers to anneal to the template. 
Elongation – the temperature is increased back up to approximately 72°C – the optimum temperature 
for the polymerase to work to extend the primer by incorporating dNTPs. Each stage is 
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5.7.10.1 First step – Reverse transcription (RT) to create cDNA 
We firstly checked the concentration of each RNA sample (DNase treated) using the 
nanodrop then calculated how much of each sample was required (in µl)in order to ensure 
approximately 1µg of RNA in each 20µl reaction e.g. approximately 1.4µl of an RNA 
sample of concentration 700ng/µl would be required. 
Each 20µl reaction contained 12.3µl of master mix, the required amount of RNA and the 
remaining volume was made up with nuclease free water (NFW). We used the Taqman® 
reverse transcription master mix (Applied Biosystems) which consisted of; RT buffer, 
Magnesium Chloride (MgCl2) solution, RNase inhibitors, OligodT primers and 
Multiscribe™ reverse transcriptase enzyme.  
On a 96 well plate we added the RNA, NFW and the master mix to each well in a systematic 
order labelling the wells appropriately. The plate was sealed with an adhesive clear plastic 
lid and placed onto the thermocycler. Once cDNA had been created we a ded 40µl of NFW 
to create enough stock cDNA from each sample (60µl) to be used to assess all our genes of 
interest. Spare cDNA was stored at -20°C. 
 
5.7.10.2 Second step – qRT-PCR 
We made up the qRT-PCR reaction mix using Taqman® universal master mix (Applied 
Biosystems) plus a probe for the housekeeping gene (GAPDH) and finally the Taqman® 
probe corresponding to our gene of interest. The housekeeping probe and the probe 
corresponding to our gene of interest were labelled with different reporter dyes. GAPDH was 
labelled with VIC® whereas our genes of interest were labelled with FAM®. The two dyes 
fluoresce at different wavelengths so can be easily distinguished on subsequent analyses. 3µl 
of the combined master mix and probe solution was added to 2ul of cDNA into each well of 
a 384 well plate and sealed with an adhesive optically clear plastic id (total reaction volume 
5µl in each well). We loaded all samples onto the plate in triplicates to produce reliable CT 
values. We then placed the plate into a 7900HT sequence detection system (Applied 
Biosciences) and programmed the platform to read the plate using Sequence Detection 
System (SDS) Software (version 2.4) (Applied Biosystems). The 7900HT system 
encompasses a heating block for thermal cycling and detectors to measure fluorescence in 
each well of a 384-well optical plate. 
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5.7.11 Data analysis 
Fluorescence is measured after every amplification cycle to quantify the accumulation of 
PCR product. During the exponential phase of PCR cycling the rate of product accumulation 
is proportional to template concentration therefore relative template abundance can be 
quantified by monitoring increasing fluorescence in each well during temperature cycling.  
We performed statistical analysis using CT values. The CT value is the cycle number at the 
threshold level of log-based fluorescence (the level at which fluorescence exceeds 
background noise). CT levels are inversely proportional to the amount of target nucleic acid 
in the sample (i.e. the lower the CT level the greater the amount of target nucleic acid in the 
sample). 
Firstly we calculated dCT values for all replicates of all the samples, the dCT value is the 
difference in CT values between the gene of interest and the housekeeper (measured in the 
same sample). As we performed all of the PCR in triplicate, we took the mean dCT value 
from the 3 readings per biological replicate. We used this data to calculate the overall mean 
dCT plus the standard error of the mean for all 4 animals in each group and to perform a 
two-tailed T test to establish whether there was a significa t difference in dCT values 
between the WKY and SHRSP. 
We then used the overall mean dCT for each group to calculate the ddCT [delta-delta CT] 
value i.e. the difference between the mean dCT of SHRSP and the mean dCT value of WKY. 
This results in the mean ddCT for the "control" group equalling 0. As larger CT values mean 
lower gene expression, a negative ddCT will mean that a group has more gene expression on 
average than the "control" group.  Also, an increase of 1 in a dCT value implies a halving of 
gene expression; an increase of 2 implies expression is one quart r of the value (reduction of 
75%); a decrease of 1 implies a doubling of expression; a decrease of 2 implies a 
quadrupling of expression etc.  
In order to correlate our data with the microarray findings we wished to express the PCR 
data in terms of fold change, however because differences in expression u ing CT values are 
on an negative exponential/power scale, in order to express the data as fold changes we 
converted ddCT values using the following formula; 
 
RQ = 2^(-ddCT)  
where RQ = relative quantification (this value is equivalent to fold change)and ^ means "to 
the power of", e.g. 20=1. 
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We plotted the RQ numbers on a bar chart using excel. We calculated the error bars from 
ddCT values and exponentiated them using the 2^(-value) formula because the RQ scale is 
not symmetric (it is a ratio scale) therefore the lower end of an error bar will be nearer the 
RQ value than the upper end. 
 
5.7.12 Gene sequencing 
5.7.12.1 Standard (End point) PCR 
All end point PCR and sequencing was performed by Miss Wendy Crawford (Centre for 
Cardiovascular Research, Glasgow University) and was performed on an MJ Research PTC 
Gradient Cycler in 96 well plates (ABgene). 
Firstly we designed forward (n=4) and reverse (n=3) primers cor esponding to the portion of 
the GUCY1a3 gene sequence covered by the Illumina microarray probe. All primers were 
designed by eye and all contained close to a 50% GC content to prevent a high melting 
temperature causing non specific bands to appear on electrophoresis. W  purchased all 
primers from MWG Biotech.  
To test for insertions or deletions within the sequence between strai s we ran end point PCR 
using these primers, on DNA taken from the livers of SHRSP (n=4) and WKY (n=3). End 
point PCR (unlike qRT-PCR – see above) does not provide a quantitative assessment of the 
level of gene expression it simply provides a yes/no answer as to whether the gene is 
expressed. This was used to test for any changes within the length of sequence between the 
two strains such as the presence of an insertion or a deletion. We performed end point PCR 
on both cDNA and genomic DNA depending on the pairing of primers, for example AF 
when paired with CR covered the complete open reading frame and was therefore performed 
on genomic DNA.  
Due to the need for absolute fidelity of DNA replication instead of using Taq DNA 
polymerases (as used in qRT-PCR see above) which are liable to incorporate incorrect 
nucleotides every 10,000 nucleotides, we used ‘Kod Hot Start’ DNA polymerase (Novagen). 
We performed Kod PCR’s using the designated kit and to manufacturer’s instructions. For 
full details of the reaction mixture and heat cycling protocol see appendix I. Briefly, the 
cycling conditions we used consisted of heating the PCR mixture to 95°C for 2 minutes to 
activate the polymerase, a denaturing step at the same temperature for 20 seconds, followed 
by a 30 second annealing phase at 52°C for all primers. Extension times depended on the 
length of sequence being created, for the forward primers we allowed 2.5 minutes whereas 
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for the reverse primers we allowed 10 minutes to ensure that all dNTP’s were fixed (see 
www.novagen.com/protocol for a full version of the protocol). The MJ Research PTC 
Gradient Cycler then repeated this cycle 20-40 times and the results were analysed using 
agarose gel electrophoresis.  
We used 1% agarose (Eurogentec) gels which were dissolved and electrophoresed at 6V per 
cm of gel in 1x Tris-Borate EDTA (TBE) buffer (Fisher Bioreagents) using BIO-RAD 
Power Pac 300 and BIO-RAD electrophoresis tanks. We added 1ng/100ml ethidium bromide 
(Sigma) to molten agarose before pouring gels and we loaded samples with 6x loading dye 
(50% glycerol, 0.05% bromophenol blue). We visualised gels using UV transillumination on 
a BIO-RAD Fluor-S Multimager. We assessed the size of PCR products using Promega 
100bp or 1kb DNA ladders.   
 
5.7.12.2 DNA Sequencing  
We performed DNA sequencing by firstly purifying PCR products (WKY n=3, SHRSP n=2) 
to remove un-incorporated dNTPs, salts and / or primers using an Agencourt AMPure kit. 
This technique separates DNA products over 100bp in length via binding to paramagnetic 
beads (a full protocol is available in appendix J). We used the purified product (~8µl per 
20µl PCR reaction) to conduct dideoxy sequencing.  
We used Applied Biosystems BigDye Terminator n3.1 Cycle Sequencing kits for all 
sequencing reactions and reactions were performed in 96 well plates. All sequencing 
reactions included sequencing buffer (3.5µl), ready reaction (0.5µl), primer (3.2µl) and water 
(4.8µl). We used a temperature cycling program of 96°C for 45 seconds, 50°C for 25 
seconds and 60°C for 4 minutes which was repeated 25 times.  
We purified sequencing reactions to remove reaction constituents, u-incorporated 
nucleotides and / primers prior to electrophoresis using Agencourt CleanSeq reagent. We 
subsequently loaded 20µl of purified sequencing product into optically clear 96 well plates 
and filled any remaining wells on the plate with water to prevent drying of capillaries. We 
covered plates with Applied Biosystems Septa Seals which allow the entry of capillaries to 
the plate whilst preventing the evaporation of products.  
We performed sequencing capillary electrophoresis on a 48-capillary Applied Biosystems 
3730 Genetic Analyser with 36cm capillaries filled with POP-7 polymer (Applied 
Biosystems) and warmed to 60°C. We separated sequencing products by size using 
electrophoresis set to 8500V for 50 minutes.  
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5.7.13 Data analysis 
We analysed sequencing using Applied Biosystems SeqScape software version 2.1. We 
aligned experimental sequences with known sequences derived from bioinformatic databases 
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CHAPTER 6 : QUALITATIVE AND QUANTITATIVE ASSESSMENT OF 
MICROVASCULAR AND PERIVASCULAR CHANGES WITH 
HEMATOXYLIN AND EOSIN STAIN.  
 
6.1 Background 
The cerebral pathology in the SHRSP was first assessed in the 1970’s using conventional 
stains such as H&E along with light microscopy. The focus of this research was the end 
stage pathology therefore most papers describe changes in the brains of older animals which 
suffered a symptomatic ‘stroke’. What the current literature lacks is a simple qualitative 
assessment of pathological changes in the brain from a young normotensive stage through to 
the end ‘stroke’ stage. This is important in order to establish the sequence of pathological 
changes in the brain and vessels. To our knowledge only one, Tagami et l, examined the 
perforating arterioles histologically every 4 weeks from 4 weeks to 52 weeks of age(Tagami 
et al. 1987). However, they did not compare SHRSP with a control strain (e.g. WKY or 
SHR), did not blind the analysis and provided few details on animals less than 12 weeks 
old(Tagami et al. 1987). Since then many studies focused on older ages and used salt-loa ing 
to accelerate pathological changes or induced large artery occlusion to test new stroke 
treatments, rather than trying to determine the spontaneous microvas ular changes and 
possible mechanisms. The SHRSP literature also lacks quantitative assessments of features 
such as vessel and neuronal density and other changes to the neurovascular unit e.g. 
oligodendrocytes. 
In the SHRSP, there is wide consensus that the arteries and arterioles display signs of 
arteriolar wall thickening and sclerosis which has been attributed to hypertension(Ogata et al. 
1980;Fredriksson et al. 1985;Mies et al. 1999). However, there does not appear to have been 
any quantification of the scale of thickening although a sclerotic ratio for human small vessel 
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Therefore in this study we aimed to; 
A) Describe qualitatively the brain parenchymal and vascular histopathology in SHRSP 
animals compared with WKY controls, from a young normotensive age throug  to a stroke 
prone stage.  
B) Quantify the pathological changes by performing density counts of neurovascular unit 
components.  
C) Quantify the degree of vessel narrowing using a sclerotic index(Lammie et al. 
1997)originally described in human microvascular disease.  
 
6.2 Materials and Methods 
6.2.1 Animals & Tissue preparation 
As previously stated we assessed 5, 16 & 21 week old animals fed on a normal diet (n=30) 
and 21 week old WKY and SHRSP exposed to salt-loading (n=10). Hemisphere  w e fixed 
in formalin divided into 2mm slices and embedded in paraffin before being sectioned 
according to the standard sampling protocol described in chapter 5. We cut sections at 7µm 
from both a frontal and mid coronal section from each animal and mounted them on double 
frost slides for H&E staining.  
 
6.2.2 Methods 
H&E staining was conducted according to the protocol described in chapter 5. Briefly, we 
brought sections to water, incubated for 30mins in picric acid then stained them in 
hematoxylin for 7 minutes. Then we washed the sections in water, differentiated them in acid 
alcohol, washed them in water once more and dipped them in lithium carbonate before 
staining them in Eosin for 10 minutes. Sections were washed in water then dipped three 
times in the mordant potassium aluminate. After a final wash wit ater, we dehydrated 
slides via graded alcohols and finally cleared them in xylene.  
 
6.2.3 Qualitative assessment of morphological changes  
Three observers blinded to the animals age, strain and diet (EB, CS & JW) assessed all slides 
of both frontal and mid coronal sections for any gross pathology under a light microscope 
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(Olympus BX51). We recorded the presence of any vessel thickening, white matter 
rarefaction, and any other evidence of microinfarction or haemorrhage. We also examined 
the lining of the lateral ventricles for evidence of structural changes or leakage of 
cerebrospinal fluid (CSF) into the brain parenchyma.  
 
6.2.4 Quantitative assessment of pathological changes  
We performed two quantitative assessments on both frontal and mid coronal sections for 
each animal. Firstly we counted components of the neurovascular unit and secondly we 
assessed vessel wall thickening using the sclerotic index(Lammie et al. 1997) on three 
regions of interest (cortical grey, white matter and deep grey matter) using a standard 
sampling protocol that we described previously (see chapter 5).  
 
6.2.4.1 Density counts of components of the neurovascular unit. 
As described in more detail in chapter 5 of this thesis, using Ima ePro™ (version 6.2), we 
designed a stereology protocol that generated three random sampling points of 300µm2 at 
x20 objective within each region of interest for each slide – cortical grey, white matter and 
deep grey matter. Within each sampling point, we counted all capilaries, neurons and 
oligodendrocytes (‘objects’) within the same frame, in each sampling point in a random 
order. We exported the data for each region of interest to an excel spreadsheet for analysis.  
The increase in size of the rat brain with advancing age would result in a different total area 
sampled at each age. To adjust for this, we adjusted the object counts for age by calculating 
ratios - 5:16 & 16:21 for all cross section areas and applying the ratio to the counts. The 
counts were not normally distributed so we calculated the median object count for each age, 
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6.2.4.2  Quantification of the presence / absence of vessel wall thickening usi  a sclerotic 
index. 
To assess vessel wall thickening we used Lammie’s scleroti  index(Lammie et al. 1997) 
where the following formula is applied; 
 
Index = 1-(internal /external vessel diameter). 
 
Normal vessels lie within the range of 0.2-0.3, and 0.3-0.5 constitutes moderate sclerosis, 
and severe sclerosis is anything over 0.5. 
We sampled 5 vessels from each of the cortical and deep grey matter and three from the 
white matter for each section in each animal. Using the distance measurement tool on Image 
ProTM, we took the internal lumen diameter and the external diameter of the vessel. For more 
detail see chapter 5 of this thesis. We exported the data to an excel spreadsheet for 
calculation of the ratio and further statistical analyses. 
 
6.2.5 Data analysis 
The increase in size of the rat brain with advancing age would result in a different total area 
sampled at each age. To adjust for this, we adjusted the object counts for age by calculating 
ratios - 5:16 & 16:21 for all cross section areas and applying the ratio to the counts. The 
counts were not normally distributed so we calculated the median object count for each age, 
strain and brain section (frontal or mid coronal) for use in a general linear model (GLM).  
We performed statistical analysis using R software. We performed a GLM using either the 
median counts or the mean ratio of all vessels sampled within a region of interest per strain 
per age. We analysed the effect of age, strain and salt-loading on both sets of data. P values 
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6.3 Results 
6.3.1 Qualitative assessment of morphological changes 
6.3.1.1 Animals fed on a normal diet – ages 5, 16 and 21 weeks; 
5 week old – no differences were noted on H&E staining in 5 week old SHRSP compared 
with WKY. In SHRSP there was one area of endothelial prolifeation in a frontal meningeal 
vessel (figure 6.1). 
16 week old – no differences were noted between strains at age 16 weeks in the frontal or 
mid coronal sections. 
21 week old animals – in the WKY animals there were a few areas of vessel wall thickening 
and endothelial proliferation (figure 6.2). In the SHRSP there were many thickened vessel 
walls and we saw hyalinization in a wide variety of vessels across all regions in meningeal 
arteries to the small perforating arterioles in the deep grey matter in both frontal and mid 




                                                              
Figure 6.1. H&E stained frontal sections .  
Taken from 5 week old A) WKY and B) SHRSP rat. The leptomeningeal vessel in the SHRSP rat 
shows evidence of endothelial cell proliferation ( ). Images x20 objective. Scale bar = 25µm 
 
A  B 
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Figure 6.2. H&E staining of cortical arterioles tak en from 21 week old A) WKY and B) SHRSP 
animals raised on a normal diet .  
Both images taken at x20 objective. The vessel from the WKY rat has an even wall with a clearly 
visible lumen and endothelial cell layer. The vessel from the SHRSP rat in contrast has unevenly thick 
walls in places obscuring the lumen and lacks a defined internal elastic lamina and endothelial cell 
layer.  
 
   
 
Figure 6.3. H&E staining of arterioles taken from t he deep grey matter of 21 week old A) WKY 
and B) SHRSP animals raised on a normal diet.   
Both images taken at x20 objective. The vessel from the WKY rat once again has an even wall with a 
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Salt-loaded (+NaCl) animals (21 weeks) – Both strains showed more morphological changes 
when salt-loaded than when fed on a normal diet. Two WKY+NaCl rats showed vacuolated 
white matter and others showed vessel hyalinization (figure 6.4). Thickening of vessels due 
to smooth muscle and endothelial proliferation was common in all sections. Additionally, 
there was an area of white matter rarefaction and cavitation in the internal capsule of one 







Figure 6.4. H&E staining of A) a 21 week WKY+NaCl v ersus B) a 21 week WKY .  
Both images taken at x10 objective. Scale bar = 25µm. In two WKY+NaCl animals we saw potential 
vacuolation (black triangles) in the white matter surrounding the lateral ventricle. Despite all tissue 























Figure 6.5. H&E staining of a mid coronal section t aken from a 21 week SHRSP+NaCl showing an area of w hite matter cavitation in the internal capsule. Lef t 
image is a tiled image taken at x4 objective.   
Right image taken at x10 objective. This area of rarefaction enveloped approximately half the length of the internal capsule in this section. Calcified neurons were also 
found close to the site.   
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6.3.2 Quantitative assessment of pathological changes  
6.3.2.1 Density counts of components of the neurovascular unit. 
All median count data and the results of statistical analysis can be seen in table 6.1. 
 
6.3.2.2 Animals fed on a normal diet – ages 5, 16 and 21 weeks 
Capillaries (figure 6.6) – There were no strain or age differences in capillary counts in the 
white matter of either brain section. In the frontal section there were significantly higher 
counts at ages 16 & 21 weeks in both cortical grey (p<0.001) and deep grey matter (p<0.001) 
compared to 5 week olds.  
Neurons (figure 6.7) – There were no strain or age differences in neuronal cell counts in the 
frontal or mid coronal white matter. In the frontal section, the neuronal cell count was 
significantly higher in the cortical grey matter at 21 weeks than at 5 weeks (p=0.02) and 
significantly higher in the deep grey matter at 16 weeks than at 5 weeks (p=0.01). In mid 
coronal sections there were no strain or age differences in the cortical grey matter. In the 
deep grey matter neuronal cell counts were significantly higher at 16 weeks compared to 5 
weeks (p=0.02).  
Oligodendrocytes (figure 6.8) – There were no differences in oligodendrocyte counts in the 
white matter of either brain section or in the frontal cortical grey matter. In the frontal deep 
grey matter both species showed a trend towards a higher count of oligodendrocytes at age 
16 weeks compared to 5 weeks (p=0.07). In the mid coronal cortical grey matter the 
oligodendrocyte counts were higher in SHRSP than WKY at all ages (p=0.03). 
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AGE 5 weeks (median ± 95% CI) 16 weeks (median ± 95 % CI) 21 weeks (median ± 95% CI)  
REGION Cortex White Matter Deep Grey Cortex White M atter Deep Grey Cortex White Matter Deep Grey 
WKY 26 (24-33) 27 (26-42) 34 (22-34) 64 (54-67) 30 (29-33) 51 (47-67) 38 (31-42) 27 (26-27) 32 (31-33) 
SHRSP 27 (21-33) 30 (30-33) 24 (14-28) 67 (46-68) 31 (24-40) 50 (42-63) 53 (48-57) 36 (22-39) 42 (40-44) 
P for strain                            Cortex = NS                                                   White Matter = NS                                                   Deep Grey = NS 
Capillaries 
Frontal 
P for age                                Cortex  p<0.001                                                     White Matter = NS                                                            Deep Grey = NS 
WKY 33 (30-40) 30 (24-36) 35 (29-41) 69 (60-76) 27 (23-32) 49 (38-54) 31 (26-34) 25 (24-28) 24 (22-29) 
SHRSP 38 (35-50) 23 (23-24) 31 (29-32) 42 (41-52) 20 (19-23) 30 (25-39) 46 (31-46) 25 (18-27) 35 (28-44) 
P for strain                                Cortex = NS                                                           White Matter = NS                                                            Deep Grey = NS 
Capillaries 
Mid Coronal 
P for age                                Cortex = NS                                                           White Matter = NS                                                            Deep Grey = NS 
WKY 99 (89-160) 225 (223-239) 168 (164-182) 208 (192-266) 223 (216-311) 208 (205-272) 163 (157-200) 264 (257-295) 172 (155-173) 
SHRSP 156 (124-158) 272 (222-306) 168 (164-188) 212 (148-213) 297 (257-386) 234 (198-325) 246 (223-274) 249 (227-282) 205 (194-205) 
P for strain                                Cortex = NS                                                          White Matter = NS                                                             Deep Grey = NS 
Neurons 
Frontal 
P for age                                Cortex  p<0.05                                                      White Matter = NS                                                             Deep Grey  p<0.05 
WKY 185 (177-201) 252 (214-257) 155 (138-221) 286 (278-296) 285 (261-296) 245 (211-333) 188 (177-208) 288 (278-361) 151 (124-208) 
SHRSP 229 (161-235) 263 (154-365) 166 (146-178) 237 (182-240) 315 (300-346) 270 (254-315) 267 (182-276) 318 (305-318) 244 (240-262) 
P for strain                                Cortex = NS                                                         White Matter = NS                                                               Deep Grey = NS 
Neurons 
Mid Coronal 
P for age                                Cortex = NS                                                         White Matter = NS                                                               Deep Grey  p<0.05 
WKY 16 (12-21) 24 (22-31) 17 (14-17) 15 (14-15) 36 (33-38) 23 (14-28) 9 (7-10) 13 (11-18) 12 (12-16) 
SHRSP 16 (15-23) 23 (22-24) 12 (11-21) 19 (16-24) 25 (25-28) 24 (23-26) 17 (14-18) 18 (17-20) 12 (9-14) 
P for strain                               Cortex = NS                                                        White Matter = NS                                                                 Deep Grey = NS 
Oligodendrocytes 
Frontal 
P for age                               Cortex = NS                                                        White Matter = NS                                                                 Deep Grey = NS 
WKY 16 (15-18) 28 (20-34) 17 (16-20) 26 (22-28) 31 (27-38) 28 (20-52) 12 (12-17) 16 (15-21) 13 (9-14) 
SHRSP 24 (23-26) 29 (26-41) 21 (21-28) 17 (14-17) 26 (19-26) 17 (17-22) 19 (19-23) 19 (18-35) 19 (15-20) 
P for strain                               Cortex  p<0.05                                                   White Matter = NS                                                                  Deep Grey = NS 
Oligodendrocytes  
Mid Coronal 
P for age                               Cortex = NS                                                      White Matter = NS                                                                   Deep Grey = NS 
 Each value represents n=5 animals. NS = No significant difference.  
Table 6.1. Median count data ± 95% confidence inter vals for capillaries, neurons and oligodendrocytes in 5, 16 and 21 week old WKY and SHRSP. 
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CAPILLARIES  
A) Frontal Section 
 
 
B) Mid Coronal Section 
 
Figure 6.6. Bar graphs showing the median number of  capillaries (y axis) counted in 3x300µm 2 
frames in n=5 rats per group at ages 5, 16 and 21 w eeks.  
A) frontal and B) mid coronal brain sections. Error bars represent 95% confidence intervals. We found 
no overall significant differences between the two strains however the capillary count in the cortical 
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NEURONS 
A) Frontal Section 
 
 
B) Mid Coronal Section 
 
 
Figure 6.7 . Bar graphs showing the median number of neurons (y axis) counted in 3x300µm 2 
frames in n=5 rats per group at ages 5, 16 and 21 w eeks .  
A) frontal and B) mid coronal brain sections. Error bars represent 95% confidence intervals. We found 
no significant differences in neuronal count between the strains. We did find a significant increase in 
neuronal count with age in the cortical grey and deep grey matter of the frontal section as well as the 
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OLIGODENDROCYTES  
A) Frontal Section 
 
 
B) Mid Coronal Section 
 
 
Figure 6.8. Bar graphs showing the median number of  oligodendrocytes (y axis) counted in 
3x300µm 2 frames in n=5 rats per group at ages 5, 16 and 21 w eeks.   
A) frontal and B) mid coronal brain sections. Error bars represent 95% confidence intervals. We found 
significantly more oligodendrocytes in the cortical grey matter of the mid coronal section in SHRSP rats 
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6.3.2.3 Salt-loaded (+NaCl) animals (aged 21 weeks)  
For all count data and results of statistical analysis see table 6.2. 
Salt was associated with a decrease in capillary count (figure 6.9) in the white matter of the 
mid coronal section in WKY+NaCl versus SHRSP+NaCl (p=0.02).  
Salt had no significant effect on any of the neuronal cell counts (figure 6.10) or 
oligodendrocyte counts (figure 6.11) in any region of either brain section.  
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Each value represents n=5 animals. NS = no significant difference.
SALT No Salt (median ± 95% CI) Salt (median ± 95% CI) 
COUNT 
REGION Cortex White Matter Deep Grey Cortex White M atter Deep Grey 
WKY 17 (16-18) 7 (6-9) 14 (12-17) 15 (13-17) 9 (7-12) 15 (14-16) 
SHRSP 18 (17-22) 13 (9-15) 19 (17-19) 16 (13-22) 12 (10-12) 16 (15-17) Capillaries 
Frontal 
P for salt 
WKY:WKY+NaCl                                       WKY+NaCl :SHRSP+NaCl                                           SHRSP:SHRSP+ NaCl  
No significant differences                               No significant differences                                    No significant differences 
WKY 12 (11-16) 8 (8-9) 14 (9-17) 15 (11-16) 4 (2-5) 13 (12-13) 
SHRSP 16 (16-18) 9 (8-9) 14 (13-15) 16 (13-18) 9 (8-11) 11 (10-18) Capillaries 
Mid Coronal 
P for salt 
WKY:WKY+NaCl                                        WKY+NaCl :SHRSP+ NaCl                                           SHRSP:SHRSP+NaCl 
                                         No significant differences          Cortex = NS  White Matter p=0.02  Deep Grey = NS               No significant differences 
WKY 72 (66-89) 102 (97-103) 80 (80-108) 76 (74-85) 95 (78-100) 72 (72-83) 
SHRSP 91 (79-105) 98 (84-102) 91 (89-92) 79 (68-86) 112 (91-114) 94 (83-95) Neurons 
Frontal 
P for salt 
WKY:WKY+NaCl                                        WKY+salt:SHRSP+NaCl                                           SHRSP:SHRSP+NaCl 
No significant differences                               No significant differences                                    No significant differences 
WKY 75 (70-77) 102 (98-103) 76 (65-92) 86 (82-98) 95 (78-100) 90 (61-91) 
SHRSP 83 (78-97) 98 (84-102) 94 (85-94) 98 (64-106) 112 (91-114) 96 (94-108) Neurons 
Mid Coronal 
P for salt 
WKY:WKY+NaCl                                        WKY+salt:SHRSP+NaCl                                           SHRSP:SHRSP+NaCl 
                                           No significant differences         Cortex = NS    White matter = NS    Deep grey  p=0.04           No significant differences 
WKY 5 (3-6) 5 (4-9) 5 (5-6) 3 (3-3) 4 (4-5) 6 (5-7) 
SHRSP 7 (5-8) 7 (6-7) 4 (4-5) 5 (4-5) 5 (5-8) 4 (3-6) Oligodendrocytes 
Frontal 
P for salt 
WKY:WKY+NaCl                                        WKY+NaCl:SHRSP+NaCl                                          SHRSP:SHRSP+NaCl 
No significant differences                              No significant differences                                   No significant differences 
WKY 5 (4-7) 6 (4-7) 5 (5-6) 4 (3-6) 8 (8-9) 5 (5-5) 
SHRSP 7 (6-9) 11 (6-12) 6 (6-7) 7 (6-7) 7 (5-10) 6 (6-7) Oligodendrocytes 
Mid Coronal 
P for salt 
WKY:WKY+NaCl                                        WKY+NaCl:SHRSP+NaCl                                           SHRSP:SHRSP+salt 
 No significant differences                              No significant differences                                   No significant differences 
Table 6.2. Median count data ± 95% confidence inter vals for capillaries, neurons and oligodendrocytes in 21 week old WKY and SHRSP fed either standard 
rat chow or exposed to 1% salt-loading from the age  of 18 weeks.  
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CAPILLARIES 
A) Frontal Section 
 
B) Mid Coronal Section 
 
 
Figure 6.9. Bar graphs showing the median number of  capillaries (y axis) counted in 3x300µm 2 
frames .  
Counts taken from the cortical grey matter, white matter and deep grey matter of in both A) frontal and 
B) mid coronal brain sections in salt-loaded rats of both strains versus rats fed standard rat chow (n=5 
rats per bar). Error bars represent 95% confidence intervals. We found no effect of salt loading on 
capillary count in the frontal section. In the mid coronal section we found significantly more capillaries 
in the white matter in SHRSP+NaCl versus WKY+NaCl (p<0.05).  
*  
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NEURONS 
   A) Frontal Section 
 
 
B) Mid Coronal Section 
 
 
Figure 6.10. Bar graphs showing the median number o f neurons (y axis) counted in 3x300µm 2 
frames.   
Counts taken from the cortical grey matter, white matter and deep grey matter of in both A) frontal and 
B) mid coronal brain sections in salt-loaded rats of both strains versus rats fed standard rat chow (n=5 
rats per bar). Error bars represent 95% confidence intervals. We found no difference in neuronal count 
in the frontal section. In the deep grey matter of the frontal section we found significantly more neurons 
in SHRSP+NaCl versus WKY+NaCl (p<0.05). 
*  
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OLIGODENDROCYTES 
A) Frontal Section 
 
 
B) Mid Coronal Section 
 
Figure 6.11. Bar graphs showing the median number o f oligodendrocytes (y axis) counted in 
3x300µm 2 frames .  
Counts taken from the cortical grey matter, white matter and deep grey matter of in both A) frontal and 
B) mid coronal brain sections in salt-loaded rats of both strains versus rats fed standard rat chow (n=5 
rats per bar). Error bars represent 95% confidence intervals. We found no significant difference in 
oligodendrocyte count in either brain section due to salt loading in both strains. 
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6.3.3 Quantitative assessment of vessel wall thickening. 
6.3.3.1 General observation 
All the index values were equal to or above 0.45 (range 0.45-0.68), indicating that all vessels 
measured, regardless of age, strain and salt diet were classified as showing moderate to 
severe sclerosis according to Lammie’s scale(Lammie et al. 1997). 
 
6.3.3.2 Animals fed on a normal diet – ages 5, 16 and 21 weeks (figure 6.12) 
For all data and the results of two way ANOVA analysis see table 6.3. 
In the cortical grey matter of the frontal section we found a significantly higher sclerotic 
index in 21 week old SHRSP versus 21 week WKY (p=0.03). Otherwise we found no effect 
of age on the sclerotic index of vessels in the frontal sections of either strain. 
In the mid coronal sections there was a significant increase in the sclerotic index with age in 
the cortical grey and deep grey matter in both strains. In the cortical grey matter these 
occurred between 5 and 16 weeks (p=0.02) and 5 and 21 weeks (p=0.04). In the deep grey 
matter the increase was also significant between 5 and 21 weeks (p=0.03). This gradual 
increase in sclerotic index was not seen in the white matter of the section in any strain. 
 
6.3.3.3 Salt-loaded (+NaCl) animals (aged 21 weeks) (figure 6.13).  
For all data and the results of two way ANOVA analysis see table 6.4. 
We found no difference in sclerotic ratio between salt-loaded and non salt-loaded animals of 
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SECTION FRONTAL SECTION 
AGE 5 weeks ( ±S.E.M) 16 weeks ( ±S.E.M) 21 weeks ( ±S.E.M) 
REGION Cortex White Matter Deep Grey Cortex 
White 
Matter Deep Grey Cortex 
White 
Matter Deep Grey 
WKY 0.602±0.055 0.614±0.060 0.610±0.035 0.588±0.052  0.558±0.039 0.593±0.058 0.583±0.072 0.568±0.072 0. 599±0.049 
SHRSP 0.580±0.040 0.596±0.048 0.596±0.087 0.604±0.0 28 0.602±0.038 0.607±0.036 0.654±0.023 0.655±0.041 0.643±0.023 
P for strain Cortex = NS                                                           White Matter = NS                                                        Deep Grey = NS 
P for age Cortex = NS                                                           White Matter = NS                                                        Deep Grey = NS 
SECTION MID CORONAL SECTION 
AGE 5 weeks ( ±S.E.M) 16 weeks ( ±S.E.M) 21 weeks ( ±S.E.M) 
REGION Cortex White Matter Deep Grey Cortex 
White 
Matter Deep Grey Cortex 
White 
Matter Deep Grey 
WKY 0.587±0.037 0.630±0.027 0.607±0.018 0.624±0.034  0.611±0.067 0.624±0.048 0.639±0.030 0.678±0.016 0. 661±0.019 
SHRSP 0.595±0.023 0.560±0.042 0.645±0.026 0.655±0.0 27 0.648±0.039 0.636±0.047 0.632±0.044 0.643±0.036 0.681±0.026 
P for strain Cortex  = NS                                                          White Matter = NS                                                        Deep Grey = NS 
P for age     Cortex  p<0.05                                                       White Matter = NS                                                        Deep Grey  p<0.05 
 
Each value represents the mean of 5 animals. NS = No significance.  
 
Table 6.3. Measurements of sclerotic ratio accordin g to Lammie’s equation (Lammie et al. 1997) in 5, 1 6 and 21 week old WKY and SHRSP. 
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SECTION FRONTAL SECTION 
SALT No Salt ( ±S.E.M) Salt (±S.E.M) 
REGION Cortex White Matter Deep Grey Cortex White M atter Deep Grey 
WKY 0.583±0.052 0.568±0.072 0.599±0.038 0.615±0.037  0.646±0.043 0.619±0.035 
SHRSP 0.654±0.028 0.655±0.041 0.643±0.040 0.640±0.0 39 0.659±0.018 0.617±0.044 
P for salt 
                     WKY:WKY+NaCl                                   WKY+salt:SHRSP+NaCl                                     SHRSP:SHRSP+NaCl 
              No significant differences                             No significant differences                               No significant differences 
SECTION MID CORONAL SECTION 
SALT No Salt ( ±S.E.M) Salt (±S.E.M) 
REGION Cortex White Matter Deep Grey Cortex White M atter Deep Grey 
WKY 0.639±0.030 0.678±0.016 0.661±0.019 0.639±0.021  0.654±0.026 0.645±0.023 
SHRSP 0.632±0.044 0.643±0.036 0.681±0.026 0.643±0.055 0.661±0.038 0.665±0.025 
P for salt 
                     WKY:WKY+NaCl                                   WKY+NaCl:SHRSP+NaCl                                     SHRSP:SHRSP+NaCl 
 No significant differences                             No significant differences                               No significant differences 
 
Each value represents the mean of 5 animals. NS = No significance.  
Table 6.4. Measurements of sclerotic ratio accordin g to Lammie’s equation (Lammie et al. 1997) in 21 w eek old WKY and SHRSP animals 
fed standard rat chow ± 1% NaCl salt-loading from t he age of 18 weeks. 
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SCLEROTIC INDEX 
A) Frontal Section 
 
 
B) Mid Coronal Section 
 
 
Figure 6.12. Plots showing the mean sclerotic ratio  (y axis) calculated from vessels in the 
cortical grey, white matter and deep grey matter. 
A) frontal and B) mid coronal brain sections. N=5 rats per group at ages 5, 16 and 21 weeks. Error bars 
represent ± the standard error of the mean. We found no significant difference in sclerotic ratio 
between the strains at any age. 
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SALT-LOADED ANIMALS 
A) Frontal Section 
 
B) Mid Coronal Section 
 
 
Figure 6.13. Plots showing the mean sclerotic ratio  (y axis) calculated from vessels in the 
cortical grey, white matter and deep grey matter .  
A) frontal and B) mid coronal brain sections in 21 week old rats. No salt indicates rat fed standard rat 
chow. Salt represents rats exposed to 1% NaCl salt-loading in drinking water from the age of 18 
weeks. N=5 rats per group. Error bars represent ± the standard error of the mean. We found salt 
loading had no effect on sclerotic ratio in both strains.
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6.4 Discussion 
6.4.1 Summary of main findings 
6.4.1.1 Qualitative assessments 
Our assessment of H&E stained slides taken from 5 week, 16 week and 21 week old WKY 
and SHRSP found that most morphological changes were in general not visible until 21 
weeks of age in SHRSP. However we also found evidence of endothelial cell proliferation in 
SHRSP at 5 weeks of age. This finding needs further validation but could indicate that not all 
vascular changes in the SHRSP are purely a consequence of hypertension.  
Finding evidence of endothelial proliferation in young SHRSP is not u expected. The few 
studies that have looked for evidence of vascular impairments in young SHRSP devoid of 
hypertension have found disturbances in vasoreactivity(Hirafuji et al. 2002) and the structure 
of the vascular tree(Coyle 1987) as well as tight junction protein expression (see chapter 7) 
and polarity(Lippoldt et al. 2000). However this does not mean that hypertension is not 
accountable for changes seen at older ages. 
By 21 weeks vessel wall thickening in the SHRSP was more evid nt in the deep grey vessels 
and very obvious in the larger (e.g. meningeal) vessels. These changes are common in 
hypertensive animal strains(Yamori et al. 1976b;Ogata et al. 1980) and in hypertensive 
human patients(Lammie 2002b) and are at least in part, a response to th raised blood 
pressure in the SHRSP which by 16 weeks is fully established at a malignant level(Yamori 
and Horie 1977).  
In salt-loaded animals, the vascular changes of 21 week old WKY+NaCl were exacerbated 
compared to age matched WKY. More striking was the appearance of vacuolated whiter 
matter in 40% of the WKY+NaCl especially as salt has no effect on the blood pressure of 
WKY animals at this age (see chapter 7). SHRSP+NaCl displayed heightened degrees of 
vessel wall thickening to SHRSP fed standard rat chow but additionally there was an area of 
white matter rarefaction and cavitation in the internal capsule of one 21 week old 
SHRSP+NaCl. It is unclear how prevalent these infarcts are in animals of this age as most 
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6.4.1.2 Quantitative assessments 
In general we found no differences in the density counts of capillaries and neurons between 
WKY and SHRSP rats. We did however find that capillary and neuron density increased 
with age in both strains of rat. This would be expected due to the growth and development of 
more neurovascular connections with age but goes against findings in some vascular 
dementia and small vessel disease patients which show a decrease in vessel and neuronal 
densities(Roman et al. 2002;Schuff et al. 2003;Moody et al. 2004). This discrepancy could 
simply be because our rats were biologically younger than the aged humans in these studies. 
Unlike the capillary and neuron counts we found no evidence of an increase in 
oligodendrocyte numbers with age in either strain. In salt-loaded nimals, only the white 
matter of the mid coronal section showed a significantly lower oligodendrocyte density in 
WKY+NaCl compared to WKY. Therefore, whilst striking differences in cell densities due 
to salt were not seen, we cannot rule out that even relatively mild salt-loading could impact 
on cell densities even in WKY animals and larger studies ar needed. A previous study has 
already highlighted the impact of salt-loading on proteins relating to the vascular unit in both 
SHRSP and WKY animals (see chapter 7) and the impact of salt on vascular pathology in 
particular needs to be fully assessed in both strains.  
Our assessment of sclerotic ratio using Lammie’s index(Lammie et al. 1997) did not reveal 
any significant differences between the two strains, although both strains showed an increase 
in vessel wall thickness with increasing age. More surprisingly we found that every 
measurement we took regardless of age or strain or salt intke fell within the range of 
moderate to severe sclerosis (>0.5). This suggests that the sclerotic index for humans needs 
to be modified if it is to be applied to other species. Our animals underwent exsanguination 
before the brains were fixed as they were primarily being used for genetic studies. Perfusion 
prior to fixation might preserve the vascular structure and make the human ranges of the 








Doctor of Philosophy University of Edinburgh 138 
6.4.1.3 Study methodology  
Our qualitative assessment of morphological changes was performed by three observers so 
we are confident that we did not miss any although all studies have limitations. Pathology is 
by its nature, a static assessment of a dynamic process. However, by selecting age groups 
covering a pre-hypertensive stage, an established hypertensive stage and a stroke-prone stage 
we have tried to asses the sequence of changes. Having accessto an age between 5 and 16 
weeks and an older possibly symptomatic animal would have made the study more complete, 
however we were restricted by animal availability. We did, however use a standardised 
method to reduce bias and assess the two regions most likely to display damage, as defined 
by previous studies(Ogata et al. 1980;Fredriksson et al. 1988)). However, by restricting 
ourselves to these regions we may have missed focal pathology at other levels.  
This study was performed blind to age, strain and diet of the rats and used randomly 
generated sampling points. We also performed each of the assessments eparately so density 
counts and sclerotic ratio measurements were not influenced by qualitative findings. As well 
as using these methods to reduce bias, it is important to use control strains and to test the 
effect of salt when looking at the SHRSP. There is a need for future experiments to methods 
which can detect more subtle changes e.g. immunohistochemistry on targeted regions (see 
chapter 7) rather than simple macroscopic examinations of coronal brain slices. Using 
standardised protocols and sampling methods such as ours can also enable more quantitative 
assessments such as lesion frequency and number to be conducted in ways more comparable 
to those used in human imaging studies.  
 
6.5 Conclusion   
Most morphological changes in SHRSP rats are not visible until after the development of 
hypertension and are characteristic of vascular remodelling, however ndothelial cell 
proliferation at 5 weeks was also evident and warrants a larger investigation of young 
SHRSP. Salt-loading caused heightened remodelling in the SHRSP and an old infarct. 
Evidence of white matter damage in WKY+NaCl was also evident. More studies are needed 
on the effects of salt on control strains. Vessel and neuronal densities are unaltered in 
SHRSP compared to age matched WKY. Finally clear evidence of v ssel hypertrophy in 
SHRSP could not be quantified using a sclerotic ratio designed for human vessels. This may 
be due to our method of fixation or species differences. Future st die  should use a method 
of fixation optimized for preserving vessel structure.  
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CHAPTER 7 : CEREBRAL SMALL VESSEL ENDOTHELIAL 
STRUCTURAL CHANGES PREDATE HYPERTENSION IN STROKE 
PRONE SPONTANEOUSLY HYPERTENSIVE RATS: A BLINDED, 
CONTROLLED IMMUNOHISTOCHEMICAL STUDY OF 5-21 WEEK 
OLD RATS.  
 
7.1 Background 
While there is an association between the severity of arteriolosclerosis and the number of 
lacunar lesions(Dozono et al. 1991b), a causal relationship has never been demonstrated. In 
SVD the chronic arteriolar damage affects all areas of the vascular unit including vessel wall 
and basement membrane thickening(Jellinger 2007), luminal narrowing, collagen 
deposition(Zhang et al. 2010), degeneration of smooth muscle cells, loss of activated 
astrocytes and vascular leakage(Wardlaw 2005).  
As previously noted, pathological descriptions from autopsy material p ovide static 
information about a dynamic process, and have limitations in describing the underlying 
mechanisms of the vessel damage. Consequently, appropriate animalmodels such as the 
SHRSP may have a role in determining the dynamic processes und rlyi g the development 
of vessel pathology seen in conditions such as vascular dementia and lacunar stroke.  
A number of studies have assessed parenchymal and vessel damage in SHRSP 
retrospectively after spontaneous strokes have occurred (see chapter 4). However, few 
studies have looked at the progressive development of pathology over the rat’s life(Bailey et 
al. 2011a). Additionally, there is little information regarding the cerebral small vessels in 
young animals before hypertension develops.  
Many groups now use a Japanese diet or salt-loading in order to quicken the development of 
the cerebral pathology in SHRSP(DiNicolantonio and Silvapulle 1988). The direct effect of 
this diet on the vascular changes of SHRSP rats and WKY rats has not been properly 
compared with rats fed standard rat chow (see chapter 4). 
With this background the aims of this study were to use immunohistocemi al techniques to 
a) assess changes in the neurovascular unit and their time sequ nc , in SHRSP fed standard 
rat chow versus WKY controls at 5, 16 and 21 weeks and b) to compare salt-loaded WKY 
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7.2 Materials and methods 
7.2.1 Animals & tissue preparation 
See chapter 5 for detailed descriptions of animal maintenanc , sacrifice, and subsequent 
tissue preparation. 
We used n=5 male rats aged 5, 16 & 21 week rats fed a normal diet (total n=30) plus n=5 
salt-loaded 21 week old rats from each strain (total n=10). Salt-loaded animals had 1% NaCl 
added to their drinking water at the age of 18 weeks, which continued until sacrifice at 21 
weeks.  
 
7.2.2 The use of antibodies to assess the structural integrity of the vascular unit. 
We selected antibodies which would assess the integrity of vascular unit right from the 
endothelial layer on the inside out via the basal lamina and vessel wall. Therefore we chose a 
major structural protein of the endothelial tight junctions (Claudin-5), Collagen IV to assess 
basal lamina integrity, the major cellular component of the vessel wall media (Smooth 
Muscle Actin), and Collagen I to assess evidence of vessel wall scarring.  
 
7.2.3 The use of antibodies to assess the presence / absence of vessel disease  
As well as assessing the vascular unit we wanted to assess changes in the surrounding 
extracellular domain including astrocyte activation (glial f brillary acidic protein [GFAP]) 
and matrix remodelling (matrix metalloproteinase 9 [MMP9]). We also wanted to assess any 
response to vascular disease so we looked for the presence of inflammation (Iba-1) and any 
myelin loss (myelin basic protein (MBP)).   
For a full list of antibodies, suppliers and dilutions see chapter 5.  
 
7.2.4 Protocol 
We used the ABC immunoperoxidase method (Vector Laboratories) briefly described in 
chapter 5 and available in full in appendix G of this thesis. Antige  heat retrieval using a 
pressure cooker (with slides immersed in citric acid buffer) was used as a pre-treatment for 
all antibodies. Slides were blocked against non-specific binding in hydrogen peroxide for 
10mins followed by either rabbit or swine serum. We used 3.3'-diaminobenzidine (DAB) 
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tetrahydrochloride to reveal immunoreactivity. Sections were lightly counterstained in 
Harris' haematoxylin. TBS 
 
7.2.5 Image analysis 
 We measured percentage staining using ImageProTM s ftware (version 6.3), blinded to 
species and age, in cortical, deep grey and white matter. We develop d a standard sampling 
protocol to assess the same 3 areas (and therefore vessels) of interest across all animals (see 
chapter 5), by identifying standard cross sections using landmarks such as the rhinal fissure 
and piriform cortex. We divided the cross section into cortical grey matter, white matter and 
deep grey matter using the freehand tool on ImagePro™. We applied the full image analysis 
protocol to both frontal cortex and mid coronal sections in each animal. To determine the 
amount of positive immunostaining present we used the count tool in ImagePro to determine 
the colour which best represented positive staining. This involved moving the cursor over an 
area of the section strongly stained for our antibody of interest and clicking on a strongly 
highly stained pixel. ImagePro subsequently highlights all pixels within the region of interest 
that match the colour specified by the observer. If any positive s aining remained one of 
these pixels was clicked on next and any other pixels corresponding to the next hue where 
cumultively highlighted until the observer felt all the positive immunostaining was 
accounted for. For reproducibility we performed all immunostaining for each antibody on the 
same day (i.e. all Claudin-5 staining performed in the same run). We then applied colour 
matched pixel counts, counting each region of interest separately. W  converted counts into 
percentage areas of staining as a measure of immunoreactivity using ImagePro™, once each 
region had been defined by hand.  
 
7.2.6 Image analysis intra-observer reliability study  
To assess the viability of our image analysis protocol before applying it to all slides, we 
assessed intra-observer reliability using a randomly selected slide counted on 5 separate 
occasions. Each slide photographed on the same day using the same microscope and 
software settings (x4 lens, 4ms exposure) in ImagePro™ 6.3.  
We assessed all regions of interest on the slide. The observer was blinded to the age, strain 
and antibody used on the slide. We obtained the area of immunoreactivity by colour 
thresholding segmentation (pixel counts). From this value the percentage of the region of 
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interest stained was calculated. We analysed the data using a coefficient of variance analysis 
to assess the effect of day on the percentage staining count.  
 
7.2.7 Data Analysis 
We performed statistical analysis in Minitab using a general linear model (two-way 
ANOVA) followed by Tukeys test for pairwise comparisons. For the assessment of 
antibodies we calculated the effects of strain and age. We assessed the effect of salt diet and 
strain for the salt loaded animals. For all of the statistical analysis, we analysed frontal cortex 
and mid-coronal sections separately as there were significant differences in the distribution 
of grey and white matter within the regions. We also assessed the effect of brain territory on 
the expression of the different vascular markers. We considered values of p<0.05 to be 
statistically significant. All data are shown as mean ± SEM. 
 
7.3 Results 
7.3.1 Image analysis intra-observer reliability study  
Our reliability study to assess the reproducibility of our image analysis protocol found that 
less than 10% of the variance within the counts was due to the effect o  day (cortical grey – 
Cv = 0.03, white matter – Cv = 0.06 and deep grey – Cv = 0.09). We therefore concluded that 
our protocol was reproducible and the observer was consistent in assessing percentage 







































Figure 7.1. The results of a one way ANOVA assessin g the impact of day (replicate) on 
percentage staining counts of smooth muscle actin ( SMA) immunoreactivity by the same 
observer.   
A coefficient of variance analysis revealed that less than 10% of the variance within the counts was 





7.3.2 Antibodies used to assess the structural integrity of the vascular unit. 
7.3.2.1 Animals fed on a normal diet (standard rat chow) aged 5, 16 and 21 weeks.  
A summary of the results for the frontal cortex and the mid coronal sections for all regions 
and all antibodies are shown in Tables 7.1 and 7.2 which summarise the results from 2 way 
ANOVA analysis. Figure 7.2 shows the appearance of immunoreactivity for each antibody. 
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Claudin-5 (Figure 7.3). 
Claudin-5 immunoreactivity was significantly lower in SHRSP rats compared to age 
matched WKY rats across the cortical grey, white matter and deep grey matter in both 
frontal and mid-coronal sections (p<0.01 for all regions). This decrease in Claudin-5 
immunoreactivity was present even in 5 week old rats in the deep gr y matter of the frontal 
sections ((p<0.001). Claudin-5 expression in WKY rats tended to increase with age although 
this was only significant in the cortical grey matter of the frontal sections (p<0.01). We 
found no increase in Claudin-5 immunoreactivity with age in the SHRSP rats.  
 
SMA: (Figure 7.4). 
In SHRSP versus WKY, there was more SMA staining in the cortical grey and white matter 
of the frontal sections (p<0.05 for both regions) and in the deep gr y matter of the mid 
coronal sections (p<0.05). We saw a significant increase of SMA staining with age 
particularly between the ages of 5 and 16 weeks in all regions of the frontal section 
(p<0.001). In the mid-coronal sections we also saw a progressive incr ase in SMA 
expression with age which was significant in the deep grey and white matter (p<0.01 for 





































Figure 7.2. Immunohistochemical staining of Claudin -5 (A&B), Collagen I (C&D), Collagen IV 
(E&F) and Smooth muscle actin (G&H).   
In all images WKY is on the left and SHRSP is on the right. Claudin images taken at x20 objective from 
the deep grey matter of 5 week old animals. Note the decrease in the intensity of Claudin-5 staining in 
SHRSP (panel B). Collagen I images taken at x10 objective from leptomeningeal vessels of 16 week 
old animals. Collagen IV images taken at x10 objective from the white matter of 21 week old animals. 
Note the more intense staining in SHRSP (panel F). Smooth muscle actin images taken at x10 
objective from the leptomeningeal vessels of 21 week old animals. Note the increased thickness of the 
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Collagen I:(Figure 7.5)  
In SHRSP rats, there was significantly less collagen I immunoreactivity in the white matter 
of the frontal sections compared with WKY (p<0.05). There were no significant differences 
between the strains in the mid coronal sections. In WKY rats, collagen I expression was low 
at 5 weeks, increased by 16 weeks and reduced slightly by 21 weeks. This increase with age 
was particularly apparent in the deep grey matter of the mid-coronal sections, where there 
was a large increase in collagen I immunoreactivity in both SHRSP and WKY rats from 5 to 
16 weeks (p<0.01), with at least twice as much staining here than in any other region.
 
Collagen IV: (Figure 7.6)  
We found no significant difference between the strains in frontal or mid-coronal sections. 
Collagen IV increased with advancing age in both strains, significa tly in the white matter of 
both the frontal section and mid coronal section (p<0.05). In mid coronal sections, collagen 
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SECTION FRONTAL SECTION 
AGE 5 weeks 16 weeks 21 weeks 
 
REGION Cortex White Matter Deep Grey Cortex 
White 
Matter Deep Grey Cortex 
White 
Matter Deep Grey 
WKY 0.107±0.049 0.116±0.006 0.135±0.061 0.225±0.027  0.191±0.091 0.118±0.069 0.280±0.124 0.268±0.127 0. 231±0.162 
SHRSP 0.090±0.042 0.101±0.061 0.045±0.024 0.113±0.0 50 0.090±0.016 0.083±0.24 0.132±0.027 0.073±0.045 0 .047±0.033 
P for strain Cortex      p<0.001 White Matter       p<0.01 Deep Grey         p<0.001 
Claudin5 
P for age Cortex   p<0.01 White Matter = NS Deep Grey  = NS 
WKY 0.040±0.017 0.052±0.035 0.067±0.026 0.260±0.147  0.356±0.288 0.145±0.101 0.172±0.047 0.134±0.079 0. 119±0.074 
SHRSP 0.041±0.017 0.015±0.006 0.047±0.034 0.168±0.0 85 0.131±0.090 0.081±0.057 0.138±0.100 0.066±0.032 0.030±0.014 
P for strain Cortex = NS                 White Matter     p<0.05 Deep Grey = NS 
Collagen I  
P for age Cortex  p<0.001 White Matter     p<0.001 Deep Grey = NS 
WKY 0.151±0.107 0.073±0.035 0.145±0.091 0.293±0.178  0.140±0.075 0.179±0.100 0.183±0.120 0.234±0.016 0. 062±0.017 
SHRSP 0.141±0.073 0.063±0.017 0.110±0.095 0.410±0.2 37 0.102±0.057 0.119±0.079 0.361±0.075 120±0.032 0. 100±0.044 
P for strain Cortex = NS White Matter = NS Deep Grey = NS 
Collagen 
IV 
P for age Cortex = NS White Matter  p<0.05 Deep Grey  = NS 
WKY 0.111±0.062 0.108±0.060 0.094±0.057 0.427±0.091  0.287±0.104 0.280±0.087 0.189±0.075 0.100±0.049 0. 139±0.044 
SHRSP 0.129±0.048 0.108±0.041 0.082±0.030 0.583±0.2 40 0.328±0.061 0.421±0.072 0.356±0.121 0.260±0.136 0.199±0.088 
P for strain Cortex    p<0.05 White Matter    p<0.05 Deep Grey = NS 
SMA 
P for age Cortex  p<0.001 White Matter    p<0.001 Deep Grey  p<0.001 
Data taken from frontal section tissue in SHRSP versus WKY rats fed a normal diet. Numbers indicate percentage staining ± the standard error of the mean from n=5 
animals. NS = No significant difference. 
Table 7.1 . Results of two way ANOVA analysis on the effect of strain and/or age on the percentage staining of 4 a ntibodies assessing the structural integrity of ves sels. 
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SECTION MID CORONAL SECTION 
AGE 5 weeks 16 weeks 21 weeks 
 
REGION Cortex White Matter Deep Grey Cortex White M atter Deep Grey Cortex White Matter Deep Grey 
WKY 0.173±0.043 0.130±0.055 0.132±0.050 0.156±0.047  0.169±0.044 0.345±0.106 0.200±0.025 0.261±0.140 0. 415±0.125 
SHRSP 0.067±0.027 0.081±0.077 0.078±0.025 0.114±0.0 82 0.076±0.038 0.344±0.172 0.080±0.070 0.129±0.058 0.113±0.084 
P for strain Cortex   p<0.001 White Matter   p<0.01 Deep Grey   p<0.01 
Claudin5 
P for age Cortex = NS White Matter = NS Deep Grey   p<0.001 
WKY 0.071±0.011 0.079±0.047 0.050±0.029 0.113±0.071  0.144±0.081 0.446±0.164 0.088±0.064 0.060±0.012 0. 732±0.190 
SHRSP 0.043±0.019 0.025±0.012 0.041±0.031 0.090±0.0 73 0.096±0.074 0.536±0.172 0.307±0.135 0.147±0.081 0.356±0.187 
P for strain Cortex = NS White Matter = NS Deep Grey = NS 
Collagen 
I 
P for age Cortex   p<0.01 White Matter   p<0.05 Deep Grey   p=0.001 
WKY 0.234±0.075 0.066±0.032 0.080±0.016 0.218±0.061  0.361±0.095 0.313±0.133 0.240±0.089 0.265±0.121 0. 152±0.018 
SHRSP 0.373±0.109 0.253±0.110 0.253±0.084 0.129±0.0 47 0.166±0.062 0.143±0.053 0.183±0.082 0.054±0.033 0.146±0.044 
P for strain Cortex = NS White Matter = NS Deep Grey = NS 
Collagen 
IV 
P for age Cortex   p<0.05 White Matter  p=0.01 Deep Grey = NS 
WKY 0.265±0.114 0.153±0.073 0.199±0.106 0.286±0.042  0.235±0.075 0.335±0.066 0.292±0.043 0.385±0.183 0. 291±0.087 
SHRSP 0.250±0.109 0.144±0.059 0.179±0.068 0.281±0.0 90 0.310±0.107 0.514±0.218 0.529±0.237 0.517±0.231 0.704±0.225 
P for strain Cortex = NS White Matter = NS Deep Grey    p<0.05 
SMA 
P for age Cortex = NS White Matter   p<0.01 Deep Grey   p<0.01 
Data taken from mid coronal tissue in SHRSP versus WKY rats fed a normal diet. Numbers indicate percentage staining ± the standard error of the mean from n=5 
animals. NS = No significant difference. 
Table 7.2 . Results of two way ANOVA analysis on the effect of strain and/or age on the percentage staining of 4 a ntibodies assessing the structural integrity of 
vessels. 
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CLAUDIN-5 
A) Frontal Section 
 
 
B) Mid Coronal Section 
 
Figure 7.3. Claudin-5 staining in both A) frontal a nd B) mid coronal sections of 5, 16 and 21wk 
old WKY and SHRSP rats.  
N=5 rats per group. Error bars represent the standard error of the mean. Overall SHRSP had less 
Claudin-5 immunoreactivity in the cortical grey, white matter and deep grey matter of both the frontal 
and mid coronal sections (p<0.01). 
 
 
*  *  
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SMOOTH MUSCLE ACTIN 
A) Frontal Section 
 
 
B) Mid Coronal Section 
 
 
Figure 7.4. Smooth muscle actin staining in both A)  frontal and mid coronal sections of 5, 16 
and 21wk old WKY and SHRSP rats.   
N=5 rats per group. Error bars represent the standard error of the mean. SHRSP had significantly more 
SMA immunoreactivity in the cortical grey and white matter of the frontal section (p<0.05) and in the 
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COLLAGEN I 
A) Frontal Section 
 
B) Mid Coronal Section 
 
 
Figure 7.5. Collagen I staining profiles of both a frontal (A) and mid coronal section (B) in WKY 
versus SHRSP.   
Each bar represents N=5. Error bars represent the standard error of the mean. No significant difference 
in immunoreactivity was found between the strains overall. A significant increase in Col I was found 
with increasing age in both strains and in both brain sections (p<0.05). 
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COLLAGEN IV 
A) Frontal Section 
 
 
B) Mid Coronal 
 
 
Figure 7.6. Collagen IV staining profiles of both a  frontal (A) and a mid-coronal section (B) in 
WKY and SHRSP.   
Each bar represents N=5. Error bars represent standard error of the mean. Overall no significant 
difference in immunoreactivity was found between WKY and SHRSP, however a significant decrease 
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7.3.3 Antibodies used to assess the presence / absence of vessel disease  
7.3.3.1 Animals fed on a normal diet (standard rat chow) aged 5, 16 and 21 weeks. 
A table of the results for the frontal cortex and the mid coronal sections for all regions and 
all antibodies are shown in Tables 7.3 and 7.4 which summarise the results from 2 way 
ANOVA analysis. Figure 7.7 shows the appearance of immunoreactivity for each antibody. 
For pictures of the immunostaining of each antibody at each age see appendix K. 
 
MMP9: (Figure 7.8)  
There was no significant difference between strains at any age except in the cortical grey 
matter of the mid coronal section (p<0.05). In both strains, cortical grey matter displayed the 
highest levels of immunoreactivity in both frontal and mid-coronal sections. We found a 
significant increase in MMP9 immunoreactivity with age in the cortical grey matter of the 
frontal section (p<0.05) and also in the deep grey matter of the mid coronal section 
(p<0.001). 
 
GFAP: (Figure 7.9). 
In the frontal sections we saw significantly more GFAP staining in the cortical grey and 
white matter of SHRSP rats (p<0.01 & p<0.001 respectively) than WKY. There was no 
difference between strains in the mid-coronal section. 
In the frontal section we also found that GFAP increased with age in all three tissue regions 
(p<0.001). In mid coronal sections we found a similar significant increase with age across all 
three regions (p<0.01). 
 
Iba-1: (Figure 7.10)  
SHRSP showed higher levels of Iba-1 immunoreactivity than WKY rats in the cortical grey 
matter of both the frontal and mid coronal sections (p=0.05 & p<0.01 respectively), as well 
as the deep grey matter of the mid coronal section (p<0.01).There was a significant increase 
in Iba-1 immunoreactivity with age in the white matter of the frontal sections (p<0.05). This 
was repeated in the cortical grey matter of the mid coronal sections where there was a 
significant increase in Iba-1 immunoreactivity between ages 5 and 16 weeks (p<0.01). There 
was no significant effect of age on Iba-1 in the white matter or deep grey matter. 
 
 


























Figure 7.7. Immunohistochemical staining of MMP9 (A &B), GFAP (C&D), Iba-1 (E&F) and MBP 
(G&H). 
In all images WKY is on the left and SHRSP is on the right. MMP9 images taken at x10 objective from 
the deep grey matter of 21 week old animals. GFAP images taken at x10 objective from the deep grey 
matter of 16 week old animals where GFAP staining was quantitatively higher (panel D). Iba-1 images 
taken at x10 objective from the cortex of 21 week old animals. MBP images taken at x4 objective from 
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MBP: (Figure 7.11).  
We found significantly less MBP staining in both the cortical grey and white matter of both 
frontal and mid coronal sections of SHRSP compared to WKY (all p values < 0.01). This 
decrease was also significant in the deep grey matter of the frontal section (p<0.01). The 
strain difference was particularly evident at the earlier ages of 5 & 16 weeks. The effect of 
age on MBP immunoreactivity varied widely between regions. In the white matter and deep 
grey matter of the frontal section along with the cortical grey matter of the mid coronal 
section there was an increase in MBP expression with age (although this only reached 
significance in the white matter of the frontal section where p<0.01). In the cortical grey 
matter of the frontal section in both strains there was a dramatic decrease in MBP 
immunoreactivity at 21 weeks (p<0.001). This trend was similar in the white matt r and deep 
grey matter of the mid coronal section (both p values <0.01).
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Data taken from frontal section tissue in SHRSP versus WKY rats fed a normal diet. Numbers indicate percentage staining ± the standard error of the mean from n=5 
animals. NS = No significant difference. 
SECTION FRONTAL SECTION 
AGE 5 weeks 16 weeks 21 weeks  
REGION Cortex White Matter Deep Grey Cortex 
White 
Matter Deep Grey Cortex White Matter Deep Grey 
WKY 0.167±0.087 0.035±0.018 0.150±0.080 0.319±0.145  0.478±0.315 0.119±0.078 0.349±0.301 0.154±0.101 0. 096±0.065 
SHRSP 0.232±0.200 0.438±0.225 0.321±0.180 0.581±0.2 83 0.164±0.125 0.151±0.101 0.148±0.077 0.143±0.081 0.030±0.020 
P for strain Cortex  = NS White Matter  = NS Deep Grey = NS 
MMP9 
P for age Cortex  p<0.05 White Matter = NS Deep Grey = NS 
WKY 0.125±0.023 1.615±0.166 1.359±0.198 0.711±0.158  2.198±0.573 0.863±0.283 0.914±0.199 1.387±0.254 1. 490±0.567 
SHRSP 0.343±0.119 7.170±1.188 3.588±0.643 0.152±0.0 41 2.152±0.547 0.507±0.138 0.715±0.169 2.420±0.758 1.034±0.304 
P for strain Cortex   p<0.01 White matter   p<0.001 Deep Grey = NS 
GFAP 
P for age Cortex  p<0.001 White Matter  p<0.001 Deep Grey  p<0.001 
WKY 0.032±0.017 0.024±0.015 0.043±0.016 0.039±0.006  0.033±0.011 0.036±0.028 0.063±0.012 0.110±0.042 0. 048±0.013 
SHRSP 0.038±0.016 0.064±0.017 0.033±0.014 0.084±0.0 23 0.071±0.029 0.068±0.027 0.071±0.034 0.084±0.048 0.052±0.028 
P for strain Cortex       p<0.05 White Matter  = NS Deep Grey = NS 
IBA-1 
P for age Cortex  p=0.01 White Matter  p=0.01 Deep Grey = NS 
WKY 2.132±0.653 0.490±0.155 0.681±0.161 2.502±0.921  0.609±0.293 1.518±0.421 0.462±0.205 1.403±0.611 1. 690±0.797 
SHRSP 1.215±0.469 0.213±0.080 0.340±0.439 1.147±0.5 24 0.174±0.070 0.237±0.062 0.477±0.191 0.632±0.324 0.472±0.186 
P for strain Cortex  p<0.01 White matter  p<0.01    Deep Grey  p<0.01  
MBP 
P for age Cortex  p<0.01 White Matter  p<0.01 Deep Grey = NS 
Table7.3. Results of two way ANOVA analysis on the effect of strain and/or age on the percentage stain ing of 4 antibodies assessing the presence/absence 
of vascular disease. 
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SECTION MID CORONAL SECTION 
AGE 5 weeks 16 weeks 21 weeks 
 
REGION Cortex White Matter Deep Grey Cortex White M atter Deep Grey Cortex White Matter Deep Grey 
WKY 0.279±0.102 0.148±0.042 0.103±0.035 0.351±0.105  0.181±0.095 0.088±0.032 0.141±0.058 0.023±0.012 0. 520±0.171 
SHRSP 0.367±0.107 0.074±0.032 0.066±0.013 0.367±0.1 09 0.099±0.062 0.121±0.050 0.452±0.133 0.207±0.102 0.380±0.106 
P for strain Cortex   p<0.05 White Matter  = NS Deep Grey = NS 
MMP9 
P for age Cortex = NS White Matter = NS Deep Grey   p<0.001 
WKY 0.346±0.102 2.399±0.600 2.170±0.477 0.694±0.327  0.966±0.338 1.616±0.377 0.638±0.353 2.388±0.529 1. 898±0.496 
SHRSP 0.214±0.065 2.415±0.650 1.745±0.498 0.332±0.1 27 1.206±0.512 0.894±0.253 0.702±0.172 2.093±0.501 2.246±0.515 
P for strain Cortex = NS White matter = NS Deep Grey = NS 
GFAP 
P for age Cortex  p<0.01 White Matter  p<0.001 Deep Grey  p=0.001 
WKY 0.022±0.007 0.024±0.012 0.023±0.008 0.033±0.007  0.037±0.026 0.038±0.015 0.032±0.020 0.022±0.011 0. 013±0.006 
SHRSP 0.030±0.020 0.042±0.022 0.050±0.032 0.094±0.0 44 0.039±0.017 0.041±0.025 0.045±0.015 0.036±0.019 0.036±0.020 
P for strain Cortex   p<0.01 White Matter  = NS Deep Grey    p<0.01 
IBA-1 
P for age Cortex  p<0.01 White Matter = NS Deep Grey = NS 
WKY 1.742±0.544 0.861±0.206 0.266±0.095 2.425±0.921  2.337±0.921 1.374±0.777 3.922±1.252 1.659±0.633 0. 583±0.228 
SHRSP 1.457±0.362 0.298±0.089 0.613±0.102 1.465±0.6 94 1.134±0.183 0.910±0.091 1.570±0.786 1.098±0.661 0.383±0.235 
P for strain Cortex   p<0.01 White matter   p<0.05    Deep Grey  = NS 
MBP 
P for age Cortex = NS White Matter  p<0.05 Deep Grey  p<0.01 
Data taken from mid coronal tissue in SHRSP versus WKY rats. Numbers indicate percentage staining ± the standard error of the mean from n=5 animals. NS = No 
significant difference.
Table7.4. Results of two way ANOVA analysis on the effect of strain and/or age on the percentage stain ing of 4 antibodies assessing the presence/absence of 
vascular disease 
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MMP9 
A) Frontal Section 
 
 
B) Mid Coronal Section 
 
Figure 7.8.  MMP9 staining profiles of both a front al (A) and mid coronal (B) section of WKY and 
SHRSP.  
Each bar represents N=5. Error bars represent the standard error of the mean. We found that SHRSP 
had significantly more MMP9 immunoreactivity in the cortical grey matter of the mid coronal section 
(p<0.05). We also found a significant increase in immunoreactivity with age in the cortical grey matter 
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GFAP 
A) Frontal section 
 
B) Mid Coronal Section 
 
Figure 7.9. GFAP staining profiles of both frontal (A) and mid coronal (B) sections of WKY 
versus SHRSP.   
Each bar represents n=5. Error bars represent the standard error of the mean. We found a significant 
increase in GFAP immunoreactivity in the SHRSP in the cortical grey and white matter of the frontal 
section (p<0.01). We also found a significant increase with age in both strains in all regions of both the 
frontal and mid coronal section (p<0.01). 
 
*  
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IBA-1 
A) Frontal Section 
 
 
B) Mid Coronal Section 
 
Figure 7.10.  Iba-1 staining profiles of both front al (A) and mid coronal sections (B) in WKY and 
SHRSP.  
Each bar represents N=5. Error bars represent standard error of the mean. SHRSP had significantly 
higher immunoreactivity in the cortical grey matter of the frontal and mid coronal sections (p<0.05) as 
well as the deep grey matter of the mid coronal section (p<0.01). We also found an effect of age in the 
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MBP 
A) Frontal Section 
 
 
B) Mid Coronal Section 
 
Figure 7.11. MBP staining profiles of both a fronta l (A) and mid coronal (B) section of WKY 
versus SHRSP .  
Each bar represents N=5. Error bars represent the standard error of the mean. We found significantly 
less MBP immunoreactivity in the SHRSP in all regions of both brain sections except the deep grey 
matter of the mid coronal section (p<0.01). We also found an increase with age in both strains in the 
cortical grey and white matter of the frontal section (p<0.01), as well as the white matter and deep grey 





*  *  *  
*  
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7.3.4 Animals with salt-loading (+NaCl) (all rats aged 21 weeks) 
7.3.4.1 All Antibodies 
A summary of the results for the frontal cortex and the mid coronal sections for all regions 
and all antibodies are shown in Tables 7.5–7.8 which summarise the results from 2 way 
ANOVA analysis. Figures 7.15-7.22 are graphical representations of this data for each 
antibody. For pictures of the immunostaining of each antibody in both non salt-loaded and 
salt-loaded animals see appendix L. 
 
Weekly systolic blood pressure readings of 21 week old SHRSP+NaCl were significantly 
higher than SHRSP (236.9±4.22mmHg versus 200.1±6.7mmHg, p=<0.05) We found no 
difference between systolic blood pressure readings of WKY+NaCl r ts versus WKY -
154.4±2.97mmHg salt versus 151.8±4.47 mmHg normal rat chow.  
 
7.3.4.2 WKY+NaCl versus WKY: 
In WKY+NaCl versus WKY, we found GFAP immunoreactivity (figure 7.13 & 7.20) was 
significantly reduced in the frontal section cortical grey matter (p<0.05), claudin-5 
immunoreactivity was reduced in all areas particularly in the frontal cortex, although this did 
not reach statistical significance (figure 7.12 & 7.15). Also in WKY+NaCl MBP 
immunoreactivity (figure 7.14 & 7.22) was significantly increased in the cortical grey matter 
of the frontal section (p=0.01), whilst significantly decreased in the white matter of the same 
section (p<0.05). MBP in the white matter of the mid coronal section was significantly 
increased (p<0.05) in WKY+NaCl.  
 
7.3.4.3 SHRSP+NaCl versus SHRSP:  
In SHRSP+NaCl versus SHRSP, we found Collagen IV was significa tly decreased in the 
cortical grey matter of the frontal section (p<0.05) (figure 7.18). Iba-1 expression varied 
greatly within the cortical grey matter of the two brain sections in SHRSP+NaCl (figure 
7.21). It was significantly lower in the cortical grey matter of the frontal section (p<0.01), 
however it was significantly higher in the same region of the mid coronal section (p=0.01). 
GFAP immunoreactivity (figure 7.20) was significantly increas d in the mid-coronal section 
white matter (p<0.01), SHRSP+NaCl tended to have less SMA immunoreactivity across all 
regions in both frontal and mid coronal sections (although this did not reach statistical 
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significance) (figure 7.16). Finally MBP immunoreactivity (figure 7.22) was significantly 
decreased in SHRSP+NaCl the white matter of the mid coronal section (p=0.006). 
 
7.3.4.4 WKY+NaCl versus SHRSP+NaCl:  
Salt-loading obscured some between-strain differences seen in rats fed normal chow, and 
exaggerated others. For example, we did not we see the difference in claudin-5 
immunoreactivity between WKY and SHRSP rats fed a normal diet repeated in the salt-
loaded animals, as the amount of claudin-5 immunoreactivity in salt-loaded WKY rats had 
decreased (figure 7.15). We found more GFAP immunoreactivity in mid coronal white 
matter (p<0.05) than WKY+NaCl rats (figure 7.20). Iba-1 immunoreactivity (figure 7.21) 
was no difference between salt-loaded animals in the frontal brain section, however, in the 
mid coronal section SHRSP+NaCl had significantly increased Iba-1 immunoreactivity in the 













Figure 7.12. Immunoreactivity of Claudin-5 in 21 we ek old animals A) WKY B) WKY+NaCl C) 
SHRSP D) SHRSP+NaCl.  
All images taken at x20 objective in the deep grey matter of a frontal section.  In WKY+NaCl we saw a 
trend towards a decrease in immunopositive staining versus WKY (B versus A). There was no 
difference between SHRSP+NaCl and SHRSP (C versus D). The reduction in staining in C vs A is a 


















Figure 7.13 . Immunoreactivity of GFAP in 21 week old animals A) WKY B) WKY+NaCl C) SHRSP 
D) SHRSP+NaCl.  
All images taken at x10 objective in the deep grey matter of a frontal section. Note the increase in 












Figure 7.14. Immunoreactivity of MBP in 21 week old  animals A) WKY B) WKY+NaCl C) SHRSP 
D) SHRSP+NaCl.  
All images taken at x4 objective in the cortical grey matter of a frontal section.  Note the decrease in 
MBP staining in SHRSP+NaCl versus SHRSP (panel D vs B). Also note the decrease in MBP staining 
























Data taken from frontal section tissue in 21 week old SHRSP versus WKY rats fed either a normal diet or salt-loaded with 1% NaCl from the age of 18 weeks. 
Numbers indicate percentage staining ± the standard error of the mean from n=5 animals. NS = No significant difference.
SECTION FRONTAL SECTION 
SALT No Salt Salt  
REGION Cortex White Matter Deep Grey Cortex White M atter Deep Grey 
WKY 0.280±0.123 0.268±0.127 0.231±0.162 0.160±0.063  0.112±0.057 0.085±0.049 
SHRSP 0.132±0.027 0.073±0.045 0.048±0.033 0.104±0.0 29 0.126±0.048 0.117±0.087 
Claudin5 
P for salt 
WKY:WKY+NaCl 
No significant differences 
WKY+NaCl:SHRSP+NaCl 
No significant differences 
SHRSP:SHRSP+NaCl  
No significant differences 
WKY 0.172±0.047 0.134±0.079 0.120±0.072 0.094±0.050  0.080±0.039 0.077±0.051 
SHRSP 0.138±0.100 0.066±0.032 0.030±0.014 0.097±0.0 64 0.099±0.067 0.030±0.014 
Collagen I  
P for salt 
WKY:WKY+NaCl  
No significant differences   
WKY+NaCl:SHRSP+NaCl  
No significant differences 
SHRSP:SHRSP+NaCl  
No significant differences 
WKY 0.183±0.120 0.234±0.162 0.062±0.017 0.203±0.142  0.106±0.062 0.089±0.025 
SHRSP 0.361±0.074 0.120±0.032 0.100±0.044 0.113±0.0 53 0.041±0.028 0.098±0.049 Collagen 
IV 
P for salt 
WKY:WKY+NaCl  
No significant differences   
WKY+NaCl:SHRSP+NaCl  
No significant differences   
SHRSP:SHRSP+NaCl  
Cortex p=0.02    White = NS   Deep Grey = NS 
WKY 0.189±0.075 0.100±0.049 0.139±0.043 0.298±0.161  0.087±0.025 0.146±0.056 
SHRSP 0.356±0.121 0.260±0.136 0.199±0.087 0.231±0.0 27 0.171±0.094 0.139±0.067 
SMA 
P for salt 
WKY:WKY+NaCl  
No significant differences 
WKY+NaCl:SHRSP+NaCl  
No significant differences 
SHRSP:SHRSP+NaCl  
No significant differences 
Table 7.5. Results of ANOVA analysis on the effect of salt on the percentage staining of 4 antibodies assessing vascular structure. 
 


















   
Data taken from mid coronal tissue in 21 week old SHRSP versus WKY rats fed either a normal diet or salt-loaded with 1% NaCl from the age of 18 weeks. Numbers 
indicate percentage staining ± the standard error of the mean from n=5 animals. NS = No significant difference. 
SECTION MID CORONAL SECTION 
SALT No Salt Salt  
REGION Cortex White Matter Deep Grey Cortex White M atter Deep Grey 
WKY 0.200±0.025 0.261±0.140 0.414±0.125 0.233±0.122  0.144±0.084 0.439±0.222 
SHRSP 0.080±0.070 0.129±0.058 0.113±0.084 0.177±0.1 03 0.233±0.054 0.223±0.085 
Claudin5 
P for salt 
WKY:WKY+NaCl 
No significant differences 
WKY+NaCl:SHRSP+NaCl 
No significant differences 
SHRSP:SHRSP+NaCl  
No significant differences 
WKY 0.088±0.064 0.060±0.012 0.732±0.381 0.242±0.150  0.131±0.080 0.475±0.202 
SHRSP 0.308±0.135 0.147±0.081 0.356±0.237 0.154±0.0 50 0.171±0.138 0.349±0.135 
Collagen I  
P for salt 
WKY:WKY+NaCl  
No significant differences   
WKY+NaCl:SHRSP+NaCl  
No significant differences 
SHRSP:SHRSP+NaCl  
No significant differences 
WKY 0.239±0.089 0.265±0.121 0.151±0.018 0.311±0.100  0.116±0.068 0.230±0.153 
SHRSP 0.183±0.112 0.054±0.033 0.146±0.044 0.413±0.1 98 0.229±0.143 0.239±0.085 Collagen 
IV 
P for salt 
WKY:WKY+NaCl  
No significant differences   
WKY+NaCl:SHRSP+NaCl  
No significant differences   
SHRSP:SHRSP+NaCl  
No significant differences   
WKY 0.292±0.044 0.385±0.183 0.291±0.087 0.262±0.076  0.219±0.092 0.649±0.187 
SHRSP 0.530±0.237 0.517±0.231 0.704±0.352 0.426±0.2 00 0.403±0.118 0.398±0.252 
SMA 
P for salt 
WKY:WKY+NaCl 
Cortex = NS    White = NS    Deep Grey p<0.05 
WKY+NaCl:SHRSP+NaCl  
No significant differences 
SHRSP:SHRSP+NaCl  
                  No significant differences 
Table 7.6. Results of ANOVA analysis on the effect of salt on the percentage staining of 4 antibodies assessing vascular structure. 
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Data taken from frontal section tissue in 21 week old SHRSP versus WKY rats fed either a normal diet or salt-loaded with 1% NaCl from the age of 18 weeks. 
Numbers indicate percentage staining ± the standard error of the mean from n=5 animals. NS = No significant difference.
SECTION FRONTAL SECTION 
SALT No Salt Salt  
REGION Cortex White Matter Deep Grey Cortex White M atter Deep Grey 
WKY 0.349±0.211 0.154±0.101 0.096±0.065 0.132±0.098  0.112±0.073 0.087±0.057 
SHRSP 0.148±0.077 0.143±0.081 0.030±0.023 0.264±0.1 06 0.248±0.174 0.158±0.132 
MMP9 
P for salt 
WKY:WKY+NaCl 
No significant differences 
WKY+NaCl:SHRSP+NaCl  
No significant differences 
SHRSP:SHRSP+NaCl 
No significant differences 
WKY 0.914±0.199 1.387±0.254 1.490±0.567 0.493±0.136  1.991±0.230 0.835±0.161 
SHRSP 0.715±0.169 2.419±0.758 1.034±0.304 1.046±0.2 99 1.840±0.314 1.190±0.139 
GFAP 
P for salt 
WKY:WKY+NaCl  
Cortex p<0.05       White = NS      Deep Grey = NS      
WKY+NaCl:SHRSP+NaCl  
Cortex p<0.01      White = NS      Deep Grey = NS 
SHRSP:SHRSP+NaCl  
No significant differences 
WKY 0.063+0.013 0.109+0.042 0.048+0.013 0.031+0.011 0.054+0.016 0.027+0.010 
SHRSP 0.071+0.035 0.084+0.048 0.052+0.028 0.014+0.002 0.030+0.013 0.051+0.026 
IBA-1 
P for salt 
WKY:WKY+NaCl 
No significant differences    
WKY+NaCl:SHRSP+NaCl  
No significant differences 
SHRSP:SHRSP+NaCl  
Cortex p<0.01      White = NS     Deep Grey = NS 
WKY 0.477±0.191 1.402±0.611 1.690±0.697 1.990±0.794  0.346±0.117 1.165±0.092 
SHRSP 0.462±0.204 0.632±0.224 0.472±0.286 0.427±0.2 37 0.561±0.294 1.189±0.290 
MBP 
P for salt 
WKY:WKY+NaCl  
Cortex p=0.01      White p<0.05     Deep Grey = NS  
WKY+NaCl:SHRSP+NaCl  
Cortex p<0.01      White = NS     Deep Grey = NS 
SHRSP:SHRSP+NaCl  
No significant differences 
Table 7.7. Results of ANOVA analysis on the effect of salt on the percentage staining of 4 antibodies assessing the presence / absence of vascular 
disease. 
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Data taken from mid coronal tissue in 21 week old SHRSP versus WKY rats fed either a normal diet or salt-loaded with 1% NaCl from the age of 18 weeks. Numbers 
indicate percentage staining ± the standard error of the mean from n=5 animals. NS = No significant difference.
SECTION MID CORONAL SECTION 
SALT No Salt Salt  
REGION Cortex White Matter Deep Grey Cortex White M atter Deep Grey 
WKY 0.141±0.058 0.217±0.013 0.521±0.171 0.162±0.115  0.367±0.225 0.717±0.346 
SHRSP 0.452±0.232 0.207±0.102 0.380±0.196 0.350±0.2 25 0.119±0.056 0.375±0.182 
MMP9 
P for salt 
WKY:WKY+NaCl  
No significant differences 
                  WKY+NaCl:SHRSP+NaCl  
No significant differences 
SHRSP:SHRSP+NaCl  
No significant differences 
WKY 0.683±0.302 2.388±0.529 1.898±0.496 0.615±0.174  2.439±0.382 2.551±0.382 
SHRSP 0.702±0.172 2.093±0.500 2.246±0.515 0.504±0.1 62 3.965±0.766 2.552±0.702 
GFAP 
P for salt 
WKY:WKY+NaCl  
 No significant differences   
WKY+NaCl:SHRSP+NaCl  
Cortex = NS         White p<0.05       Deep Grey = NS 
SHRSP:SHRSP+NaCl  
Cortex = NS       White p<0.01     Deep Grey = NS 
WKY 0.032+0.020 0.022+0.011 0.013+0.006 0.055+0.020 0.034+0.021 0.019+0.009 
SHRSP 0.045+0.015 0.034+0.019 0.036+0.020 0.112+0.033 0.109+0.099 0.063+0.026 
IBA-1 
P for salt 
WKY:WKY+NaCl  
No significant differences    
WKY+NaCl:SHRSP+NaCl  
Cortex p<0.05      White = NS     Deep Grey p=0.01 
SHRSP:SHRSP+NaCl  
Cortex p=0.01      White = NS     Deep Grey = NS 
WKY 4.622±2.152 1.659±0.634 0.582±0.228 3.834±1.410  0.521±0.150 0.292±0.107 
SHRSP 1.570±0.786 1.098±0.761 0.383±0.233 1.944±0.8 86 0.063±0.046 0.130±0.105 
MBP 
P for salt 
WKY:WKY+NaCl  
No significant differences    
WKY+NaCl:SHRSP+NaCl  
Cortex p<0.05      White = NS     Deep Grey p=0.01 
SHRSP:SHRSP+NaCl  
Cortex p=0.01      White = NS     Deep Grey = NS 
Table 7.8. Results of ANOVA analysis on the effect of salt on the percentage staining of 4 antibodies assessing the presence / absence of vascular diseas e. 
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CLAUDIN-5 
A) Frontal Section 
 
 
B) Mid Coronal Section 
 
 
Figure 7.15. Claudin-5 staining profiles of both a frontal (A) and a mid-coronal section (B) taken 
from 21 week old rats either salt-loaded from 18 we eks of age or raised or standard rat chow.  
Each bar represents N=5. Error bars represent standard error of the mean. We found no significant 
effect of salt loading on Claudin-5 staining with salt loading in either strain. However note the reduction 




*  *  
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SMOOTH MUSCLE ACTIN 
A) Frontal Section  
 
B) Mid Coronal Section 
 
 
Figure 7.16. Smooth Muscle Actin staining profiles of both a frontal (A) and a mid-coronal 
section (B) taken from 21 week old rats either salt -loaded from 18 weeks of age or raised or 
standard rat chow.  
Each bar represents N=5. Error bars represent standard error of the mean. We found no significant 
effect of salt on SMA staining in the frontal section. In the mid coronal section WKY+NaCl had more 
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COLLAGEN I 
A) Frontal Section 
 
 
B) Mid Coronal Section 
 
 
Figure 7.17. Collagen I staining profiles of both a  frontal (A) and a mid-coronal section (B) taken 
from 21 week old rats either salt-loaded from 18 we eks of age or raised or standard rat chow.  
Each bar represents N=5. Error bars represent standard error of the mean. We found no significant 
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COLLAGEN IV 
A) Frontal Section 
 
 
B) Mid Coronal Section  
 
 
Figure 7.18. Collagen IV staining profiles of both a frontal (A) and a mid-coronal section (B) 
taken from 21 week old rats either salt-loaded from  18 weeks of age or raised or standard rat 
chow.   
Each bar represents N=5. Error bars represent standard error of the mean.We found significantly less 
Collagen IV staining in the cortical grey matter of SHRSP+NaCl versus SHRSP (p<0.05) in the frontal 
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MMP9 
A) Frontal Section 
 
 
B) Mid Coronal Section 
 
 
Figure 7.19. MMP9 expression in 21 week old salt-lo aded versus 21 week old rats fed a normal 
diet.  
Note the reversal in MMP9 expression between the salt-loaded and non-salt loaded animals. Each bar 
represents N=5. Error bars represent the standard error of the mean. We found no significant 
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GFAP 
A) Frontal Section 
 
 
B) Mid Coronal Section 
 
 
Figure 7.20. GFAP staining profiles of both a front al (A) and a mid-coronal section (B) taken 
from 21 week old rats either salt-loaded from 18 we eks of age or raised or standard rat chow.  
Each bar represents N=5. Error bars represent standard error of the mean. We found WKY+NaCl had 
significantly less GFAP staining in the cortical grey matter of the frontal section versus WKY (p<0.05). 
In turn SHRSP+NaCl had significantly more GFAP than WKY+NaCl in the same region (p<0.01). In the 
mid coronal section SHRSP+NaCl had significantly more GFAP staining in the white matter than both 
SHRSP (p<0.01) and WKY+NaCl (p<0.05). 
*  
*  *  
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IBA-1  
A) Frontal Section 
 
B) Mid Coronal Section 
 
 
Figure 7.21 . Iba-1 staining profiles of both a frontal (A) and a  mid-coronal section (B) taken from 
21 week old rats either salt-loaded from 18 weeks o f age or raised or standard rat chow.   
Each bar represents N=5. Error bars represent standard error of the mean. We found SHRSP+NaCl 
had significantly less Iba-1 staining in the cortical grey matter of the frontal section  (p<0.01). In the mid 
coronal section SHRSP+NaCl had significantly more Iba-1 staining in the cortical grey matter than both 
WKY+NaCl (p<0.05) and SHRSP (p<0.01). SHRSP+NaCl also had significantly more Iba-1 staining in 
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MBP 
A) Frontal Section 
 
B) Mid Coronal Section 
 
 
Figure 7.22. MBP staining profiles of both a fronta l (A) and a mid-coronal section (B) taken from 
21 week old rats either salt-loaded from 18 weeks o f age or raised or standard rat chow.  
Each bar represents N=5. Error bars represent standard error of the mean. We found WKY+NaCl had 
significantly more MBP staining than both WKY (p<0.01) and SHRSP+NaCl (p<0.01) in the cortical 
grey matter of the frontal section. However, WKY+NaCl had significantly less MBP staining in the white 
matter versus WKY (p<0.05). In the mid coronal section SHRSP+NaCl had significantly less MBP 
staining in the cortical grey and deep grey matter than WKY+NaCl (p<0.05). 
*  
*  
*  *  
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7.4 Discussion 
7.4.1 Summary of main findings 
For a summary of all the significant differences in immunostaining found with age in this 
chapter see table 7.9. We found a significant reduction in a major neural tight junction protein 
(Claudin-5) in SHRSP from the earliest ages. We saw increased immunoreactivity for SMA at 
16 weeks – but not at 5 weeks in SHRSP, which would reflect smooth muscle hyperplasia or 
hypertrophy in response to hypertension. We found increased immunoreactivity for Iba-1 in 
the cortical grey matter of SHRSP in both the frontal and mid coronal sections which suggests 
increased activation of microglia in these regions. Finally sa t-loading affected the expression 
of neurovascular markers in both the control animals (WKY) and SHRSP. 
The difference in Claudin-5, a major endothelial tight junction protein, was seen in SHRSP 
from 5 weeks of age, before the development of hypertension, adding further evid nce to the 
hypothesis that not all small vessel and brain tissue changes are due to hypertension 
alone(Wardlaw et al. 2001;Jackson and Sudlow 2005a). Cerebral endothelial cell tight 
junctions are complex structures involving the interactions of multiple proteins, and are a key 
component in maintenance of the blood brain barrier. Claudin-5 functionally contributes 
towards the sealing of tight junctions(Nitta et al. 2003). It is empting to postulate that a 
decrease in Claudin-5 as early as 5 weeks of age, possibly from birth, may predispose to 
disruption of the blood brain barrier and thence the affected vessels to subsequent 
arteriopathy. Increasing evidence from the human literature tends to support this hypothesis.  
The increase in SMA immunoreactivity at 16 weeks in SHRSP versus WKY agrees with 
previous findings(Lin et al. 2001;Fujita et al. 2008) and may represent smooth muscle 
hypertrophy compensating for the steady increase in blood pressure in SHRSP. The increase 
in collagen I immunoreactivity in SHRSP in all regions of the mid coronal section by the age 
of 16 weeks, suggests focal medial scarring, possibly secondary to hypertensive damage to 
smooth muscle cells. Our results agree with previous findings which indicate that the effects 
of hypertension in this rat show similarities with human small vessel disease(Nabika et al. 
2004). Vessel wall hypertrophy and scarring are common observations from hypertensive 
patients(Laurent 1995). 
The increased Iba-1 immunoreactivity in the grey matter of SHR P in both the frontal and 
mid coronal sections increased activation of microglia. We did not find any significant 
changes in the immunoreactivity of MMP9 in SHRSP versus WKY rats suggestin  that, at the 
ages we studied there was little matrix remodelling in the perivascular tissues. We found no 
difference in collagen IV immunoreactivity between the strains implying that the basal lamina 
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was mostly intact in SHRSP or at least no different to WKY, or that any changes were too 
small to be detected by immunohistochemistry and image analysis.  
 
Table 7.9. A summary table of all the significant d ifferences in immunoreactivity with age in the 
SHRSP and WKY.  
 
Significant differences in immunostaining due to st rain across all ages 
Brain section and region of interest 
ANTIBODY 
Direction 




Frontal Mid Coronal 
Claudin-5 Decrease p<0.01 All ROI All ROI 
SMA Increase p<0.05 CG & WM  DG 
Collagen I N/A N/A N/A N/A 
Collagen IV N/A N/A N/A N/A 
GFAP Increase p<0.01 CG & WM N/A 
MMP9 N/A N/A N/A N/A 
Iba-1 Increase p<0.01 CG CG & DG 
MBP Decrease p<0.05 All ROI CG &WM 
 
Data represents the results of ANOVA analysis comparing the mean percentage staining within a region 
of interest. * Level of significance quoted is the lowest value across all comparisons therefore if p<0.01 
is stated then significance reached a minimum of this level in all regions quoted -some regions may 
have been more highly significant. CG = cortical grey. WM = white matter. DG = deep grey. ROI = 
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7.4.1.1 The effects of salt-loading: 
For a summary of all the significant differences found in respon e to salt loading in this 
chapter see table 7.10. We also found that a salt diet has effects on the structure of the blood 
brain barrier - decreased immunoreactivity of claudin-5 and increased microglial activation 
(Iba-1) in SHRSP and WKY rats, although not all changes reached significance. Additionally, 
SHRSP+NaCl have increased levels of GFAP immunoreactivity indicating more reactive 
gliosis than in non salt-loaded animals. These effects were observed without any increase in 
blood pressure in the WKY strain, while salt-loading significantly increased the already raised 
blood pressure in the SHRSP. SHRSP+NaCl develop high levels of hypertension and end 
stage pathology sooner than those left to have ‘spontaneous’ strokes(DiNicolantonio and 
Silvapulle 1988) and rarely live beyond 28 weeks of age. We found the difference in the 
immunoreactivity of claudin-5 between the strains at 21 weeks of age was absent in salt-
loaded animals because the WKY rats also had lower levels of claudin-5. We found some 
evidence that salt-loading causes activation of microglial cells particularly in the mid coronal 
sections of SHRSP when compared to salt loaded WKY. This could sugge t an increased 
inflammatory response to salt-loading in the SHRSP. MBP immunoreactivity was also 
affected by salt-loading in the cortical grey (frontal section) and white matter (both sections) 
of the WKY rats, although the changes were somewhat erratic wi h expression both 
increasing and decreasing. An increase in MBP may not be seen as harmful an event as a 
decrease but MBP is directly involved in T lymphocyte mediated inflammatory pathways and 
can therefore lead to increased permeability of the BBB(Cserr and Knopf1992). 
Many studies have suggested an inflammatory mechanism in salt loaded rats which in turn 
compromises the blood brain barrier(Blezer et al. 1998;Guerrini et al. 2002;Sironi et al. 
2004). However, our results using animals reared on a normal diet show that the SHRSP has 
changes occurring at the endothelial tight junctions without the need for salt-loading. 
Therefore previous studies may have been confounded in their assessment of blood brain 
barrier integrity by routine use of salt-loading. The SHRSP in its spontaneous state is 
advantageous when trying to model human small vessel stroke as, although high salt intake is 
a recognised risk factor for all ischaemic stroke, it has not specifically been associated with a 
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Table 7.10. A summary table of all the significant differences in immunoreactivity in response to 
mild salt loading in SHRSP and WKY aged 21 weeks. 
 
Significant differences in immunostaining due to sa lt loading 








Frontal Mid Coronal 
WKY N/A N/A N/A N/A Claudin-5 
SHRSP N/A N/A N/A N/A 
WKY Decrease p<0.05 N/A WM SMA 
SHRSP Decrease p<0.01 N/A WM 
WKY N/A N/A N/A N/A Collagen I 
SHRSP N/A N/A N/A N/A 
WKY N/A N/A N/A N/A Collagen IV 
SHRSP Decrease p<0.05 CG N/A 
WKY Decrease p<0.05 CG N/A GFAP 
SHRSP Increase p<0.05 N/A WM 
WKY N/A N/A N/A N/A MMP9 
SHRSP N/A N/A N/A N/A 
WKY N/A N/A N/A N/A Iba-1 
SHRSP Increase p<0.01 CG CG 
WKY Decrease p<0.05 CG & WM N/A MBP 
SHRSP Decrease p<0.01 N/A WM 
 
Data represents the results of ANOVA analysis comparing the mean percentage staining within a region 
of interest. *Level of significance quoted is the minimum value across all comparisons therefore if 
p<0.01 is stated then significance reached a minimum of this level in all regions quoted - some regions 
may have been more highly significant. CG = cortical grey. WM = white matter. DG = deep grey. ROI = 
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7.4.2 Aspects of study methodology 
This study has limitations. Firstly the SHRSP is inbred. The animals we used have been bred 
in a colony separately from the original source for over 15 years. Thus there may be subtle 
genetic differences between our colony and other SHRSP colonies, so our findings may differ 
qualitatively or quantitatively from other colonies. Secondly, we found some strong trends in 
our data that did not achieve statistical significance. This may reflect the small number of 
animals studied (5 rats per group) and a larger study would make the data more robust. Some 
antibodies produced larger errors due to their diffuse immunoreactivity (e.g. MMP9). This 
made colour threshold assessment using pixel counts inherently more difficult, increasing the 
likelihood of human error.  
However, this study also has several strengths, particularly as few studies have described the 
changes in the small vessels and surrounding tissue in young SHRSP rats. We selected young 
rats still at a normotensive stage, an established hypertensive stage (16 weeks) and a stroke-
prone stage (21 weeks). Further advantages are that we sourced all animals from the same 
colony where both the control WKY and the SHRSP are kept in the same conditions and fed 
exactly the same diet. Additionally, the observer was blinded to the age and strain of the rats 
throughout the immunohistochemistry and image analysis protocols. We used a standardised 
sampling protocol to standardise anatomical areas of cortical grey, white matter and deep grey 
matter to ensure sampling from consistent regions despite the challenge of differences in brain 
size at different ages. The importance of this is demonstrated in the differences we have found 
between regions within the same brain sections and the differences between frontal and 
coronal sections. For example a significant increase in collagen I with age was evident in all 
regions of the mid coronal section but only the cortical grey matter of the frontal section. 
Likewise the increase in SMA immunoreactivity was more evident in the mid coronal section. 
Frontal and mid coronal sections of the brain have differing ratios of cortical grey, white 
matter and in particular deep grey matter – the mid coronal section has a much larger area of 
deep grey matter. The vascular beds feeding cortical structures are very different from those 
feeding subcortical structures. Cortical vessels anastomose efficiently with surrounding 
vessels whereas arterioles of the deep grey structures are end arterioles with no access to 
collateral flow. This difference is also important as the SHRSP has been suggested as a model 
of subcortical diseases such as vascular dementia(Kimura et al. 2000) but few studies have 
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7.5 Conclusion 
In conclusion we have shown that from a pre-hypertensive age, the SHRSP has less of the 
tight junction protein claudin-5. We have also confirmed that prolonged hypertension causes 
vessel wall hypertrophy (due to an increase in SMA) and an accumulation of collagen 1 
within the vessel wall. Salt decreases tight junction proteins not only in the SHRSP rats but 
also in the WKY animals. The changes in vascular endothelium tight junctions are then 
exacerbated by both an increase in blood pressure and a high salt intake. However in the 
WKY+NaCl, these changes occurred without any measurable change in blood pressure, 
suggesting that the effects of salt may be mediated through direct action on the endothelium 
rather than simply through raised blood pressure. Therefore a high salt diet in people, with or 
without hypertension, may compromise the structure of the blood brain arrier and increase 
the risk of cerebrovascular disease, cognitive decline and dementia. This effect would be 
particularly relevant in conditions such as lacunar stroke wh re there is already evidence 
indicating that blood brain barrier failure is a causative mechanism(Wardlaw et al. 2003).  
Future experiments should focus on examining the SHRSP endothelium in more detail in 
young rats, at narrower age intervals, in larger numbers and look for the potential genetic 
differences in the SHRSP rat that could account for endothelial tight junction structural 
differences. The structure of the vascular endothelium outside of the brain (e.g. in the kidney) 
should also be investigated to assess whether the alteration in tight junction proteins within 
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CHAPTER 8 : TIME COURSE AND SALT SPECIFIC MICROARRAY 
ANALYSIS OF GENE EXPRESSION IN BRAIN REGIONS 
SUSCEPTIBLE TO SPONTANEOUS STROKES AND VASCULAR 
PATHOLOGY IN THE SPONTANEOUSLY HYPERTENSIVE STROKE 
PRONE RAT (SHRSP).  
 
8.1 Background 
The SHRSP was originally considered to be (and still is) a model of malignant hypertension 
and cardiovascular disease as it displays left ventricular hypertrophy, however only a few 
microarray studies of hypertensive (SHR, SHRSP) and salt sensitiv  (Dahl salt sensitive) rat 
strains have been performed to identify the genetics underlying cardiovascular disease 
(e.g.(Garrett et al. 2002;McBride et al. 2003;Garrett et al. 2005)). However these studies were 
performed in adult rats when hypertension is fully established, maning that any changes in 
gene expression could simply have been secondary to increased blood pressure. Few studies 
have assessed the SHRSP at more than one time point over the development of hypertension 
in order to separate candidate genes for hypertension from those which might contribute to 
other disease states the SHRSP is used to model – kidney disease, attention deficit 
hyperactive disorder and in our case stroke. Whilst a couple of microarray studies of temporal 
mRNA expression in the SHRSP kidney have been performed (Seubert et al. 2005;Clemitson 
et al. 2007;Polke 2008) there have not been any studies on brain tissue to correlate changes in 
mRNA expression with the cerebral vascular and parenchymal pathology. Therefore the 
question of what makes the SHRSP ‘stroke prone’ (Hinojos et al. 2005) upon exposure to 
levels of hypertension the SHR experiences is still unanswered(Bailey et al. 2011a).  
The STR1 (stroke related -1) locus on chromosome 1 in the SHRSP was originally suggested 
as the ‘stroke-prone’ locus despite containing no obvious candidate genes(Rubattu et al. 1999) 
as it affected latency to stroke in SHRSP crossed with stroke esistant SHR in a study 
designed to eliminate the influence of blood pressure(Rubattu et al. 1996). The polygenic 
nature of stroke makes it unlikely that this one locus would be the only genetic factor 
conferring stroke-proneness in SHRSP and soon afterwards another locus on hromosome 5 
was also proposed as a contributing factor to stroke sensitivity(Jeffs et al. 1997b). This locus 
surrounds Atrial and Brain Naturetic Peptides and SHRSP and is also blood pressure 
independent. Indeed SHRSP sampled from a range of ages (4-36 weeks), have been shown to 
have multiple genetic differences (all compared to WKY) considered to have a direct 
influence on the incidence or timing of stroke, independently of hypertension including: 
decreased endothelial nitric oxide (NO) and increased superoxide specie (Grunfeld et al. 
1995;McBride et al. 2005), impaired endothelial dependent vasorelaxation(Negishi et al. 
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1999), irregular Na+ exchange in vascular smooth muscle cells(Thompson et al. 
1988;Kobayashi et al. 1990) and impaired activation and decreased aggregation of 
platelets(Tomita et al. 1984;Umegaki et al. 1986;Klee et al. 1993;Ikeda et al. 1996).  
Although the above are considered independent of hypertension, longitudinal study of the 
brain (including young animals) is necessary to identify sequential changes in brain 
parenchymal and/or cerebrovascular mRNA expression to distinguish secondary effects of 
hypertension from underlying susceptibility to tissue damage. In this thesis we have already 
shown that SHRSP have features indicating susceptibility to brain vascular and parenchymal 
damage at 5 weeks of age, prior to the onset of hypertension including: impaired endothelial 
tight junctions, perivascular inflammation and glial damage (see chapter 7).  
However, whilst the study of young SHRSP is not confounded by hypertension the study of 
older age groups is confounded not just by exposure to hypertension but invariably to dietary 
interventions too. Over the last 20 years the use of salt administered either as a ‘Japanese 
Diet’ or as salt added to drinking water, has been used increasingly in research using SHRSP 
(Bailey et al Int J Stroke in press) as a means to quicken the onset of pathological changes and 
create a more severe phenotype of cardiovascular and cerebrovascular disease 
(DiNicolantonio and Silvapulle 1988;Schmidlin et al. 2005;Yamamoto et al. 2008). The effect 
of salt sensitivity on cerebrovascular gene expression in the SHRSP has not been fully 
determined. Perhaps more importantly, the effect of salt on the cerebrovascular pathology of 
control strains such as the Wistar Kyoto rat (WKY) - the parent strain of the SHRSP and 
SHR, has also not been assessed  
 
8.1.1 Aims of the study 
In light of the unanswered questions raised above we used a microarray approach to measure 
mRNA expression in order to assess two aims; Firstly, to assess differences in cerebral gene 
expression between the WKY and SHRSP from weanling to maturity (5, 16 and 21 weeks) 
and secondly, to determine the impact of salt loading on cerebral gene expression in both 
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8.2 Methods 
8.2.1.1 Animals and tissue 
For our serial timepoint study we used male WKY and SHRSP animals from three age groups 
(5 week, 16 week and 21 week old animals) with four WKY and four SHRSP animals per age 
group (total animals n=24). To study the effect of salt loading (+NaCl) we used WKY and 
SHRSP animals all aged 21 weeks (n=4 of each strain) at time of sacrifice. All rats were fed 
standard rat chow throughout, however in half of the 21 week old WKY and SHRSP we 
added 1%NaCl to their drinking water at 18 weeks, producing 3 weeks of salt loading. We 
kept all animals in identical conditions. We preserved one brain hemisphere from each animal 
in liquid nitrogen. We then immersed the entire hemisphere in x10 volume of RNAlater®-
ICE solution (Ambion) and incubated for 24 hours at -20°C to enable full penetration of the 
solution. The next day we mounted the hemisphere in a Zivic rat slicer matrix and cut a 2mm 
coronal slice from a frontal and a mid coronal region based on a previously described protocol 
(see chapter 5) to capture standardised brain areas matched for age. These areas captured the 
frontal cortex, thalamus, internal capsule and basal ganglia – areas susceptible to cerebral and 
vascular pathology in the SHRSP. 
 
8.2.1.2 RNA extraction  
We placed the slices in approximately 1.5ml (x10 volume) of lysis buffer (Qiazol (Qiagen)) 
and homogenized the tissue using a POLYTRON® homogenizer (Capitol Scientific Inc.). We 
then applied a Qiagen RNAeasy lipid tissue minikit (www.qiagen.com) for the extraction of 
RNA from fatty tissues to the homogenates. We eluted the resulting RNA with nuclease free 
water (2x50µl). We treated half the elute with turbo DNase to rmove any remaining genomic 
DNA. We then assessed the quality of the resulting RNA on a Nanodrop ND 1000 and 
Agilent bioanalyser 2100.  
 
8.2.1.3 RNA amplification and purification 
We performed transcriptions from RNA to cRNA using an Ambion Illumina Total Prep RNA 
amplification kit (www.ambion.com). We generated first strand cDNA with a first strand 
master mix containing an oligo (dT) tagged with a phage T7 promotor. Second strand cDNA 
was generated with a master mix containing DNA polymerase. To the elute we added the in 
vitro master mix solution according to kit instructions which amplifies and labels the cDNA 
with biotin UTP. We obtained a final cRNA elute of just less then 200µl. We checked the 
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cRNA profiles of all samples by running them on the Agilent bioanalyser. We added 5µl of 
cRNA (~750ng) to 10µl of hybridisation buffer and loaded the resulting 15µl onto a RatRef12 
chip (www.illumina.com) in the appropriate inlet port. We incubated chips at 58°C overnight, 
washed them with E1BC solution, incubated chips in E1 buffer for 10 minutes and stained 
them in a solution of E1 buffer plus 1:1000 dilution of streptavidin-Cy3. We performed a 
final wash with E1BC wash buffer on the orbital shaker then dried the chips by centrifuging.  
For analysis if mRNA expression we used RatRef12 microarray chips (www.illumina.com) 
which contain a total of 22,519 gene and probe sets. This is the one of the most 
comprehensive rat chips commercially available. We scanned chips on an Illumina Bead 
Reader and recorded the intensity of the green fluorescent signal emitted. Samples with a 
signal intensity of >600 passed the bead array reader’s quality control.  
 
8.2.1.4 Quantitative real time polymerase chain reaction (qRT-PCR) 
We performed qRT-PCR to quantitatively confirm differential expression measured in the 
microarray experiment. We used the same DNase-treated RNA from the microarray 
experiment as the template for the synthesis of cDNA. We performed qRT-PCR reactions 
using Applied Biosystems Taqman® Gene Expression Assay. Probes were obtained from 
Applied Biosystems. Briefly we reverse transcribed 20 µl reactions on a 96 well plate 
containing approximately 1µg of RNA using the Taqman® reverse transcription master mix 
(Applied Biosystems) which included OligodT primers and Multiscribe™ reverse 
transcriptase enzyme. We performed qRT-PCR on the cDNA by creating a reaction mix in the 
same Eppendorf containing Taqman® universal master mix (Applied Biosystems) plus a 
probe for a housekeeping (control) gene e.g. GAPDH (VIC® labelled) and the Taqman® 
probe corresponding to our gene of interest (FAM® labelled) (See tabl 8.1 for a list of all 
Taqman® probes used). The samples were run on a 384 well plate on a 7900HT Sequence 
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Table 8.1. Taqman® probes used to validate candidat e genes of interest using qRT-PCR.  
 




ACTB Rn00667869_m1 91 Ch12     13452437 -
13456026 
4-5 
ALB Rn00592480_m1 96 Ch14     19126935 -
19142214 
6-7 
AVP Rn00566449_m1 66 Ch3       118205007 - 
118206985 
1-2 
GFAP Rn00566603_m1 76 Ch10     92059881 – 
92068555 
7-8 
GPR98 Rn01757838_m1 54 Ch2       9575038 – 
9704399 
32-33 
GUCY1a3 Rn00567252_m1 77 Ch2       173756824 -
173818316 
6-7 
GUCY1b3 Rn00562775_m1 135 Ch2       173683153 -
173735298    
3-4 
MBP Rn01399619_m1 80 Ch18     78943608 – 
79057329 
3-4 
MMP14 Rn00579172_m1 62 Ch15     32493852 – 
32503077 
1-2 




Properties of each of the 10 Taqman probes used to validate candidate genes of interest including 
length of the probe and section of the gene covered. ACTB = Beta Actin. ALB = Albumin, AVP = 
Arginine Vasopressin, GFAP = Glial Fibrillary Acidic Protein, GPR98 = G-Protein Coupled Receptor 98, 
GUCY1a3 = Guanylate Cyclase 1 alpha 3 subunit, GUCY1b3 = Guanylate Cyclase 1 beta 3 subunit, 
MBP = Myelin Basic Protein, MMP14 = Matrix Metallopeptidase 14 and SLC24a2 = 
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8.2.1.5 Standard PCR 
We designed forward and reverse primers corresponding to the portion f he GUCY1a3 gene 
sequence covered by the Illumina microarray probe. For a full list of probes see table 8.2. To 
test for insertions or deletions within the sequence between strai s we ran end point PCR 
using these primers, on DNA taken from the livers of SHRSP (n=4) and WKY (n=3). We 
used a proofreading ‘Kod Hot Start’ DNA polymerase (Novagen) and performed PCR’s using 
the designated kit and to manufacturer’s instructions. Extension times depended on the length 
of sequence being created. We performed all PCR’s on a MJ Research PTC Gradient Cycler 
using 96 well plates. Results were analysed using agarose gel electrophoresis. We visualised 
gels on a BIO-RAD Fluor-S Multimager and assessed the size of PCR products using 
Promega 100bp or 1kb DNA ladders.   
 
 
Table 8.2 . Characteristics of the primers designed for sequenc ing GUCY1a3.  
 
Within the name of each probe GUCY1a3 = Guanylate cyclase 1 alpha subunit 3, 3pr = 3’ prime UTR, 
A/B/C/D refers to the order the probes were designed in, the letters F/R refer to either ‘forward’ or 
‘reverse’. Tm = melting temperature.  
 







GUCY1a3_AF GTTCTCACACACAGCCTTC (19) 345 56.7 52.6 
GUCY1a3_Ex6_BF GTCAAATGAATCTACATCGTTGA 
(23) 
229 55.3 34.8 
GUCY1a3_3pr_CF GTAGTTCAGTAAGTGTCAAAG (21) 207 54.0 38.1 
GUCY1a3_3pr_DF GACAACTAAACCACCCAA (18) 291 51.4 44.4 
GUCY1a3_3pr_AR CTTCTGCAATCCTAAAGTCA (20) 232 53.2 40.0 
GUCY1a3_3pr_BR GATACAGTTCCTCCATTTGC (20) 246 55.3 45.0 
GUCY1a3_3pr_CR CCAAAACACCCACAATCA (18) 163 51.4 44.4 
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8.2.1.6 DNA Sequencing 
We used Applied Biosystems BigDye Terminator n3.1 Cycle Sequencing kits for all 
sequencing reactions and performed reactions in 96 well plates (WKY n=3, SHRSP n=2). A 
reaction solution of sequencing buffer, ready reaction, primer, purified PCR product and 
water was loaded into each well. To sequence, we used a temperature cycling program of 
96°C for 45 seconds, 50°C for 25 seconds and 60°C for 4 minutes, repeated 25 times. We 
subsequently loaded 20µl of purified sequencing product into optically clear 96 well plates 
covered with Applied Biosystems Septa Seals. We performed sequencing capillary 
electrophoresis on a 48-capillary Applied Biosystems 3730 Genetic Analyser with 36cm 
capillaries filled with POP-7 polymer (Applied Biosystems) and warmed to 60°C. We 
separated sequencing products by size using electrophoresis set to 8500V for 5  minutes.  
 
8.2.2 Data and statistical analysis 
8.2.2.1 Microarray data 
We firstly normalised data from the Bead Array reader in Bead Studio (Illumina) and then 
exported it into third party software (R). Rank Products (RP) analysis is a non parametric test 
that compares the ranks of the fold changes of differentially expressed genes in replicated 
microarray experiments. A nominal significance level of false discovery rate (FDR) q<0.05 
determined using the Bejamini-Hochberg method (Bejamini and Hochberg 1995) was taken 
as the threshold for significant differential expression. We did not set a minimum fold change 
for significance or signal intensity. We uploaded all data from RP analysis onto Ingenuity 
Pathway Analysis (IPA) (Ingenuity® Systems www.ingenuity.com) and analysed both sets of 
data using both a candidate gene approach (looking for changes in gnes and pathways of 
interest) and a genome wide approach (to generate new hypotheses). IPA uses an extensive 
peer previewed literature base to assess whether genes are directly functionally connected as 
well as using statistical methods (e.g. Fischer’s exact test) to identify over represented genes 
within functional groups (for more detail see chapter 5 and appendix H).  
 
8.2.2.2 qRT-PCR data 
Cycle threshold (CT) values were exported from sequence detection system (SDS) software 
into an Excel spreadsheet where the mean delta cycle threshold (dCT) values and standard 
errors versus the housekeeper gene were calculated (Students T Test). From these values the 
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delta delta CT (ddCT) values and relative quantification of mRNA expression changes 
(2^ddCT) values were calculated and plotted using functions in Excel.    
 
8.2.2.3 Sequencing data 
We analysed sequencing using Applied Biosystems SeqScape software and aligned 
experimental sequences with known sequences derived from bioinformatic databases such as 
ENSEMBL genome browser.   
 
8.3 Results 
8.3.1 mRNA expression data 
After analyzing the microarray data using rank products (RP) analysis we generated Venn 
diagrams in order to visualize the results in terms of age groups, brain sections and +/- NaCl. 
These diagrams were then used to upload gene lists of interest onto IPA for further analysis. 
All significant fold changes reported = q<0.05.  
 
8.3.2 Animals aged 5, 16 and 21 weeks.  
8.3.2.1 The genome wide approach 
 i) Analysis of Venn diagrams 
RP data used to generate the following Venn diagrams can be accessed in Appendix M.  
In the frontal brain section we found 62 genes from RP analysis were differentially expressed 
between WKY and SHRSP across all ages, whilst in the mid coronal section we found 55 
common to all ages (figure 8.1). Of these, 49 genes were common to both frontal and mid 
coronal brain sections. However, we found no direct functional connectio s between these 
genes using IPA. 
. 
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Figure 8.1. 3 way Venn diagrams of RP significant I llumina probes for WKY versus SHRSP at ages 5, 16 a nd 21 weeks. 
A) Genes differentially expressed in frontal brain sections and B) Genes differentially expressed in mid coronal brain sections. The centre values (ABC) in both figures 
represent genes which were commonly significantly differentially expressed in SHRSP versus WKY at all ages. 49 genes were found to be commonly differentially expressed 
across all ages and in both brain sections.    
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After looking across all age groups we focused on 5 week old animals as we found there to be 
over double the number of significantly differentially expressed genes at this age common to 
both brain sections compared to 16 and 21 weeks (162 versus 71 at 16 weeks and 63 at 21 
weeks). We also focused on this age group in order to identify changes i  gene expression 
prior to the onset of hypertension. Here RP analysis showed that there were 162 genes 
differentially expressed between WKY and SHRSP at 5 weeks of age that were common to 
both brain sections (figure 8.2) (For RP data see Appendix N). These g n s generated 
numerous significant interactions, in particular a cluster of early growth response genes 
involved in cell proliferation were significantly up regulated in SHRSP by approximately 
~1.5 fold change (figure 8.3). A heatmap displaying genes of interest from this comparison 
















Figure 8.2. A 2 way Venn diagram representing the n umber of significantly differentially 
expressed genes in both sections of 5 week old SHRS P versus age matched WKY.   
The red circle represents genes differentially expressed within the frontal section alone. The green circle 
represents genes differentially expressed within the mid coronal section alone. The intersection 
represents genes commonly differentially expressed in both brain sections.  
 
 




Figure 8.3. A network generated by IPA software rep resenting interactions between differentially 
expressed genes at 5 weeks of age.  
Genes highlighted red were down regulated in SHRSP. Genes highlighted in green are up regulated in 
SHRSP. Statistics quoted are from top to bottom – p value, fold change and intensity of fluorescence 
generated by the probe when scanned by the array reader. Solid lines indicate direct interactions. 
Dotted lines indicate indirect interactions. The purple box highlights a cluster of genes all up regulated in 
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ii) The top 10 most up and down regulated genes in terms of fold change (all significant 
q<0.05) at ages 5, 16 and 21 weeks 
When looking at the most up and down regulated genes we focused on the top 10 in each 
direction as we found a strong consistency across all age groups (see table 8.3). One gene of 
interest which appeared in the top 10 up-regulated genes was Guanylate c clase soluble 
subunit alpha-3 (GUCY1a3) – the intracellular receptor for nitric oxide in vascular smooth 
muscle cells (Kloss et al. 2003). This gene was up regulated in SHRSP by a fold change of ~ 
20 in both sections at all ages. Interestingly its corresponding heterodimer subunit - 
GUCY1b3 showed no changes in gene expression at any age or in any brain section.  
G-protein receptor 98 (GPR98) a g protein coupled receptor with a role in neuropeptide 
signalling was consistently down-regulated in SHRSP by a fold change of ~3 in both sections. 
Albumin (ALB) was also down regulated in SHRSP by ~3-4 fold change i  at least one brain 
section at all ages. Genes which were highly differentially expressed only at specific age 
groups included Arginine vasopressin (AVP) which was down regulated by a fold change of 4 
in the mid coronal section of 5 week old SHRSP, guanine nucleotide binding protein, alpha 
inhibiting 1 (GNAI1) which was down by a 3 fold change in the frontal section of 16 week 
old SHRSP and Beta Actin (ACTB) which was down-regulated in the frontal section of 21 
week old SHRSP.  
 
iii) Analysis of over-represented biological pathways determined by IPA 
IPA uses Fischers exact test to identify biological pathwys (known as canonical pathways in 
IPA) which contain the largest proportion of significantly differentially expressed genes in 
given conditions. From this we found that the acute phase response signalling p thway (figure 
8.4), consistently appeared within the top five over represented pathways in at least one brain 
section of the SHRSP at all ages. Tight junction signalling featur d highly within the top five 
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Table 8.3 . The top 10 up and down regulated genes in SHRSP ver sus WKY in each brain section 
and for each age group. 
All genes listed are significantly expressed FDR <0.05 is applied.  RGD = Rat genome database. RPS9 
= Ribosomal protein S9. GUCY1A3 = guanylate cyclase 1, soluble, alpha 3. FAM151B = family with 
sequence similarity 151, member B. ARC = activity-regulated cytoskeleton-associated protein. ZNF = 
Zinc finger protein. RNF149 = Ring finger protein 149. JUNB = jun B proto-oncogene. MRPL18 = 
mitochondrial ribosomal protein L18. HCG = Human chorionic gonadotrophin. AVP = Arginine 
vasopressin. LOC = Location. GPR = G-protein coupled receptor.  ALB = Albumin. COLQ = collagen-
like tail subunit of asymmetric acetylcholinesterase. PXMP4 = peroxisomal membrane protein 4. 
CSNK2A1 = casein kinase 2, alpha 1 polypeptide. VPS13C = vacuolar protein sorting 13 homolog C. 
C20ORF7 = Chromosome 20 open reading frame 7. HLA-C = Myosin heavy chain class 1 receptor C. 
ADPGK = ADP-dependent glucokinase. C7ORF23 = Chromosome 7 open reading frame 23. GNAI1 = 
guanine nucleotide binding protein, alpha inhibiting 1. OPCML = opioid binding protein/cell adhesion 
molecule-like.  ACTB = Beta actin. OXT = Oxytocin. MOBP = myelin-associated oligodendrocyte basic 
protein. 
 FRONTAL SECTION MID CORONAL SECTION 
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8.3.2.2 Candidate gene approach 
i) Identifying differentially expressed genes within biological pathways of interest. 
As well as looking for pathways which contained an over representatio  of genes, we also 
looked for genes which were differentially expressed in the SHRSP within pathways 
considered from the literature to be relevant to cerebral small vessel disease e.g. Nitric Oxide 
signalling, Renin-angiotensin signalling.  
Within nitric oxide signalling in the cardiovascular system, we found more significantly 
differentially expressed genes at the age of 5 weeks in the SHRSP compared to the older ages. 
GUCY1a3 was highly up-regulated in the SHRSP and this gene also occurs in the endothelin-
1 vasoconstriction pathway within which GNAI1 (guanine nucleotide binding protein, alpha 
inhibiting 1) was down regulated with a fold change ranging from 1.6-3.0, in 5 and 16 week 
old SHRSP. 
Several genes functionally associated with tight junctions had significantly altered expression, 
some across all ages (e.g. PPP2R1A, (protein phosphatase 2 regulato y subunit A, alpha 
isoform), up regulated by ~1.5 fold in SHRSP)) whilst others just in 5 week old SHRSP (e.g. 
FBJ murine osteosarcoma viral oncogene homolog (FOS) up regulated 3 fol ). We found 
several acute phase response signalling pathway genes were significantly differentially 
expressed, in some cases across all ages and others just in 5 week old SHRSP. In this 
pathway, the most consistently down regulated genes were transcription fac or 4 (TCF4) (~2.0 
fold change) and albumin (ALB) (~3.5 fold change). Within the renin-angiotensin signalling 
pathway, two protein kinases (PRKAR2B and PRKCD) and cFOS were significantly 
differentially expressed in SHRSP however, these genes have multiple functions and are not 
pivotal to this pathway. In the atherosclerosis pathway, the onlygenes significantly 
differentially expressed were at 5 weeks of age in both brain sections; PLA2G2A (a member 
of the phospholipase A2 family) was up regulated in SHRSP (1.9 fold change), and COL3A1 
was significantly down regulated in SHRSP (1.7 fold change). Due to its role in vascular wall 
structure, humans deficient in Col3a1 protein exhibit increased art rial fragility and vascular 




































Figure 8.4 . Biological pathways in IPA containing an over repre sentation of significantly 
differentially expressed genes in the frontal secti on of 5, 16 and 21 week old SHRSP versus 
WKY.  
The blue bar represents how significant the uploaded data set is to the pathway (log p value) and the 
orange line represents the number of genes differentially expressed as a proportion of the total genes 
within that pathway.   
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ii) Gene expression versus protein immunoreactivity assessed in chapter 7 (Bailey et al. 
2011b) 
We compared the mRNA expression analysis directly to proteins assessed previously in the 
same animals using immunohistochemistry and found the following results. Glial fibrillary 
acidic protein (GFAP) mRNA expression was significantly down-regulated in the frontal 
section of 5 week old SHRSP versus WKY (1.5 fold change) which contradicted the 
significant increase in GFAP immunoreactivity we have previously described. Meanwhile in 
21 week old SHRSP, we found myelin basic protein (MBP) to be significa tly down-
regulated in the frontal section of SHRSP versus WKY (2.6 fold change) and this agreed with 
our immunohistochemistry data (chapter 7 figure 7.11 table 7.4). We saw no significant 
differences in the mRNA expression of Claudin-5, Collagen I, Collagen IV, SMA, MMP9 or 
Iba-1 between the strains despite finding significant reductions in the immunoreactivity of 
Claudin-5 at all ages, Collagen I at 5 and 16 weeks and increases in the immunoreactivity of 
SMA and Iba-1 at 16 weeks and beyond (chapter 7). We did however find that MMP14 in the 
microarray analysis was significantly down-regulated in SHRP in the frontal section of 5 
week old animals and this gene has direct influences upon Claudins, Collagens and other 
matrix metalloproteinases such as MMP9.  
 
8.3.3 qRT-PCR of candidate genes 
From the results above we chose the following genes for quantitative validation with qRT-
PCR; GUCY1a3, GUCY1b3, MMP14, GFAP, ALB, MBP, GPR98 and AVP (see tabl  8.2 
for details of Taqman probes and table 8.4 for reasons as to why these particular genes were 
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Table 8.4 . Genes from the microarray analysis which were chose n for quantitative validation with 
qRT-PCR and the reasons they were chosen as genes o f interest. 
 
Gene Reason chosen for qRT-PCR 
GUCY1a3 Due to its consistent up regulation of over x15 fold change at all ages in both sections.  
GUCY1b3 Due to its coexistence with GUCY1a3 as a heterodimer. 
MMP14 Due to its direct interactions with other genes of interest and down regulation at 5 weeks 
of age. At 5 weeks in the frontal section there was significantly less MMP14 gene 
expression in the SHRSP rats.  
GFAP To validate findings from a previous immunohistochemistry study (chapter 7) and 
significant microarray data at 5 weeks.  
ALB Due to consistent findings of down regulation at all ages and in both sections 
MBP Due to significant microarray findings at 21 weeks and significant differences in protein 
expression at 21 weeks in a previous immunohistochemistry study (chapter 7).  
GPR98 Due to significant down regulation across all ages. 
AVP Due to significant finding at 5 weeks and relevant to vasoactive mechanisms.  
 
 
ALB = Albumin, AVP = Arginine Vasopressin, GFAP = Glial Fibrillary Acidic Protein, GPR98 = G-Protein 
Coupled Receptor 98, GUCY1a3 = Guanylate Cyclase 1 alpha 3 subunit, GUCY1b3 = Guanylate 
Cyclase 1 beta 3 subunit, MMP14 = Matrix Metallopeptidase 14 and SLC24a2 = 
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GFAP (protein) was increased in the frontal section of 5 week old SHRSP on 
immunohistochemistry compared with WKY (chapter 7). However, the microarray data 
showed GFAP mRNA expression to be significantly down-regulated in SHRSP in the same 
brain section at the same age. qRT-PCR replicated the microarray data by showing that 
SHRSP had a 2-fold down-regulation in GFAP mRNA expression compared to WKY rats 
(p=0.01) (figure 8.5a).  
MMP14 in the microarray analysis was significantly down-regulated in SHRSP in the frontal 
section of 5 week old animals. qRT-PCR showed a 5 fold decrease in MMP14 mRNA 
expression in the frontal section of SHRSP versus WKY (p<0.01) see figure 8.5b.  
AVP, according to the mRNA analysis, was significantly down-regulated in the mid coronal 
section of 5 week old SHRSP. qRT-PCR showed a similar result, where only a quarter of the 
gene expression was seen in SHRSP in this section (p<0.001) versus WKY (figure 8.5c) 
GUCY1a3, despite being consistently up-regulated by >15 fold change in SHRSP at all ages 
and in both brain sections on the microarray, showed no significant differences in mRNA 
expression at any age or in any brain section using qRT-PCR. Similarly qRT-PCR did not 
validate the findings of ALB, MBP or GPR98 by showing no significant difference in gene 
expression between WKY and SHRSP at any age. qRT-PCR did however validate the 
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Table 8.5. Data obtained from qRT-PCR analysis for each gene of interest.  
Data represents the relative quantity (RQ) values (± the standard error of the mean) between the gene of interest and the house keeper gene GAPDH for WKY and SHRSP at 
ages 5-21 weeks and from both frontal (F) and mid coronal (M) brain sections. Green highlights significant results which agreed with mRNA expression data. Red indicates 
significant results which did not agree with mRNA expression data. Some genes were only tested at ages of interest. N/A corresponds to ages where gene expression was not 
validated with qRT-PCR.
Probe/Gene RQ values ± standard error  
Age & Section  5F 5M 16F 16M 21F 21M 
WKY 1.47 ± 0.26 1.00 ± 0.18 0.72 ± 0.03 1.00 ± 0.39 1.68 ± 0.22 1.00 ± 0.43 
SHRSP 1.00 ± 0.50 0.33 ± 0.78 1.00 ± 0.34 0.84 ± 0.29 1.00 ± 0.19 1.48 ± 0.30 GUCY1a3 
p value NS NS NS NS 0.05 NS 
WKY 1.49 ± 0.98 1.00 ± 0.21 1.17 ± 0.16 1.00 ± 1.03 1.4 3 ± 0.23 1.00 ± 0.24 
SHRSP 1.00 ± 0.48 1.26 ± 0.11 1.00 ± 0.45 1.45 ± 0.71 1.0 0 ± 0.32 1.24 ± 0.44 GUCY1b3 
p value NS NS NS NS NS NS 
WKY 5.45 ± 0.45 1.00 ± 0.26 0.27 ± 0.12 1.00 ± 0.62 2.22 ± 1.38 1.00 ± 0.42 
SHRSP 1.00 ± 0.31 2.22 ± 0.48 1.00 ± 0.54 1.14 ± 1.05 1.00 ± 0.60 1.57 ± 0.20 MMP14 
p value <0.01 <0.05 NS NS NS NS 
WKY 2.33 ± 0.47 1.00 ± 0.24 0.87 ± 0.24 1.00 ± 0.36 1.59 ± 0.45 1.0 0 ± 0.13 
SHRSP 1.00 ± 0.20 0.69 ± 0.09 1.00 ± 0.42 1.15 ± 0.46 1.00 ± 0.25 0.9 8 ± 0.23 GFAP 
p value <0.05 NS NS NS NS NS 
WKY 4.39 ± 0.07 1.00 ± 0.64 0.30 ± 0.14 1.00 ± 1.06 2.22. ± 0.21 1.00 ± 1.16 
SHRSP 1.00 ± 1.23 -23.2 ± 20.35 1.00 ± 0.87 1.04 ± 0.68 1.00 ± 1.12 1.56 ± 1.16 ALB 
p value <0.05 <0.05 NS NS NS NS 
WKY 1.49 ± 0.76 1.00 ± 0.26 
SHRSP 1.00 ± 0.43 0.26 + 0.08 AVP 
p value NS <0.01 
N/A  
WKY 0.48 ± 0.33 1.00 ± 1.00 





WKY 1.68 ± 1.13 1.00 ± 0.54 


































































Figure 8.5. Validation of significant changes in ge ne expression of A) GFAP, B) MMP14 and C) AVP in 5 week old rats.  
Figures A & B display data from analysis of the frontal brain section only. Figure C displays data from analysis of the mid coronal section only.  Bars represent the difference in 
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8.3.4 DNA sequencing of GUCY1a3 
In order to determine why the microarray findings relating to GUCY1a3 did not correlate 
with qRT-PCR we performed end point PCR and DNA sequencing using primers designed to 
capture the area of the gene covered by the GUCY1a3 Illumina microarray probe. Using PCR 
we found that the signal from both WKY DNA and SHRSP DNA was the same meaning that 
no large scale insertion or deletions were present in the area of the Illumina probe in the 
SHRSP (see Appendix R for an image of the electrophoresis gel). Knowing this we then 
sequenced the gene and found a single nucleotide polymorphism in the 3’UTR (untranslated 
region) of the GUCY1a3 gene at position 4379. This is a known SNP in this strain 
(RS13457820 – www.ensembl.org). In Norwegian Brown rats and in WKY a cytosine (C) 




Figure 8.6. Identification of a SNP found in SHRSP within the 3’UTR of the GUCY1a3 gene.  
Image taken from Applied Biosystems SeqScape software version 2.1 and shows sequences from WKY 
and SHRSP (n=2 for each strain). The black box highlights position 4379 where the C in WKY is 
replaced by a T in SHRSP.  
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8.3.5 B) Salt-loaded animals (+NaCl) versus age matched animals fed standard rat 
chow 
8.3.5.1 The genome wide approach 
 i) Analysis of Venn diagrams 
To assess the influence of NaCl we generated Venn diagrams to identify the effect on salt 
across 3 comparisons, WKY+NaCl versus WKY, SHRSP+NaCl versus SHRSP and 
WKY+NaCl versus SHRSP+NaCl. RP data used to generate Venn diagrams can be accessed 
in Appendix O 
 
WKY+NaCl versus WKY (see figure 8.7). 
As there were few genes (n=9) which were differentially exprssed in both brain sections of 
WKY+NaCl versus WKY we focussed on the frontal section alone. I  this section, RP 
analysis idenified 31 genes which were differentially expressed and within these genes we 
found a small network of 11 genes which were directly functio ally connected (according to 
IPA’s Knowledge Base), centred around amyloid precursor protein (APP). Most of the genes 
in this network were down-regulated in WKY+NaCl (figure1a). Interestingly when the RP 
analysis of SHRSP+NaCl versus SHRSP was overlaid onto this network, all of the genes 
surrounding APP (except albumin and APP itself) were once again found to be differentially 
expressed but this time they were all significantly up-regulated rather than down-regulated in 
the salt loaded animal suggesting a different response to salt l ading in the two strains (figure 
8.8b). 
 
SHRSP+NaCl versus SHRSP 
We found no significantly differentially expressed genes which were common to both brain 
sections in SHRSP+NaCl versus SHRSP. Therefore, as with WKY+NaCl versus WKY we 
focussed on genes significantly differentially expressed within the frontal section where there 
were over 10 times as many expressed versus the mid coronal section 83 versus 7) Within 
these 83 genes, we found a small network of 13 genes (figure 8.9) centered around beta actin 
(ACTB) including genes functionally related to maintaining the structural integrity of the 
vascular cytoskeleton (e.g. ACTB, Destrin (DSTN) and beta-catenin (CTNNB1)).  
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Figure 8.7. A four way Venn diagram from rank produ cts analysis representing genes which were 
significantly differentially expressed in all compa risons of all WKY and SHRSP (+/-NaCl) in both 
frontal (F) and mid coronal (M) brain sections.  
The violet circle represents the number of genes differentially expressed in the frontal section of 
WKY+NaCl versus WKY. These genes were used to generate the network seen in figure 8.9. The 
orange circle represents the number of differentially expressed genes in both brain sections in salt 
loaded SHRSP versus non salt loaded SHRSP (in this case 0). The green circle represents genes which 
were differentially expressed between salt loaded SHRSP versus non salt loaded SHRSP in the frontal 
section only. These genes were used to generate the network seen in figure 8.10. This diagram also 
shows that very few genes were significantly differentially expressed between WKY+NaCl and 
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WKY+NaCl versus SHRSP+NaCl  
We found only 1 gene (Mitochondrial ribosomal protein L18 - MRPL18) which was 
differentially expressed in WKY+NaCl versus SHRSP+NaCl which was common to both 
brain sections. We found only 7 which were differentially expressed in the frontal section 
alone (Albumin (ALB), (Peroxisomal membrane protein 4 (PXMP4), Family with sequence 
similarity 151 B (FAM151B), Zinc finger protein 597 (ZNF597), Ribosomal protein S9 
(RPS9), Ribosomal protein L17 pseudogene 39 (RPL17P39), Transthyretin (TTR) and none 
were differentially expressed in the mid coronal section. Incidently no networks of interest 
could be generated from this data in IPA.  
Heatmaps displaying the genes of interest from all 3 salt comparisons can be seen in appendix 
Q. 
 
ii) The top 10 up and down-regulated genes in terms of fold change in salt loaded animals 
versus non salt loaded animals of the same strain and between strains (table 8.6). 
In stark contrast to the previous data on age-related changes, the addition of NaCl produced 
very inconsistent and often small (albeit significant) fold changes in both WKY+NaCl versus 
WKY and SHRSP+NaCl versus SHRSP.  
 
WKY+NaCl versus WKY 
The only gene to appear in the 10 most highly up-regulated genes of both brain sections in 
this comparison was Albumin (up 2 fold). A cluster of genes involved in the acute phase 
response pathway and closely associated with albumin were up- g lated in the frontal 
section: Alpha-1-microglobulin/bikunin precursor (AMBP), Apolipoprotein H (APOH) and 
Alpha-2-HS-glycoprotein (AHSG) were all up-regulated by 2.2-2.5 fold.  
The most down-regulated gene in salt loaded versus non-salt loaded WKY was MBP in the 
frontal section (2.6 fold). Only three genes were highly down-regulated in both sections. Beta 
actin (ACTB) was down 2.3 fold, whilst N-ethylmaleimide-sensitive factor (NSF) and M2-
pyruvate kinase (PKM2) were down 2 fold.  
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Figure 8.8. A) A network generated by IPA software representing interactions between differentially ex pressed genes within the frontal sections of age ma tched 
WKY versus salt loaded WKY.  
All genes highlighted in green are down regulated in salt loaded WKY. Genes highlighted red are up regulated in salt loaded WKY. Statistics quoted are from top to bottom – p 
value, fold change and signal intensity. Solid lines indicate direct interactions. Dotted lines indicate indirect interactions. B) The same network with salt loaded SHRSP versus 
non salt loaded SHRSP data over laid. In this network genes highlighted in red indicate genes up regulated in salt loaded SHRSP when compared to non salt loaded SHRSP
 





Figure 8.9. A network generated by IPA software rep resenting interactions between differentially 
expressed genes within the frontal sections of age matched SHRSP versus salt loaded SHRSP. 
 All genes highlighted in green are down regulated in salt loaded SHRSP. Genes highlighted red are up 
regulated in salt loaded SHRSP. Statistics quoted are from top to bottom – p value, fold change and 
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SHRSP+NaCl versus SHRSP 
Genes highly up-regulated in the frontal section included, carboxypeptidase E (CPE) (3.8 fold 
change) and ACTB (3.7 fold change). In the mid coronal section two solute carriers 
(SLC17a6 - fold change of 2.2 and SLC24a2 - fold change of 2.0) were up-r g lated in the 
mid coronal section. Albumin was also within the top 10 up-regulated genes with a fold 
change of 1.7 in the mid coronal section. 
In the frontal section there were several genes that differed by approximately a 2 fold change, 
including VOPP1 (vesicular, overexpressed in cancer, prosurvival protein 1) with a fold 
change of 2.7. CYR61 – an angiogenic inducer was down-regulated by a fold change of 1.9. 
Only 8 genes in the mid coronal section were significantly down-regulated in the salt loaded 
versus non-salt loaded SHRSP, of which Transthyretin (TTR) came top with a fold change of 
3.1 (table 8.4). Von Willebrand factor (VWF) and vascular growth factor (VGF) were down-
regulated in the mid coronal section (down 2.3 and 1.9 fold respectively) in SHRSP+NaCl.  
 
WKY+NaCl versus SHRSP+NaCl 
The most highly differentially expressed genes between salt loaded WKY and salt loaded 
SHRSP matched previous observations from 5 and 16 week old non-salt loaded WKY and 
SHRSP (unpublished observations) (see table 8.3) indicating the effect o  strain on gene 
expression was more substantial than the effect of salt (see table 8.6). 
 
iii) Analysis of over-represented biological pathways determined by IPA 
Using RP data, we found the acute phase response signalling pathway cont ined the most 
differentially expressed genes in all salt versus no salt comparisons consistently appearing 
within the top five pathways in IPA (figure 8.10). Salt-loading i  both rat strains was 
associated with changes within the tight junction signalling pathway of frontal brain sections 
(figure 8.4). Pathways pertaining to oxidative stress and leukocyte extravasation also 
contained a high proportion of differentially expressed genes in both salt-loaded versus non 
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8.3.5.2 Candidate gene approach 
i) Identifying differentially expressed genes within biological pathways of interest. 
As with the age-related data above we looked for genes which were significantly 
differentially expressed within biological pathways of interest avail ble on IPA.  
In the acute phase response pathway ALB was consistently down-regulated across all salt 
comparisons, although in WKY+NaCl in the frontal section a group of closely associated 
genes, AMBP (alpha-1-microglobulin/bikunin precursor), AHSG (alpha-2-HS-glycoprotein) 
and APOH (Apolipoprotein H) were down-regulated by approximately 2 fold change (see 
figure 8.8).  
In the frontal section of salt loaded versus non salt loaded SHRSP we found Claudin-11 to be 
down-regulated 2.3 fold within the tight junction signalling pathway. However, we also found 
Claudin-11 to be up-regulated in salt loaded SHRSP when compared to salt loaded WKY (1.8 
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Table 8.6. The top 10 up and down regulated genes w ithin and between strain salt comparisons  
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LOC = Location. AMBP = alpha-1-microglobulin/bikunin precursor. APOH = Apolipoprotein H. ALDOB = aldolase B, fructose-bisphosphate. AHSG = alpha-2-HS-glycoprotein. GC = 
group specific component. GPM6A = glycoprotein m6a. TCEB1 = transcription elongation factor B (SIII), polypeptide 1. NTS = neurotensin. CPE = carboxypeptidase E. ACTB = 
Beta Actin. TSPAN7 = tetraspanin 7. MAP1B = microtubule-associated protein 1B. PPP3CB = protein phosphatase 3, catalytic subunit, beta isoform. TPI1 = triosephosphate 
isomerase 1. NSF = N-ethylmaleimide-sensitive factor. PKM2 = pyruvate kinase, muscle. SETD3 = SET domain containing 3. TMEM27 = transmembrane protein 27. SLCO1A5 = 
solute carrier organic anion transporter family, member 1a5. MCTP1 = multiple C2 domains, transmembrane 1. TAC1 = tachykinin 1. GPR88 = G Protein coupled receptor 88. TTR 
= Transthyretin. LRRC7 = leucine rich repeat containing 7.  SLC17A6 = solute carrier family 17 member 6. SLC24A2 = solute carrier family 24 member 2. OPCML = opioid binding 
protein/cell adhesion molecule-like. VGF = Vascular growth factor. PRKCG = protein kinase C, gamma. SOSTDC1 = sclerostin domain containing 1. OTX2 = orthodenticle 
homeobox 2. F5 = coagulation factor V. GDI1 = GDP dissociation inhibitor 1. SNURF = SNRPN upstream reading frame. VOPP1 = vesicular, over expressed in cancer, prosurvival 
protein 1.  SEC61G = SEC61, gamma subunit. ROCK2 = Rho-associated coiled-coil containing protein kinase 2. CYR61 = cysteine-rich, angiogenic inducer, 61. HBXIP = hepatitis 
B virus x interacting protein. MYEF2 = myelin expression factor 2. GSK3B = glycogen synthase kinase 3 beta. IL11 = Interleukin 11. HBB = hemoglobin, beta. SEPT7 = septin 7. 
CABP7 = calcium binding protein 7. ANXA1 = annexin A1. ADORA2A = adenosine A2a receptor. AQP1 = aquaporin 1. SCN4B = sodium channel, voltage-gated, type IV, beta. 
SLC32A1 – solute carrier family 32 member 1. RASD2 = RASD family, member 2. DLX5 = distal-less homeobox 5. PMCH = pro-melanin-concentrating hormone. SIPA1L2 = signal-
induced proliferation-associated 1 like 2. RGD = Rat genome database. RSP9 = Ribosomal protein 9. GUCY1a3 = Guanylate cyclase alpha subunit 3. FAM151B = family with 
sequence similarity 151, member B. ZNF597 = Zinc finger protein 597. OXT = Oxytocin. MRPL18 = Mitochondrial ribosomal protein L18.PXPM4 = peroxisomal membrane protein 4. 
GPR18 = G protein coupled receptor 18. CSNK2A1 = casein kinase 2, alpha 1 polypeptide. AVP = Arginine vasopressin. HLA-C = major histocompatibility complex, class C. 
VPS13C = vacuolar protein sorting 13 homologue.
 



























Figure 8.10. The top 5 biological pathways in IPA c ontaining an over representation of 
significantly differentially expressed genes in the  frontal sections of A) WKY+NaCl versus WKY, 
B) WKY+NaCl versus SHRSP+NaCl and C) SHRSP+NaCl ver sus SHRSP.  
The blue bar represents how significant the uploaded data set is to the pathway (log p value) and the 
orange line represents the number of genes differentially expressed as a proportion of the total genes 
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ii) A comparison of gene expression versus protein expression, of biomarkers assessed in the 
same animals using immunohistochemistry (chapter 7). 
When comparing gene expression of proteins we assessed in the same animals using 
immunohistochemistry, we found only MBP was differentially expressed. In WKY versus salt 
loaded WKY, MBP was down regulated in the frontal section (2.6 fold change). This was also 
consistent between SHRSP and salt loaded SHRSP with a 2.2 fold down regulation in the 
frontal section. MBP was not differentially expressed between salt loaded WKY and salt 
loaded SHRSP.  
 
8.3.6  qRT-PCR of candidate genes 
From the microarray results above, we chose the following genes for quantitative validation 
with qRT-PCR: MBP, ACTB and SLC24a2. For all statistical data see tabl  8.7.  
MBP - In salt loaded WKY versus non salt loaded WKY, the microarray showed that MBP 
was significantly down regulated in the frontal section in the salt lo ded animals (2.6 fold 
change). This was also consistent in salt loaded SHRSP versus non salt loaded SHRSP (salt 
loaded SHRSP had ~2.2 fold less MBP in the frontal section versus non- alt loaded SHRSP. 
No significant differences in gene expression were detected with qRT-PCR.  
ACTB – The microarray showed ACTB to be significantly down regulated in WKY+NaCl 
versus WKY in both brain sections (fold change 2.3). The microarray data also showed a 
significant up regulation of ACTB in the frontal section of SHRSP+NaCl versus SHRSP (fold 
change 3.7). These results indicated a possible salt specific effect. qRT-PCR however, did not 
validate this finding with no significant differences in gene xpression found between any of 
the salt / no salt comparisons. 
SLC24a2 – was chosen for validation because, like ACTB, the microarray data showed two 
significant results. Firstly we found SLC24a2 to be significantly down regulated in both 
sections of WKY+NaCl versus WKY (~2 fold change). Secondly we found SLC24a2 to be 
significantly up regulated in the mid coronal section of SHRSP+NaCl (2 fold change) versus 
SHRSP. Unfortunately qRT-PCR did not validate these findings with no significant changes 
in the gene expression of SLC24a2 with salt-loading in any strain.
 
Doctor of Philosophy University of Edinburgh 215 












Data represents the relative fold change (RQ value) ± the standard error between the gene of interest and the house keeper gene GAPDH for non salt-loaded and salt loaded 
WKY and SHRSP at age 21 weeks and from both frontal (F) and mid coronal (M) brain sections. NS = No significant difference.  
 
Probe/Gene RQ (relative fold change) ± standard err or  
Age / Salt / Section  21 no salt F 21 no salt M 21 salt F 21 salt M 
WKY 1.65 ± 0.36  1.00 ± 0.34 1.07 ± 0.40 1.00 ± 0.86 
SHRSP 1.00 ± 0.71 1.10 ± 0.10 1.00 ± 0.28 1.74 ± 1.13 MBP 
p value NS NS NS NS 
WKY 1.57 ± 0.44 1.00 ± 0.14 0.87 ± 0.15 1.00 ± 0.21 
SHRSP 1.00 ± 0.35 1.00 ± 0.30 1.00 ± 0.13 1.29 ± 0.15 ACTB 
p value NS NS NS NS 
WKY 1.68 ± 1.13 1.00 ± 0.54 0.91 ± 0.41 1.00 ± 0.70 
SHRSP 1.00 ± 0.68 1.02 ± 0.18 1.00 ± 0.31 0.75 ± 0.52 SLC24a2 
p value NS NS NS NS 
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8.4 Discussion  
8.4.1 Summary of results – animals aged 5, 16 & 21 weeks 
In this study we have found differential gene expression in several k y pathways in the 
SHRSP at 5 weeks prior to the onset of hypertension which together, contribute towards the 
SHRSP having heightened susceptibility to small vessel disease and cerebral pathology via 
dysfunction of; the structural integrity of astrocytes (GFAP – decreased mRNA expression 
validated by qRT-PCR), components of the extracellular matrix (MMP14 – decreased mRNA 
expression validated by qRT-PCR ), tight junction signalling (pathway contained a significant 
number of significantly differentially expressed genes), fluid transport (ALB – decreased 
mRNA expression) and defects in nitric oxide signalling / vasoreactivity (AVP – decreased 
mRNA expression validated by qRT-PCR, GUCY1a3 – increased mRNA expression, GNAI1 
– decreased mRNA expression). In addition we found a network of early growth response 
genes which were up-regulated in SHRSP at 5 weeks which supports our observations of 
endothelial proliferation on H&E sections (chapter 6). Our results a so showed that an 
inflammatory pathway (the acute phase response) contained many up-regulated genes, at all 
ages in the SHRSP, indicating a chronically challenged immune syst m across the SHRSP 
life course. We also found evidence that myelination is disrupted a  21 weeks (reduced 
MBP(Bailey et al. 2011b)).  
Direct comparison of mRNA expression with proteins we assessed using 
immunohistochemistry in the same animals (chapter 7) produced 2 significant results (GFAP 
and MBP). GFAP mRNA levels were down-regulated in the frontal section of 5 week old 
SHRSP. This is the opposite finding to our immunohistochemistry data which showed 
significantly more GFAP in this section at the same age (chapter 7) (Bailey et al. 2011b). This 
discrepancy could be explained by post-transcriptional modification, which directly 
determines how much of the mRNA is translated into protein. Post-transc iptional 
modification can be influenced by simple changes such as over exposure to a neurotrasmitter 
or increased levels of reactive oxygen species (Adachi 2010). Further investigation into the 
structure and function of astrocytes in young SHRSP is needed. The mRNA expression of 
MBP at 21 weeks in the SHRSP mirrored our immunohistochemsitry findings with a 
significant reduction in MBP expression in SHRSP in both sections versus WKY. This 
finding indicates that the SHRSP suffers axonal pathology most likely secondary to 
microvascular pathology. 
Additionally we also found a down-regulation of MMP14 in the frontal section of 5 week old 
SHRSP. This could suggest changes in the extra cellular matrix existing as early as 5 weeks 
of age in the frontal brain region. MMP14 directly influences collagens and claudins thereby 
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influencing vascular integrity (Sounni et al. 2010). This is consistent with our previous 
finding of significantly reduced immunoreactivity of Claudin-5 at the same age (Bailey et al. 
2011b). Further investigation of both mRNA expression and protein levels of MMP14 in 
young animals will be necessary in order to fully establish its influence on the structure of 
both tight junctions and the vascular cytoskeleton. 
Using a genome wide approach, we found that the most highly differentially expressed genes 
(both up-regulated and down-regulated) were mostly conserved across all ages. In particular 
we found that GUCY1a3 (an intracellular nitric oxide receptor) was highly up-regulated in 
both brain sections of SHRSP by >15 fold change at all ages. Through sequencing we 
subsequently found a SNP in the 3’UTR end of the gene in SHRSP. Whilst this may in part 
explain the discrepancy between our microarray and PCR data it may not be the sole reason 
for seeing such a significant difference (x20 fold change) between the SHRSP and WKY on 
the microarray as 1 SNP in a 77 amplicon sequence would not affect the binding ability of the 
probe enough to produce a 20 fold change. SHRSP from the same colony have been shown to 
have a 5 fold up-regulation of GUCY1a3 in the heart at 5 weeks of age (unpublished 
observations). Further work addressing the role of microRNAs in this region and studies to 
look for evidence of alternate splicing are currently underway. V lidation of this result via the 
assessment of corresponding protein expression is also needed; however, suitable antibodies 
for immunohistochemistry are currently unavailable for paraffin sections. 
However despite this, our finding for GUCY1a3 coupled with the significant decrease in 
expression of AVP at 5 weeks suggests that SHRSP have impaired v soreactivity from birth. 
This hypothesis is supported by previous data which has shown young SHRSP to have 
impairments in vasodilation (Volpe et al. 1996), impairments in the renin-angiotensin system 
(Unger 2002;Racasan et al. 2005), heightened responses of the vasculature to sympathetic 
stimulation (Luft et al. 1986) and significantly lower bioavailability of nitric oxide - attributed 
to the increased presence of superoxide species (Grunfeld et al. 1995;Gotoh et al. 
1996;McBride et al. 2005). Therefore the up-regulation of this intracellular receptor could be 
a compensatory mechanism trying to capture as much as the available n tric oxide as possible 
before it is degraded.  
In the opposite direction, albumin was consistently down-regulated in SHRSP across all ages 
by ~3 fold change however the signal intensity was very low and subsequently this finding 
was not validated at all ages by qRT-PCR. Albumin is a veryubiquitous protein but it is a 
regulator of osmotic pressure and can signal changes in endothelial permeability (Menzies et 
al. 1993). Recently it has been shown that 10 week old SHRSP have a significantly reduced 
level of oxidised albumin in the serum (Michihara et al. 2010), low albumin could enhance 
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fluid transport across the BBB leading to an increase in perivascular edema and we believe 
the contribution of albumin to a ‘stroke-prone’ state needs to be investigated further.  
Using the predetermined biological pathways within IPA software we found acute phase 
response signalling and tight junction signalling featured most often within the top 5 
pathways over represented by changes in gene expression. Elements of these pathways have 
been investigated in SHRSP using various assays but never using microarray technology on 
brain tissue (Lippoldt et al. 2000;Sironi et al. 2001;Uehara 2003). In relation to the acute 
phase response, previous studies have shown an increase in proteinuria and inflammatory 
proteins in serum at ages both prior to the onset of hypertension and ‘stroke prone’ ages 
(Sironi et al. 2001;Ballerio et al. 2007). Differences in gene expression within the tight 
junction pathway indicate that the blood brain barrier in SHRSP could be compromised from 
a young age which also agrees with previous findings (Lippoldt et al. 2000;Bailey et al. 
2011b). One possible reason for the inflammatory response, high levels of oxidative stress 
and impaired vasoreactivity seen in 5 week old SHRSP could be the l vels of hypertension 
SHRSP foetus’ are exposed to in the womb – i.e. the Barker Hypothesis which correlates fetal 
adaptation to adverse environmental conditions in the perinatal period with the manifestation 
of cardiovascular disease in adult life (Barker 2002). There is already evidence in SHR that 
this is the case (see Racasan 2005 for a review (Racasan et al. 2005)) with an imbalance in 
nitric oxide and reactive oxygen species playing a pivotal role. As the SHR does not ‘stroke’ 
this suggests that alongside this imbalance there are other facto s which contribute to the 
‘stroke-proneness’ of the SHRSP.    
 
8.4.2 Summary of results – salt-loaded versus non salt-loaded animals (all aged 21 
weeks) 
Through conducting mRNA expression analysis and qRT-PCR on WKY+NaCl and 
SHRSP+NaCl versus non salt-loaded age matched animals we found the majority of changes 
in gene expression due to salt-loading occurred in the frontal brain section. Within this frontal 
brain region salt induced differential expression of genes associated with myelin integrity and 
solute carriers in WKY rats. In SHRSP+NaCl a whole network of genes integral to vascular 
structure was down-regulated and components of the tight junction signallin  pathway were 
also significantly differentially expressed. Pathways pertaining to oxidative stress and 
inflammation were affected by changes in gene expression due to salt-l ading in both strains. 
Finally the differences in gene expression between WKY+NaCl versus SHRSP+NaCl were 
almost identical to those in non salt-loaded animals (see table 8.3), suggesting that inherent 
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strain differences have more of an effect on gene expression than salt. However, the fact that 
we found differences due to salt-loading in both strains cannot be ignored. 
In WKY rats, salt-loading resulted in several genes in a network centered around APP and 
MBP being up-regulated, indicating increased expression of myelin associ ted proteins. The 
same group of genes were down-regulated in SHRSP+NaCl versus SHRSP. This indicates a 
very different response to salt in the two different strains of rat or perhaps a different stage in 
disease and requires further investigation. 
In the SHRSP, salt-loading resulted in a down-regulation of a genen twork involved in 
maintaining vascular structure. In addition, tight junction signalling featured within the top 5 
pathways affected in the frontal section of WKY+NaCl versus SHRSP+NaCl, as well as 
SHRSP+NaCl versus SHRSP. Within the tight junction signalling pathway we found 
Claudin-11 to be significantly down-regulated in SHRSP+NaCl versus SHRSP in the frontal 
section and conversely up-regulated in the same section in SHRSP+NaCl when compared to 
WKY+NaCl. As the SHRSP already has reduced Claudin-5 protein expression independently 
of salt-loading (Bailey et al. 2011b) the difference in Claudin-11 could indicate problems 
within tight junctions and increased leakiness of blood vessels particul rly when coupled with 
changes in the expression of albumin.  
This is not to say that the WKY is immune to vascular damage due to salt-loading. The 
changes in APP and MBP could be a response to self-inflicted vascular damage. Also Von 
Willebrand factor (VWF) and vascular growth factor (VGF) were both down-regulated in the 
mid coronal section (2.3 and 1.9 fold respectively) of WKY+NaCl versus WKY. 
We found the acute phase response signalling pathway contained the most differentially 
expressed genes in all salt versus no salt comparisons indicating that the inflammatory 
response is significantly affected by salt-loading.  
Pathways pertaining to oxidative stress and leukocyte extravasation contained a significant 
proportion of differentially expressed genes in salt versus no salt comparisons in both strains. 
These results agree with previous data which showed increased levels of oxidative stress and 
an increased inflammatory response to be systemic responses to high salt intake in SHRSP 
(McBride et al. 2005;Kim-Mitsuyama et al. 2005;Kobayashi et al. 2009;Michihara et al. 
2010).  
Previous studies have linked a systemic inflammatory condition to stroke susceptibility in the 
SHRSP (Sironi et al. 2004) and the network of genes we found to be up-r gulated in 
WKY+NaCl versus WKY (including MBP and APP) contained many genes involved in the 
acute phase response as well as myelin formation and maintenance. This inflammatory 
pathway could be detrimental to myelin integrity and cause white matter damage and could 
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explain why we encountered evidence of white matter vacuolation in WKY+NaCl seen in 
H&E sections of the same animals (chapter 6 of this thesis) and saw a significant reduction in 
the expression of MBP protein using immunohistochemistry on the sam animals (chapter 7 
of this thesis).  
Genes within the two networks mentioned above (e.g. MBP, ALB and ACTB) were also 
amongst the top 10 up or down-regulated genes in the salt-loaded animals making their 
presence very significant. Few genes were differentially expressed by over 3 fold change and 
those that were, were mostly pseudogenes whose function is still undetermined or are 
essentially ‘dead’ genes i.e. genes that are still subject to regulation by transcriptions factors 
or other agents and not functional themselves. In the SHRSP, solute carriers such as SLC24a2 
were frequently within the top 10 up or down-regulated genes. SLC24a2 is a 
sodium/potassium/calcium exchanger therefore its presence in response to increased sodium 
was not unexpected. The fact that it was affected in SHRSP and not WKY may be consistent 
with previous findings that show the SHRSP to be salt sensitive as a strain (Rothermund et al. 
2001;Graham et al. 2007).  
 
8.4.3 Overall 
There were more genes differentially expressed in the frontal section than the mid coronal 
section and we often found genes which were consistently differentially expressed in one 
section but not the other. The reason for this is unclear. It could be due to the differences in 
tissue type distribution within the two sections (i.e. the frontal section will have a larger 
proportion of cortical grey matter, whilst the mid coronal section will have a larger proportion 
of white and deep grey matter). It could also be due to the differenc s in brain functions 
located within the two sections. A larger study would have to be performed to establish the 
reason for these differences.  
None of the significantly expressed genes we found were located in or around the STR1 locus 
on chromosome 1 – the so called ‘stroke-prone’ locus. Our study is not the first to find genes 
or other loci aside from the STR1 locus which are believed to contribute to stroke 
development in the SHRSP and act independently of hypertension. Jeffs et al (Jeffs et al. 
1997a) found a quantitative trait locus on chromosome 5 which co localises with the genes 
encoding atrial and brain natriuretic factor, which along with the diff rential expression of 
albumin we found in this study, highlights the importance in fluid transport and blood 
pressure regulation as a precursor to stroke development. Stroke is a polygenic condition in 
humans and we believe that even in an inbred strain of rat, the genetic cause of stroke is 
unlikely to be monogenic or related to a single quantitative trait locus.  
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This study has limitations. Whilst using one of the most comprehensiv  chips commercially 
available the entire rat genome is not faithfully represented. Over 22,000 probes are on a 
RatRef12 chip but some genes are over represented due to the presence of multiple 
transcriptomes. Some genes of interest were absent from the chip in particular smooth muscle 
actin. Therefore we cannot directly compare protein expression of SMA with RNA 
expression. Gene expression does not always mimic protein expression and this could explain 
why our previous finding of increased GFAP at 5 weeks on immunohistocemistry (see 
chapter 7) was completely reversed in the microarray. Whilst qRT-PCR validated the findings 
of GFAP, MMP14, AVP and GUCY1b3 it did not verify the differential expression of 
GUCY1a3, MBP, SLC24a2, ACTB, GPR98 and ALB as mentioned above. There are s veral 
possible reasons for the disparity between microarray and PCR data. The probe used for PCR 
(Taqman®) and the probe for the same gene on the microarray chip could map to different 
sections of the gene sequence. For example the GUCY1a3 probe on the microarray maps to a 
region downstream of the 3’UTR (all Illumina probes are biased towards the 3’ end), in 
contrast the Taqman® probe crosses exons 6 and 7 of the gene. A separation of more than 
1000 nucleotides between the PCR primer location and the microarray p obe lowers the 
likelihood of agreement between the two techniques (Etienne et al. 2004). Additionally, we 
did not measure microRNAs which directly effect mRNA levels(Ambros 2004).  
We used an unbiased and randomised approach and used a candidate gene and ome wide 
evaluation of transcription. No microarray of SHRSP brain tissue has been performed on 
animals as young as 5 weeks of age and therefore by doing this we have looked at an age 
group which is prior to the influence of hypertension as well as ages that are. All tissue was 
taken from the same brains used for our previous immunohistochemistry study (chapter 7) 
albeit the opposite cerebral hemisphere of the brain. Therefore when comparing the two 
separate techniques we are directly comparing the same animals.  We randomized samples 
throughout the entire microarray protocol and were careful to use the same batch of IVT kits 
and RNA extraction kits where possible. The quality of every sample (both RNA and cRNA) 
was checked prior to loading onto the microarray on both a nanodrop and Agilent bioanalyzer 
and all samples were hybridized to the chips and scanned at the same time. We did not set a 
cut off level for fold change. Some studies set a fold change of 2 as a minimum for 
significance however we believe that a cluster of genes all significantly altered by a 1.7 fold 
change, for example, could still indicate a biologically significant finding.  
Studies of salt-loaded animals should always have salt-loaded controls to establish salt 
specific changes in gene expression and avoid confounding due to salt. Studies using the 
SHRSP as a model of cerebral small vessel disease should refrain from salt-loading their 
animals as it only serves to complicate an already complex pattern of pathological changes. 
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Studies to assess salt-loading in younger animals are urgently r quired and salt intake should 
be assessed in studies of human cerebrovascular disease. 
 
8.5 Conclusions  
Our microarray and qRT-PCR data have revealed a significant proportion of genes which are 
differentially expressed in biological pathways which indicate imparments in vasoreactivity, 
the structural integrity of astrocytes and changes in the extra cellular matrix and the 
inflammatory response, all before the onset of hypertension in the SHRSP. Future work 
should focus on looking for changes in gene expression in more targeted ar as e.g. extracting 
vessels using laser capture microdissection. Congenic strains and / or the SHR should also be 
tested in this way to enable genetic differences due solely t  h pertension to be distinguished 
from those which could reveal more about the ‘stroke-proneness’ of the SHRSP.  
Whilst a microarray approach is not able to distinguish the underlying pathogenic insult from 
secondary changes in cellular function and pathophysiology, it is able to highlight changes in 
gene expression which could contribute to the development of pathology or highlig t 
potential genetic susceptibilities or pre disposing factors. We have used a time series to 
monitor initial changes at a young age which may cause effects later and tracked these 
changes over time. Finally, many genes that we found to be differentially expressed are of 
unknown function – however new information is constantly becoming available and the entire 
WKY and SHRSP genomes are nearing completion meaning our microarray data can be 
reanalysed in the future to incorporate new knowledge in the contxt of genome-wide SNPs 
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CHAPTER 9 : GENERAL DISCUSSION 
 
9.1 Main findings of this thesis 
There has been widespread investigation into the potential causes of lacunar stroke pathology. 
However the majority of these studies have been performed in post mortem human tissue 
which is not optimal for addressing causative mechanisms. In order to find an alternative 
approach, in this thesis we have systematically assessed all the available potential 
experimental models of lacunar stroke, identified the most pertinent (the spontaneous 
pathology of the SHRSP rat) and discovered significant gaps in knowledge pertaining to the 
primary cause of highly relevant cerebral pathology in this model. We also discovered 
experimental manipulations (e.g. salt-loading) which only serve to hinder our understanding 
of the causative mechanisms in this model. Through our experimental work we have tried to 
address the relevant gaps in knowledge by assessing pathological changes within the cerebral 
vasculature of the SHRSP across a variety of ages (particul ly young pre-hypertensive 
animals), as well as looking at the effects of salt loading on both the SHRSP and its control 
strain. This experimental work revealed that the presence of inflammation, as well as 
alterations in vascular reactivity, the nitric oxide signalli g pathway and the structural 
integrity of the blood brain barrier are all evident before th onset of hypertension and 
perhaps more importantly, in the absence of salt loading. We also confirmed previous 
findings of vessel remodelling at older ages as a secondary response to hypertension. 
Furthermore, salt loading in control animals may induce some of these features without 
exposure to raised blood pressure. Therefore the findings from this thesis provide additional 
support for a non-ischaemic primary causativei mechanism for small vessel disease and 
lacunar stroke, with, in addition, the possibility that some species for brains are particularly 
disposed to developing the features of SVD.  
 
9.2 Human pathology – is the reliance on a few retrospective pathology studies 
coupled with disparate terminology hampering our understanding? 
Lacunar stroke is considered to have a distinct clinical picture ompared to large artery stroke 
due to growing evidence of distinct differences in risk factor profiles(Jackson and Sudlow 
2005a) and well recognised differences in arteriopathy(Wardlaw 2005;Jackson et al. 2010). 
The original descriptions of this arteriopathy by Fisher are widely accepted despite his 
retrospective pathological material collectively coming from less than 20 patients(Fisher 
1965;Fisher 1968;Fisher 1978). This population is restricted and may represent only a small 
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proportion of lesions which are now seen on imaging, especially now we know that only 
approximately 20% of lacunar lesions actually cavitate(Potter e  al. 2010b)). This reliance on 
a few core studies and the pathological presumptions engrained from these studies are not 
conducive to advancing our knowledge of lacunar stroke etiology, especially when there are 
several other relevant pathology studies available in the current litera ure. 
Our systematic review of human lacunar stroke pathology (chapter 2) found almost 40 
pathology studies describing over 4000 relevant lesions. However over half of these lesions 
came from only one study and only 15 studies addressed the pathology of patients with a 
clinically verified lacunar syndrome. Studies of lacunar lesions in general were dogged by 
mixed terminology, non-standardised pathological assessment, and a lack of in depth 
histology targeting specific biomarkers (e.g. markers of inflammation, vascular structural 
integrity, axonal pathology etc).  
Neurologists, Neuropathologists and Neuroradiologists should preferably work together in 
studies but will have to harmonise the differing terminology used in their respective fields in 
order to advance our knowledge in this area more rapidly.  
All pathological investigations of lacunar stroke and associated conditions (e.g. vascular 
dementia, leukoaraiosis etc) need to be wary of artefacts. Early studies from Marie(Marie P 
1901), Ferrand(Ferrand J 1902) and Dechambre(Dechambre 1838) described findings 
particularly in the white matter which, from examination of the images provided were more 
than likely an artifact of fixation – something possibly not appreciat d at the time. Whilst 
observers now are much more aware of these artifacts, our relianc  on these earlier works 
may inadvertently have diverted us to look for pathology that is not there or relevant.   
Within studies of lacunar stroke or SVD a Neuropathologist is the ideal observer for 
examination of histopathological data in order to avoid such artifacts or unrelated pathology. 
However, it is important to blind the pathologist to appropriate daa. For example, knowledge 
of clinical data may influence examination or interpretation of the specimen. This can mean 
either an excess of ‘relevant’ findings or failure to notice other pathology which could be 
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9.2.1 Future directions for human pathology studies 
Put simply, more autopsy specimens are needed and whilst specimens assessed for SVD are 
available, they are usually contained within an Alzheimer’s disease, other dementia, general 
aging or possibly sudden death (in older people) cohort banks. These brain banks could utilise 
this tissue resource to focus on SVD. Failing that brain banks need to be established in order 
to truly separate SVD etiology from related disorders. However, brains from patients who 
have died suddenly from non neurological disease both with and without risk factors for SVD 
may also be a valuable resource with which to study very early signs of SVD.  
Like experimental animal studies, work conducted on human brain tissue needs to be 
conducted blind to clinical records and any in vivo imaging data. Preferably the imaging data 
should also be blindly assessed by at least one radiologist, if not more, so that a consensus 
view is established. In this context, sample size is also of paramount importance in pathology 
studies of both human and animal tissue. Not having a large enough sample size can result in 
finding non significant differences from quantitative assessments that may not reflect visual 
difference(s). Therefore, whilst we recommend the use of standardised quantitative methods 
in future studies, they must be performed to a high standard as outlined by guidelines 
available on the equator network (www.equator-network.org). 
The terminology applied to lacunar stroke and cerebral small vessel disease must be 
standardised in pathology and on imaging. Thankfully the issue is increasingly coming to the 
fore(Pantoni et al. 2006;Potter et al. 2011) and hopefully a defined set of terms will soon 
follow. Preferably, separate terms should be used for imaging and pathology as transient 
lesions are not the same as an established infarct and appearances on imaging are very 
different to those under a microscope. However, there should be a common frame within 
clinical, imaging and pathology settings from which to devise appropriate terminology.  
Multiple pathological abnormalities occur in vessels of different sizes and furthermore vessels 
at different sites in the brain show different pathologies under the same conditions (e.g. the 
medullary arteries display more severe thickening and dilatation than other arteries of 
comparable size)(Dozono et al. 1991a). More targeted approaches which segregate different 
vascular territories and brain regions are needed.  
Therefore to summarise, more, well characterised autopsy material, backed by detailed 
clinical, imaging and risk factor data plus a more open-minded appro ch is needed in order to 
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9.3 The SHRSP – its relevance as a model of SVD and lacunar stroke.  
Our systematic review of potential animal models of lacunar stroke identified a variety of 
models claiming to produce infarcts pertinent to lacunar stroke, however most of these 
produced infarcts which were too large or affected the wrong brain / vascular territory to be 
fully relevant (chapter 3). Whilst a few models produced infarcts of a relevant size and 
situation their method of induction was not pertinent and little / no vascular pathology was 
achieved. Representing both parenchymal and vascular pathology is vital in order for an 
animal model to be truly useful for investigating the cause of lacunar stroke and SVD. In 
conclusion, our review found only the spontaneous pathology of the SHRSP rat could satisfy 
these requirements (chapter 3).  
Unfortunately, in the current research climate, the SHRSP is being used to model a wide 
range of disorders and is now rarely used in its ‘spontaneous’ state. Furthermore, our 
systematic review of the cerebral pathology of the SHRSP (chapter 4) revealed a distinct lack 
of studies describing changes in the small vessels and at young ages despite this strain being 
highlighted as the most relevant model of small vessel disease(H insworth and Markus 2008) 
and vascular dementia(Saito et al. 1995) by others as well as being, in our opinion, the most 
pertinent model of lacunar stroke (chapter 3)(Bailey et al. 2009;Bailey et al. 2011a).  
The use of high salt diets and / or salt-loading has increased ov r the last 20 years. This in 
turn means that both the scale and the evolution of relevant vascular pathology is artificially 
hastened and exaggerated(Schmidlin et al. 2005). Most studies of SHRSP which described a 
systemic inflammatory condition salt-loaded their animals. This makes it hard to dissect 
whether inflammatory changes are a direct response to salt r  heightened response to a pre 
existing condition, as there is at least one study which describes vasoactive edema in 
relatively young SHRSP in the absence of salt loading(Fredriksson et al. 1985). Also salt, 
whilst being a risk factor for all  subtypes of stroke considere  to act through raising blood 
pressure(Warlow et al. 2008b), has not been proven as a specific risk factor for small vessel 
disease or lacunar stroke. Therefore we feel the use of salt only serves to complicate a picture 
that is already complex. In order to be used effectively to study small vessel changes, the 
SHRSP (and any control strain) should not be exposed to any dietary, pharmacological or 
artifical experimental manipulation. The effects of salt should be testd separately.   
In its ‘spontaneous state’ the SHRSP provides a model which incorporates both vascular and 
parenchymal lesions which develop over a timescale relevant to human pathology and 
harbours a pertinent risk factor in the form of hypertension. It is not a transgenic animal and 
therefore has no solitary genetic mutation which can be heldsolely to blame for the 
pathological changes seen. On the contrary the SHRSP probably has many genetic differ nces 
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which have yet to be identified. We are fully aware that tis species is highly inbred and may 
therefore be of limited relevance to the average human, but the microvascular and brain 
morphological features are so similar to those described in humans that it is hard to ignore. To 
truly rule out a genetic disorder as a primary cause of the cerebral pathology seen in the 
SHRSP congenic strain analyses and correlative human tissue studies are neded.  
Laboratories using the SHRSP must be aware that their findings should only be extrapolated 
to other SHRSP colonies with caution. This is because the selection processes for maintaining 
colonies differ between countries and colonies within those countries. For example, Japanese 
rat colonies are selectively bred to have higher systolic blood pressure than the Glasgow 
colony (230mmHg versus 190mmHg average systolic blood pressure respectively(Davidson 
et al. 1995;Kato et al. 2003). The reason for this is unclear. 
Researchers who use the SHRSP often select the WKY as their control animal of choice as it 
is the parent strain of the SHRSP and SHR. However, there is evidence that the genetic 
background of the WKY is more heterogeneous than previously thought(Kurtz and Morris, Jr. 
1987;Kurtz et al. 1989) which could potentially influence genetic studies and could explain 
some seemingly erroneous results between colonies. However lots of her methodological 
factors could also be to blame, such as the lack of blinding and / or randomisation as well as 
small sample sizes. Also the presence of heterogeneity within a model may be useful when 
trying to translate findings from experimental models into the heterogeneous human 
population, as long as the experimental design accounts for the variation. 
 
9.3.1 The gaps in SHRSP knowledge – future directions 
We identified 100 studies reflecting over 30 years of cerebral pathological investigation of the 
SHRSP. Despite this we found only one potential sequential histopathological investigation of 
vascular and tissue changes throughout the life of the SHRSP(Tagami et al. 1987). 
Additionally, the relationship of these changes to spontaneous strokes (particularly 
concerning the small vessels and prior to the development of hypertension) has not been 
specifically studied, despite much agreement that the small vessels suffer the major impact of 
the vascular changes(Mies et al. 1999). In addition the venular system has been overlooked.  
Future studies in this area should include more targeted sensitiv tudies of pathological 
changes in young SHRSP, such as profiling inflammatory markers in SHRSP rats who have 
not been raised on a high salt intake, or where a direct salt / no salt comparison is conducted, 
are required. Detailed analysis of the differences in separate vascular structures such as the 
arteriolar walls and endothelium, plus how changes in the arterioles and venules relate to the 
sequence of spontaneous tissue pathological changes, are also needed. Larger sample sizes 
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assessing a wider range of age groups plus further genetic characterisation, particularly with 
the use of congenic strains, will hopefully be able to shed more light on the ‘stroke proneness’ 
of the SHRSP. Our microarray and PCR data (see below) havealready highlighted 
abnormalities pertaining to instabilities in the BBB and vascular structure plus impairments in 
the vasoactive response from very early ages in the SHRSP. These are the type of findings 
which could give clues as to why some people are more susceptible than others to SVD and 
lacunar stroke. 
 
9.4 Experimental data 
From the experimental studies conducted in this thesis (chapters 6-8) we made several 
significant findings. 
 
9.4.1 Normotensive animals – 5 weeks of age 
Firstly, we had several important results at 5 weeks of age when SHRSP are still 
normotensive.  
In chapter 6 we discovered evidence of endothelial cell proliferation in 5 week old SHRSP on 
H&E staining, which supported the discovery of a network of early growth response genes 
that were significantly up regulated in the frontal section of SHRSP at the same age 
(microarray data see chapter 8).  
We found the immunoreactivity of the tight junction protein Claudin-5 to be significantly 
decreased in 5 week old SHRSP in all the areas of the brain an lysed (chapter 7). Our 
microarray data did not specifically highlight any changes in the gene expression of BBB 
components but did reveal a significant decrease in MMP14 expression at the same young 
age. MMP14 directly influences the collagen family (degrading collagen I, II and III) as well 
as laminin and fibronectin which are substrates(Bini et al. 1999). A decrease in MMP14 gene 
expression could therefore have implications for the integrity of the vascular structure 
including that of the BBB as MMP14 is produced by endothelial cells(Lafleur et al. 2003) and 
directly interacts with tight junction proteins(Bar-Or et al. 2003). This is not the first evidence 
for a potential structural BBB impairment in SHRSP prior to stroke. Lippoldt et al showed 
that a loss of polarity across the BBB exists in cerebral vascular endothelial cells at 13 weeks 
just after hypertension is fully established(Lippoldt et al. 2000). 
Also in relation to the BBB, our microarray data demonstrated a significant and consistent 
decrease in the gene expression of Albumin (ALB). Coupled with this was a significant 
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decrease in arginine vasopressin (AVP) expression in the mid coronal section at 5 weeks. 
ALB is a plasma protein with many functions. However, one of the most fundamental is to 
regulate blood volume(Menzies et al. 1993). AVP regulates water reabsorption(Miller 2006) 
from interstitial tissues to blood meaning a decrease in the level of both of these proteins 
could cause an increase in edema due to a decrease in oncotic pressure(Menzies et al. 1993) 
which in turn would make the BBB appear more permeable. This, plus any pre existing 
structural deficits in the BBB, could add up to resulting BBB leakage.   
In the tissue surrounding the cerebral vessels we found increased microglial activation (Iba-1) 
increased astrocytosis (GFAP) (both from IHC – chapter 7 and the microarray data – chapter 
8) along with altered gene expression within an inflammatory signalling pathway receptive to 
acute injury in the SHRSP at 5 weeks (chapter 8). These data combined suggest a heightened 
inflammatory response and / or the presence of inflammation at a young age. Previous studies 
showed an ‘atypical inflammatory response’ in young SHRSP(Sironi et al. 2004) although 
this was after salt loading. Our observations are independent of the effect of salt and 
hypertension (at 5 weeks SHRSP are still normotensive) therefor  both of these risk factors 
could simply be exacerbating a pre-existing condition within the SHRSP.  
Our microarray study (chapter 8) highlighted a major difference i  gene expression of an 
intracellular nitric oxide (NO) receptor (GUCY1a3) in the SHRSP at 5 weeks of age (~20 fold 
change) right through to 21 weeks (~15 fold change). This suggests that SHRSP have an 
altered NO signalling pathway from birth, which may in turn compromise vascular reactivity. 
This evidence adds to previous data which described a lack of NO bioavailability in the 
SHRSP(Gotoh et al. 1996;Ma et al. 2001;Hirafuji et al. 2002), attribu ed to a heightened 
presence of reactive oxygen species which remove NO faster than usual, rather than to a 
change in the gene expression of nitric oxide synthases(Grunfeld et al. 1995;Gotoh et al. 
1996;Michihara et al. 2010). Our data suggest that the NO pathway is abnormal from the start 
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9.4.2 Hypertensive animals- 16 and 21 weeks 
As well as reporting novel findings in very young SHRSP, we also confirmed the presence of 
vascular alterations directly attributable to hypertension in anim ls aged 16 and 21 weeks. 
Increased vessel wall thickening due to the accumulation of SMA (IHC study chapter 7) 
confirmed previous findings(Lin et al. 2001;Fujita et al. 2008) and supported our 
morphological observations in H&E sections (see chapter 6) which s owed thickened vessels 
of a variety of sizes in all brain regions. In our IHC study, we also saw increased 
immunoreactivity of collagen I in 16 week SHRSP in all regions f the mid coronal section 
indicating focal medial scarring. This is most likely to be a secondary response to damage 
incurred in smooth muscle cells brought on by exposure to high blood pressure. We found 
that our study was too small to reveal significant changes in relevant cell or vessel densities 
and using a sclerotic index developed for human vasculature was too insensitive to quantify 
increases in vascular smooth muscle hypertrophy in rats. However, we would encourage 
larger studies which enable the quantification of pathological changes wherever possible.  
 
9.4.3 The effects of salt 
9.4.3.1  WKY animals aged 21 weeks 
In 21 week old WKY given 1% NaCl in their drinking water from the age of 18 weeks, we 
found white matter vacuolation on H&E sections (chapter 6), increased astrocytosis (GFAP) 
and decreased MBP, VGF and vWF gene expression (chapters 7 and 8) compared with WKY, 
indicating that even the vasculature and white matter of the control strain is susceptible to 
salt.  In the case of the cerebral white matter, a network of genes centred round MBP and APP 
was significantly down regulated in WKY+NaCl (chapter 8) indicating axonal pathology, 
which was confirmed by the appearance of MBP immunostaining (chapter 7).  
Genes within the acute phase response signalling pathway were the most affected by salt 
loading as determined by IPA analysis (chapter 8). An inflammatory response to salt in the 
SHRSP has been demonstrated by several studies(Blezer et al. 1998;Sironi et al. 
2001;Guerrini et al. 2002;Sironi et al. 2004) but importantly they did not try to quantify the 
effect of salt specifically. Furthermore the specific effect of salt on WKY rats or other 
‘control’ strains has not been addressed. 
Finally, a down regulation of SLC24a2- a sodium/potassium/calcium hannel - was seen in 
salt loaded WKY versus WKY fed a normal diet (chapter 8). This finding comes in response 
to what was a short period of mild salt exposure in the adult rat and without a significant 
change in blood pressure. Therefore, changes in the control strain like this cannot be ignored 
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when trying to address the impact of salt loading on the SHRSP. Animals exposed to salt 
from birth may be much more affected.  
 
9.4.3.2  SHRSP animals aged 21 weeks 
SHRSP+NaCl rats displayed the most severe vascular pathology n H&E sections and we 
found an established internal capsule infarct in one salt loaded SHRSP rat (chapter 6). Like 
the WKY animals, salt loading caused significant changes in gene expr ssion within the acute 
phase signalling response pathway indicating an inflammatory response to salt (chapter 8). As 
mentioned above, an inflammatory response to salt loading in the SHRSP is well described 
using imaging and proteomics in SHRSP given salt from 6 weeks of age and was supported 
by the increase in microglial activation seen in the salt loaded SHRSP animals from IHC data 
(chapter 7). This data highlights that there are salt specific effects taking place before the 
onset of hypertension and that the accelerated vasculopathy seen in SHRSP+NaCl may not be 
due to the combination of salt plus an increase in blood pressure. 
SHRSP+NaCl also displayed significant reductions in MBP immunoreactivity, increased 
astrocytosis and microglial activation on IHC (chapter 7) all indicate secondary vascular 
damage. Microarray data supported a decrease in MBP expression in the frontal section of 
SHRSP+NaCl (chapter 8). Additionally our microarray study highlighted a decrease in ACTB 
(a major structural protein closely associated with tight junction signalling) and Claudin-11 (a 
tight junction protein) in SHRSP+NaCl versus SHRSP indicating once again how fragile the 
BBB is in the SHRSP (chapter 8).  
Finally our microarray data also showed that SHRSP+NaCl have an up regulation of the same 
sodium/potassium/calcium channel that was down regulated in WKY+NaCl rats (chapter 8). 
This difference in the expression of the same gene in response to salt between the WKY and 
SHRSP could imply a difference in physiological response to salt in the strains - a salt 
susceptibility effect – or reflect differences in the stage of development of disease between 
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9.5 Aspects of the methodologies used in this thesis 
9.5.1 New methodologies and advantages of the approaches used in this thesis 
Before conducting any experimental studies, we extensively and systematically searched the 
literature in order to assess gaps in knowledge in an unbiased and comprehensive fashion. We 
firstly assessed the human pathology data related to lacunar stroke and tried to harmonise 
disparate terminology in these studies which can impair the interpre ation and understanding 
of pathology in both humans and experimental models. We applied this knowledge of the 
disparate terminology when searching for potential animal models of lacunar stroke to devise 
the most comprehensive search strategy possible. Consequently our finding that the SHRSP 
was the most appropriate animal model of lacunar stroke was supported by another 
independent research group looking for animal models of small vessel disease(Hainsworth 
and Markus 2008). We subsequently systematically assessed available data concerning the 
cerebral pathology of this strain before designing any experimental work. 
We undertook study quality assessments in all our reviews with the elp of recognised study 
reporting guidelines(Stroup et al. 2000;Macleod et al. 2004;von Elm et al. 2007) to highlight 
reporting issues which could bias publications, hamper interpretation of results and contribute 
to the low translational success of animal models in stroke. Consequently we made a 
conscious effort to apply study quality guidelines to all the experimental work conducted in 
this thesis. 
We developed standard sampling protocols for sampling brain tissue from different ages and 
strains of rat – we can therefore be confident that we sampled the same brain areas from all 
animals. We applied this protocol across 3 different types of xperimental study with success. 
This approach has not been explicitly used in experimental studie  previously but is an 
obvious extension of methods commonly used in human experimental imaging studies. 
We separated out the effects of salt from the spontaneous state of the animals to look at the 
effects of salt separately in not only the SHRSP but also control animals. We looked at 
specific brain regions pertinent to regions associated both with SVD pathology in humans and 
the development of pathology in the SHRSP. We also deliberately geared our approach 
towards pathological changes in the cerebral vasculature – an aspect which has so far been 
neglected, especially in young SHRSP.  
We used both control animals and experimental animals from the sam colony. This ensured 
exactly the same housekeeping conditions, blood pressure measurements and dietary 
protocols. Salt loading was administered under exactly the sameconditions and for the same 
period of time for both the WKY and the SHRSP. Additionally, we used parate 
hemispheres from the same animals for histology and microarray work meaning a direct 
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comparison between these experimental findings can be made as the spontaneous pathology 
of the SHRSP and WKY is not hemisphere specific.  
We carried out all pathological assessments in a blinded and random fashion. Microarray 
experiments were randomized to try and prevent any chip effects, batch effects, age and / or 
strain bias. As mentioned previously these aspects of methodology are important if the ‘bench 
to beside’ approach to translational studies is to succeed.  
Finally we used two statistical tests to analyse the microarray data to try and limit the number 
of false positive results and to control for multiple comparisons.  
 
9.5.2 Disadvantages of the approaches used in this thesis 
The SHRSP is highly inbred and as well as displaying both tissue and vessel changes 
strikingly similar to human small vessel disease, it also displays pathology which is not 
pertinent to the condition e.g. cortical infarcts and haemorrhages lthough how prevalent 
these other lesions are is unclear as no official estimates have been undertaken. Incidentally, 
we saw no cortical lesions or haemorrhages in our animals. Some patients with small vessel 
disease also get cortical lesions and haemorrhages, but cortical events are common in older 
humans – it does not necessarily mean they are causally related – perhaps cortical events are 
simply common in older rats too. This could simply reflect a species difference relating to the 
make up of the vascular tree and would therefore be an issue in any hypertensive rodent 
model.  
To date the brain and in particular the cerebral vessels of inducible hypertensive rats have not 
been fully characterised(Patterson et al. 2005), neither have those fr m models of 
hypoperfusion which use carotid coils(Shibata et al. 2004), but to compare the data with ours 
would be extremely valuable. We would argue that it is more advantageous towards our 
understanding of a human condition for an animal model to possess most of the features of a 
disease as well as some irrelevant pathology than to have no animal model at all or a very 
pure model. The SHRSP may reveal one mechanism of many that can contribute to the 
understanding of SVD – after all, some patients exhibit microbleeds as a result of SVD – 
therefore like humans, even genetically inbred rats may express different predispositions to 
end stage pathology. 
Our experimental numbers overall were relatively small. However, we were restricted by the 
availability of animals within a relatively short time frame. To start up our own colony would 
have a) been expensive and b) taken too long to produce tissue. In this sense all our studies 
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can be classed as pilot data. Larger studies are easily reproducible from our methodologies 
and we actively encourage them.  
Furthermore, whilst the inclusion of SHR rats would have been desirable, it would have 
introduced heterogeneity into the experiment. The Glasgow colony do not keep SHR rats 
therefore variation due to differences in breeding programs, levels of systolic hypertension, 
animal maintenance, genetic background etc would have been introduced and would have 
made interpretation of subtle changes (particularly changes in gene expression) very difficult.  
Whilst selecting age groups which covered the development of hypertension we did not look 
at an end stage animal (e.g. >28 weeks). The end stage pathology of the SHRSP is already 
extensively described in the literature and we were primarily interested in early changes rather 
than re-characterizing end stage pathology. Despite our lack of an lder age group, our 21 
week old animals replicated previous reports of end stage pathology with vessel wall 
thickening and even an old infarct in one SHRSP+NaCl. A wider variety of ages e.g. 9, 12 
and 20 week old animals in addition to the age groups we used would be beneficial. 
Working with RNA poses challenges, in particular working with small samples, as our 
attempts at laser capture microdissection highlighted. The smaller the sample, the more rapid 
the decline of RNA quality. We used an Arcturus laser capture system with an infra red laser 
which does not allow for tracing around specific structures. It essentially punches holes 
within the tissue meaning more surface area of the sample will be exposed to the elements. If 
attempting this in the future we would recommend the use a Leica system with a UV laser 
which enables entire vessels to be dissected in one piece thereby increasing the chance of 
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9.6 The potential causes of lacunar stroke and how our data contributes to a 
non-ischaemic hypothesis. 
From data gathered from the literature and our own experimental fidings we would propose 
the following hypothesis for the causative pathological mechanism of lacunar stroke. In the 
SHRSP (the most pertinent animal model) the vascular pathology ori inates with both 
structural and functional alterations inherent in the BBB from the youngest ages coupled with 
a systemic inflammatory condition and impaired vascular reactivity. The development of 
hypertension and /or the presence of salt exacerbates this pre-existing state and in addition 
initiates vascular remodelling leading to small vessel disease pathology within areas of BBB 
disruption. But how does this apply to human SVD and lacunar stroke? 
Recent human studies have revealed increased levels of homocysteine(Hassan et al. 
2004;Zylberstein et al. 2008) and other biomarkers of inflammation in small vessel disease 
and/or lacunar stroke patients(Fornage et al. 2008;Virdis et al. 2010), although unfortunately 
these studies did not use cortical stroke patients as controls. Therefore interpreting these 
findings in relation to stroke subtypes is difficult. Furthermo e, background BBB leakage on 
imaging as measured by intravenous gadolinium was higher in the subcortical white matter of 
lacunar stroke patients versus cortical stroke control patients(Wardlaw et al. 2008).  
Endothelial dysfunction is impaired in stroke patients in general but whether the extent or 
characteristics of this dysfunction differ between stroke subtypes has not yet been fully 
clarified(Stevenson et al. 2010). This is due to a lack of studies using appropriate controls e.g. 
cortical stroke patients rather than age matched non neurological patients(Stevenson et al. 
2010).  
From reviewing the literature and from our own observations, evidence of a thrombotic or 
embolic cause of infarcts in the SHRSP is rare and thrombi are most often seen as a late 
secondary event in the SHRSP(Fredriksson et al. 1988). This supports human data which 
suggests that only 20% of lacunar strokes are due to an embolic source(Chowdhury et al. 
2004) along with the rare occurrence of thrombi in autopsy specimens of lacunar stroke 
patients(Fisher 1982a;Ogata 1999).  
Therefore the data gathered from the SHRSP in this thesis adds to increasing amounts of 
human data supporting the hypothesis that cerebral small vessel disease and lacunar stroke are 
not primarily caused by an ischaemic mechanism. There are several paths which ultimately 
lead to either: SVD, lacunar stroke, leukoaraiosis, vascular dementia and / or other related 
cerebral pathology and we have tried to summarise these in figure 9.1. In simple terms there 
are a variety of risk factors aside from hypertension and diabetes that can initiate the 
development of SVD. Polygenetic factors such as the functionality of the nitric oxide system 
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or levels of oxidative stress plus vulnerability of the BBB could start the process. These risk 
factors directly influence the function of the BBB, the vasoreactivity of blood vessels and the 
regulation of cerebral blood flow. In turn, impairment of one or more of these functions will 
initiate small vessel arteriopathy which will be further exacerbated by the classic 
cardiovascular risk factors such as hypertension, diabetes and moking. Then once again 
depending on partly environmental factors coupled with genetic susceptibility, the end stage 
disease will range from mild SVD (e.g. increased white matter lesions without cognitive 






Figure 9.1. A schematic representation of the causa tive mechanism of small vessel disease, 
lacunar stroke and associated cerebral pathology.  
BBB = blood brain barrier. CBF = Cerebral blood flow. dPVS = Dilated perivascular spaces.  
 
 
Doctor of Philosophy University of Edinburgh 237 
9.7 Recent findings from other experimental models of SVD and/ or related 
pathology pertinent to our hypothesis. 
 
Aside from the experimental models of lacunar stroke we assessed in chapter 3 of this thesis, 
there are models of closely related disorders like leukoaraiosis and vascular dementia which 
can also give insights into the causative mechanisms of SVD. For example, the chronic 
cerebral hypoperfusion model which ligates both the common carotid arteries is seen as a 
model of leukoaraiosis (diffuse white matter lesions) and vascular dementia. The white matter 
lesions created are hypothesized by many to be caused by BBB dysfunction as a direct 
consequence of the chronic low flow(Fernando et al. 2006).  
Huang et al(Huang et al. 2010) found that this model induced the expression of endothelial 
cell ICAM-1 and VCAM-1 at both the protein and mRNA level in WKY rats. It also induced 
microglial activation and infiltration of macrophages into the white matter indicating 
endothelial dysfunction and ultimately causing WMLs(Huang et al. 2010). Ueno et al(Ueno et 
al. 2002) demonstrated an increase in BBB permeability in the same model using horse radish 
peroxidase, leakage of which peaked 3 days post surgery. Rats which underwent this 
procedure also showed an up regulation of MMP2(Ihara et al. 2001). Dysregulation of matrix 
metalloproteinases seems to be a common feature amongst SVD models with the SHRSP 
having increased expression of MMP13(Ueno et al. 2009) and our finding that MMP14 
mRNA is decreased at 5 weeks of age. Interestingly MMP9 and MMP3 have been shown to 
be increased in human cases of vascular dementia around WMLs(Rosenberg et al. 2001). 
Dysregulation of MMPs generally indicates a breakdown in the extracellular matrix(Intengan 
and Schiffrin 2001). The extracellular matrix directly influencs mechanical properties of the 
vessel wall, cellular adhesion and endothelial proliferation, all processes which if 
dysregulated can compromise vascular structure(Tunon et al. 2000). 
The chronic cerebral hypoperfusion model also produces a marked proliferation of collagen 
fibrils in the thickened basal lamina of white matter arterioles(Ueno et al. 2002). This 
appearance is observed in both WKY and SHR rats and the authors postulate that this 
reflected regressive changes in the endothelial cells. Treatment with an anti-oxidant (lipoic 
acid) reduced the effects of chronic cerebral hypoperfusion on endothelial c lls. They 
recommended moderating brain inflammation as a therapeutic strategy.  
A related model of subcortical ischaemic vascular dementia using bilateral common carotid 
stenosis rather than ligation is being used to re create the decr as  in blood flow due to small 
vessel arteriopathy and also produces white matter lesions via a similar proposed 
mechanism(Shibata et al. 2004;Nishio et al. 2010). It is worth noting that the effects of 
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chronic cerebral hypoperfusion on the BBB in the above models happen independently of any 
increase in blood pressure. Previous work on the SHRSP has shown there to be a significant 
decrease (up to 50%) in regional cerebral blood flow (especially in the frontal regions of the 
brain) from 6 weeks of age(Yamori and Horie 1977;Smeda et al. 1999;Jesmin et al. 2004) 
well before hypertension is established or any cerebral pathology is evident. Therefore any 
BBB leak caused by this hypoperfusion will consequently be exacerbated y the onset of 
hypertension. 
Some authors are concerned that the bilateral carotid stenosis mouse odel does not develop 
lacunar infarcts or amyloid deposits in the long term. However, this is not necessarily a 
disadvantage as it may simply reflect species differences (mouse amyloid does not have a 
tendency to aggregate like human amyloid) and /or indeed the individual differences in 
susceptibility to these pathologies seen in humans. 
 
9.8 Future work needed across both human and animal studies. 
Standardised quantitative methodologies, like those developed in this thesis, need to be used 
in order to assess cerebral small vessel pathology across different animal and human models. 
These approaches (e.g. density counts, vessel measurements and immunohistochemistry with 
accompanying image analysis) would enable easier comparisons with quantitative human data 
such as white matter lesion rating scales used in imaging studies(Fazekas et al. 1987). 
Descriptive qualitative assessments, whilst valuable, can only provide a limited amount of 
information.  
Genetic studies targeted towards tissue type and /or vascular territory plus the use of congenic 
strains will reveal more about the development of pathology, the susceptibility of different 
brain areas to that pathology and the true role of hypertension. Our experimental work along 
with data emerging from experimental models of related conditions (see above) has 
highlighted nitric oxide signalling, matrix metalloproteinases, collagens and the functional 
and structural integrity of the BBB as areas which targeted s u ies could and should focus 
upon. Again these studies are needed not just in the SHRSP but in other animal models of 
hypertension, cerebrovascular disorders and SVD as well as models of other relevant risk 
factors (e.g. diabetes, inflammatory conditions).  
Cerebral small vessel disease is often seen as a disease of the arteries, arterioles and very 
rarely the capillaries. However, it probably affects all components of the small vessels and 
therefore studies of the veins and venules are also required. Some w uld say that often it is 
difficult to distinguish venules from arterioles under a light microscope, but this should no 
longer be a problem due to major advances in microscope technology. In humas there is now 
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increasing evidence from retinal photography and imaging that differences in the venular 
system (e.g. venular diameters) may distinguish small vessel di ase from large artery 
pathologies(Kwa et al. 2002;Delles et al. 2008;Lindley et al. 2009;Doubal et al. 
2009;Rodriguez et al. 2010). Retinal studies are extremely valuable to cerebral small vessel 
disease research as retinal vessels share the same embryological source, size, and physiologic 
characteristics with cerebral small vessels, and retinopathy itself is associated with and is a 
risk factor for stroke (Doubal et al. 2009). Eyes are inherently more accessible in both humans 
and animal models than the brain and they provide a canvas for a larger ar ay of experimental 
studies particularly in vivo studies in the case of animal models. Retinal work in the SHRSP 
is scarce, mostly over 20 years old, not published in mainstream journals and is often 
confounded by the introduction of dietary modulations (e.g. cholesterol)(Affymetrix ;Lin and 
Essner 1988;Hamada 1991). More assessments of retinal pathology in animal models such as 
the SHRSP are not only feasible but necessary.  
 
9.9 Conclusion 
The data presented in this thesis provides evidence which supports bl od brain barrier 
dysfunction, impaired vascular reactivity and inflammation as primary causative mechanisms 
for cerebral small vessel disease and lacunar stroke. Any thrombotic vessel lesions 
encountered in both human tissue and the most relevant animal model, are usu lly a late stage 
event. This suggests that patients with an innate susceptibility o increased blood brain barrier 
permeability and/or inflammatory conditions could be at higher risk of developing small 
vessel disease pathology and related end stage diseases (e.g. vascular dementia, lacunar 
stroke). Further research is required to determine if patients with lacunar stroke should be 
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APPENDIX A) THE SEARCH STRATEGY DEVISED FOR RETRIEV ING 
HUMAN LACUNAR STROKE PATHOLOGY LITERATURE.  
 
This search strategy was applied across both Medline and Embase databases. Mesh terms 
were altered automatically to match each database by the programme as both are owned by 
Ovid.  
 
1. brain edema/ or cerebrovascular disorders/ or basal ganglia cerebrovascular disease/ or brain 
ischemia/ or cadasil/ or cerebral arterial diseases/ or intracranial arteriosclerosis/ or "intracranial 
embolism and thrombosis"/ or stroke/ or brain infarction/ or vasospasm, intracranial/ or hypoxia, brain/ 
or hypertensive encephalopathy/ 
2. (Stroke$ or cerebrovasc$).mp. or cerebral vasc$.tw. [mp=title, original title, abstract, name of 
substance word, subject heading word] 
3. 1 or 2 
4. lacun$.tw. 
5. ((lacunar or small or subcortical or silent or micro) adj5 (infarct$ or lesion$ or stroke$)).tw. 
6. (small vessel adj5 (stroke$ or occlusion or disease)).tw. 
7. 4 or 5 or 6 
8. (leukoaraiosis or leucoaraiosis or leukoariosis r leucoariosis or MARCD or microangiopathy related 
cerebral damage or microangiopathy-related cerebral damage).tw. 
9. (white matter lesion$ or WML or white matter hyperintensit$ or WMH or white matter change$ or 
small vessel disease or small-vessel disease or microangiopath$ or white matter hypointensit$ or white 
matter hyperdens$ or white matter hypodens$).tw. 
10. 8 or 9 
11. (caus$ or histolog$ or immunohisto$ or patholog$ r autopsy).tw. 
12. (Lipohyalinosis or fibrinoid necrosis or hyaline thickening).tw. 
13. ((enlarged or dilated) adj3 perivascular spaces).tw. 
14. 7 or 13 or 10 or 12 
15. 3 and 14 
16. 11 and 15 
17. limit 16 to humans 
18. (CADASIL or Notch3 or NOTCH3).tw. 
19. 18 and 17 
20. (vascular dementia or VaD or Alzheimer$).tw. 
21. 17 and 20 
22. 21 not 18 
23. from 22 keep 1-259 
24. 16 not (19 or 22).
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APPENDIX B) The data extraction form used to compil e the systematic review of human lacunar stroke pat hology.  
HT = Hypertension. DM = Diabetes Mellitus, AF = Atrial Fibrillation. DWI = Diffusion Weighted Imaging.  
STUDY CHARACTERISTICS Options  
Author   
Date of Publication   
Prospective / Retrospective Study   
Population Type & Source e.g. General, Stroke Specific, Outpatient, 
Brain Bank etc 
 
Number of Subjects   
   
PATIENT CHARACTERISTICS   
Clinical History Available?   
Vascular Risk Factors analysed. HT, DM, Smoking, AF, Hypercholestrolaemia 
etc 
 
Cognitive Status Dementia scale?   
Medication (e.g. Anti-Hypertensives)   
Mean Age at Death   
Cause(s) of Death   
CLINICAL METHODOLOGY   
Time from Stroke to Admission   
Presence of a Lacunar Syndrome?   
Imaging Method MRI, CT, Both, DWI etc  
Other clinical methods  Angiography, blood samples etc.  
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Data extraction form continued…… 
PATHOLOGICAL METHODOLOGY   




Post Mortem Imaging? Whole brain, specific blocks etc  
Histopathology methods Fixative, stains  
 
Who performed the histological assessment? Pathologist, Technician, 
Neuropathologist? 
 
Number of observers   
RESULTS   
Mean number of Infarcts per patient   
Infarct /Lesion – symptomatic / asymptomatic Lesion directly related to 
syndrome / symptoms / imaging 
feature? 
 
Brain region studied / affected   
 
Mean size of lesion / lesion classed as lacunar. Diameter / volume?  
 
Vessels studied Territory / specific vessel  
 
Description of vascular pathology   
 
Proposed causative mechanism   
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APPENDIX C) The search strategy used to find potent ial animal 
models of lacunar stroke within the published liter ature.  
 
Like the human lacunar pathology search strategy above, Mesh terms were converted by 
Ovid to match those in Medline and Embase respectively. Mesh terms were also matched as 
closely as possible with terms in Biosis Previews.  
 
1. exp Models, Biological/ or exp Disease Models, Animal/ or exp Models, Animal/ 
2. (experimental adj5 stroke).tw. 
3. Animals/ 
4. exp mammals/ or exp primates/ or exp mice/ or exp rats/ or exp rats, inbred strains/ or exp 
rats, mutant strains/ 
5. 1 or 2 or 3 or 4 
6. exp cerebrovascular disorders/ or exp basal ganglia cerebrovascular disease/ or exp brain 
ischemia/ or exp cerebrovascular accident/ or exp brain infarction/ or exp hypoxia-ischemia, 
brain/ 
7. brain edema/ or cerebrovascular accident/ or exp dementia, vascular/ or exp int acranial 
arterial diseases/ or exp "intracranial embolism and thrombosis"/ or exp vasospasm, 
intracranial/ 
8. (Stroke$ or cerebrovasc$ or cerebral vasc$ or cerebral$).tw. 
9. 6 or 7 or 8 
10. 5 and 9 
11. limit 10 to animals 
12. (((micro or small or perforat$) adj3 vessel) or arteriole).tw. 
13. (lacunar stroke or lacunar infarct).tw. 
14. (focal or multifocal or subcortical).tw. 
15. (emboli or microemboli).tw. 
16. (Blood brain barrier or BBB or plasma proteins).tw. 
17. ((small or micro) adj5 (stroke$ or occlusion$ or disease$)).tw. 
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18. ((lacun$ or small or subcortical or deep or silent) adj5 (infarct$ or lesion$ or 
stroke$)).tw. 
19. (microgli$ or astrocyte).tw. 
20. 12 or 13 or 14 or 15 or 16 or 17 or 18 or 19 
21. 11 and 20 
22. limit 21 to humans 
23. 21 not 22 
24. (heart or bone or eye or lung or kidney or liver or renal or intestin$ or spinalor 
pulmonary or hepatic or global).mp. [mp=title, abstract, subject headings, heading word, 
drug trade name, original title, device manufacturer, drug manufacturer nam]
25. 23 not 24 
26. (AD or PD or Alzheimer$ or Parkinson$ or epilepsy or MS or Multiple Sclerosis).tw. 
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APPENDIX D) THE DATA EXTRACTION FORM USED TO COMPIL E THE SYSTEMATIC REVIEW OF POTENTIAL 
ANIMAL MODELS OF LACUNAR STROKE.  
1.1 Author  
1.2 Country of origin  




Stated purpose of research 
Explicitly lacunar related? Yes/No 
Which aspect of pathology is the paper trying to model? 
 
1.5 Species and strain of animals used (Rat,Wistar etc.)  






Sex of animals used 
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Other (please state) 
 
Blinded Induction (Yes/No) 
 







Other (please state) 
 
1.11 Control of physiological variables: 
Body Temperature (Y/N) 
Blood pressure (Y/N) 






Method of sacrifice: 
Cardiac Perfusion 
Other (please state) 




Doctor of Philosophy University of Edinburgh 274 




Size of infarct produced and units of measurement (area, volume, 
diameter etc.) 
 
Method of measurement (e.g. microscopic calibrator, imaging, area 
on histology sections etc.) 
 
1.14 Territory of infarct produced  
1.15 Definition of infarct  














Type of staining used 
Number of sections taken 
Size of sections taken (µm / mm) 
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How many had infarcts on MRI? Etc 
 
Mortality rate (% total of animals used) 
 
 
1.19 Blinded assessment of outcome (Y/N)  
1.20 Observer reliability (e.g. more than one observer?)  
Notes Any additional useful information  
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APPENDIX E)  SUMMARY OF THE STUDIES INCLUDED FOR AN ALYSIS IN THE SYSTEMATIC REVIEW OF THE CEREBRAL 
PATHOLOGY OF THE SHRSP, IN CHRONOLOGICAL ORDER; 
Abbreviations: n/a = information unobtainable, unclear or irrelevant. BG = basal ganglia, BA = basilar artery, MCA = middle cerebral artery, ACA = anterior cerebral artery, PCA = posterior cerebral artery, CC = 
corpus callosum, AC = anterior commisure, IC = inter al capsule, CP = caudate and putamen, GP = globus pallidus, WM = white matter, CB = cerebellum, MB = midbrain, HT = hypothalamus, MO = medulla 
oblongata, HP = hippocampus, ST = striatum. N= total number of experimental animals used – in general this equated to 50% WKY and 50% SHRSP unless otherwis  stated. $ = All SHRSP, # = SHR included as well
as WKY.  
 




loaded? Aspect of pathology studied Specific brain territory? 
Yamori (Yamori et al. 1975) 1975 24 32wks No Brain parenchyma No 
Okuma(Okuma and Yamori 1976) # 1976 29 14-16wks No Serum, urine or CSF biomarkers No 
Yamori(Yamori et al. 1976) 1976 1278 n/a No All cerebral arteries No 
Yamori(Yamori and Horie 1977) 1977 150 20-40wks No All cerebral arteries Frontal cortex 
Hazama(Hazama et al. 1979) # 1979 17 8-52wks No Basal arteries No 
Knox(Knox et al. 1980) 1980 43 12-108wks No Intraparenchymal arteries Frontal cortex 
Tagami(Tagami et al. 1981) $ 1981 62 8-40wks No Intracranial extracerebral No 
Rieke(Rieke et al. 1981) 1981 13 13-20wks No 
Supply to BG etc including perforators & 
parent. CP & GP 
Ogata(Fisher 1965) 1981 5 40-80wks No Cerebral arterioles No 
Matsuo(Matsuo and Nagaoka 1981) $ 1981 75 0-22wks Yes Brain parenchyma No 
Sadoshima(Sadoshima and Heistad 
1982) 1982 24 4-26wks Yes Brain parenchyma 
Cerebrum / frontoparietal 
cortex. 
Takeshita(Takeshita et al. 1982) $ 1982 59 8-16wks Yes Serum, urine or CSF biomarkers No 
Sadoshima(Sadoshima and Heistad 
1983) 1983 n/a n/a No All cerebral vessels No 
 
Doctor of Philosophy University of Edinburgh 277 
Author  Date N Age Salt 
loaded? 
Aspect of pathology studied Specific brain territor y? 
Kanbe(Kanbe et al. 1983) # 1983 n/a 12-24wks No Aorta No 
Takiguchi (Takiguchi 1983) $ 1983 n/a n/a No Brain parenchyma No 
Rodda(Rodda et al. 1983) 1983 57 n/a No Brain parenchyma No 
Tamaki(Tamaki et al. 1984b) # 1984 96 20-30wks No Carotid & pial vessels  No 
Werber(Werber and Heistad 1984) 1984 37 3-64wks No Aorta & cortical pial vessels No 
Yamada(Yamada et al. 1985) # 1984 n/a 5-24wks No Serum, urine or CSF biomarkers HT 
Tomita(Tomita et al. 1984) # 1984 n/a 4-25wwks No Serum, urine or CSF biomarkers No 
Yamada(Yamada et al. 1984) # 1985 n/a 5-24wks No Serum, urine or CSF biomarkers HT 
Norborg(Nordborg et al. 1985) # 1985 48 28-52wks No Intracranial, pial, basal & extracranial 
cervical. 
No 
Minami(Minami et al. 1985) 1985 27 15-60wks No Brain parenchyma No 
Fredriksson(Fredriksson et al. 1985) $ 1985 23 24-36wks No Brain parenchyma No 
Umegaki(Umegaki et al. 1986) 1985 100 4-41wks No Serum, urine or CSF biomarkers No 
Luft(Luft et al. 1986) 
 
1986 n/a n/a No All cerebral vessels No 
Coyle(Coyle 1987) 1987 11 5-69wks No Dorsal cerebral collaterals No 
Fredriksson (Fredriksson et al. 1987) 1987 n/a 20-36wks No MCA territory No 
Tagami(Tagami et al. 1987) $ 1987 84 4-52wks No Perforating arteries Anteriomedial & occipital cortex 
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Author  Date N Age Salt 
loaded? 
Aspect of pathology studied Specific brain territor y? 
Fredriksson(Fredriksson et al. 1988) # 1988 32 24-36wks No Cerebral microvessels extraparenchymal. Cerebral cortex & BG 
Lee(Lee et al. 1988) 1988 278 24-37wks No BA, Circle of Willis, MCA & ACA No 
Stier(Stier et al. 1988) 1988 43 6-18wks Yes Serum, urine or CSF biomarkers No 
Shimizu(Shimizu et al. 1988) $ 1988 n/a 12wks No Serum, urine or CSF biomarkers No 
Thompson(Thompson et al. 1988) 1988 24 24wks No Serum, urine or CSF biomarkers No 
Schober(Schober et al. 1989) 1989 41 16-52wks No Serum, urine or CSF biomarkers Adrenal medulla 
Furspan(Furspan and Bohr 1990) 1990 36 16-24wks No Serum, urine or CSF biomarkers No 
Kobayashi(Kobayashi et al. 1990) 1990 n/a 12wks No Serum, urine or CSF biomarkers No 
Mangiarua(Mangiarua and Lee 1992) # 1992 45 28wks No Basilar, superior cerebellar, PCA & MCA No 
Matsuo(Matsuo et al. 1992) 1992 12 24wks No Serum, urine or CSF biomarkers No 
Contard(Contard et al. 1993) 1993 24 6-13wks Yes Aorta & coronary vessels No 
Coyle(Coyle and Feng 1993) 1993 36 8-13wks No MCA and connecting vessels No 
Furspan(Furspan and Webb 1993) 1993 36 16-20wks No Serum, urine or CSF biomarkers No 
Chue(Chue et al. 1993) 1993 76 8-24wks No Serum, urine or CSF biomarkers Cortex & subcortical WM 
Liu(Liu et al. 1994) 1994 46 16-24wks No Serum, urine or CSF biomarkers No 
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Author  Date N Age Salt 
loaded? 
Aspect of pathology studied Specific brain territor y? 
Kanagy(Kanagy et al. 1994) 1994 20 20-24wks No Serum, urine or CSF biomarkers No 
Hajdu(Hajdu and Baumbach 1994) 1994 14 24-32wks No PCA (large 2nd order and small 3rd order 
branches. 
No 
Kitazono(Kitazono et al. 1995) 1995 77 24-36wks No Basilar No 
Ito(Ito et al. 1995a) 1995 n/a n/a No Serum, urine or CSF biomarkers No 
Grunfeld(Grunfeld et al. 1995) 1995 13 5-16wks No Serum, urine or CSF biomarkers No 
Yang(Yang et al. 1995) # 1995 89 12-16wks No Serum, urine or CSF biomarkers MO 
Volpe(Volpe et al. 1996) # 1996 80 6-18wks Yes Aorta & basilar artery No 
Arribas(Arribas et al. 1996) 1996 84 16-44wks No Basilar artery No 
Ikeda(Ikeda et al. 1996) 1996 n/a 14-18wks No Serum, urine or CSF biomarkers No 
Ono(Ono et al. 1996) # 1996 45 12-13wks No Serum, urine or CSF biomarkers No 
Gotoh(Gotoh et al. 1996) 1996 n/a n/a No Serum, urine or CSF biomarkers No 
Togashi(Togashi et al. 1996) 1996 n/a 15-40wks No Serum, urine or CSF biomarkers CB, MB, HP, HT, MO & ST. 
Cabrera(Cabrera et al. 1996) 1996 12 12wks No Serum, urine or CSF biomarkers No 
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Author  Date N Age Salt 
loaded? 
Aspect of pathology studied Specific brain territor y? 
Zanchi(Zanchi et al. 1997) # 1997 133 4-32wks No Carotid artery No 
Lin(Lin et al. 1997)  1997 n/a 12-38wks No Serum, urine or CSF biomarkers No 
Takeda(Takeda et al. 1997) 1997 156 2-9wks No Serum, urine or CSF biomarkers No 
Blezer(Blezer et al. 1998) $ 1998 23 7-16wks Yes Serum, urine or CSF biomarkers No 
Smeda(Smeda et al. 1999)  1999 25 10-27wks Yes MCA No 
Smeda(Smeda and King 1999) 1999 24 10-22wks Yes MCA & PCA No 
Sunano(Sunano et al. 1999) 1999 60 16wks No 2nd branch arterioles No 
Mies(Mies et al. 1999) $ 1999 20 6-12wks Yes All cerebral arteries No 
Negishi(Negishi et al. 1999) 1999 35 6-17wks No Serum, urine or CSF biomarkers No 
Shimamura(Shimamura et al. 1999) # 1999 63 7-17wks No Serum, urine or CSF biomarkers No 
Kerr(Kerr et al. 1999) 1999 88 12-16wks No Serum, urine or CSF biomarkers No 
Kimoto - Kinoshita(Kimoto-Kinoshita et 
al. 1999)  
1999 80 15-31wks No Serum, urine or CSF biomarkers HP & Cortex 
Mizuno(Mizuno et al. 1999) 1999 100 10-12wks No Serum, urine or CSF biomarkers No 
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Author  Date N Age 
Salt 
loaded? Aspect of pathology studied Specific brain territory 
Lippoldt(Lippoldt et al. 2000) # 2000 39 13wks No Capillaries No 
Enea(Enea et al. 2000) # 2000 133 6-10wks Yes Serum, urine or CSF biomarkers No 
Boumaza(Boumaza et al. 2001)  2001 44 13wks No Internal carotid & aorta No 
Lin(Lin et al. 2001) 2001 38 4-20wks No Cerebral arteries  CC, AC, IC & CP. 
Sironi(Sironi et al. 2001) # 2001 18 6-13wks Yes Serum, urine or CSF biomarkers No 
Hamilton(Hamilton et al. 2001) 2001 150 12-52wks No Serum, urine or CSF biomarkers No 
Ito(Ito et al. 2001) 2001 n/a 19-23wks No 
Serum, urine or CSF biomarkers & "cerebral 
microvessels" No 
Ma(Ma et al. 2001) 2001 44 12-25wks Yes Serum, urine or CSF biomarkers No 
Michihara(Michihara et al. 2001) 2001 n/a 1-9wks No Serum, urine or CSF biomarkers No 
Sekiguchi(Sekiguchi et al. 2001) 2001 62 5-15wks No 
Serum, urine or CSF biomarkers & carotid, 
aorta & iliac arteries No 
Hirafuji(Hirafuji et al. 2002) 2002 n/a 6-7wks No Aorta No 
Guerrini(Guerrini et al. 2002) 2002 68 6-52wks Yes Brain parenchyma No 
Yamashita(Yamashita et al. 2002) 2002 12 10-23wks No 
Serum, urine or CSF biomarkers & arterioles 
20-25µm in diameter No 
Taka(Taka et al. 2002) 2002 n/a 28-31wks No Serum, urine or CSF biomarkers No 
 
Doctor of Philosophy University of Edinburgh 282 
Author  Date N Age Salt 
loaded? 
Aspect of pathology studied Specific brain territor y? 
Tabuchi(Tabuchi et al. 2002) $ 2002 127 4-10wks No Serum, urine or CSF biomarkers No 
Izzard(Izzard et al. 2003) # 2003 27 4-12wks Yes MCA No 
Sironi(Sironi et al. 2003) $ 2003 50 8-14 wks Yes Brain parenchyma No 
Chander(Chander et al. 2003)  2003 58 8-12wks Yes Serum, urine or CSF biomarkers No 
Ueno(Ueno et al. 2004b) # 2004 18 12wks No All cerebral arteries, arterioles & capillaries HP & cortex 
Sironi(Sironi et al. 2004) $ 2004 28 6-11wks Yes Brain parenchyma CP 
Jesmin(Jesmin et al. 2004) 2004 71 6wks No Serum, urine or CSF biomarkers & all 
cerebral vessels 
No 
Kishi(Kishi et al. 2004) 2004 10 14-18wks No Serum, urine or CSF biomarkers No 
Schmidlin(Schmidlin et al. 2005) $ 2005 83 6-15wks Yes Serum, urine or CSF biomarkers No 
Kim-Mitsuyama(Kim-Mitsuyama et al. 
2005) $ 
2005 235 8-14wks Yes Serum, urine or CSF biomarkers HP & Cortex 
Masineni(Masineni et al. 2005)$ 2005 18 53wks No Serum, urine or CSF biomarkers No 
Izzard(Izzard et al. 2006) 2006 20 5-24wks Yes MCA No 
Ballerio(Ballerio et al. 2007) $ 2007 100 6-18wks Yes Serum, urine or CSF biomarkers No 
Lee(Lee et al. 2007) $ 2007 10 8-18wks Yes All cerebral vessels No 
Ishizuka(Ishizuka et al. 2007) $ 2007 n/a 9-14wks Yes Serum, urine or CSF biomarkers No 
Ueno(Ueno et al. 2009) 2009 36 4-12wks No ‘Randomly sampled’ microvessels Frontal cortex & HP 
Henning(Henning et al. 2010) 2010 12 24 wks + No Vessels within lesions – 100-250µm 
diameter. 
Whole brain – wherever there 
was a lesion. 
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APPENDIX F) H&E staining protocol – used for both q ualitative and 
quantitative assessments. 
 
Sections to water 
1. 2 x 5 mins deparaffin Xylene (in hood). 
2. 2 x 5 mins 74ºP. 
3. 2 x 5mins 70% Alcohol. 
4. 30 mins Picric Acid. 
5. Wash in water until all excess picric acid removed. 
 
Staining 
6. Stain in Harris Hematoxylin for 8-10 mins. 
7. Wash with water until all excess stain removed. 
8. Differentiate staining in acid alcohol (~3 dips).  
9. ‘Blue’ slides in Lithium Carbonate (~3 dips). 
10. Place slide rack straight into Putt’s Eosin solution for ~10mins. 
11. Wash with water until all excess stain is removed. 
12. If necessary dip slides in pot aluminium solution and replace in Eosin for 1-2 mins to 
fix staining.  
13. Dehydrate slides through alcohols (70%, 74ºP & 2x absolute alcohol) ~ 5 dips in 
each. 
14. Clear in xylene for 2 x 5 mins.  
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APPENDIX G) Immunohistochemistry ABC protocol 
 
Sections to water – same as H&E 
2 x 5 mins deparaffin Xylene (in hood). 
2 x 5 mins 74ºP. 
2 x 5mins 70% Alcohol. 
30 mins Picric Acid. 
 
ABC Method –  
1. Wash off picric acid in water until clear. 
2. Block in hydrogen peroxide (H2O2) for 10 mins in a glass container on top of a 
rocker. (Dilution = 1:10 in distilled water). 
3. Pretreatment step if required (e.g. Citric acid). 
4. Wash in water. 
5. Transfer slides to Sequenza (separate the negative). Mount with Tris (TBS) Buffer in 
squeezy bottle (1:10 in saline – make 500mls). Check flow.  
6. Wash in TBS buffer for 5 mins.  
7. Treat with 100µl/slide of Serum (NRS – 1:5 dilution with TBS for 10 mins.  
8. Treat with 100µl/slide of primary antibody (e.g. GFAP – made to recommended 
dilution e.g.1:250) for 30 mins. Omit from negative control – treat this with serum. 
9. Wash in buffer 2 x 5 mins. 
10. Incubate in RAMBO (or other secondary antibody made to dilution e.g. 1:200) for 30 
mins.  
11. Prepare ABC – 30 mins prior to use. (5ml TBS, 1 drop A, 1 drop B). 
12. Wash in buffer 2 x 5 mins. 
13. Incubate in ABC for 30 mins. 
14. Wash in buffer 2 x 5 mins. 
15. Remove slides from coverplates and place in water.  
16. Treat with DAB on relevant bench for 1 minute. (DAB – 5 ml distilled water, 2 drops 
H2O2, 2 drops buffer, 4 drops DAB from kit in fridge.) Use immediately – drop 
enough to cover tissue. 
17. Wash off excess DAB in water. Check staining. 
18. Counterstain in Haematoxylin (15-20 seconds). Blue in Lithium carbonate.  
19. Dehydrate through alcohols, clear in xylene & mount.  
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APPENDIX H) IPA – the statistical methods used to a nalyse uploaded 
data. Ingenuity® Systems www.ingenuity.com.  
 
1. Network Generation 
A data set containing gene (or chemical) identifiers and corresponding expression values was 
uploaded into in the application. Each identifier was mapped to its corresp nding object in the 
Ingenuity® Knowledge Base. A <insert expression value type here> cutoff of <insert 
expression value cutoff here> was set to identify molecules whose expression was 
significantly differentially regulated. These molecules, called Network Eligible molecules, 
were overlaid onto a global molecular network developed from information contained in the 
Ingenuity Knowledge Base.Networks of Network Eligible Moleculs were then 
algorithmically generated based on their connectivity. 
 
2. Functional Analysis of an Entire Data Set 
The Functional Analysis identified the biological functions and/or diseases that were most 
significant to the data set. Molecules from the dataset that met the <insert expression value 
type here> cutoff of <insert expression value cutoff here> and were associated with 
biological functions and/or diseases in the Ingenuity Knowledge Base were considered for the 
analysis.Right‐ ailed Fisher’s exact test was used to calculate a p‐v lue determining the 
probability that each biological function and/or disease assigned to that data set is due to 
chance alone. 
 
3. Functional Analysis of a Network 
The Functional Analysis of a network identified the biological functions and/or diseases that 
were most significant to the molecules in the network. The network molecules associated with 
biological functions and/or diseases in the Ingenuity Knowledge Base were considered for the 
analysis. Right‐ ailed Fisher’s exact test was used to calculate a p‐value determining the 
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4. Canonical Pathway Analysis: Entire Data Set 
When publishing part of or an entire Ingenuity canonical pathway(s), cite IPA (see options 
above) in the reference section of your publication. You may also want to cite some of the 
references contained within that canonical pathway(s).Canonical pathways analysis identified 
the pathways from the IPA library of canonical pathways that were most significant to the 
data set. Molecules from the data set that met the <insert expression value type here> cutoff 
of <insert expression value cutoff here> and were associated with a canonical pathway in the 
Ingenuity Knowledge Base were considered for the analysis. The significance of the 
association between the data set and the canonical pathway was measured in 2 ways: 
1) A ratio of the number of molecules from the data set that map to the pathway divided by 
the total number of molecules that map to the canonical pathway is displayed.  
2) Fisher’s exact test was used to calculate a p‐v lue determining the probability that the 
association between the genes in the dataset and the canonical pathway is explained by chance 
alone. 
 
5. Network/My Pathways/ Path Designer Graphical Representation 
A network/My Pathways is a graphical representation of the molecular relationships between 
molecules. Molecules are represented as nodes, and the biological relationship between two 
nodes is represented as an edge (line). All edges are supported by at least one reference from 
the literature, from a textbook, or from canonical information stored in the Ingenuity 
Knowledge Base. Human, mouse, and rat orthologs of a gene are stored as s parate objects in 
the Ingenuity Knowledge Base, but are represented as a single node in the network. The 
intensity of the node color indicates the degree of up‐ (red) or down‐ (green) regulation. 
Nodes are displayed using various shapes that represent the functional class of the gene 
product. Edges are displayed with various labels that describe the nature of the relationship 
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APPENDIX I) Standard PCR protocol performed on DNA taken from the 
liver of WKY and SHRSP rats for sequencing. 
 
Kod Hot Start DNA polymerase (Novagen®) kits contained the following reaction mix for 
each well; 
  
Reaction Mix   Volume (µl) 
10x PCR buffer   5 
dNTPs (1mM ea.)   5 
MgSO4 (25mM)   3 
Fwd primer (5pmol/µl)  1.5 
Rvs primer (5pmol/µl)  1.5 
DNA    1.0-5.0 
Kod    1 




Polymerase activation 94°C 2 min 
Denature   94°C 15 secs 
Annealing   52°C 30 secs 
Extension   68°C 2.5 min 
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APPENDIX J) DNA sequencing reaction mix and tempera ture cycling. 
 
Applied Biosystems BigDye Terminator n3.1 Cycle Sequencing kits included the following 
reaction mix ; 
 
Reaction Mix    Volume (µl) 
5x Sequencing buffer   3.5 
Ready Reaction    0.5 
Template (purified PCR product) 8 
Primer (1pmol/µl)   3.2 




1) 96°C   45 secs 
2) 50°C   25 secs 
3) 60°C   4 min 
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APPENDIX K) Figures of immunohistochemical staining  – all antibodies 




Figure K.1 – Claudin-5 staining from WKY and SHRSP rats aged 5-21 weeks raised on standard 
rat chow.  
A&B represent 5 weeks of age. C&D represent 16 weeks of age. E&F represent 21 weeks of age. In all 
images WKY is on the left and SHRSP is on the right. Images taken at x20 objective from the deep grey 
matter of mid coronal sections. Scale bar = 10µm. We found a significant decrease in Claudin-5 staining 
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Figure K.2 – SMA staining from WKY and SHRSP rats a ged 5-21 weeks raised on standard rat 
chow.  
A&B represent 5 weeks of age. C&D represent 16 weeks of age. E&F represent 21 weeks of age. In all 
images WKY is on the left and SHRSP is on the right. Images taken at x10 objective from frontal brain 
sections and show meningeal arteries. Scale bar = 25µm. Note the increasing wall thickness with age in 













Figure K.3 – Collagen I staining from WKY and SHRSP  rats aged 5-21 weeks raised on standard 
rat chow. 
A&B represent 5 weeks of age. C&D represent 16 weeks of age. E&F represent 21 weeks of age. In all 
images WKY is on the left and SHRSP is on the right. Images taken at x10 objective from frontal brain 
sections and show meningeal arteries. Scale bar = 25µm. We found no significant difference in Collagen 














Figure K.4 – Collagen IV staining from WKY and SHRS P rats aged 5-21 weeks raised on standard 
rat chow.  
A&B represent 5 weeks of age. C&D represent 16 weeks of age. E&F represent 21 weeks of age. In all 
images WKY is on the left and SHRSP is on the right. Images taken at x10 objective in the deep grey 
matter of mid coronal sections. Scale bar = 25µm. We found no significant difference in Collagen IV 















Figure K.5 – MMP9 staining from WKY and SHRSP rats aged 5-21 weeks raised on standard rat 
chow.  
A&B represent 5 weeks of age. C&D represent 16 weeks of age. E&F represent 21 weeks of age. In all 
images WKY is on the left and SHRSP is on the right. Images taken at x10 objective from the border of 
the white matter and deep grey matter from mid coronal brain sections. Scale bar = 25µm. MMP9 
staining did not significantly differ between SHRSP and WKY, however not the increased staining 












Figure K.6 – GFAP staining from WKY and SHRSP rats aged 5-21 weeks raised on standard rat 
chow. 
A&B represent 5 weeks of age. C&D represent 16 weeks of age. E&F represent 21 weeks of age. In all 
images WKY is on the left and SHRSP is on the right. Images taken at x10 objective in the deep grey 
matter from frontal brain sections. Scale bar = 25µm. Quantitatively SHRSP showed increased GFAP 
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Figure K7 – Iba-1 staining from WKY and SHRSP rats aged 5-21 weeks raised on standard rat 
chow.   
A&B represent 5 weeks of age. C&D represent 16 weeks of age. E&F represent 21 weeks of age. In all 
images WKY is on the left and SHRSP is on the right. Images taken at x10 objective in the cortical grey 
matter of frontal brain sections. Scale bar = 25µm. Quantitatively SHRSP showed higher levels of Iba-1 















Figure K8 – MBP staining from WKY and SHRSP rats ag ed 5-21 weeks raised on standard rat 
chow.  
A&B represent 5 weeks of age. C&D represent 16 weeks of age. E&F represent 21 weeks of age. In all 
images WKY is on the left and SHRSP is on the right. Images taken at x4 objective in the cortical grey 
matter of frontal brain sections. Scale bar = 50µm. We found a significant decrease in MBP staining in 
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APPENDIX L) Immunohistochemical staining from salt- loaded versus 








Figure L.1 -.Immunoreactivity of Claudin-5 in 21 we ek old animals A) WKY B) WKY+NaCl C) 
SHRSP D) SHRSP+NaCl.  
All images taken at x20 objective in the deep grey matter of mid coronal brain sections. Scale bar = 














Figure L.2 -.Immunoreactivity of SMA in 21 week old  animals A) WKY B) WKY+NaCl C) SHRSP D) 
SHRSP+NaCl.  
All images taken at x10 objective and show meningeal arteries from frontal brain sections. Scale bar = 
25µm. We found no significant difference due to salt loading in this brain section. SHRSP had 
















Figure L.3 -.Immunoreactivity of Collagen I in 21 w eek old animals A) WKY B) WKY+NaCl C) 
SHRSP D) SHRSP+NaCl. 
All images taken at x10 objective and show meningeal arteries from frontal brain sections. Scale bar = 















Figure L.4 -.Immunoreactivity of Collagen IV in 21 week old animals A) WKY B) WKY+NaCl C) 
SHRSP D) SHRSP+NaCl.  
All images taken at x10 objective in the deep grey matter / white matter border fron mid coronal brain 
sections. Scale bar = 25µm.  We found no significant differences in Collagen IV staining due to salt 

















Figure L.5 -.Immunoreactivity of MMP9 in 21 week ol d animals A) WKY B) WKY+NaCl C) SHRSP 
D) SHRSP+NaCl.  
All images taken at x10 objective in the deep grey matter of mid coronal brain sections. Scale bar = 


















Figure L.6 -.Immunoreactivity of GFAP in 21 week ol d animals A) WKY B) WKY+NaCl C) SHRSP 
D) SHRSP+NaCl.  
All images taken at x10 objective in the deep grey matter from frontal brain sections. Scale bar = 25µm. 


















Figure L.7 -.Immunoreactivity of Iba-1 in 21 week o ld animals A) WKY B) WKY+NaCl C) SHRSP D) 
SHRSP+NaCl.  
All images taken at x10 objective in the cortical grey matter of frontal brain sections. Scale bar = 25µm. 




















Figure L.8 -.Immunoreactivity of MBP in 21 week old  animals A) WKY B) WKY+NaCl C) SHRSP D) 
SHRSP+NaCl. 
All images taken at x4 objective in the cortical grey matter of frontal brain sections. Scale bar = 50µm.  
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APPENDIX M) Data from Rank Products Analysis of mRN A expression in the frontal section of SHRSP versus  WKY of 
all ages. Data shown are genes commonly differentia lly expressed over all three age groups. N=62 (see figure 8.1 for 
corresponding Venn diagram).  
ABC FRONTAL SECTIONS     
   A B C 
PROBE_ID ILMN_GENE CHROMOSOME FDR.WKY.5wk.F-SP.5wk.F FDR.WKY.16wk.F-SP.16wk.F FDR.WKY.21wk.F-SP.21wk.F 
ILMN_1365113 RGD1564649_PREDICTED  0 0 0 
ILMN_2038795 RPS9 1 0 0 0 
ILMN_1371357 LOC497757  0 0 0 
ILMN_2038796 RPS9 1 0 0 0 
ILMN_1359040 RGD1561110_PREDICTED 2 0 0 0 
ILMN_1368735 RGD1311103_PREDICTED  0 0 0 
ILMN_1361865 ZFP597 10 0 0 0 
ILMN_1372230 RNF149 9 4.13E-05 0.000710227 0 
ILMN_1351340 LOC500950  7.27E-05 0 0.004449036 
ILMN_1371004 RPS16  0.000117302 0 0 
ILMN_1367530 LOC497727  0.000160428 0.001326781 0.013008264 
ILMN_1372711 LOC502316  0.000160428 0.000118577 0.003023715 
ILMN_1366713 ZNF575_PREDICTED  0.000227273 0.008311688 0.00799609 
ILMN_1353766 RGD1566136_PREDICTED X 0.000317125 0 0 
ILMN_1360786 FKBP8 16 0.000317125 0.000242424 0 
ILMN_1363342 SLC1A3 2 0.000618182 0.001748252 0.000633609 
ILMN_1364120 POLL 1 0.000714286 0.000962567 0.000501567 
ILMN_1349793 LOC684139  0.000651801 0.007204117 0.000828877 
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ILMN_1376530 RT1-A3 20 0.000861244 0.00026393 0.00012987 
ILMN_1369562 LOC499096  0.00119697 0.01525974 0.005090909 
ILMN_1368305 LOC499613  0.001124807 0.001194805 0.001181818 
ILMN_1373217 ADPGK  0.001633729 0 0.00020979 
ILMN_1650689 CPE 16 0.006217839 0.039892473 0.001048951 
ILMN_1357461 ZFP61 1 0.003237998 0.002136364 0.003570248 
ILMN_1368780 CLIC2 20 0.004415584 0.000798898 0.000933661 
ILMN_1372466 ZCCHC9 2 0.008783107 0.004161616 0.007932068 
ILMN_1353304 RGD1561287_PREDICTED  0.009307057 0.001262626 0.003827751 
ILMN_1364975 LOC298980  0.00540054 0.008730408 0.002156448 
ILMN_1362409 BAI2_PREDICTED 5 0.008701299 0.008730408 0.006522727 
ILMN_1362692 MAP1B 2 0.015577014 0.016491677 0.004967062 
ILMN_1370371 TM4SF2_MAPPED X 0.01756993 0.033048128 0.000857143 
ILMN_1357368 LOC497841  0.03056229 0.036713287 0.003493761 
ILMN_1356949 COL6A1_PREDICTED 20 0.01375383 0.000242424 0.00012987 
ILMN_1359375 LOC499418 20 0.012542188 0.042884972 0.007390374 
ILMN_1364683 NECAB2  0.017802335 0.007946128 0.007463002 
ILMN_1349772 FTCD 20 0.039682259 0.007058824 0.004060606 
ILMN_1360243 LOC362350  0.021338056 0.043158861 0.017813674 
ILMN_1371662 PPP2R1A 1 0.048310249 0.009379509 0.001028708 
ILMN_1369541 TCF4 18 0.011252914 0.000174825 0.003827751 
ILMN_1357413 LOC360443  0.007355372 0.001411483 0.00023569 
ILMN_1361722 RBM8_PREDICTED  0.011111111 0.009225037 0.017185771 
ILMN_1372988 FHL2 9 0.002472284 0.022260766 0.024813249 
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ILMN_1357163 SYMPK  0.001251863 0.004624506 0.032288401 
ILMN_1349624 KIF5C_PREDICTED  0.002223587 0.009013867 0.005176768 
ILMN_1358541 IGFBP6 7 0.000117302 0.002505543 0.032739475 
ILMN_1363262 CSNK2A1  0.000395257 0.007058824 0.003487941 
ILMN_1358234 RGD1562351_PREDICTED  0.000142045 0.000227273 0.001884701 
ILMN_1364214 LOC497864  0.000117302 0.007204117 0.047861517 
ILMN_1351068 RGD1309829_PREDICTED  7.27E-05 0.000151515 0.003570248 
ILMN_1368752 LOC499378  7.27E-05 0.000174825 0.005172855 
ILMN_1351487 RT1-A1 20 0 0.00582205 0.000292208 
ILMN_1353260 PXMP4 3 0 0 0.000145455 
ILMN_1353156 COLQ  0 0.002835498 0.040998943 
ILMN_1651096 RGD1560364_PREDICTED  0 8.26E-05 0.000545455 
ILMN_2038792 ALB 14 0 4.33E-05 4.78E-05 
ILMN_1650062 RGD1563903_PREDICTED  0 4.33E-05 0.000145455 
ILMN_1370031 LOC362068  0 4.33E-05 0.000145455 
ILMN_1371684 LOC499103  0 0 4.78E-05 
ILMN_1358480 LOC365566  0 0 0 
ILMN_1376663 LOC287167 10 0 4.33E-05 0 
ILMN_1349205 RGD1562905_PREDICTED 1 0 0 0 
ILMN_1359180 MRPL18_PREDICTED 1 0 0 0 
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APPENDIX M CONTINUED  
ii) Data from Rank Products Analysis of mRNA expression in the mid coronal section of SHRSP versus WKY of all ages. Data shown 
are genes commonly differentially expressed over all three age groups. N=55 (see figure 8.1 for the corresponding Venn diagram).  
 
ABC MID CORONAL SECTIONS     
   A B C 
PROBE_ID ILMN_GENE CHROMOSOME FDR.WKY.5wk.M-SP.5wk.M FDR.WKY.16wk.M-SP.16wk.M FDR.WKY.21wk.M-SP.21wk.M 
ILMN_1365113 RGD1564649_PREDICTED  0 0 0 
ILMN_2038796 RPS9 1 0 0 0 
ILMN_2038795 RPS9 1 0 0 0 
ILMN_1371357 LOC497757  0 0 0 
ILMN_1359040 RGD1561110_PREDICTED 2 0 0 0 
ILMN_1368735 RGD1311103_PREDICTED  0 0 0 
ILMN_1361865 ZFP597 10 0 0 0 
ILMN_1372230 RNF149 9 0 0.000227273 4.13E-05 
ILMN_1371004 RPS16  0 0 0 
ILMN_1376530 RT1-A3 20 0 0.00037037 0 
ILMN_1353766 RGD1566136_PREDICTED X 8.26E-05 0.000165289 7.27E-05 
ILMN_1367530 LOC497727  0.000146628 0.00037037 0.018295455 
ILMN_1368305 LOC499613  0.000277778 0.000666667 0.001267943 
ILMN_1351340 LOC500950  0.000187166 0.00037037 0.000668449 
ILMN_1360786 FKBP8 16 0.000125392 0.000823864 0.004242424 
ILMN_1372711 LOC502316  0.000146628 0.000438871 0.00025974 
ILMN_1373217 ADPGK  0.000847107 0.00038961 0 
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ILMN_1368780 CLIC2 20 0.000847107 0.00248337 0.002509881 
ILMN_1357461 ZFP61 1 0.002540107 0.003555556 0.003075435 
ILMN_1349793 LOC684139  0.002306649 0.001767677 0.001450216 
ILMN_1363342 SLC1A3 2 0.001018182 0.011109399 0.00031348 
ILMN_1353304 RGD1561287_PREDICTED  0.004159402 0.005581818 0.010681818 
ILMN_1369562 LOC499096  0.007554545 0.010606061 0.00465035 
ILMN_1356949 COL6A1_PREDICTED 20 0.006753247 0.001480519 0.000469208 
ILMN_1359375 LOC499418 20 0.013913949 0.047282717 0.020363636 
ILMN_1371662 PPP2R1A 1 0.024218835 0.012227273 0.019676214 
ILMN_1357368 LOC497841  0.030909091 0.02981588 0.001606765 
ILMN_1650271 LOC498813  0.046209617 0.025381818 0.028419913 
ILMN_1649874 RGD1559605_PREDICTED  0.04476785 0.002400932 0.026121979 
ILMN_1372988 FHL2 9 0.007204301 0.022369146 0.031024033 
ILMN_1359627 LOC360919 14 0.01020475 0.027655502 0.031678322 
ILMN_1349336 ADD3 1 0.005140693 0.008330579 0.011160839 
ILMN_1357413 LOC360443  0.004427391 0.002344498 4.13E-05 
ILMN_1649821 HAGHL  0.001603306 0.003810445 0.017844156 
ILMN_1349624 KIF5C_PREDICTED  0.002306649 0.003095238 0.033049242 
ILMN_1357163 SYMPK  0.000868687 0.031829545 0.002121212 
ILMN_1350743 PRMT5_PREDICTED 15 0.002164502 0.001294766 0.016933514 
ILMN_1369541 TCF4 18 0.000871212 0.000823864 0.004821429 
ILMN_1364214 LOC497864  0.000170455 0.018636364 0.040458874 
ILMN_1358234 RGD1562351_PREDICTED  0.000233766 4.33E-05 0.000884521 
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ILMN_2038792 ALB 14 0.000871212 0 0 
ILMN_1353156 COLQ  9.74E-05 0.003553719 0.008166915 
ILMN_1368752 LOC499378  9.74E-05 4.33E-05 0.000393939 
ILMN_1351068 RGD1309829_PREDICTED  9.74E-05 0.000197628 7.27E-05 
ILMN_1651096 RGD1560364_PREDICTED  9.74E-05 4.33E-05 0.00020202 
ILMN_1363262 CSNK2A1  0.000187166 0 0.001328671 
ILMN_1351487 RT1-A1 20 9.74E-05 0.00248337 0.000805195 
ILMN_1353260 PXMP4 3 4.33E-05 4.33E-05 0.000174825 
ILMN_1370031 LOC362068  0 0 0 
ILMN_1650062 RGD1563903_PREDICTED  0 0 7.27E-05 
ILMN_1371684 LOC499103  0 0 0 
ILMN_1358480 LOC365566  0 0 0 
ILMN_1376663 LOC287167 10 0 4.33E-05 0 
ILMN_1349205 RGD1562905_PREDICTED 1 0 0 0 
ILMN_1359180 MRPL18_PREDICTED 1 0 0 0 
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APPENDIX N) Data from Rank Products Analysis of sig nificant differences in mRNA expression between WKY  and 



















AB     
   A B 
PROBE_ID ILMN_GENE CHROMOSOME FDR.WKY.5wk.F-SP.5wk.F FDR.WKY.5wk.M-SP.5wk.M 
ILMN_1365113 RGD1564649_PREDICTED  0 0 
ILMN_2038795 RPS9 1 0 0 
ILMN_1371357 LOC497757  0 0 
ILMN_2038796 RPS9 1 0 0 
ILMN_1359040 RGD1561110_PREDICTED 2 0 0 
ILMN_1368735 RGD1311103_PREDICTED  0 0 
ILMN_2039673 ARC 7 0 0 
ILMN_1361865 ZFP597 10 0 0 
ILMN_1372230 RNF149 9 4.13E-05 0 
ILMN_1350784 JUNB 19 0.00010101 0.00030303 
ILMN_1351340 LOC500950  7.27E-05 0.000187166 
ILMN_1368356 FOS 6 0.000117302 0.00030303 
ILMN_1367486 DUSP1 10 0.00010101 0 
ILMN_1371004 RPS16  0.000117302 0 
ILMN_1367530 LOC497727  0.000160428 0.000146628 
ILMN_1372711 LOC502316  0.000160428 0.000146628 
ILMN_1367467 PER2 9 0.000383838 0.000465632 
 




















ILMN_1367162 GPM6A 16 0.000317125 0.000386364 
ILMN_1352667 NAB1  0.000317125 0.000890538 
ILMN_1366713 ZNF575_PREDICTED  0.000227273 0.001603306 
ILMN_1353766 RGD1566136_PREDICTED X 0.000317125 8.26E-05 
ILMN_1353839 PER1  0.000317125 0.00030303 
ILMN_1360786 FKBP8 16 0.000317125 0.000125392 
ILMN_1363342 SLC1A3 2 0.000618182 0.001018182 
ILMN_1359704 LOC307332  0.000371901 0.00161442 
ILMN_1364120 POLL 1 0.000714286 0.000847107 
ILMN_1362834 DUSP6 7 0.001124807 0.01020475 
ILMN_1369573 LOC688712 19 0.001792208 0.006753247 
ILMN_1375922 NR4A3 5 0.000482375 0.007217069 
ILMN_1349793 LOC684139  0.000651801 0.002306649 
ILMN_1358205 RGD1560975_PREDICTED  0.008009404 0.028941878 
ILMN_1360210 LOC499068  0.001805378 0.01180303 
ILMN_1376530 RT1-A3 20 0.000861244 0 
ILMN_1369562 LOC499096  0.00119697 0.007554545 
ILMN_1368305 LOC499613  0.001124807 0.000277778 
ILMN_1373217 ADPGK  0.001633729 0.000847107 
ILMN_1355124 GALNT2_PREDICTED  0.000714286 0.008354978 
ILMN_1368809 BTG2 13 0.01057352 0.013769231 
ILMN_1364113 CTGF 1 0.002249417 0.004427391 
 





















ILMN_1367428 ZFP189_PREDICTED  0.004554637 0.013664773 
ILMN_1370045 TRAPPC2 X 0.002683983 0.008354978 
ILMN_1364821 LOC500720  0.009307057 0.028941878 
ILMN_1350533 RGD1563551_PREDICTED 4 0.017192118 0.00161442 
ILMN_1367827 LOC298998  0.003996212 0.005117845 
ILMN_1352722 LOC316550  0.003839458 0.025268474 
ILMN_1349422 PTGS2 13 0.004818182 0.016441558 
ILMN_1359441 PLA2G2A 5 0.009950187 0.024345238 
ILMN_1357461 ZFP61 1 0.003237998 0.002540107 
ILMN_1368780 CLIC2 20 0.004415584 0.000847107 
ILMN_1359630 LOC679663 16|NW_047479.1 0.008343109 0.045305577 
ILMN_1372466 ZCCHC9 2 0.008783107 0.001607143 
ILMN_1353304 RGD1561287_PREDICTED  0.009307057 0.004159402 
ILMN_1374612 TM9SF4_PREDICTED  0.01004329 0.023941242 
ILMN_1368506 LOC497770  0.012253444 0.021175449 
ILMN_1362561 LOC498378  0.023521336 0.029085968 
ILMN_1359795 LOC499555  0.009918495 0.024214876 
ILMN_1356628 NFKBIA 6 0.01039312 0.046209617 
ILMN_1374199 GIOT1 7 0.006464646 0.013769231 
ILMN_1353935 FARP1_PREDICTED  0.009307057 0.027335423 
ILMN_1362409 BAI2_PREDICTED 5 0.008701299 0.002714097 
ILMN_1370369 EGR2 20 0.009307057 0.003713188 
ILMN_1372919 CYR61 2 0.003996212 0.006986166 
 




















ILMN_1355401 RGD1563543_PREDICTED  0.021554002 0.0188 
ILMN_1362451 RGS2 13 0.007420147 0.0072147 
ILMN_1365095 DHX40 10 0.011252914 0.030909091 
ILMN_1376434 PGRMC1 X 0.008343109 0.033276328 
ILMN_1349269 SGK 1 0.011998871 0.002164502 
ILMN_1361423 RKHD2_PREDICTED  0.011998871 0.036649595 
ILMN_1649981 STRN3 6 0.01487781 0.042800325 
ILMN_1361139 TMPRSS8 10 0.015932282 0.033140909 
ILMN_1357368 LOC497841  0.03056229 0.030909091 
ILMN_1356949 COL6A1_PREDICTED 20 0.01375383 0.006753247 
ILMN_1368116 LOC367398  0.017802335 0.015773059 
ILMN_1359375 LOC499418 20 0.012542188 0.013913949 
ILMN_1352529 IER2 19 0.01724612 0.043680416 
ILMN_1354120 LOC691762 Un|NW_047990.1 0.012963959 0.027361039 
ILMN_1373383 TIPARP_PREDICTED  0.009131615 0.004731935 
ILMN_1364683 NECAB2  0.017802335 0.002306649 
ILMN_1360868 RNF40 1 0.021361686 0.015614973 
ILMN_1373434 RAB28 14 0.01620753 0.043683386 
ILMN_1354535 ZNF386 6 0.014258893 0.029966683 
ILMN_1374435 C1GALT1C1 X 0.024523282 0.030423928 
ILMN_1362029 LOC502490  0.04383255 0.022875929 
ILMN_1351127 PLCL1 9 0.019282511 0.020445748 
 





















ILMN_1361932 MLL5 4 0.037223421 0.029966683 
ILMN_1369005 EGR1 18 0.035286665 0.010340909 
ILMN_1360758 RGD1308626 15 0.044931617 0.043680416 
ILMN_1359043 EGR4 4 0.030741362 0.027467899 
ILMN_1368493 RGD1562629_PREDICTED  0.038248485 0.034655248 
ILMN_1349772 FTCD 20 0.039682259 0.009592184 
ILMN_1361370 RYBP_PREDICTED 4 0.017995019 0.023480201 
ILMN_1373798 PLCB1 3 0.024981672 0.020053129 
ILMN_1372236 ZFP36L1 6 0.038386514 0.040504587 
ILMN_1349546 MDGA2 6 0.047363636 0.017687075 
ILMN_1353576 GPR149 2 0.04383255 0.024593868 
ILMN_1354065 LOC686053 Un|NW_047874.1 0.042841958 0.014360902 
ILMN_1357903 RGD1564171_PREDICTED 2 0.028060375 0.033276328 
ILMN_1361346 RGD1564940_PREDICTED 5 0.031886608 0.033533363 
ILMN_1370101 LOC499058  0.046880878 0.022875929 
ILMN_1352135 CEACAM10 1 0.045470541 0.003838384 
ILMN_1371662 PPP2R1A 1 0.048310249 0.024218835 
ILMN_1363414 LOC365025  0.043867069 0.005140693 
ILMN_1370033 LOC498604  0.037413057 0.04984 
ILMN_1359027 RGD1563482_PREDICTED 12 0.047780599 0.019192584 
ILMN_1350094 SDPR 9 0.019282511 0.011280632 
ILMN_2039346 HLA-DMA 20 0.017802335 0.00802139 
ILMN_1349530 CRSP6  0.02584 0.007749775 
ILMN_1369447 RGD1565673_PREDICTED 3 0.015577014 0.043683386 
 





















ILMN_1355984 TPX2_PREDICTED  0.036723549 0.016383399 
ILMN_1350525 XPNPEP1 1 0.011273885 0.036497199 
ILMN_1360785 LOC361929 2 0.01569697 0.004775604 
ILMN_1651182 ANKRD15 1 0.013436679 0.029966683 
ILMN_1360040 NUDT14_PREDICTED  0.007355372 0.01180303 
ILMN_1354941 COL3A1 9 0.008265852 0.007226814 
ILMN_1374043 ERAF_PREDICTED  0.011252914 0.012742299 
ILMN_1351156 GNAI1 4 0.038758971 0.006236786 
ILMN_1352524 USMG5 1 0.012053872 0.004427391 
ILMN_1374825 LOC294789  0.00608658 0.029223587 
ILMN_1369541 TCF4 18 0.011252914 0.000871212 
ILMN_1357413 LOC360443  0.007355372 0.004427391 
ILMN_1650955 IFI27L  0.028212577 0.01020475 
ILMN_1375028 HTATIP2_PREDICTED  0.023521336 0.036142857 
ILMN_1348843 SLC17A6 1 0.009307057 0.016441558 
ILMN_1361722 RBM8_PREDICTED  0.011111111 0.001194296 
ILMN_1359627 LOC360919 14 0.002249417 0.01020475 
ILMN_1358978 RGD1306126 10 0.002584885 0.007217069 
ILMN_1350985 INPP5D 9 0.002191781 0.004427391 
ILMN_1367329 PPP1R16A_PREDICTED 7 0.002684492 0.00848199 
ILMN_1361915 PDE10A 1 0.001931818 0.008296558 
ILMN_1365885 MMP14 15 0.002472284 0.043683386 
ILMN_1371064 RPS18 20 0.002236842 0.01076555 
 






















ILMN_1372988 FHL2 9 0.002472284 0.007204301 
ILMN_1651148 POLR2I_PREDICTED 1 0.0015427 0.001276224 
ILMN_1350743 PRMT5_PREDICTED 15 0.001505682 0.002164502 
ILMN_1350481 LOC499790  0.000482375 0.014687924 
ILMN_1352269 RT1-149  0.0015427 0.016747759 
ILMN_1362726 HMGN3 8 0.001564171 0.011285266 
ILMN_1357163 SYMPK  0.001251863 0.000868687 
ILMN_1357432 CYP11B1 7 0.000641711 0.003168831 
ILMN_1359619 LYZL4_PREDICTED 8 0.001564171 0.049642205 
ILMN_1360418 RGD1302996 20 0.000714286 0.001320755 
ILMN_1649821 HAGHL  0.00040619 0.001603306 
ILMN_1349624 KIF5C_PREDICTED  0.002223587 0.002306649 
ILMN_1358541 IGFBP6 7 0.000117302 0.002201705 
ILMN_1363262 CSNK2A1  0.000395257 0.000187166 
ILMN_1359301 IGF2  0.000181818 0.011375291 
ILMN_1358234 RGD1562351_PREDICTED  0.000142045 0.000233766 
ILMN_1364214 LOC497864  0.000117302 0.000170455 
ILMN_1351068 RGD1309829_PREDICTED  7.27E-05 9.74E-05 
ILMN_1368752 LOC499378  7.27E-05 9.74E-05 
ILMN_1351487 RT1-A1 20 0 9.74E-05 
ILMN_1353260 PXMP4 3 0 4.33E-05 
ILMN_1353156 COLQ  0 9.74E-05 
ILMN_1651096 RGD1560364_PREDICTED  0 9.74E-05 
 
Doctor of Philosophy University of Edinburgh 318 
ILMN_2038792 ALB 14 0 0.000871212 
ILMN_1650062 RGD1563903_PREDICTED  0 0 
ILMN_1370031 LOC362068  0 0 
ILMN_1371684 LOC499103  0 0 
ILMN_1358480 LOC365566  0 0 
ILMN_1376663 LOC287167 10 0 0 
ILMN_1349205 RGD1562905_PREDICTED 1 0 0 
ILMN_1359180 MRPL18_PREDICTED 1 0 0 
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APPENDIX O) Data from Rank Products Analysis of mRN A expression between WKY+NaCl and WKY in the fronta l 
brain section alone. N=31.  For the corresponding V enn diagram see figure 8.7.  
 
B.only    
   B 
PROBE_ID ILMN_GENE CHROMOSOME FDR.WKY.21wkS.F-WKY.21wk.F 
ILMN_1351310 NCKAP1 3 0.018383838 
ILMN_1365134 DBC1 5 0.018383838 
ILMN_1363732 VARS2  0.022932551 
ILMN_1367140 ACVR1C 3 0.045470219 
ILMN_1367508 EEF1A2 3 0.039690522 
ILMN_1349150 RGD1565099_PREDICTED 1 0.048243451 
ILMN_1365487 LOC501282  0.041616162 
ILMN_1348958 RAB14 3 0.044074675 
ILMN_1350522 NFIX  0.032464115 
ILMN_1352293 BMPR2 9 0.022932551 
ILMN_1363601 RGD1560020_PREDICTED  0.039690522 
ILMN_1374435 C1GALT1C1 X 0.039943182 
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ILMN_1363881 LOC498449  0.016098485 
ILMN_1352524 USMG5 1 0.040055659 
ILMN_1356910 RGD1560729_PREDICTED  0.039556025 
ILMN_1350873 NTS_PREDICTED 7 0.041423671 
ILMN_1359630 LOC679663 16|NW_047479.1 0.019278997 
ILMN_1358592 CYP2E1 1 0.044194577 
ILMN_1352722 LOC316550  0.009760766 
ILMN_2038793 ALB 14 0.01 
ILMN_1350338 GC 14 0.022954545 
ILMN_1352471 AHSG 11 0.028353808 
ILMN_1353635 ALDOB 5 0.018072727 
ILMN_1351672 APOH 10 0.019155844 
ILMN_1369573 LOC688712 19 0.003116883 
ILMN_1374571 LOC297568 4 0.00973262 
ILMN_1370481 AMBP 5 0.011185771 
ILMN_1371501 SERPINA3K 6 0.001636364 
ILMN_1361155 LOC682605  0 
ILMN_1355639 MUP5 5 0 
ILMN_1370140 MUP4 5 0 
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APPENDIX O) CONTINUED II) DATA FROM RANK PRODUCTS A NALYSIS OF MRNA EXPRESSION BETWEEN 
SHRSP+NACL AND SHRSP IN THE FRONTAL BRAIN SECTION A LONE. N=83.  FOR THE CORRESPONDING VENN 
DIAGRAM SEE FIGURE 8.7.  
 
A.only    
   A 
PROBE_ID ILMN_GENE CHROMOSOME FDR.SP.21wkS.F-SP.21wk.F 
ILMN_1650700 LOC360941  0.00012987 
ILMN_1366732 RGD1306494_PREDICTED 4 0.000227273 
ILMN_1355142 LOC500959  0.011558442 
ILMN_1360197 RGD1565117_PREDICTED  0.009683794 
ILMN_1353667 LOC681549  0.020646853 
ILMN_1359238 ROCK2 6 0.021338843 
ILMN_1368898 RGD1561587_PREDICTED  0.023318903 
ILMN_1358078 HBXIP_PREDICTED 2 0.02952862 
ILMN_1352300 LOC363306  0.036497326 
ILMN_1351707 RGD1560706_PREDICTED  0.032959381 
ILMN_1358943 MYEF2  0.035502392 
ILMN_2040245 MAP1B 2 0.041172472 
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ILMN_1360715 LOC360303  0.015159705 
ILMN_1363538 NAV3_PREDICTED  0.042966942 
ILMN_1371109 RGD1561135_PREDICTED  0.011558442 
ILMN_1369996 SDK2_PREDICTED  0.049123377 
ILMN_1365861 LOC687298  0.032959381 
ILMN_1358768 LOC503192  0.041793161 
ILMN_1348850 HNRPA2B1_PREDICTED 4 0.040969125 
ILMN_1359382 AMPH 17 0.040969125 
ILMN_1358980 ATP6V0E2 4 0.041557239 
ILMN_1350087 NS5ATP4 3 0.035754452 
ILMN_1354352 LOC314472  0.036497326 
ILMN_1354875 LOC497991  0.039276258 
ILMN_1351551 MLC1_PREDICTED 7 0.032959381 
ILMN_1650386 GNB5 8 0.025376623 
ILMN_1358379 LOC315496  0.023337856 
ILMN_1366333 CACNG3 1 0.048034398 
ILMN_1373428 LONRF2_PREDICTED  0.032959381 
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ILMN_1348848 TMEFF1  0.029102564 
ILMN_1356275 RGD1561850_PREDICTED Un|NW_047851.1 0.036054545 
ILMN_1370876 ANK2  0.02952862 
ILMN_1358657 RIMS1 9 0.023337856 
ILMN_1356423 SYTL2_PREDICTED  0.032959381 
ILMN_1649757 PPP2R5B 1 0.029355581 
ILMN_1373124 MFRP_PREDICTED  0.022399404 
ILMN_1373296 SCGB1C1_PREDICTED 1 0.023049853 
ILMN_1368395 DDX23_PREDICTED 7 0.025376623 
ILMN_1363928 PTBP2 2 0.026737235 
ILMN_1353696 HBB 1 0.028696172 
ILMN_1368109 DDX21A_PREDICTED  0.03286631 
ILMN_1349428 RGD1565052_PREDICTED 2 0.023337856 
ILMN_1374082 SLC25A11 10 0.029879518 
ILMN_1368188 LOC690262 7 0.016807611 
ILMN_1358663 ENPP5 9 0.022399404 
ILMN_1371000 DNAJB4  0.025200535 
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ILMN_1357622 CAPNS1 1 0.017414141 
ILMN_1650851 GOLPH3 2 0.040017483 
ILMN_1352570 VAMP7 12 0.018330241 
ILMN_1358347 PLS3  0.02084048 
ILMN_1350658 SACS_PREDICTED  0.036054545 
ILMN_1370967 SNAP91 8 0.015159705 
ILMN_1367994 GLRB 2 0.022399404 
ILMN_1365940 SPTBN1 14 0.016807611 
ILMN_1369132 PRAF2_PREDICTED X 0.02057041 
ILMN_1351568 KBTBD2_PREDICTED 4 0.026737235 
ILMN_1371457 KCNIP4  0.029879518 
ILMN_1373796 RGD1561932_PREDICTED 10 0.013210227 
ILMN_1350714 OXR1 7 0.022399404 
ILMN_1350875 LOC365214  0.015159705 
ILMN_1351182 APLP2  0.018330241 
ILMN_1366848 GPSN2 19 0.016807611 
ILMN_1650120 CLDN11 2 0.012507837 
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ILMN_1362283 YY1 6 0.015159705 
ILMN_1358924 LOC501116  0.029102564 
ILMN_1363443 RGD1564087_PREDICTED  0.01576555 
ILMN_1355098 RGD1562658_PREDICTED  0.016807611 
ILMN_1370118 RPL7  0.015159705 
ILMN_1357805 RGD1563441_PREDICTED 10 0.0104 
ILMN_1651181 CAP1 5 0.007561983 
ILMN_1354897 JAK1  0.012844575 
ILMN_1365855 ATP6V1A1_PREDICTED  0.018330241 
ILMN_1362105 DSTN_PREDICTED 20 0.012545455 
ILMN_1352103 RGD1312005_PREDICTED  0.003787879 
ILMN_1373102 LOC316573 9 0.005545455 
ILMN_1352752 CTNNB1 8 0.004545455 
ILMN_1355138 CLN6_PREDICTED  0.001871658 
ILMN_1349652 OPCML 8 0.001871658 
ILMN_1363490 NPM1 10 0.017414141 
ILMN_1360728 OXT 3 0.018563636 
ILMN_1650420 VSNL1 6 0.000974026 
ILMN_1371753 F5_MAPPED 13 0.000363636 
ILMN_1365900 OTX2 15 0.00012987 
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        APPENDIX P) HEATMAP - 5 WEEKS OF AGE  
Heatmap showing 37 genes of interest (a subset of 1 49 genes) which were differentially expressed betwe en 5 
week old SHRSP versus 5 week old WKY in the frontal  brain section. (See 5 week IPA network figure for 






































































Data represents the median intensities for each group (horizontal axis) (n=4 per group), scaled per gene (vertical axis) by 
the mean and standard deviation. Green is low intensity and red is high intensity; Black is intermediate. The black lines 
on the left side are a dendrogram illustrating how the genes shown cluster. 
 
Doctor of Philosophy University of Edinburgh 327 
APPENDIX Q) SALT COMPARISON HEAT MAPS 
P1. Heatmap showing 31 genes differentially express ed between WKY+NaCl versus WKY aged 21 weeks in the  
































































Data represents the median intensities for each group (horizontal axis) (n=4 per group), scaled per gene (vertical axis) by 
the mean and standard deviation. Green is low intensity and red is high intensity; Black is intermediate. The black lines 
on the left side are a dendrogram illustrating how the genes shown cluster. 
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P2. Heatmap showing 29 genes of interest (a subset of 8 3 genes) differentially expressed between SHRSP+NaC l 































































Data represents the median intensities for each group (horizontal axis) (n=4 per group), scaled per gene (vertical axis) by 
the mean and standard deviation. Green is low intensity and red is high intensity; Black is intermediate. The black lines 







Doctor of Philosophy University of Edinburgh 329 
P3. Heatmap showing 7 genes differentially expressed be tween SHRSP+NaCl versus SHRSP and WKY+NaCl 











































Data represents the median intensities for each group (horizontal axis) (n=4 per group), scaled per gene (vertical axis) by 
the mean and standard deviation. Green is low intensity and red is high intensity; Black is intermediate. The black lines 
on the left side are a dendrogram illustrating how the genes shown cluster. 
Note: although significant for both comparisons, the direction of the differenetial expression changes (i.e.all genes are 
down-regulated in WKY+NaCl and up-regulated in SHRSP+NaCl).
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APPENDIX R) Image of PCR gels showing no difference  in signal intensity between WKY and SHRSP correspo nding to 




Samples left to right in each block of 4 are WKY, WKY, SHRSP and SHRSP. Each block of four corresponds to a different pairing of forward and reverse primers. The gel 
shows no difference in the size of the gene products formed, indicating the sequence is the same length in both WKY and SHRSP and no insertions or deletions exist in the 
SHRSP. 
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